{
    "id": 83706,
    "title": "Danske lægemiddelstandarder 1997 ",
    "documentTypeId": "60",
    "isSagsforlobPeriodValid": false,
    "shortName": "BEK nr 15035 af 25/11/1996",
    "documentHtml": "<div class=\"bjelke\">Den fulde tekst</div><DIV CLASS=PARA ID=\"INDHOLD\"> \r\n\r\n\r\n\r\n<H1 CLASS=TITLE ALIGN=CENTER>Danske lægemiddelstandarder 1997 </H1>  \r\n\r\n<P></P>  \r\n\r\n<P>Efter indstilling fra Farmakopenævnet fastsætter styrelsen herved, at  \r\n\r\n nærværende udgave af Danske Lægemiddelstandarder (DLS) kraft den 1. januar  \r\n\r\n 1997 jfr. Lægemiddellovens §§ 4 og 8. </P>  \r\n\r\n<P>Meddelelse om ikrafttræden indføres i Statstidende, jfr. Kongelig  \r\n\r\n anordning nr. 742 af 13. november 1987. </P>  \r\n\r\n<P>Fra samme dato ophæves de af Sundhedsstyrelsen i Danske  \r\n\r\n Lægemiddelstandarder 1996 bekendtgjorte bestemmelser. </P>  \r\n\r\n<PRE>  \r\n\r\n  Sundhedsstyrelsen, den 25. november 1996  \r\n\r\n Mogens Bjørnbak-Hansen                      Per Frandsen  \r\n\r\n</PRE>  \r\n\r\n<P> <B>INDHOLDSFORTEGNELSE</B>  Forord </P>  \r\n\r\n<P> <B>Sektion 1</B>  </P>  \r\n\r\n<P>Ændringer </P>  \r\n\r\n<P>Nyoptaget </P>  \r\n\r\n<P>Udgået </P>  \r\n\r\n<P>Ændret standard </P>  \r\n\r\n<P>Forkortelser, symboler og definitioner </P>  \r\n\r\n<P>Fortegnelse over love, bekendtgørelser m.m. </P>  \r\n\r\n<P>Almene bestemmelser </P>  \r\n\r\n<P>Den Europæiske Farmakope </P>  \r\n\r\n<P>Almene bestemmelser for DLS-standarder </P>  \r\n\r\n<P>Referencesubstanser </P>  \r\n\r\n<P>Opbevaringsbestemmelser for råvarer og lægemidler </P>  \r\n\r\n<P>Analysemetoder </P>  \r\n\r\n<P>Test for Alpha-1,6-Glucans </P>  \r\n\r\n<P>Krav til lægemidlers mikrobielle renhed </P>  \r\n\r\n<P> <B>Sektion 2</B>  </P>  \r\n\r\n<P>Introduktion til fortegnelse over standarder for råvarer </P>  \r\n\r\n<P>Fortegnelse over standarder for råvarer </P>  \r\n\r\n<P>Standarder for råvarer </P>  \r\n\r\n<P> <B>Sektion 3</B>  </P>  \r\n\r\n<P>Fremstilling af lægemidler </P>  \r\n\r\n<P>Produktion </P>  \r\n\r\n<P>Kontrol </P>  \r\n\r\n<P>Lagerhold </P>  \r\n\r\n<P>Fremstilling af magistrelle lægemidler </P>  \r\n\r\n<P>Produktion </P>  \r\n\r\n<P>Kontrol </P>  \r\n\r\n<P>Lagerhold </P>  \r\n\r\n<P>Introduktion til fortegnelse over standarder for lægemiddelformer samt  \r\n\r\n termer, der kan benyttes til mærkning </P>  \r\n\r\n<P>Fortegnelse over standarder for lægemiddelformer samt termer der kan  \r\n\r\n benyttes til mærkning </P>  \r\n\r\n<P>Standarder for lægemiddelformer samt termer der kan benyttes til mærkning  \r\n\r\n</P>  \r\n\r\n<P>Introduktion til fortegnelse over standardtermer for administrationsveje  \r\n\r\n samt standardtermer for beholdere, lukker m.v. </P>  \r\n\r\n<P>Fortegnelse over standardtermer for administrationsveje </P>  \r\n\r\n<P>Fortegnelse over standardtermer for beholdere, lukker m.v. </P>  \r\n\r\n<P>Introduktion til fortegnelse over standarder for lægemidler </P>  \r\n\r\n<P>Fortegnelse over standarder for lægemidler </P>  \r\n\r\n<P>Standarder for lægemidler </P>  \r\n\r\n<P>Stikordsregister </P>  \r\n\r\n<P> <B>FORORD</B>  </P>  \r\n\r\n<P>Med Danske lægemiddelstandarder 1997 (DLS 97) indføres der 4 ændringer,  \r\n\r\n der har fået væsentlige konsekvenser for bogens indhold, i forhold til de  \r\n\r\n tidligere udgaver af Danske Lægemiddelstandarder. Den første er  \r\n\r\n implementeringen af den Europæiske Farmakopes 3. udgave (Ph. Eur. 3rd Ed.),  \r\n\r\n der sættes i kraft 1. januar 1997. Hermed tages der afsked med den Europæiske  \r\n\r\n Farmakopes 2. udgave (Ph. Eur. 2nd Ed.), hvor der i alt nåede at udkomme 19  \r\n\r\n hæfter (fasciculer). Da der ved indførelsen af Ph. Eur. 3rd Ed. er sket en  \r\n\r\n række ændringer, må disse naturligvis få konsekvenser for DLS 97. I de  \r\n\r\n publicerede monografier i Ph. Eur. 3rd Ed., er titlen på de enkelte  \r\n\r\n monografier skiftet til engelsk. Dette betyder, at referencerne til  \r\n\r\n monografier i DLS 97 også er ændret til engelsk. Hermed er betegnelser på  \r\n\r\n latin, der har været farmaciens sprog i århundreder, med få undtagelser  \r\n\r\n forsvundet fra DLS. En anden væsentlig ændring er, at den Europæiske  \r\n\r\n Farmakopekommision har vedtaget de såkaldte <B>Standard Terms</B> , som er en  \r\n\r\n omfattende liste over tilladte betegnelser som må bruges i forbindelse med  \r\n\r\n lægemiddelformer, administrationsveje beholdere, lukker m.v. Disse  \r\n\r\n betegnelser bliver obligatoriske i hele EU. I skrivende stund har den  \r\n\r\n formelle vedtagelse af <B>Standard Terms</B> af EU-kommissionen dog ikke  \r\n\r\n fundet sted, hvorfor den endelige ikraftsættelse af disse betegnelser i EU  \r\n\r\n sammenhæng vil blive bekendtgjort senere. I Danmark er de dog blevet  \r\n\r\n inkluderet i DLS 97. Dette har medført en gennemgribende ændring af afsnittet  \r\n\r\n vedrørende lægemiddelformer og især navne på disse. Afsnittet vedrørende  \r\n\r\n medicinske utensilier er fjernet fra DLS. Denne har ellers i en årrække  \r\n\r\n udgjort DLS sektion 4, men da medicinske utensilier ikke er lægemidler, og da  \r\n\r\n Ph. Eur. monografierne derfor ikke har gyldighed, har man vurderet, at disse  \r\n\r\n ikke længere skal bekendtgøres i DLS. </P>  \r\n\r\n<P>I 1997-udgaven af Danske Lægemiddelstandarder bekendtgøres standarder, der  \r\n\r\n især henviser til den Europæiske Farmakopes 3. udgave (Ph. Eur. 3rd Ed.),  \r\n\r\n samt et fåtal nationale standarder, hvoraf de fleste også er gældende i de  \r\n\r\n øvrige nordiske lande. I forhold til Ph. Eur. 2nd Ed. indeholder 3rd Ed. ialt  \r\n\r\n 106 nye og 161 reviderede standarder for råvarer, lægemidler eller  \r\n\r\n lægemiddelformer. Den 1. januar 1997 træder yderligere 1 hasterevideret  \r\n\r\n råvarestandard i kraft. </P>  \r\n\r\n<P>Ph. Eur. 3rd Ed indeholder 3 nye og 9 reviderede tekster til bogens  \r\n\r\n generelle kapitler. I DLS 97 er der henvisninger til nogle af disse tekster.  \r\n\r\n</P>  \r\n\r\n<P>I Sektion 1 er &#187;Fortegnelse over love, bekendtgørelser m.m.&#171;  \r\n\r\n blevet opdateret. Fortegnelsens indhold vedrører især lægemidlers kvalitet.  \r\n\r\n</P>  \r\n\r\n<P>I Sektion 2 er listen med &#187;Fortegnelse over standarder for  \r\n\r\n råvarer&#171; ændret således, at engelske navne har erstattet latinske,  \r\n\r\n ligesom henvisningerne nu er til Ph. Eur. 3rd Ed. For drogerne er de latinske  \r\n\r\n navne dog fortsat anført som synonymer, som en service for brugerne. I øvrigt  \r\n\r\n er 86 nye råvarestandarder og 113 standarder er revideret. Af disse er der en  \r\n\r\n enkelt hasterevision <B>Sulfasalazin</B> . 1 råvarestandard  \r\n\r\n<B>Cinchocainhydrochlorid </B> , hidtil publiceret i DLS, erstattes af en  \r\n\r\n standard i Ph. Eur. 3rd Ed. En standard for råvaren <B>Sterilt vand</B> er  \r\n\r\n udskilt fra <B>Vand til injektionsvæsker</B> . Her er tale om en præcisering  \r\n\r\n af kravene til sterilt vand, da monografien for de 2 råvarer i Ph. Eur. 3rd  \r\n\r\n Ed. er en samlemonografi for begge råvarer. Samtlige råvaremonografier i DLS  \r\n\r\n 97 er blevet opdateret til stilen for opbygning af monografier i Ph. Eur. 3rd  \r\n\r\n Ed., også med henvisninger til de heri publicerede metoder. </P>  \r\n\r\n<P>I Sektion 3 er der foretaget en fuldstændig ændring af afsnittet  \r\n\r\n &#187;Standarder for lægemiddelformer&#171;. De officielle danske  \r\n\r\n oversættelser af  <B>Standard terms</B> er sat ind i en fortegnelse sammen  \r\n\r\n med de tilsvarende engelske betegnelser. På denne måde kan man med et simpelt  \r\n\r\n opslag oversætte de nye betegnelser til dansk. Da der er indført en lang  \r\n\r\n række betegnelser, som ikke før var defineret, er dette afsnit øget  \r\n\r\n væsentligt med definitioner, eventuelt suppleret med krav. </P>  \r\n\r\n<P>Alle ændringerne, der i store træk er omtalt ovenfor, samt en række af  \r\n\r\n detaljerne findes som sædvanlig kommenteret i fagpressen, hvortil der  \r\n\r\n henvises. </P>  \r\n\r\n<P> <B>SEKTION 1 </B></P>  \r\n\r\n<P>ÆNDRINGER </P>  \r\n\r\n<P>Nyoptaget </P>  \r\n\r\n<P>Følgende standarder er nyoptaget i Danske Lægemiddelstandarder fra den 1.  \r\n\r\n januar 1997. </P>  \r\n\r\n<P> <I>Råvarer</I>  </P>  \r\n\r\n<P>Alfentanil hydrochloride Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Almond oil, refined Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Alprazolam Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Alprenolol benzoate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Astemizole Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Betacarotene Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Betacyclodextrine Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Betahistidine mesilate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Betaxolol hydrochloride Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Biotin Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Biperiden hydrochloride Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Budesonide Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Bumetanide Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Buserelin Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Calcium hydroxide Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Captopril Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Caraway fruit Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Carboplatin Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Castor oil, polyoxyl Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Castor oil, polyoxyl hydrogenated Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Cetirizine dihydrochloride Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Cetostearyl isononanoate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Chlorcyclizine hydrochloride Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Chlorpropamide Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Ciprofloxacin Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Clobetasone butyrate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Clove oil Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Cyclizine hydrochloride Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Cyclopentolate hydrochloride Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Cyproterone acetate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Devil's claw root Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Doxepine hydrochloride Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Enoxaparin sodium Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Erythromycin lactobionate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Ethylene glycol monostearate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Eugenol Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Fentanyl citrate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Fluoxetine hydrochloride Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Glycerol triacetate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Indapamide Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Iohexol Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Iopamidol Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Isosorbide dinitrate, diluted Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Isosorbide mononitrate, diluted Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Isoxsuprine hydrochloride Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Lactose anhydrous Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Lisinopril dihydrate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Lorazepam Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Macrogol 7 glycerol cocoate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Macrogol cetostearyl ether Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Macrogol lauryl ether Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Macrogol oleyl ether Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Marshmallow root Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Methacrylic acid-acrylate copolymer (1:1) L100 Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Methacrylic acid-acrylate copolymer (1:1) L100-55 Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Methacrylic acid-acrylate copolymer dispersion </P>  \r\n\r\n<P>30 per cent L30D Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Methacrylic acid-acrylate copolymer (1:2) S100 Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Methyl prednisolone hydrogen succinate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Methylthioninium chloride for external use Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Metrifonate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Nadroparin calcium Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Nitrofural Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Octyldodecanol Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Pentamidine diisetionate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Phentolamine mesilate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Potassium acetate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Potassium clavulanate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Potassium hydrogen carbonate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Povidone, iodinated Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Propylene glycol monostearate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Protirelin Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Roxitromycin Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Selenium disulphide Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Sertaconazole nitrate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Shellac Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Sodium amidotrizoate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Sodium lactate solution Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Spectinomycin hydrochloride Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Star anise Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Tenoxicam Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Tiaprofenic acid Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Tolnaftate Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Tropicamide Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Tyrosine Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Xylometazoline hydrochloride Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P> <I>Lægemidler</I>  </P>  \r\n\r\n<P>Allergen products Ph. eur. 3rd Ed. </P>  \r\n\r\n<P>Avian infectious laryngotracheitis vaccine (live) for chickens </P>  \r\n\r\n<P>Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Feline calicivirosis vaccine (inactivated) Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Feline calicivirosis vaccine (live) Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Hepatitis A vaccine (inactivated) Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Indium (111In) oxine solution Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Interferon alfa-2 concentrated solution Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Iobenguane (123I) injection Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Iobenguane (131I) injection for therapeutic use Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Iobenguane (131I) injection for diagnostic use Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>Typhoid polysaccharide vaccine Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P> <I>Lægemiddelformer</I>  </P>  \r\n\r\n<P>Se forord samt sektion 3 vedrørende Standard Terms. </P>  \r\n\r\n<P>Udgået </P>  \r\n\r\n<P>Følgende standarder er udgået af Danske Lægemiddelstandarder fra den 1.  \r\n\r\n januar 1997. </P>  \r\n\r\n<P> <I>Råvarer</I>  </P>  \r\n\r\n<P>Butobarbitalum Ph. Eur. 2nd Ed. </P>  \r\n\r\n<P>Cefaloridinum Ph. Eur. 2nd Ed. </P>  \r\n\r\n<P>Cyclobarbitalum calcicum Ph. Eur. 2nd Ed. </P>  \r\n\r\n<P>Secobarbitalum natricum Ph. Eur. 2nd Ed. </P>  \r\n\r\n<P> <I>Lægemidler</I>  </P>  \r\n\r\n<P>Ferri (59Fe)- citratinjektionsvæske Ph. Nord. 63 Add. </P>  \r\n\r\n<P>Ferri (59Fe)- chloridinjektionsvæske Ph. Nord. 63 Add. </P>  \r\n\r\n<P>Ferri (59Fe)- chloridopløsning Ph. Nord. 63 Add. </P>  \r\n\r\n<P>Immunoglobulinum humanum vaccinium Ph. Eur. 2nd Ed. </P>  \r\n\r\n<P>Ioderet (131I) albumininjektionsvæske Ph. Nord. 63 Add. </P>  \r\n\r\n<P>Kalium (42K)- chloridinjektionsvæske Ph. Nord. 63 Add. </P>  \r\n\r\n<P>Natrium (24Na)-chloridinjektionsvæske DLS 96 </P>  \r\n\r\n<P>Natriumbromid (82Br)- injektionsvæske Ph. Nord. 63 Add. </P>  \r\n\r\n<P>Natriumfluorid (18F)- injektionsvæske Ph. Nord. 63 Add. </P>  \r\n\r\n<P>Natriumiodid (131I)- injektionsvæske Ph. Nord. 63 Add. </P>  \r\n\r\n<P>Natriumiodid (131I)- opløsning til diagnostisk brug Ph. Nord. 63 Add. </P>  \r\n\r\n<P>Natriumphosphat (32P)- opløsning Ph. Nord. 63 Add. </P>  \r\n\r\n<P>Stibii sulfidi colloidalis et technetii (99mTc) solutio iniectabilis Ph.  \r\n\r\n Eur. 2nd Ed. (130) </P>  \r\n\r\n<P>Vaccinum variolae dermicum vivum Ph. Eur. 2nd Ed. </P>  \r\n\r\n<P> <I>Alle medicinske utensilier</I>  </P>  \r\n\r\n<P>Ændret </P>  \r\n\r\n<P>Følgende standarder er ændret i Danske Lægemiddelstandarder fra den 1.  \r\n\r\n januar 1997. </P>  \r\n\r\n<P> <I>Råvarer</I>  </P>  \r\n\r\n<P>Sulfasalazine (hasteimplementeret pr. 1. januar 1997 jf. publikation i  \r\n\r\n Pharmeuropa nr. 8.3, 1996). </P>  \r\n\r\n<P>Acacia </P>  \r\n\r\n<P>Acacia, spray-dried </P>  \r\n\r\n<P>Alginic acid </P>  \r\n\r\n<P>Almond oil </P>  \r\n\r\n<P>Aluminium oxide, hydrated </P>  \r\n\r\n<P>Ampicillin anhydrous </P>  \r\n\r\n<P>Ampicillin trihydrate </P>  \r\n\r\n<P>Bacitracin zinc </P>  \r\n\r\n<P>Baclofen </P>  \r\n\r\n<P>Bentonite </P>  \r\n\r\n<P>Benzylpenicillin benzathine </P>  \r\n\r\n<P>Benzylpenicillin procaine </P>  \r\n\r\n<P>Betamethasone </P>  \r\n\r\n<P>Bupivacaine hydrochloride </P>  \r\n\r\n<P>Calcium gluconate </P>  \r\n\r\n<P>Calcium glycerophosphate </P>  \r\n\r\n<P>Calcium stearat </P>  \r\n\r\n<P>Cascara </P>  \r\n\r\n<P>Cefalotin sodium </P>  \r\n\r\n<P>Chamomile flower, roman </P>  \r\n\r\n<P>Charcoal, activated </P>  \r\n\r\n<P>Chloramphenicol palmitate </P>  \r\n\r\n<P>Chlorhexidine diacetate </P>  \r\n\r\n<P>Chlorhexidine digluconate solution </P>  \r\n\r\n<P>Chlorhexidine dihydrochloride </P>  \r\n\r\n<P>Cinchocaine hydrochloride </P>  \r\n\r\n<P>Citric acid anhydrous </P>  \r\n\r\n<P>Citric acid monohydrate </P>  \r\n\r\n<P>Cloxacillin sodium </P>  \r\n\r\n<P>Cortisone acetate </P>  \r\n\r\n<P>Daunorubicin hydrochloride </P>  \r\n\r\n<P>Deoxycortone acetate </P>  \r\n\r\n<P>Dexamethasone </P>  \r\n\r\n<P>Dexamethasone acetate </P>  \r\n\r\n<P>Dexamethasone sodium phosphate </P>  \r\n\r\n<P>Dextromethorphan hydrobromide </P>  \r\n\r\n<P>Dihydrostreptomycin sulphate </P>  \r\n\r\n<P>Dimethyl sulfoxide </P>  \r\n\r\n<P>Disulfiram </P>  \r\n\r\n<P>Doxorubicin hydrochloride </P>  \r\n\r\n<P>Doxycycline hyclate </P>  \r\n\r\n<P>Extracts </P>  \r\n\r\n<P>Ferrous gluconate </P>  \r\n\r\n<P>Framycetin sulphate </P>  \r\n\r\n<P>Fructose </P>  \r\n\r\n<P>Gelatin </P>  \r\n\r\n<P>Gentamicin sulphate </P>  \r\n\r\n<P>Glucose anhydrous </P>  \r\n\r\n<P>Glucose monohydrate </P>  \r\n\r\n<P>Gonadotrophin, chorionic </P>  \r\n\r\n<P>Human fibrinogen freeze-dried </P>  \r\n\r\n<P>Hyaluronidase </P>  \r\n\r\n<P>Hydrocortisone acetate </P>  \r\n\r\n<P>Hydrocortisone hydrogen succinate </P>  \r\n\r\n<P>Indometacin </P>  \r\n\r\n<P>Ipecacuanha root </P>  \r\n\r\n<P>Kanamycin acid sulphate </P>  \r\n\r\n<P>Kanamycin monosulphate </P>  \r\n\r\n<P>Kaolin, heavy </P>  \r\n\r\n<P>Lactose monohydrate </P>  \r\n\r\n<P>Lactulose solution </P>  \r\n\r\n<P>Lincomycin hydrochloride </P>  \r\n\r\n<P>Magnesium chloride hexahydrate </P>  \r\n\r\n<P>Maize starch </P>  \r\n\r\n<P>Mannitol </P>  \r\n\r\n<P>Methylprednisolone </P>  \r\n\r\n<P>Miconazole nitrate </P>  \r\n\r\n<P>Minocycline hydrochloride </P>  \r\n\r\n<P>Neostigmine bromide </P>  \r\n\r\n<P>Oxymetazoline hydrochloride </P>  \r\n\r\n<P>Pancreas powder </P>  \r\n\r\n<P>Peppermint oil </P>  \r\n\r\n<P>Pepsin powder </P>  \r\n\r\n<P>Pindolol </P>  \r\n\r\n<P>Piroxicam </P>  \r\n\r\n<P>Polyacrylate dispersion 30 per cent </P>  \r\n\r\n<P>Polymyxin B Sulphate </P>  \r\n\r\n<P>Potato starch </P>  \r\n\r\n<P>Povidone </P>  \r\n\r\n<P>Prednisone </P>  \r\n\r\n<P>Propantheline bromide </P>  \r\n\r\n<P>Psyllium seed </P>  \r\n\r\n<P>Riboflavine sodium phosphate </P>  \r\n\r\n<P>Rice starch </P>  \r\n\r\n<P>Rifamycin sodium </P>  \r\n\r\n<P>Sodium alginate </P>  \r\n\r\n<P>Sodium chloride </P>  \r\n\r\n<P>Sodium hydrogen carbonate </P>  \r\n\r\n<P>Sodium salicylate </P>  \r\n\r\n<P>Somatostatin </P>  \r\n\r\n<P>Sorbitol </P>  \r\n\r\n<P>Sorbitol 70 per cent (crystallising) </P>  \r\n\r\n<P>Sorbitol 70 per cent (non-crystallising) </P>  \r\n\r\n<P>Soya bean oil </P>  \r\n\r\n<P>Streptokinase </P>  \r\n\r\n<P>Streptomycin sulphate </P>  \r\n\r\n<P>Talc </P>  \r\n\r\n<P>Theophylline </P>  \r\n\r\n<P>Theophylline-ethylenediamine </P>  \r\n\r\n<P>Thyme </P>  \r\n\r\n<P>Tinctures </P>  \r\n\r\n<P>Tobramycin </P>  \r\n\r\n<P>Tragacanth </P>  \r\n\r\n<P>Triglycerides, medium-chain </P>  \r\n\r\n<P>Trypsin </P>  \r\n\r\n<P>Water purified </P>  \r\n\r\n<P>Wheat starch </P>  \r\n\r\n<P> <I>De følgende 6 råvaremonografier er hasteimplementeret pr. 1. juli 1996  \r\n\r\n jf. publikation i Pharmeuropa nr. 8.1 samt meddelelse i Statstidende den 31.  \r\n\r\n maj 1996.</I>  </P>  \r\n\r\n<P>Cellulose acetate phthalate </P>  \r\n\r\n<P>Cellulose, microcrystalline </P>  \r\n\r\n<P>Cellulose, powdered </P>  \r\n\r\n<P>Ethylcellulose </P>  \r\n\r\n<P>Hydroxyethylcellulose </P>  \r\n\r\n<P>Hydroxypropylmethylcellulose phthalate </P>  \r\n\r\n<P> <I>Lægemidler</I>  </P>  \r\n\r\n<P>Cholera vaccine </P>  \r\n\r\n<P>Cholera vaccine, freeze-dried </P>  \r\n\r\n<P>Diphtheria and tetanus vaccine (adsorbed) </P>  \r\n\r\n<P>Diphtheria and tetanus vaccine (adsorbed) for adults and adolescents </P>  \r\n\r\n<P>Diphtheria vaccine (adsorbed) </P>  \r\n\r\n<P>Diphtheria vaccine (adsorbed) for adults and adolescents </P>  \r\n\r\n<P>Diphtheria, tetanus and pertussis vaccine (adsorbed) </P>  \r\n\r\n<P>Hepatitis B vaccine (rDNA) </P>  \r\n\r\n<P>Human tetanus immunoglobulin </P>  \r\n\r\n<P>Immunosera for human use </P>  \r\n\r\n<P>Immunosera for veterinary use </P>  \r\n\r\n<P>Influenza vaccine (inactivated) split virion </P>  \r\n\r\n<P>Influenza vaccine (inactivated) (surface antigen) </P>  \r\n\r\n<P>Influenza vaccine (inactivated) (whole virion) </P>  \r\n\r\n<P>Insulin </P>  \r\n\r\n<P>Insulin human </P>  \r\n\r\n<P>Insulin preparations, injectable </P>  \r\n\r\n<P>Measles vaccine (live) </P>  \r\n\r\n<P>Measles, mumps and rubella vaccine (live) </P>  \r\n\r\n<P>Meningococcal polysaccharide vaccine </P>  \r\n\r\n<P>Mumps vaccine (live) </P>  \r\n\r\n<P>Pertussis vaccine (adsorbed) </P>  \r\n\r\n<P>Pertussis vaccine </P>  \r\n\r\n<P>Pneumococcal polysaccharide vaccine </P>  \r\n\r\n<P>Poliomyelitis vaccine (inactivated) </P>  \r\n\r\n<P>Rabies vaccine for human use prepared in cell cultures </P>  \r\n\r\n<P>Rubella vaccine </P>  \r\n\r\n<P>Sodium iodide (123I) solution </P>  \r\n\r\n<P>Sodium iodohippurate (123I) injection </P>  \r\n\r\n<P>Tetanus vaccine (adsorbed) </P>  \r\n\r\n<P>Typhoid vaccine </P>  \r\n\r\n<P>Typhoid vaccine, freeze-dried </P>  \r\n\r\n<P>Varicella vaccine (live) </P>  \r\n\r\n<P>Yellow Fever vaccine (live) </P>  \r\n\r\n<P> <I>Lægemiddelformer</I>  </P>  \r\n\r\n<P>Se forord samt sektion 3 vedrørende Standard Terms </P>  \r\n\r\n<P>Ændret titel </P>  \r\n\r\n<P>Alle titler er ændret fra latin til engelsk. </P>  \r\n\r\n<PRE>  \r\n\r\n  FORKORTELSER, SYMBOLER OG DEFINITIONER  \r\n\r\n                             Forkortelser  \r\n\r\n DLS 97                      Danske Lægemiddelstandarder 1997  \r\n\r\n ICRS                        International Chemical Reference  \r\n\r\n                             Substance  \r\n\r\n NLN                         Nordisk Lægemiddelnævn  \r\n\r\n NRP                         Nordic Reference Preparation  \r\n\r\n Ph. Eur.                    European Pharmacopoeia  \r\n\r\n Ph. Eur. 3rd Ed.            European Pharmacopoeia, Third Edition  \r\n\r\n Symboler  \r\n\r\n *                           Angiver en lægemiddelformstandard, der  \r\n\r\n                             er baseret på en monografi i den  \r\n\r\n                             Europæiske Farmakope  \r\n\r\n                  Angiver termer, der kan anvendes som  \r\n\r\n                             lægemiddelformbetegnelse ved mærkning.  \r\n\r\n</PRE>  \r\n\r\n<P>Ved forkortelser af enheder i det internationale enhedssystem er anvendt  \r\n\r\n de internationalt vedtagne symboler, som fremgår af Handelsministeriets og  \r\n\r\n Industriministeriets bekendtgørelser om det internationale enhedssystem (SI).  \r\n\r\n</P>  \r\n\r\n<P>Definitioner </P>  \r\n\r\n<P> <B>Lægemiddelstof</B>  </P>  \r\n\r\n<P>Ved et <I>lægemiddelstof</I> forstås en råvare, der betinger et  \r\n\r\n lægemiddels virkning. </P>  \r\n\r\n<P> <B>Hjælpestof</B>  </P>  \r\n\r\n<P>Ved et <I>hjælpestof</I> forstås en råvare, der anvendes ved fremstilling  \r\n\r\n af lægemidler, og som ikke er et lægemiddelstof. </P>  \r\n\r\n<P> <B>Specifikation</B>  </P>  \r\n\r\n<P>Ved en <I>specifikation</I> forstås en af råvare- eller  \r\n\r\n lægemiddelfremstilleren opstillet forskrift, der definerer kvaliteten af  \r\n\r\n råvaren eller lægemidlet. Specifikationen skal omfatte de nødvendige  \r\n\r\n angivelser af råvarens eller lægemidlets oprindelse, sammensætning og  \r\n\r\n fremstillingsmåde, de prøver med tilhørende grænser som skal kunne opfyldes,  \r\n\r\n og opbevaringsforhold der skal respekteres. Specifikationen danner grundlag  \r\n\r\n for Sundhedsstyrelsens godkendelse i forbindelse med optagelse i  \r\n\r\n specialitetsregisteret i medfør af lov om lægemidler. </P>  \r\n\r\n<P> <B>Standard</B>  </P>  \r\n\r\n<P>Ved en <I>standard</I> forstås en af myndighederne publiceret forskrift,  \r\n\r\n der definerer kvaliteten af en råvare, et lægemiddel eller en lægemiddelform.  \r\n\r\n</P>  \r\n\r\n<P> <B>FORTEGNELSE OVER LOVE, BEKENDTGØRELSER M.M. </B></P>  \r\n\r\n<P>Der er i Danske Lægemiddelstandarder henvist til de med mærkede love,  \r\n\r\n bekendtgørelser og lignende. </P>  \r\n\r\n<PRE>  \r\n\r\n                             Lægemiddelloven  \r\n\r\n Lovbekendtgørelse nr. 656 af 28. juli 1995 om lægemidler.  \r\n\r\n                             Kongelig anordning  \r\n\r\n Anordning nr. 742 af 13. november 1987 om, at standarder for  \r\n\r\n    lægemidlers kvalitet og for fremstilling, kontrol og lagerhold af  \r\n\r\n    lægemidler ikke indføres i Lovtidende.  \r\n\r\n                             Bekendtgørelser  \r\n\r\n</PRE>  \r\n\r\n<P>Sundhedsstyrelsens bekendtgørelse nr. 968 af 13. december 1993 om god  \r\n\r\n fremstillings- og distributionspraksis for lægemidler, som ændret ved  \r\n\r\n bekendtgørelse nr. 642 af 24 juli 1995. </P>  \r\n\r\n<P>Sundhedsstyrelsens bekendtgørelse nr. 49 af 8. januar 1987 om lægemidlers  \r\n\r\n kvalitet. </P>  \r\n\r\n<P>Sundhedsstyrelsens bekendtgørelse nr. 165 af 13. marts 1995 om  \r\n\r\n markedsføringstilladelse til lægemidler. </P>  \r\n\r\n<P>Miljøministeriets bekendtgørelse nr. 829 af 15. oktober 1993 om  \r\n\r\n klassificering, emballering, mærkning, salg og opbevaring af kemiske stoffer  \r\n\r\n og produkter, som ændret ved bekendtgørelse nr. 966 af 12. december 1995.  \r\n\r\n</P>  \r\n\r\n<P>Sundhedsstyrelsens bekendtgørelse nr. 314 af 18. maj 1993 om mærkning af  \r\n\r\n og indlægssedler til lægemidler, som ændret ved bekendtgørelse nr. 245 af 7.  \r\n\r\n april 1994 og bekendtgørelse nr. 641 af 24. juli 1995 samt bekendtgørelse nr.  \r\n\r\n 1028 af 15. december 1995. </P>  \r\n\r\n<P>Sundhedsstyrelsens bekendtgørelse nr. 129 af 20. februar 1995 om  \r\n\r\n forbrugerpakninger af magistrelle lægemidler, som ændret ved bekendtgørelse  \r\n\r\n nr. 1027 af 15. december 1995. </P>  \r\n\r\n<P>Sundhedsministeriets bekendtgørelse nr. 574 af 5. juli 1995 om  \r\n\r\n fremstilling og forhandling m.v. af foderlægemidler til fisk. </P>  \r\n\r\n<P>Sundhedsministeriets bekendtgørelse nr. 1140 af 15. december 1992 om  \r\n\r\n fremstilling og forhandling m.v. af foderlægemidler til dyr. </P>  \r\n\r\n<P>Sundhedsministeriets bekendtgørelse nr. 1134 af 15. december 1992 om  \r\n\r\n radioaktive lægemidler, som ændret ved bekendtgørelse nr. 1190 af 23.  \r\n\r\n december 1993, bekendtgørelse nr. 733 af 10. august 1994 og bekendtgørelse  \r\n\r\n nr. 48 af 17. januar 1995. </P>  \r\n\r\n<P>Sundhedsstyrelsens bekendtgørelse nr. 1136 af 15. december 1992 om indkøb  \r\n\r\n og håndtering af radioaktive lægemidler på sygehuse, laboratorier m.v. </P>  \r\n\r\n<P>Sundhedsministeriets bekendtgørelse nr. 791 af 29. august 1996 om aromaer  \r\n\r\n m.m., der må anvendes til levnedsmidler. </P>  \r\n\r\n<P>Sundhedsministeriets bekendtgørelse nr. 790 af 21. september 1992 om  \r\n\r\n naturlægemidler, som ændret ved bekendtgørelse nr. 573 af 5. juli 1995. </P>  \r\n\r\n<P>Sundhedsministeriets bekendtgørelse nr. 567 af 18. juni 1996 om vitamin-  \r\n\r\n og mineralpræparater. </P>  \r\n\r\n<P>Sundhedsministeriets bekendtgørelse nr. 632 af 5. juli 1994 om  \r\n\r\n homøopatiske lægemidler, som ændret ved bekendtgørelse nr. 1078 af 15.  \r\n\r\n december 1994 og bekendtgørelse nr. 199 af 24. marts 1995 og bekendtgørelse  \r\n\r\n nr. 956 af 8. december 1995. </P>  \r\n\r\n<P>Indenrigsministeriets bekendtgørelse nr. 81 af 19. februar 1979 om  \r\n\r\n svangerskabsforebyggende midler, som ændret ved bekendtgørelse nr. 1009 af 9.  \r\n\r\n december 1994. </P>  \r\n\r\n<P>Sundhedsministeriets bekendtgørelse nr. 774 af 16. september 1992 om  \r\n\r\n kontaktlinsevæsker, som ændret ved bekendtgørelse nr. 1008 af 9. december  \r\n\r\n 1994. </P>  \r\n\r\n<P>Sundhedsstyrelsens bekendtgørelse nr. 1026 af 15. december 1995 om  \r\n\r\n varenumre til lægemidler. </P>  \r\n\r\n<PRE>  \r\n\r\n                             Cirkulærer  \r\n\r\n</PRE>  \r\n\r\n<P>Sundhedsstyrelsens cirkulære af 3. maj 1991 om undersøgelse af donorblod  \r\n\r\n for hepatitis C antistof (anti-HCV). </P>  \r\n\r\n<P>Sundhedsstyrelsens cirkulære af 14. februar 1994 vedrørende undersøgelse  \r\n\r\n af donorblod for antistof mod HTLV I/II, med tilhørende vejledning af 14.  \r\n\r\n februar 1994. </P>  \r\n\r\n<P>Sundhedsstyrelsens cirkulære nr. 167 af 12. september 1994 vedrørende  \r\n\r\n undersøgelse af donorblod for antistof mod human immundefekt virus type 1 og  \r\n\r\n type 2 (anti-HIV-1/-2), med tilhørende vejledning nr. 168 af 12. september  \r\n\r\n 1994. </P>  \r\n\r\n<P>Sunhedsministeriets cirkulære nr. 203 af 13. december 1994 om regulativ  \r\n\r\n for Sundhedsstyrelsens eksportregister for lægemidler m.v.. </P>  \r\n\r\n<PRE>  \r\n\r\n                             Andre bestemmelser m.v.  \r\n\r\n</PRE>  \r\n\r\n<P>Gældende fortegnelse over godkendte tilsætningsstoffer til levnedsmidler  \r\n\r\n (Positivlisten), Levnedsmiddelstyrelsen. </P>  \r\n\r\n<P>Sundhedsstyrelsens vejledning af 21. september 1989 vedrørende forhandling  \r\n\r\n og anvendelse af &#187;kontrollerede råvarer&#171;. </P>  \r\n\r\n<P>Sundhedsstyrelsens vejledning nr. 91 af 7. juni 1993 om mærkning af og  \r\n\r\n indlægssedler til lægemidler optaget i Sundhedsstyrelsens  \r\n\r\n specialitetsregister. </P>  \r\n\r\n<P>Sundhedsstyrelsens vejledning af 3. januar 1994 vedrørende  \r\n\r\n ometikettering/tillægsetikettering af færdigvarepakninger. </P>  \r\n\r\n<P>Sundhedsstyrelsens vejledning af 23. februar 1993 om ændringer i  \r\n\r\n specifikationer for farmaceutiske specialiteter. </P>  \r\n\r\n<P>Sundhedsstyrelsens regler af 29. december 1982 for undersøgelse af  \r\n\r\n donorblod for syfilis og hepatitis B. </P>  \r\n\r\n<P>Sundhedsstyrelsens vejledning af 3. maj 1991 om undersøgelse af  \r\n\r\n bloddonorer for antistof mod hepatitis C. </P>  \r\n\r\n<P>Sundhedsstyrelsens meddelelse af 2. februar 1981 om mærkning af  \r\n\r\n radioaktive lægemidler. </P>  \r\n\r\n<P>Sundhedsstyrelsens vejledning af 30. september 1992 om registrering af  \r\n\r\n vitamin- og mineralpræparater. </P>  \r\n\r\n<P>Sundhedsstyrelsens vejledning af 30. september 1992 om registrering af  \r\n\r\n naturlægemidler, som ændret senest februar 1994. </P>  \r\n\r\n<P>Sundhedsstyrelsens vejledning af 15. november 1994 om registrering af  \r\n\r\n homøopatiske lægemidler. </P>  \r\n\r\n<P>Sundhedsstyrelsens regler af 31. marts 1976 om emballage, mærkning m.m.  \r\n\r\n for visse svangerskabsforebyggende midler, der er undtaget fra lov om  \r\n\r\n lægemidler. </P>  \r\n\r\n<P>Meddelelse af 31. marts 1976 fra Sundhedsstyrelsen vedrørende  \r\n\r\n kvalitetskrav, kontrol m.v. af visse mekanisk virkende  \r\n\r\n svangerskabsforebyggende midler (kondomer og okklusive pessarer af gummi).  \r\n\r\n</P>  \r\n\r\n<P>Sundhedsstyrelsens vejledning af 31. marts 1976 om kvalitetskontrol af  \r\n\r\n kondomer og okklusive pessarer af gummi. </P>  \r\n\r\n<P>Sundhedsstyrelsens forholdsregler af 17. december 1991 mod overførsel af  \r\n\r\n leishmaniasis-smitte fra bloddonorer. </P>  \r\n\r\n<PRE>  \r\n\r\n                             EU-direktiver m.v.  \r\n\r\n</PRE>  \r\n\r\n<P>Der henvises til gældende forordninger, direktiver, direktiver,  \r\n\r\n vejledninger og guidelines udsendt af EU-kommissionen indeholdt i &#187;The  \r\n\r\n Rules governing Medicinal Products in the European Union&#171;: </P>  \r\n\r\n<P>The rules governing medicinal products for human use in the European  \r\n\r\n Union, volume I (July 1995). </P>  \r\n\r\n<P>Notice to applicants for marketing authorizations for medicinal products  \r\n\r\n for human use in the European Union, volume II, s. 48-176 (januar 1989). </P>  \r\n\r\n<P>Draft Notice to applicants for marketing authorizations for medicinal  \r\n\r\n products for human use in the European Union (III/5944/94, December 1994).  \r\n\r\n</P>  \r\n\r\n<P>Draft Notice to applicants for marketing authorizations for medicinal  \r\n\r\n products for human use in the European Union (III/5429/96, May 1996). </P>  \r\n\r\n<P>Guidelines on the quality, safety and efficacy of medicinal products for  \r\n\r\n human use, volume III: </P>  \r\n\r\n<P>Bind I (Januar 1996)(III/5380/96) og bind II (Januar 1996)(III/5382/96).  \r\n\r\n</P>  \r\n\r\n<P>The rules governing medicinal products in the European Community, volume  \r\n\r\n VA: The rules governing veterinary medicinal products in the European  \r\n\r\n Community (November 1993) med senere forordninger og direktiver og volume  \r\n\r\n VII: Guidelines for the testing of veterinary medicinal products (September  \r\n\r\n 1994) med senere vedtagne guidelines. </P>  \r\n\r\n<P>Notes for Guidance on the quality of veterinary medicinal products  \r\n\r\n (III/3727/92. November 1992). </P>  \r\n\r\n<P>Note for Guidance: Compilation of texts relating to the submission of data  \r\n\r\n on active ingredients in dossiers for application for marketing authorization  \r\n\r\n of medicinal products when the European Drug Master File is used  \r\n\r\n (III/5370/93. juni 1993). </P>  \r\n\r\n<P>Draft Notice to Applicants for marketing authorizations for veterinary  \r\n\r\n medicinal products in the European Union (III/5056/95, Januar 1995) </P>  \r\n\r\n<P>Draft Notice to Applicants for marketing authorisations for veterinary  \r\n\r\n medicinal products in the European Union. Revised version of parts of Volume  \r\n\r\n V B (III/5430/96, May 1996). </P>  \r\n\r\n<P> <B>ALMENE BESTEMMELSER</B>  </P>  \r\n\r\n<P>Den Europæiske Farmakope </P>  \r\n\r\n<P>Den Europæiske Farmakope offentliggøres af Europarådet i henhold til  \r\n\r\n konventionen om udarbejdelse af en Europæisk Farmakope. I Danmark anvendes  \r\n\r\n den engelsksprogede udgave som udgives af &#187;The European Department for  \r\n\r\n the Quality of Medicines&#171; under Europarådet i Strassburg. </P>  \r\n\r\n<P>Den gældende 3. udgave af den Europæiske Farmakope (Ph. Eur. 3rd Ed.)  \r\n\r\n udgøres pr. 1. januar 1997 af en bog, der indeholder de almene bestemmelser,  \r\n\r\n afprøvningsmetoder og reagenser m.v., foruden monografier for råvarer,  \r\n\r\n lægemiddelformer, lægemidler og medicinske utensilier. </P>  \r\n\r\n<P>Reviderede, nye og udgåede monografier vil fremover forefindes i et årligt  \r\n\r\n addendum til bogen. </P>  \r\n\r\n<P>Fortegnelserne over standarder i DLS sektion 2 og 3 henviser til gældende  \r\n\r\n monografier for råvarer, lægemidler og lægemiddelformer i enten Ph. Eur. 3rd  \r\n\r\n Ed. eller DLS 97. </P>  \r\n\r\n<P>Almene bestemmelser for DLS-standarder </P>  \r\n\r\n<P>For de i DLS optagne standarder gælder General Notices, Ph. Eur. 3rd Ed.,  \r\n\r\n 1.2. </P>  \r\n\r\n<P>Referencesubstanser </P>  \r\n\r\n<P>Følgende nordiske referencepræparater stilles til disposition af NLN: </P>  \r\n\r\n<P>Chlormezanon </P>  \r\n\r\n<P>Alpha-1,6-Glucan </P>  \r\n\r\n<P>Glycopyrroniumbromid </P>  \r\n\r\n<P>Metrizoinsyre </P>  \r\n\r\n<P>Pentazocinlactat </P>  \r\n\r\n<P> <I>Nordic Reference Preparations</I> (NRP) og <I>International Chemical  \r\n\r\n Reference Substances</I> (ICRS) kan rekvireres fra: WHO Collaborating Centre  \r\n\r\n for Chemical Reference Substances, S-10514 Stockholm, Sverige. </P>  \r\n\r\n<P>Opbevaringsbestemmelser for råvarer og lægemidler </P>  \r\n\r\n<P>Råvarer og lægemidler skal opbevares i beholdere, som beskytter indholdet  \r\n\r\n mod kontaminering. Opbevaringsbeholdere må ikke påvirke indholdet på en sådan  \r\n\r\n måde, at råvaren eller lægemidlet ikke fortsat opfylder standarden. </P>  \r\n\r\n<P>Råvarer og lægemidler skal i øvrigt opbevares under iagttagelse af de  \r\n\r\n opbevaringsbetingelser, der fremgår af standarden. </P>  \r\n\r\n<P>Farlige kemiske stoffer og produkter </P>  \r\n\r\n<P>Råvarer, herunder diluenda, triturationer og lignende, der er omfattet af  \r\n\r\n Miljøministeriets bekendtgørelse om klassificering, emballering, mærkning,  \r\n\r\n salg og opbevaring af farlige kemiske stoffer og produkter, skal mærkes og  \r\n\r\n opbevares i overensstemmelse hermed. </P>  \r\n\r\n<P>Mærkning af råvarer, mellemprodukter og bulkvarer </P>  \r\n\r\n<P>Beholdere, hvori der opbevares råvarer, mellemprodukter eller bulkvarer,  \r\n\r\n skal mærkes under anvendelse af følgende betegnelser: </P>  \r\n\r\n<P>En råvare afprøvet efter en standard i en farmakope mærkes med titlen på  \r\n\r\n standarden eller med det danske navn, med tilføjelse af monografisamlingens  \r\n\r\n navn. For en råvare afprøvet efter en standard i den europæiske farmakope,  \r\n\r\n hvor der stilles specielle krav til renhed ved anvendelse til bestemte  \r\n\r\n lægemiddelformer, skal det fremgå af mærkningen, hvilke særlige krav råvaren  \r\n\r\n opfylder, mærkningen anføres kun når prøven er udført. Såfremt råvaren er  \r\n\r\n afprøvet i henhold til Danske Lægemiddelstandarder, betegnes råvaren med  \r\n\r\n standardens titel med tilføjelse af DLS uden angivelse af årstal. </P>  \r\n\r\n<P>Et mellemprodukt betegnes med titlen på den standard, hvorefter det er  \r\n\r\n fremstillet, med tilføjelse af monografisamlingens navn. Såfremt  \r\n\r\n mellemproduktet ikke findes beskrevet i en standard, skal det betegnes med  \r\n\r\n fuldstændig deklaration. </P>  \r\n\r\n<P>En bulkvare hvoraf færdigvaren er en farmaceutisk specialitet, betegnes  \r\n\r\n med specialitetens navn og D.sp.nr. </P>  \r\n\r\n<P>En bulkvare hvoraf færdigvaren er et magistrelt lægemiddel, betegnes med  \r\n\r\n fuldstændig deklaration. </P>  \r\n\r\n<P> <B>ANALYSEMETODER</B>  </P>  \r\n\r\n<P>TEST FOR Alpha-1,6-GLUCANS </P>  \r\n\r\n<P>Prepare the reference gel by pouring a warm mixture of 10 ml of  \r\n\r\n phosphateagarose and 2 ml of glucan standard solution (5 ppm) into a Petri  \r\n\r\n dish with an internal diameter of 90 mm. Place the dish in a horizontal  \r\n\r\n position and let the gel solidify at room temperature. Punch a hole of about  \r\n\r\n 3 mm in diameter in the gel using a punching tool. Carefully remove the plug  \r\n\r\n from the well. </P>  \r\n\r\n<P>Prepare the test gel as described above using the test solution prescribed  \r\n\r\n in the monograph instead of the glucan solution. </P>  \r\n\r\n<P>Pipette separately into the well of the reference gel and the test gel 5  \r\n\r\n microl of anti-alpha-1,6-glucan serum from rabbits or sheep which is  \r\n\r\n commercially available or may be prepared as described in Int. Arch. Allergy  \r\n\r\n Appl. Immun. <I>42</I> (1972) 887. Incubate the gels at 4 graderC for at  \r\n\r\n least 48 hours. </P>  \r\n\r\n<P>A distinct zone of precipitate with a diameter of 7.5 to 10.5 mm is formed  \r\n\r\n in the reference gel. No zone of precipitate is visible in the test gel. </P>  \r\n\r\n<P>REAGENTS </P>  \r\n\r\n<P> <B>Buffer (sodium phosphate) solution pH 8.0</B> Dissolve 34.70 g of  \r\n\r\n disodium hydrogen phosphate R and 0.55 g of sodium dihydrogen phosphate R in  \r\n\r\n water and dilute to 1000.0 ml. </P>  \r\n\r\n<P> <B>Phosphate agarose</B> Dissolve 10 g of agarose and 10 g of  \r\n\r\n polyethyleneglycol 6000 R in buffer (sodium phosphate) solution pH 8.0 by  \r\n\r\n warming and dilute to 1000 ml with the same solution. Dispense 10 ml portions  \r\n\r\n of the hot solution into glass test-tubes. </P>  \r\n\r\n<P>Store protected from light in a refrigerator. </P>  \r\n\r\n<P> <B>Glucan standard solution (50 ppm)</B> Dissolve 5.0 mg of  \r\n\r\n alfa-1,6-glucan NRP (average molecular weight about 2 million) in 0.9 per  \r\n\r\n cent <I>m/V </I>  solution of sodium chloride R and dilute to 100.0 ml. </P>  \r\n\r\n<P>When stored in a refrigerator the solution remains stable for 14 days.  \r\n\r\n</P>  \r\n\r\n<P> <B>Glucan standard solution (5 ppm)</B> Dilute 10.0 ml of glucan standard  \r\n\r\n solution (50 ppm) to 100.0 ml with 0.9 per cent <I>m/V</I> solution of sodium  \r\n\r\n chloride R. Prepare immediately before use. </P>  \r\n\r\n<P>KRAV TIL LÆGEMIDLERS MIKROBIELLE RENHED </P>  \r\n\r\n<P>Lægemidler skal overholde de nedenfor angivne krav til mikrobiel renhed:  \r\n\r\n</P>  \r\n\r\n<P>KATEGORI 1: </P>  \r\n\r\n<P> <I>Lægemidler der skal være sterile i henhold til standarden for den  \r\n\r\n pågældende lægemiddelform og lægemidler hvor det af mærkningen fremgår, at de  \r\n\r\n er sterile.</I>  </P>  \r\n\r\n<P>Skal overholde prøven for &#187;Sterility&#171; i Ph. Eur. 3rd Ed. 2.6.1.  \r\n\r\n</P>  \r\n\r\n<P>KATEGORI 2: </P>  \r\n\r\n<P> <I>Lægemidler til topikal anvendelse eller til brug i luftvejene, hvor  \r\n\r\n sterilitet ikke er krævet.</I>  </P>  \r\n\r\n<P>- Lægemidlet må ved prøven &#187;Total viable aerobic count&#171; i Ph.  \r\n\r\n Eur. 3rd Ed. 2.6.12. ikke indeholde mere end 10exp2 aerobe bakterier og  \r\n\r\n svampe pr. g (ml). </P>  \r\n\r\n<P>- Lægemidlet må ved prøven &#187;Tests for specified microorganisms&#171;  \r\n\r\n i Ph. Eur. 3rd Ed. 2.6.12. ikke indeholde mere end 10exp1  \r\n\r\n<I>enterobakterier</I> og visse andre <I>gramnegative bakterier</I> pr. g  \r\n\r\n (ml), og der må ikke kunne påvises <I>Pseudomonas aeruginosa</I>  eller  \r\n\r\n<I>Staphylococcus aureus</I> i 1 g (ml). </P>  \r\n\r\n<P>KATEGORI 3: </P>  \r\n\r\n<P> <I>A. Lægemidler til oral eller rektal anvendelse.</I>  </P>  \r\n\r\n<P>- Lægemidlet må ved prøven &#187;Total viable aerobic count&#171; i Ph.  \r\n\r\n Eur. 3rd Ed. 2.6.12. ikke indeholde mere end 10exp3 aerobe bakterierer og  \r\n\r\n 10exp2 svampe pr. g (ml). Ved prøven &#187;Tests for specified  \r\n\r\n microorganisms&#171; i Ph. Eur. 3rd Ed. 2.6.12. må der ikke kunne påvises  \r\n\r\n<I>Escherichia coli</I> i 1 g (ml). </P>  \r\n\r\n<P> <I>B. For lægemidler til oral anvendelse, der indeholder råvarer af  \r\n\r\n vegetabilsk eller animalsk oprindelse (hvor antimikrobiel behandling ikke er  \r\n\r\n mulig, og hvor Sundhedsstyrelsen har godkendt en initial kontaminering på  \r\n\r\n mere end 10exp3 mikroorganismer i 1 g (ml)). (Lægemidler der udelukkende  \r\n\r\n består af råvarer af vegetabilsk oprindelse eller blandinger af sådanne  \r\n\r\n råvarer er omfattet af kategori 4.)</I>  </P>  \r\n\r\n<P>- Lægemidlet må ved prøven &#187;Total viable aerobic count&#171; i Ph.  \r\n\r\n Eur. 3rd Ed. 2.6.12. ikke indeholde mere end 10exp4 aerobe bakterier og  \r\n\r\n 10exp2 svampe pr. g (ml). </P>  \r\n\r\n<P>- Lægemidlet må ved prøven &#187;Tests for specified microorganisms&#171;  \r\n\r\n i Ph. Eur. 3rd Ed. 2.6.13. ikke indeholde mere end 10exp2  \r\n\r\n<I>enterobakterier</I> og visse andre <I>gramnegative bakterier</I> pr. g  \r\n\r\n (ml) og der må ikke kunne påvises <I>Escherichia coli</I> eller  \r\n\r\n<I>Staphylococcus aureus</I> i 1 g (ml) eller <I>Salmonella</I> i 10 g (ml).  \r\n\r\n</P>  \r\n\r\n<P>KATEGORI 4 </P>  \r\n\r\n<P> <I>A. Lægemidler der udelukkende består af råvarer af vegetabilsk  \r\n\r\n oprindelse og hvor kogende vand tilsættes før anvendelsen.</I>  </P>  \r\n\r\n<P>- Lægemidlet må ved prøven &#187;Total viable aerobic count&#171; i Ph.  \r\n\r\n Eur. 3rd Ed. 2.6.12. ikke indeholde mere end 10exp7 aerobe bakterier og  \r\n\r\n 10exp5 svampe pr. g (ml). </P>  \r\n\r\n<P>- Lægemidlet må ved prøven &#187;Tests for specified microorganisms&#171;  \r\n\r\n i Ph. Eur. 3rd Ed. 2.6.13. ikke indeholde mere end 10exp2  <I>Escherichia  \r\n\r\n coli</I> i 1 g (ml), idet der anvendes passende fortyndinger. </P>  \r\n\r\n<P> <I>B. Andre lægemidler der udelukkende består af råvarer af vegetabilsk  \r\n\r\n oprindelse.</I>  </P>  \r\n\r\n<P>- Lægemidlet må ved prøven &#187;Total viable aerobic count&#171; i Ph.  \r\n\r\n Eur. 3rd Ed. 2.6.12. ikke indeholde mere end 10exp5 aerobe bakterier og  \r\n\r\n 10exp4 svampe pr. g (ml). </P>  \r\n\r\n<P>- Lægemidlet må ved prøven &#187;Tests for specified microorganisms&#171;  \r\n\r\n i Ph. Eur. 3rd Ed. 2.6.13. ikke indeholde mere end 10exp3  \r\n\r\n<I>enterobakterier</I> og visse andre <I>gramnegative bakterier</I> pr. g  \r\n\r\n (ml) og der må ikke kunne påvises <I>Escherichia coli</I> i 1 g (ml) eller  \r\n\r\n<I>Salmonella</I> i 10 g (ml). </P>  \r\n\r\n<P>VALG AF ANALYSEMETODE: </P>  \r\n\r\n<P>Såfremt der ved udførelse af prøverne skal vælges mellem analysemetoderne  \r\n\r\n<I>membrane filtration</I> , <I>plate count</I> eller <I>serial dilution</I>  \r\n\r\n vælges en af de to førstnævnte, hvor råvarens/produktets egenskaber tillader  \r\n\r\n det. <I>Serial dilution</I> må kun anvendes, hvis råvaren/produktet har  \r\n\r\n specielle egenskaber, der udelukker anvendelsen af en af de to andre metoder.  \r\n\r\n</P>  \r\n\r\n<P> <B>SEKTION 2</B>  </P>  \r\n\r\n<P> <B>INTRODUKTION TIL FORTEGNELSE OVER STANDARDER FOR RÅVARER</B>  </P>  \r\n\r\n<P>Standarder </P>  \r\n\r\n<P>En standard for en råvare er i fortegnelsen anført ved en titel og en  \r\n\r\n henvisning til en monografisamling. Såvel titlen som henvisningen er i  \r\n\r\n fortegnelsen anført med halvfed skrifttype. </P>  \r\n\r\n<P>En standards titel svarer til titlen på en monografi. I DLS 97 er titlen  \r\n\r\n ændret til den engelske titel, i lighed med den Europæiske Farmacopes skift  \r\n\r\n af titler, fra latin til engelsk. </P>  \r\n\r\n<P>Henvisning til en gældende monografi i den 3. udgave af Ph. Eur. (Ph. Eur.  \r\n\r\n 3rd Ed.) vil ikke længere være angivet ved hjælp af monografiens løbenr. og  \r\n\r\n udgivelsesårstal for den gældende version, da disse er udeladt i farmakopeens  \r\n\r\n 3. udgave. </P>  \r\n\r\n<P>Ved henvisningen DLS 97 forstås henvisning til afsnittet om standarder for  \r\n\r\n råvarer i sektion 2 i denne bog. </P>  \r\n\r\n<P>Danske navne </P>  \r\n\r\n<P>For hver standard er fastsat et dansk navn. Almindeligvis er det danske  \r\n\r\n navn en direkte oversættelse af standardens engelske titel. Ved en sådan  \r\n\r\n oversættelse er stammerne i de enkelte ord i titlen så vidt muligt overført  \r\n\r\n uændret, også med hensyn til stavemåde, medens de engelske endelser er  \r\n\r\n bortfaldet eller ændret efter sædvane. </P>  \r\n\r\n<P>I en del tilfælde kan det danske navn kun delvis eller slet ikke opfattes  \r\n\r\n som en direkte oversættelse af den engelske titel. Dette gælder især droger.  \r\n\r\n De danske drogenavne oversættes med den hidtidige stavemåde, som i vid  \r\n\r\n udstrækning også vil være kendt fra tidligere danske monografisamlinger (eks.  \r\n\r\n Clove - Kryddernellike). Hvis stamplanten for en droge er anført i Dansk  \r\n\r\n Feltflora, skal det danske navn heri anvendes. </P>  \r\n\r\n<P>Synonymer og navneændringer </P>  \r\n\r\n<P>For drogemonografierne er de oprindelige latinske titler bibeholdt som  \r\n\r\n synonymer til den engelske titel. For tidligere gældende standarder med  \r\n\r\n titler, der afviger væsentligt fra de gældende standarders, er de tidligere  \r\n\r\n danske navne optaget i fortegnelsen som navneændringer. </P>  \r\n\r\n<P>Søgeord </P>  \r\n\r\n<P>I første spalte i fortegnelsen er samtlige standarders engelske titler,  \r\n\r\n fastsatte danske navne samt latinske synonymer for droger og navneændringer  \r\n\r\n opført i alfabetisk orden som søgeord. Det danske navn vil dog ikke optræde i  \r\n\r\n første spalte, hvis standardens engelske titel og det danske navn er identisk  \r\n\r\n eller hvis den eneste forskel er -e. </P>  \r\n\r\n<P>Der kan sædvanligvis ikke søges alfabetisk under en række  \r\n\r\n tillægsbetegnelser, som f.eks: fortyndet, koncentreret, let, renset, steril,  \r\n\r\n tung, tørret, vandfri, vandsugende. I stedet opsøges det næstfølgende ord.  \r\n\r\n For eksempel skal koncentreret saltsyre søges under saltsyre, koncentreret.  \r\n\r\n</P>  \r\n\r\n<P>Til titlen på en standard i fortegnelsens første spalte svarer det  \r\n\r\n fastsatte danske navn i anden spalte. Ved at opsøge et fastsat dansk navn  \r\n\r\n eller et synonym i første spalte, findes den tilsvarende standards engelske  \r\n\r\n titel i anden spalte. Tredje spalte indeholder henvisningen til den  \r\n\r\n monografisamling, hvori standarden forekommer. </P>  \r\n\r\n<PRE>  \r\n\r\n  FORTEGNELSE OVER STANDARDER FOR RÅVARER  \r\n\r\n  Acacia                  Akaciegummi                Ph. Eur. 3rd Ed.  \r\n\r\n  Acacia, spray-dried     Akaciegummi, spraytørret   Ph. Eur. 3rd Ed.  \r\n\r\n Acaciae gummi            Acacia                     Ph. Eur. 3rd Ed.  \r\n\r\n Acaciae gummi  \r\n\r\n  dispersione             Acacia, spray-dried        Ph. Eur. 3rd Ed.  \r\n\r\n  desiccatum  \r\n\r\n  Acebutolol              Acebutololhydrochlorid  \r\n\r\n  hydrochloride                                      Ph. Eur. 3rd Ed.  \r\n\r\n Acebutololhydrochlorid   Acebutolol hydrochloride   Ph. Eur. 3rd Ed.  \r\n\r\n  Acetazolamide           Acetazolamid               Ph. Eur. 3rd Ed.  \r\n\r\n  Acetic acid, glacial    Eddikesyre                 Ph. Eur. 3rd Ed.  \r\n\r\n  Acetone                 Acetone                    Ph. Eur. 3rd Ed.  \r\n\r\n  Acetylcysteine          Acetylcystein              Ph. Eur. 3rd Ed.  \r\n\r\n  Acetylsalicylic acid    Acetylsalicylsyre          Ph. Eur. 3rd Ed.  \r\n\r\n Acetylsalicylsyre        Acetylsalicylic acid       Ph. Eur. 3rd Ed.  \r\n\r\n  Aciclovir               Aciclovir                  Ph. Eur. 3rd Ed.  \r\n\r\n  Adenine                 Adenin                     Ph. Eur. 3rd Ed.  \r\n\r\n Adeps lanae              Wool fat                   Ph. Eur. 3rd Ed.  \r\n\r\n Adeps lanae cum aqua     Wool fat, hydrous          Ph. Eur. 3rd Ed.  \r\n\r\n Adeps lanae  \r\n\r\n  hydrogenatus            Wool fat, hydrogenated     Ph. Eur. 3rd Ed.  \r\n\r\n Adeps solidus            Hard fat                   Ph. Eur. 3rd Ed.  \r\n\r\n  Adrenaline tartrate     Adrenalintartrat           Ph. Eur. 3rd Ed.  \r\n\r\n Adrenalintartrat         Adrenaline tartrate        Ph. Eur. 3rd Ed.  \r\n\r\n  Agar                    Agar                       Ph. Eur. 3rd Ed.  \r\n\r\n  Air, compressed         Luft, medicinsk            DLS 97  \r\n\r\n Akaciegummi              Acacia                     Ph. Eur. 3rd Ed.  \r\n\r\n Akaciegummi,  \r\n\r\n  spraytørret             Acacia, spray-dried        Ph. Eur. 3rd Ed.  \r\n\r\n  Alanine                 Alanin                     Ph. Eur. 3rd Ed.  \r\n\r\n  Alcohol                 Alkohol                    DLS 97  \r\n\r\n  Alcohol 96 per cent     Sprit, stærk               DLS 97  \r\n\r\n Alexandrinsk sennesbælg  Senna pods, Alexandrian    Ph. Eur. 3rd Ed.  \r\n\r\n  Alfentanil  \r\n\r\n  hydrochloride           Alfentanilhydrochlorid     Ph. Eur. 3rd Ed.  \r\n\r\n Alfentanilhydrochlorid   Alfentanil hydrochloride   Ph. Eur. 3rd Ed.  \r\n\r\n  Alginic acid            Alginsyre                  Ph. Eur. 3rd Ed.  \r\n\r\n Alginsyre                Alginic acid               Ph. Eur. 3rd Ed.  \r\n\r\n Alkohol                  Alcohol                    DLS 97  \r\n\r\n  Allopurinol             Allopurinol                Ph. Eur. 3rd Ed.  \r\n\r\n  Almond oil              Mandelolie                 Ph. Eur. 3rd Ed.  \r\n\r\n  Almond oil, refined     Mandelolie, renset         Ph. Eur. 3rd Ed.  \r\n\r\n Aloe barbadensis         Aloes, barbados            Ph. Eur. 3rd Ed.  \r\n\r\n Aloe capensis            Aloes, cape                Ph. Eur. 3rd Ed.  \r\n\r\n Aloeekstrakt, tørret     Aloes dry extract,  \r\n\r\n  standardiseret          standardised               Ph. Eur. 3rd Ed.  \r\n\r\n  Aloes dry extract,      Aloeekstrakt, tørret  \r\n\r\n   standardised           standardiseret             Ph. Eur. 3rd Ed.  \r\n\r\n Aloes extractum          Aloes dry extract,  \r\n\r\n  siccum normatum          standardised              Ph. Eur. 3rd Ed.  \r\n\r\n  Aloes, barbados         Barbados-aloe              Ph. Eur. 3rd Ed.  \r\n\r\n  Aloes, cape             Kap-aloe                   Ph. Eur. 3rd Ed.  \r\n\r\n  Alprazolam              Alprazolam                 Ph. Eur. 3rd Ed.  \r\n\r\n  Alprenolol benzoate     Alprenololbenzoat          Ph. Eur. 3rd Ed.  \r\n\r\n  Alprenolol  \r\n\r\n  hydrochloride           Alprenololhydrochlorid     Ph. Eur. 3rd Ed.  \r\n\r\n Alprenololbenzoat        Alprenolol benzoate        Ph. Eur. 3rd Ed.  \r\n\r\n Alprenololhydrochlorid   Alprenolol hydrochloride   Ph. Eur. 3rd Ed.  \r\n\r\n Althaeae radix           Marshmallow root           Ph. Eur. 3rd Ed.  \r\n\r\n Alttuberculin            Tuberculin, old, for  \r\n\r\n                          human use                  Ph. Eur. 3rd Ed.  \r\n\r\n Altæarod                 Marshmallow root           Ph. Eur. 3rd Ed.  \r\n\r\n  Alum                    Alun                       Ph. Eur. 3rd Ed.  \r\n\r\n  Aluminium chloride  \r\n\r\n  hexahydrate             Aluminiumchloridhexahydrat Ph. Eur. 3rd Ed.  \r\n\r\n  Aluminium oxide,  \r\n\r\n  hydrated                Aluminiumoxidhydrat        Ph. Eur. 3rd Ed.  \r\n\r\n  Aluminium sulphate      Aluminiumsulfat            Ph. Eur. 3rd Ed.  \r\n\r\n Aluminiumchlorid-  \r\n\r\n  hexahydrat              Aluminium chloride  \r\n\r\n                          hexahydrate                Ph. Eur. 3rd Ed.  \r\n\r\n Aluminiumoxidhydrat      Aluminium oxide, hydrated  Ph. Eur. 3rd Ed.  \r\n\r\n Aluminiumsulfat          Aluminium sulphate         Ph. Eur. 3rd Ed.  \r\n\r\n Alun                     Alum                       Ph. Eur. 3rd Ed.  \r\n\r\n  Amantadine  \r\n\r\n  hydrochloride           Amantadinhydrochlorid      Ph. Eur. 3rd Ed.  \r\n\r\n Amantadinhydrochlorid    Amantadine hydrochloride   Ph. Eur. 3rd Ed.  \r\n\r\n  Amidotrizoic acid,  \r\n\r\n  dihydrate               Amidotrizoinsyredihydrat   Ph. Eur. 3rd Ed.  \r\n\r\n Amidotrizoinsyre         Amidotrizoic acid,  \r\n\r\n                          dihydrate                  Ph. Eur. 3rd Ed.  \r\n\r\n Amidotrizoinsyredihydrat Amidotrizoic acid,  \r\n\r\n                          dihydrate                  Ph. Eur. 3rd Ed.  \r\n\r\n  Amiloride hydrochloride Amiloridhydrochlorid       Ph. Eur. 3rd Ed.  \r\n\r\n Amiloridhydrochlorid     Amiloride hydrochloride    Ph. Eur. 3rd Ed.  \r\n\r\n  Aminocaproic acid       Aminocapronsyre            Ph. Eur. 3rd Ed.  \r\n\r\n Aminocapronsyre          Aminocaproic acid          Ph. Eur. 3rd Ed.  \r\n\r\n  Amiodarone  \r\n\r\n  hydrochloride           Amiodaronhydrochlorid      Ph. Eur. 3rd Ed.  \r\n\r\n Amiodaronhydrochlorid    Amiodarone hydrochloride   Ph. Eur. 3rd Ed.  \r\n\r\n  Amitriptyline  \r\n\r\n  hydrochloride           Amitriptylinhydrochlorid   Ph. Eur. 3rd Ed.  \r\n\r\n Amitriptylin-  \r\n\r\n  hydrochlorid            Amitriptyline  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Ammonia solution,  \r\n\r\n  concentrated            Ammoniakopløsning,  \r\n\r\n                           koncentreret              Ph. Eur. 3rd Ed.  \r\n\r\n Ammoniakopløsning,  \r\n\r\n  koncentreret            Ammonia solution,  \r\n\r\n                          concentrated               Ph. Eur. 3rd Ed.  \r\n\r\n  Ammonium chloride       Ammoniumchlorid            Ph. Eur. 3rd Ed.  \r\n\r\n Ammoniumchlorid          Ammonium chloride          Ph. Eur. 3rd Ed.  \r\n\r\n  Amobarbital             Amobarbital                Ph. Eur. 3rd Ed.  \r\n\r\n  Amobarbital sodium      Amobarbitalnatrium         Ph. Eur. 3rd Ed.  \r\n\r\n Amobarbitalnatrium       Amobarbital sodium         Ph. Eur. 3rd Ed.  \r\n\r\n  Amoxicillin sodium      Amoxicillinnatrium         Ph. Eur. 3rd Ed.  \r\n\r\n  Amoxicillin trihydrate  Amoxicillintrihydrat       Ph. Eur. 3rd Ed.  \r\n\r\n Amoxicillinnatrium       Amoxicillin sodium         Ph. Eur. 3rd Ed.  \r\n\r\n Amoxicillintrihydrat     Amoxicillin trihydrate     Ph. Eur. 3rd Ed.  \r\n\r\n  Amphetamine sulphate    Amphetaminsulfat           Ph. Eur. 3rd Ed.  \r\n\r\n Amphetaminsulfat         Amphetamine sulphate       Ph. Eur. 3rd Ed.  \r\n\r\n  Ampicillin sodium       Ampicillinnatrium          Ph. Eur. 3rd Ed.  \r\n\r\n  Ampicillin trihydrate   Ampicillintrihydrat        Ph. Eur. 3rd Ed.  \r\n\r\n  Ampicillin, anhydrous   Ampicillin, vandfri        Ph. Eur. 3rd Ed.  \r\n\r\n Ampicillin, vandfri      Ampicillin, anhydrous      Ph. Eur. 3rd Ed.  \r\n\r\n Ampicillinnatrium        Ampicillin sodium          Ph. Eur. 3rd Ed.  \r\n\r\n Ampicillintrihydrat      Ampicillin trihydrate      Ph. Eur. 3rd Ed.  \r\n\r\n Amygdalae oleum          Almond oil                 Ph. Eur. 2nd Ed.  \r\n\r\n Amygdalae oleum  \r\n\r\n  raffinatum              Almond oil, refined        Ph. Eur. 3rd Ed.  \r\n\r\n Anis                     Aniseed                    Ph. Eur. 3rd Ed.  \r\n\r\n  Anise oil               Anisolie                   Ph. Eur. 3rd Ed.  \r\n\r\n  Aniseed                 Anis                       Ph. Eur. 3rd Ed.  \r\n\r\n Anisi aetheroleum        Anise oil                  Ph. Eur. 3rd Ed.  \r\n\r\n Anisi fructus            Aniseed                    Ph. Eur. 3rd Ed.  \r\n\r\n  Anisi stellati fructus  Star anise                 Ph. Eur. 3rd Ed.  \r\n\r\n Anisolie                 Anise oil                  Ph. Eur. 3rd Ed.  \r\n\r\n  Antazoline  \r\n\r\n  hydrochloride           Antazolinhydrochlorid      Ph. Eur. 3rd Ed.  \r\n\r\n Antazolinhydrochlorid    Antazoline hydrochloride   Ph. Eur. 3rd Ed.  \r\n\r\n  Apomorphine  \r\n\r\n  hydrochloride           Apomorphinhydrochlorid     Ph. Eur. 3rd Ed.  \r\n\r\n Apomorphinhydrochlorid   Apomorphine hydrochloride  Ph. Eur. 3rd Ed.  \r\n\r\n  Aprotinin               Aprotinin                  Ph. Eur. 3rd Ed.  \r\n\r\n  Aprotinin  \r\n\r\n  concentrated solution   Aprotinin, koncentreret  \r\n\r\n                          opløsning                  Ph. Eur. 3rd Ed.  \r\n\r\n Aprotinin,  \r\n\r\n  koncentreret opløsning  Aprotinin concentrated  \r\n\r\n                          solution                   Ph. Eur. 3rd Ed.  \r\n\r\n Arachidis oleum          Arachis oil                Ph. Eur. 3rd Ed.  \r\n\r\n  Arachis oil             Jordnødolie                Ph. Eur. 3rd Ed.  \r\n\r\n  Arginine                Arginin                    Ph. Eur. 3rd Ed.  \r\n\r\n  Arginine hydrochloride  Argininhydrochlorid        Ph. Eur. 3rd Ed.  \r\n\r\n  Argininhydrochlorid     Arginine hydrochloride     Ph. Eur. 3rd Ed.  \r\n\r\n  Ascorbic acid           Ascorbinsyre               Ph. Eur. 3rd Ed.  \r\n\r\n Ascorbinsyre             Ascorbic acid              Ph. Eur. 3rd Ed.  \r\n\r\n  Ascorbyl palmitate      Ascorbylpalmitat           Ph. Eur. 3rd Ed.  \r\n\r\n Ascorbylpalmitat         Ascorbyl palmitate         Ph. Eur. 3rd Ed.  \r\n\r\n Asparaginsyre            Aspartic acid              Ph. Eur. 3rd Ed.  \r\n\r\n  Aspartame               Aspartam                   Ph. Eur. 3rd Ed.  \r\n\r\n  Aspartic acid           Asparaginsyre              Ph. Eur. 3rd Ed.  \r\n\r\n  Astemizole              Astemizol                  Ph. Eur. 3rd Ed.  \r\n\r\n  Atenolol                Atenolol                   Ph. Eur. 3rd Ed.  \r\n\r\n  Atropine sulphate       Atropinsulfat              Ph. Eur. 3rd Ed.  \r\n\r\n Atropinsulfat            Atropine sulphate          Ph. Eur. 3rd Ed.  \r\n\r\n  Azathioprine            Azathioprin                Ph. Eur. 3rd Ed.  \r\n\r\n  Bacampicillin  \r\n\r\n  hydrochloride           Bacampicillinhydrochlorid  Ph. Eur. 3rd Ed.  \r\n\r\n Bacampicillin-  \r\n\r\n  hydrochlorid            Bacampicillin  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Bacitracin              Bacitracin                 Ph. Eur. 3rd Ed.  \r\n\r\n  Bacitracin zinc         Bacitracinzink             Ph. Eur. 3rd Ed.  \r\n\r\n Bacitracinzink           Bacitracin zinc            Ph. Eur. 3rd Ed.  \r\n\r\n  Baclofen                Baclofen                   Ph. Eur. 3rd Ed.  \r\n\r\n Baldrianrod              Valerian root              Ph. Eur. 3rd Ed.  \r\n\r\n Balsamum peruvianum      Peru balsam                Ph. Eur. 3rd Ed.  \r\n\r\n Barbados-aloe            Aloes, barbados            Ph. Eur. 3rd Ed.  \r\n\r\n  Barbital                Barbital                   Ph. Eur. 3rd Ed.  \r\n\r\n  Barium sulphate         Bariumsulfat               Ph. Eur. 3rd Ed.  \r\n\r\n Bariumsulfat             Barium sulphate            Ph. Eur. 3rd Ed.  \r\n\r\n  Bearberry leaf          Melbærrisblad              Ph. Eur. 3rd Ed.  \r\n\r\n Beclometasondipropionat  Beclometasone  \r\n\r\n                          dipropionate               Ph. Eur. 3rd Ed.  \r\n\r\n  Beclometasone  \r\n\r\n  dipropionate            Beclometasondipropionat    Ph. Eur. 3rd Ed.  \r\n\r\n  Belladonna leaf         Belladonnablad             Ph. Eur. 3rd Ed.  \r\n\r\n  Belladonna, prepared    Belladonna, standardiseret Ph. Eur. 3rd Ed.  \r\n\r\n Belladonna,  \r\n\r\n  standardiseret          Belladonna, prepared       Ph. Eur. 3rd Ed.  \r\n\r\n Belladonnablad           Belladonna leaf            Ph. Eur. 3rd Ed.  \r\n\r\n Belladonnae folium       Belladonna leaf            Ph. Eur. 3rd Ed.  \r\n\r\n Belladonnae pulvis  \r\n\r\n  normatus                Belladonna, prepared       Ph. Eur. 3rd Ed.  \r\n\r\n  Bendroflumethiazide     Bendroflumethiazid         Ph. Eur. 3rd Ed.  \r\n\r\n  Bentonite               Bentonit                   Ph. Eur. 3rd Ed.  \r\n\r\n  Benzalkonium chloride   Benzalkoniumchlorid        Ph. Eur. 3rd Ed.  \r\n\r\n  Benzalkonium chloride  \r\n\r\n  solution                Benzalkoniumchlorid-  \r\n\r\n                          opløsning                  Ph. Eur. 3rd Ed.  \r\n\r\n Benzalkoniumchlorid      Benzalkonium chloride      Ph. Eur. 3rd Ed.  \r\n\r\n Benzalkoniumchlorid-  \r\n\r\n  opløsning               Benzalkonium chloride  \r\n\r\n                          solution                   Ph. Eur. 3rd Ed.  \r\n\r\n  Benzethonium chloride   Benzethoniumchlorid        Ph. Eur. 3rd Ed.  \r\n\r\n Benzethoniumchlorid      Benzethonium chloride      Ph. Eur. 3rd Ed.  \r\n\r\n  Benzocaine              Benzocain                  Ph. Eur. 3rd Ed.  \r\n\r\n Benzoesyre               Benzoic acid               Ph. Eur. 3rd Ed.  \r\n\r\n  Benzoic acid            Benzoesyre                 Ph. Eur. 3rd Ed.  \r\n\r\n  Benzoyl peroxide,  \r\n\r\n  hydrous                 Benzoylperoxid, vandig     Ph. Eur. 3rd Ed.  \r\n\r\n Benzoylperoxid, vandig   Benzoyl peroxide, hydrous  Ph. Eur. 3rd Ed.  \r\n\r\n  Benzyl alcohol          Benzylalkohol              Ph. Eur. 3rd Ed.  \r\n\r\n  Benzyl benzoate         Benzylbenzoat              Ph. Eur. 3rd Ed.  \r\n\r\n Benzylalkohol            Benzyl alcohol             Ph. Eur. 3rd Ed.  \r\n\r\n Benzylbenzoat            Benzyl benzoate            Ph. Eur. 3rd Ed.  \r\n\r\n  Benzylpenicillin  \r\n\r\n  potassium               Benzylpenicillinkalium     Ph. Eur. 3rd Ed.  \r\n\r\n  Benzylpenicillin  \r\n\r\n  sodium                  Benzylpenicillinnatrium    Ph. Eur. 3rd Ed.  \r\n\r\n  Benzylpenicillin,  \r\n\r\n  benzathine              Benzylpenicillinbenzathin  Ph. Eur. 3rd Ed.  \r\n\r\n  Benzylpenicillin,  \r\n\r\n  procaine                Benzylpenicillinprocain    Ph. Eur. 3rd Ed.  \r\n\r\n Benzylpenicillin-  \r\n\r\n  benzathin               Benzylpenicillin,  \r\n\r\n                          benzathine                 Ph. Eur. 3rd Ed.  \r\n\r\n Benzylpenicillinkalium   Benzylpenicillin  \r\n\r\n                          potassium                  Ph. Eur. 3rd Ed.  \r\n\r\n Benzylpenicillinnatrium  Benzylpenicillin sodium    Ph. Eur. 3rd Ed.  \r\n\r\n Benzylpenicillinprocain  Benzylpenicillin,  \r\n\r\n                          procaine                   Ph. Eur. 3rd Ed.  \r\n\r\n  Betacarotene            Betacaroten                Ph. Eur. 3rd Ed.  \r\n\r\n  Betacyclodextrine       Betacyclodextrin           Ph. Eur. 3rd Ed.  \r\n\r\n  Betahistidine mesilate  Betahistidinmesilat        Ph. Eur. 3rd Ed.  \r\n\r\n Betahistidinmesilat      Betahistidine mesilate     Ph. Eur. 3rd Ed.  \r\n\r\n Betamethasonacetat       Betamethasone acetate      Ph. Eur. 3rd Ed.  \r\n\r\n Betamethasondi-  \r\n\r\n  natriumphosphat         Betamethasone sodium  \r\n\r\n                          phosphate                  Ph. Eur. 3rd Ed.  \r\n\r\n Betamethasondipropionat  Betamethasone  \r\n\r\n                          dipropionate               Ph. Eur. 3rd Ed.  \r\n\r\n  Betamethasone           Betamethason               Ph. Eur. 3rd Ed.  \r\n\r\n  Betamethasone acetate   Betamethasonacetat         Ph. Eur. 3rd Ed.  \r\n\r\n  Betamethasone  \r\n\r\n  dipropionate            Betamethasondipropionat    Ph. Eur. 3rd Ed.  \r\n\r\n  Betamethasone sodium  \r\n\r\n  phosphate               Betamethasondinatrium-  \r\n\r\n                          phosphat                   Ph. Eur. 3rd Ed.  \r\n\r\n  Betamethasone valerate  Betamethasonvalerat        Ph. Eur. 3rd Ed.  \r\n\r\n Betamethasonvalerat      Betamethasone valerate     Ph. Eur. 3rd Ed.  \r\n\r\n  Betanidine sulphate     Betanidinsulfat            Ph. Eur. 3rd Ed.  \r\n\r\n Betanidinsulfat          Betanidine sulphate        Ph. Eur. 3rd Ed.  \r\n\r\n  Betaxolol  \r\n\r\n  hydrochloride           Betaxololhydrochlorid      Ph. Eur. 3rd Ed.  \r\n\r\n Betaxololhydrochlorid    Betaxolol hydrochloride    Ph. Eur. 3rd Ed.  \r\n\r\n  Biotin                  Biotin                     Ph. Eur. 3rd Ed.  \r\n\r\n  Biperiden  \r\n\r\n  hydrochloride           Biperidenhydrochlorid      Ph. Eur. 3rd Ed.  \r\n\r\n Biperidenhydrochlorid    Biperiden hydrochloride    Ph. Eur. 3rd Ed.  \r\n\r\n  Bisacodyl               Bisacodyl                  Ph. Eur. 3rd Ed.  \r\n\r\n  Bismuth subcarbonate    Bismuthsubcarbonat         Ph. Eur. 3rd Ed.  \r\n\r\n Bismuthsubcarbonat       Bismuth subcarbonate       Ph. Eur. 3rd Ed.  \r\n\r\n  Bleomycin sulphate      Bleomycinsulfat            Ph. Eur. 3rd Ed.  \r\n\r\n Bleomycinsulfat          Bleomycin sulphate         Ph. Eur. 3rd Ed.  \r\n\r\n  Borax                   Borax                      Ph. Eur. 3rd Ed.  \r\n\r\n  Boric acid              Borsyre                    Ph. Eur. 3rd Ed.  \r\n\r\n Borsyre                  Boric acid                 Ph. Eur. 3rd Ed.  \r\n\r\n  Bromazepam              Bromazepam                 Ph. Eur. 3rd Ed.  \r\n\r\n Bromcriptinmesilat       Bromocriptine mesilate     Ph. Eur. 3rd Ed.  \r\n\r\n  Bromhexine  \r\n\r\n  hydrochloride           Bromhexinhydrochlorid      Ph. Eur. 3rd Ed.  \r\n\r\n Bromhexinhydrochlorid    Bromhexine hydrochloride   Ph. Eur. 3rd Ed.  \r\n\r\n  Bromocriptine mesilate  Bromcriptinmesilat         Ph. Eur. 3rd Ed.  \r\n\r\n  Brompheniramine  \r\n\r\n  maleate                 Brompheniraminmaleat       Ph. Eur. 3rd Ed.  \r\n\r\n Brompheniraminmaleat     Brompheniramine maleate    Ph. Eur. 3rd Ed.  \r\n\r\n  Budesonide              Budesonid                  Ph. Eur. 3rd Ed.  \r\n\r\n Bulmeurtblad             Hyoscyamus leaf            Ph. Eur. 3rd Ed.  \r\n\r\n  Bumetanide              Bumetanid                  Ph. Eur. 3rd Ed.  \r\n\r\n  Bupivacaine  \r\n\r\n  hydrochloride           Bupivacainhydrochlorid     Ph. Eur. 3rd Ed.  \r\n\r\n Bupivacainhydrochlorid   Bupivacaine hydrochloride  Ph. Eur. 3rd Ed.  \r\n\r\n  Buserelin               Buserelin                  Ph. Eur. 3rd Ed.  \r\n\r\n  Busulfan                Busulfan                   Ph. Eur. 3rd Ed.  \r\n\r\n  Butobarbital            Butobarbital               Ph. Eur. 3rd Ed.  \r\n\r\n  Butyl parahydroxy-  \r\n\r\n  benzoate                Butylparahydroxybenzoat    Ph. Eur. 3rd Ed.  \r\n\r\n  Butylhydroxyanisole     Butylhydroxyanisol         Ph. Eur. 3rd Ed.  \r\n\r\n  Butylhydroxytoluene     Butylhydroxytoluen         Ph. Eur. 3rd Ed.  \r\n\r\n Butylparahydroxybenzoat  Butyl parahydroxybenzoate  Ph. Eur. 3rd Ed.  \r\n\r\n  Caffeine                Caffein                    Ph. Eur. 3rd Ed.  \r\n\r\n  Caffeine monohydrate    Caffeinmonohydrat          Ph. Eur. 3rd Ed.  \r\n\r\n Caffeinmonohydrat        Caffeine monohydrate       Ph. Eur. 3rd Ed.  \r\n\r\n Calcitonin (laks)        Calcitonin (salmon)        Ph. Eur. 3rd Ed.  \r\n\r\n  Calcitonin (salmon)     Calcitonin (laks)          Ph. Eur. 3rd Ed.  \r\n\r\n  Calcitriol              Calcitriol                 Ph. Eur. 3rd Ed.  \r\n\r\n  Calcium carbonate       Calciumcarbonat            Ph. Eur. 3rd Ed.  \r\n\r\n  Calcium chloride        Calciumchloriddihydrat     Ph. Eur. 3rd Ed.  \r\n\r\n  Calcium chloride  \r\n\r\n  hexahydrate             Calciumchloridhexahydrat   Ph. Eur. 3rd Ed.  \r\n\r\n  Calcium folinate        Calciumfolinat             Ph. Eur. 3rd Ed.  \r\n\r\n  Calcium gluconate       Calciumgluconat            Ph. Eur. 3rd Ed.  \r\n\r\n  Calcium gluconate for  \r\n\r\n  injection               Calciumgluconat til  \r\n\r\n                          parenteralt                Ph. Eur. 3rd Ed.  \r\n\r\n                          brug  \r\n\r\n  Calcium  \r\n\r\n  glycerophosphate        Calciumglycerophosphat     Ph. Eur. 3rd Ed.  \r\n\r\n  Calcium hydrogen  \r\n\r\n  phosphate               Calciumhydrogenphosphat    Ph. Eur. 3rd Ed.  \r\n\r\n  dihydrate               dihydrate  \r\n\r\n  Calcium hydrogen  \r\n\r\n  phosphate,              Calciumhydrogenphosphat,  \r\n\r\n  anhydrous               vandfrit                   Ph. Eur. 3rd Ed.  \r\n\r\n  Calcium hydroxide       Calciumhydroxid            Ph. Eur. 3rd Ed.  \r\n\r\n  Calcium lactate  \r\n\r\n  pentahydrate            Calciumlactatpentahydrat   Ph. Eur. 3rd Ed.  \r\n\r\n  Calcium lactate  \r\n\r\n  trihydrate              Calciumlactattrihydrat     Ph. Eur. 3rd Ed.  \r\n\r\n  Calcium pantothenate    Calciumpantothenat         Ph. Eur. 3rd Ed.  \r\n\r\n  Calcium phosphate       Tricalciumphosphat         Ph. Eur. 3rd Ed.  \r\n\r\n  Calcium stearate        Calciumstearat             Ph. Eur. 3rd Ed.  \r\n\r\n  Calcium sulphate  \r\n\r\n  dihydrate               Calciumsulfatdihydrat      Ph. Eur. 3rd Ed.  \r\n\r\n Calciumcarbonat          Calcium carbonate          Ph. Eur. 3rd Ed.  \r\n\r\n Calciumchloriddihydrat   Calcium chloride           Ph. Eur. 3rd Ed.  \r\n\r\n Calciumchloridhexahydrat Calcium chloride  \r\n\r\n                          hexahydrate                Ph. Eur. 3rd Ed.  \r\n\r\n Calciumfolinat           Calcium folinate           Ph. Eur. 3rd Ed.  \r\n\r\n Calciumgluconat          Calcium gluconate          Ph. Eur. 3rd Ed.  \r\n\r\n Calciumgluconat til  \r\n\r\n  parenteralt             Calcium gluconate for  \r\n\r\n  brug                    injection                  Ph. Eur. 3rd Ed.  \r\n\r\n Calciumglycerophosphat   Calcium glycerophosphate   Ph. Eur. 3rd Ed.  \r\n\r\n Calciumhydrogenphosphat  Calcium hydrogen  \r\n\r\n                          phosphate                  Ph. Eur. 3rd Ed.  \r\n\r\n                          dihydrate  \r\n\r\n Calciumhydrogenphosphat  Calcium hydrogen  \r\n\r\n dihydrate                phosphate                  Ph. Eur. 3rd Ed.  \r\n\r\n                          dihydrate  \r\n\r\n Calciumhydrogen-  \r\n\r\n  phosphat, vandfrit      Calcium hydrogen  \r\n\r\n                          phosphate,                 Ph. Eur. 3rd Ed.  \r\n\r\n                          anhydrous  \r\n\r\n Calciumhydroxid          Calcium hydroxide          Ph. Eur. 3rd Ed.  \r\n\r\n Calciumlactatpenta-  \r\n\r\n  hydrat                  Calcium lactate  \r\n\r\n                          pentahydrate               Ph. Eur. 3rd Ed.  \r\n\r\n Calciumlactattrihydrat   Calcium lactate  \r\n\r\n                          trihydrate                 Ph. Eur. 3rd Ed.  \r\n\r\n Calciumpantothenat       Calcium pantothenate       Ph. Eur. 3rd Ed.  \r\n\r\n Calciumstearat           Calcium stearate           Ph. Eur. 3rd Ed.  \r\n\r\n Calciumsulfatdihydrat    Calcium sulphate  \r\n\r\n                          dihydrate                  Ph. Eur. 3rd Ed.  \r\n\r\n Campher, racemisk        Camphor, racemic           Ph. Eur. 3rd Ed.  \r\n\r\n  Camphor, racemic        Campher, racemisk          Ph. Eur. 3rd Ed.  \r\n\r\n  Captopril               Captopril                  Ph. Eur. 3rd Ed.  \r\n\r\n  Caraway fruit           Kommen                     Ph. Eur. 3rd Ed.  \r\n\r\n  Carbamazepine           Carbamazepin               Ph. Eur. 3rd Ed.  \r\n\r\n  Carbenicillin sodium    Carbenicillinnatrium       Ph. Eur. 3rd Ed.  \r\n\r\n Carbenicillinnatrium     Carbenicillin sodium       Ph. Eur. 3rd Ed.  \r\n\r\n  Carbidopa               Carbidopa                  Ph. Eur. 3rd Ed.  \r\n\r\n  Carbimazole             Carbimazol                 Ph. Eur. 3rd Ed.  \r\n\r\n  Carbocisteine           Carbocistein               Ph. Eur. 3rd Ed.  \r\n\r\n  Carbon dioxide          Carbondioxid               Ph. Eur. 3rd Ed.  \r\n\r\n Carbondioxid             Carbon dioxide             Ph. Eur. 3rd Ed.  \r\n\r\n  Carboplatin             Carboplatin                Ph. Eur. 3rd Ed.  \r\n\r\n  Carboxymethyl-  \r\n\r\n  cellulose sodium        Carboxymethylcellulose-  \r\n\r\n                          natrium                    Ph. Eur. 3rd Ed.  \r\n\r\n Carboxymethyl-  \r\n\r\n  cellulosenatrium        Carboxymethylcellulose  \r\n\r\n                          sodium                     Ph. Eur. 3rd Ed.  \r\n\r\n Carboxymethyl-  \r\n\r\n  stivelsesnatrium        Sodium starch glycollate  \r\n\r\n  (type A                 (type A)                   Ph. Eur. 3rd Ed.  \r\n\r\n Carboxymethyl-  \r\n\r\n  stivelsesnatrium        Sodium starch glycollate  \r\n\r\n  (type B)                (type B)                   Ph. Eur. 3rd Ed.  \r\n\r\n  Carmellose calcium      Carmellosecalcium          Ph. Eur. 3rd Ed.  \r\n\r\n Carmellosecalcium        Carmellose calcium         Ph. Eur. 3rd Ed.  \r\n\r\n  Carnauba wax            Carnaubavoks               Ph. Eur. 3rd Ed.  \r\n\r\n Carnaubavoks             Carnauba wax               Ph. Eur. 3rd Ed.  \r\n\r\n Carvi fructus            Caraway fruit              Ph. Eur. 3rd Ed.  \r\n\r\n Caryophylli floris  \r\n\r\n  aetheroleum             Clove oil                  Ph. Eur. 3rd Ed.  \r\n\r\n Caryophylli flos         Clove                      Ph. Eur. 3rd Ed.  \r\n\r\n  Cascara                 Purshianabark              Ph. Eur. 3rd Ed.  \r\n\r\n  Castor oil              Ricinusolie                Ph. Eur. 3rd Ed.  \r\n\r\n  Castor oil, polyoxyl    Ricinusolie, polyoxyleret  Ph. Eur. 3rd Ed.  \r\n\r\n  Castor oil, polyoxyl  \r\n\r\n  hydrogenated            Ricinusolie,  \r\n\r\n                          polyoxyleret,              Ph. Eur. 3rd Ed.  \r\n\r\n                          hydrogeneret  \r\n\r\n  Cefaclor                Cefaclor                   Ph. Eur. 3rd Ed.  \r\n\r\n  Cefadroxil              Cefadroxil                 Ph. Eur. 3rd Ed.  \r\n\r\n  Cefalexin               Cefalexin                  Ph. Eur. 3rd Ed.  \r\n\r\n  Cefalotin  sodium       Cefalotinnatrium           Ph. Eur. 3rd Ed.  \r\n\r\n Cefalotinnatrium         Cefalotin  sodium          Ph. Eur. 3rd Ed.  \r\n\r\n  Cefazolin  sodium       Cefazolinnatrium           Ph. Eur. 3rd Ed.  \r\n\r\n Cefazolinnatrium         Cefazolin  sodium          Ph. Eur. 3rd Ed.  \r\n\r\n  Cefotaxime sodium       Cefotaximnatrium           Ph. Eur. 3rd Ed.  \r\n\r\n Cefotaximnatrium         Cefotaxime sodium          Ph. Eur. 3rd Ed.  \r\n\r\n  Cefoxitin sodium        Cefoxitinnatrium           Ph. Eur. 3rd Ed.  \r\n\r\n Cefoxitinnatrium         Cefoxitin sodium           Ph. Eur. 3rd Ed.  \r\n\r\n  Cefradine               Cefradin                   Ph. Eur. 3rd Ed.  \r\n\r\n  Ceftriaxone sodium      Ceftriaxonnatrium          Ph. Eur. 3rd Ed.  \r\n\r\n Ceftriaxonnatrium        Ceftriaxone sodium         Ph. Eur. 3rd Ed.  \r\n\r\n  Cefuroxime sodium       Cefuroximnatrium           Ph. Eur. 3rd Ed.  \r\n\r\n Cefuroximnatrium         Cefuroxime sodium          Ph. Eur. 3rd Ed.  \r\n\r\n Cellulose                Cellulose, powdered        Ph. Eur. 3rd Ed.  \r\n\r\n  Cellulose acetate       Celluloseacetat            Ph. Eur. 3rd Ed.  \r\n\r\n  Cellulose acetate  \r\n\r\n  phthalate               Celluloseacetatphthalat    Ph. Eur. 3rd Ed.  \r\n\r\n  Cellulose,  \r\n\r\n  microcristalline        Cellulose,  \r\n\r\n                          mikrokrystallinsk          Ph. Eur. 3rd Ed.  \r\n\r\n Cellulose,  \r\n\r\n  mikrokrystallinsk       Cellulose,  \r\n\r\n                          microcristalline           Ph. Eur. 3rd Ed.  \r\n\r\n  Cellulose, powdered     Cellulose                  Ph. Eur. 3rd Ed.  \r\n\r\n Celluloseacetat          Cellulose acetate          Ph. Eur. 3rd Ed.  \r\n\r\n Celluloseacetatphthalat  Cellulose acetate  \r\n\r\n                          phthalate                  Ph. Eur. 3rd Ed.  \r\n\r\n Cera alba                White beeswax              Ph. Eur. 3rd Ed.  \r\n\r\n Cera carnauba            Carnauba wax               Ph. Eur. 3rd Ed.  \r\n\r\n Cera flava               Yellow beeswax             Ph. Eur. 3rd Ed.  \r\n\r\n  Cetirizine  \r\n\r\n  dihydrochloride         Citirizindihydrochlorid    Ph. Eur. 3rd Ed.  \r\n\r\n  Cetostearyl alcohol     Cetostearylalkohol         Ph. Eur. 3rd Ed.  \r\n\r\n  Cetostearyl alcohol,  \r\n\r\n  emulsifying             Cetostearylalkohol,  \r\n\r\n  (type A)                emulgerende                Ph. Eur. 3rd Ed.  \r\n\r\n                          (type A)  \r\n\r\n  Cetostearyl alcohol,  \r\n\r\n  emulsifying             Cetostearylalkohol,  \r\n\r\n  (type B)                emulgerende                Ph. Eur. 3rd Ed.  \r\n\r\n                          (type B)  \r\n\r\n  Cetostearyl  \r\n\r\n  isononanoate            Cetostearylisononanoat     Ph. Eur. 3rd Ed.  \r\n\r\n Cetostearylalkohol       Cetostearyl alcohol        Ph. Eur. 3rd Ed.  \r\n\r\n Cetostearylalkohol,  \r\n\r\n  emulgerende             Cetostearyl alcohol,  \r\n\r\n  (type B)                emulsifying                Ph. Eur. 3rd Ed.  \r\n\r\n                          (type B)  \r\n\r\n Cetostearylalkohol,  \r\n\r\n  emulgerende             Cetostearyl alcohol,  \r\n\r\n  (type A)                emulsifying                Ph. Eur. 3rd Ed.  \r\n\r\n                          (type A)  \r\n\r\n Cetostearylisononanoat   Cetostearyl isononanoate   Ph. Eur. 3rd Ed.  \r\n\r\n  Cetrimide               Cetrimid                   Ph. Eur. 3rd Ed.  \r\n\r\n  Cetyl alcohol           Cetylalkohol               Ph. Eur. 3rd Ed.  \r\n\r\n Cetyl- og stearylalkohol Cetostearyl alcohol        Ph. Eur. 3rd Ed.  \r\n\r\n Cetylalkohol             Cetyl alcohol              Ph. Eur. 3rd Ed.  \r\n\r\n  Cetylpyridinium  \r\n\r\n  chloride                Cetylpyridiniumchlorid     Ph. Eur. 3rd Ed.  \r\n\r\n Cetylpyridiniumchlorid   Cetylpyridinium chloride   Ph. Eur. 3rd Ed.  \r\n\r\n Ceylon kanel             Cinnamon                   Ph. Eur. 3rd Ed.  \r\n\r\n  Chamomile flower,  \r\n\r\n  Roman                   Romersk kamilleblomst      Ph. Eur. 3rd Ed.  \r\n\r\n Chamomillae romanae  \r\n\r\n  flos                    Chamomile flower, Roman    Ph. Eur. 3rd Ed.  \r\n\r\n  Charcoal, activated     Kul, aktivt                Ph. Eur. 3rd Ed.  \r\n\r\n Chinidinsulfat           Quinidine sulphate         Ph. Eur. 3rd Ed.  \r\n\r\n Chininhydrochlorid       Quinine hydrochloride      Ph. Eur. 3rd Ed.  \r\n\r\n Chininsulfat             Quinine sulphate           Ph. Eur. 3rd Ed.  \r\n\r\n  Chloral hydrate         Chloralhydrat              Ph. Eur. 3rd Ed.  \r\n\r\n Chloralhydrat            Chloral hydrate            Ph. Eur. 3rd Ed.  \r\n\r\n  Chlorambucil            Chlorambucil               Ph. Eur. 3rd Ed.  \r\n\r\n  Chloramine              Chloramin                  Ph. Eur. 3rd Ed.  \r\n\r\n  Chloramphenicol         Chloramphenicol            Ph. Eur. 3rd Ed.  \r\n\r\n  Chloramphenicol  \r\n\r\n  palmitate               Chloramphenicolpalmitat    Ph. Eur. 3rd Ed.  \r\n\r\n  Chloramphenicol sodium  \r\n\r\n  succinate               Chloramphenicol-  \r\n\r\n                          natriumsuccinat            Ph. Eur. 3rd Ed.  \r\n\r\n Chloramphenicol-  \r\n\r\n  natriumsuccinat         Chloramphenicol sodium  \r\n\r\n                          succinate                  Ph. Eur. 3rd Ed.  \r\n\r\n Chloramphenicolpalmitat  Chloramphenicol palmitate  Ph. Eur. 3rd Ed.  \r\n\r\n Chlorbutanol, vandfri    Chlorobutanol, anhydrous   Ph. Eur. 3rd Ed.  \r\n\r\n Chlorbutanolhemihydrat   Chlorobutanol hemihydrate  Ph. Eur. 3rd Ed.  \r\n\r\n Chlorcresol              Chlorocresol               Ph. Eur. 3rd Ed.  \r\n\r\n  Chlorcyclizine  \r\n\r\n  hydrochloride           Chlorcyclizinhydrochlorid  Ph. Eur. 3rd Ed.  \r\n\r\n Chlorcyclizin-  \r\n\r\n  hydrochlorid            Chlorcyclizine  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Chlordiazepoxide        Chlordiazepoxid            Ph. Eur. 3rd Ed.  \r\n\r\n  Chlordiazepoxide  \r\n\r\n  hydrochloride           Chlordiazepoxid-  \r\n\r\n                          hydrochlorid               Ph. Eur. 3rd Ed.  \r\n\r\n Chlordiazepoxid-  \r\n\r\n  hydrochlorid            Chlordiazepoxide  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n Chlorhexidinacetat       Chlorhexidine diacetate    Ph. Eur. 3rd Ed.  \r\n\r\n Chlorhexidindiacetat     Chlorhexidine diacetate    Ph. Eur. 3rd Ed.  \r\n\r\n Chlorhexidindi-  \r\n\r\n  gluconat-opløsning      Chlorhexidine digluconate  \r\n\r\n                          solution                   Ph. Eur. 3rd Ed.  \r\n\r\n Chlorhexidindi-  \r\n\r\n  hydrochlorid            Chlorhexidine  \r\n\r\n                          dihydrochloride            Ph. Eur. 3rd Ed.  \r\n\r\n  Chlorhexidine  \r\n\r\n  diacetate               Chlorhexidindiacetat       Ph. Eur. 3rd Ed.  \r\n\r\n  Chlorhexidine  \r\n\r\n  digluconate solution    Chlorhexidindigluconat-  \r\n\r\n                          opløsning                  Ph. Eur. 3rd Ed.  \r\n\r\n  Chlorhexidine  \r\n\r\n  dihydrochloride         Chlorhexidindi-  \r\n\r\n                          hydrochlorid               Ph. Eur. 3rd Ed.  \r\n\r\n  Chlormezanone           Chlormezanon               DLS 97  \r\n\r\n  Chlorobutanol  \r\n\r\n  hemihydrate             Chlorbutanolhemihydrat     Ph. Eur. 3rd Ed.  \r\n\r\n  Chlorobutanol,  \r\n\r\n  anhydrous               Chlorbutanol, vandfri      Ph. Eur. 3rd Ed.  \r\n\r\n  Chlorocresol            Chlorcresol                Ph. Eur. 3rd Ed.  \r\n\r\n  Chloroquine phosphate   Chloroquinphosphat         Ph. Eur. 3rd Ed.  \r\n\r\n  Chloroquine sulphate    Chloroquinsulfat           Ph. Eur. 3rd Ed.  \r\n\r\n Chloroquinphosphat       Chloroquine phosphate      Ph. Eur. 3rd Ed.  \r\n\r\n Chloroquinsulfat         Chloroquine sulphate       Ph. Eur. 3rd Ed.  \r\n\r\n  Chlorothiazide          Chlorthiazid               Ph. Eur. 3rd Ed.  \r\n\r\n  Chlorphenamine  \r\n\r\n  maleate                 Chlorphenaminmaleat        Ph. Eur. 3rd Ed.  \r\n\r\n Chlorphenaminmaleat      Chlorphenamine maleate     Ph. Eur. 3rd Ed.  \r\n\r\n  Chlorpromazine  \r\n\r\n  hydrochloride           Chlorpromazinhydrochlorid  Ph. Eur. 3rd Ed.  \r\n\r\n Chlorpromazin-  \r\n\r\n  hydrochlorid            Chlorpromazine  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Chlorpropamide          Chlorpropamid              Ph. Eur. 3rd Ed.  \r\n\r\n  Chlorprothixene  \r\n\r\n  hydrochloride           Chlorprothixenhydro-  \r\n\r\n                          chlorid                    Ph. Eur. 3rd Ed.  \r\n\r\n Chlorprothixen-  \r\n\r\n  hydrochlorid            Chlorprothixene  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Chlortalidone           Chlortalidon               Ph. Eur. 3rd Ed.  \r\n\r\n  Chlortetracycline  \r\n\r\n  hydrochloride           Chlortetracyclin-  \r\n\r\n                          hydrochlorid               Ph. Eur. 3rd Ed.  \r\n\r\n Chlortetracyclin-  \r\n\r\n  hydrochlorid            Chlortetracycline  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n Chlorthiazid             Chlorothiazide             Ph. Eur. 3rd Ed.  \r\n\r\n  Cholecalciferol         Cholecalciferol            Ph. Eur. 3rd Ed.  \r\n\r\n  Cholecalciferol  \r\n\r\n  concentrate             Cholecalciferoldiluendum   Ph. Eur. 3rd Ed.  \r\n\r\n  (oily form)  \r\n\r\n  Cholecalciferol  \r\n\r\n  concentrate             Cholecalciferol diluendum, Ph. Eur. 3rd Ed.  \r\n\r\n  (water-dispersible      vanddispergerbar  \r\n\r\n  form)  \r\n\r\n  Cholecalciferol  \r\n\r\n  concentrate (powder     Cholecalciferoltrituration Ph. Eur. 3rd Ed.  \r\n\r\n  form)  \r\n\r\n Cholecalciferol  \r\n\r\n  diluendum,              Cholecalciferol  \r\n\r\n  vanddispetgerbar        concentrate                Ph. Eur. 3rd Ed.  \r\n\r\n                          (water-dispersible form)  \r\n\r\n Cholecalciferol-  \r\n\r\n  diluendum               Cholecalciferol  \r\n\r\n                          concentrate                Ph. Eur. 3rd Ed.  \r\n\r\n                          (oily form)  \r\n\r\n Cholecalciferol-  \r\n\r\n  trituration             Cholecalciferol  \r\n\r\n                          concentrate (powder        Ph. Eur. 3rd Ed.  \r\n\r\n                          form)  \r\n\r\n  Cholesterol             Cholesterol                Ph. Eur. 3rd Ed.  \r\n\r\n Choriongonadotropin      Gonadotropin, chorionic    Ph. Eur. 3rd Ed.  \r\n\r\n  Chymotrypsin            Chymotrypsin               Ph. Eur. 3rd Ed.  \r\n\r\n  Ciclosporin             Ciclosporin                Ph. Eur. 3rd Ed.  \r\n\r\n  Cimetidine              Cimetidin                  Ph. Eur. 3rd Ed.  \r\n\r\n  Cinchocaine  \r\n\r\n  hydrochloride           Cinchocainhydrochlorid     Ph. Eur. 3rd Ed.  \r\n\r\n Cinchocainhydrochlorid   Cinchocaine hydrochloride  Ph. Eur. 3rd Ed.  \r\n\r\n  Cinchona bark           Kinabark                   Ph. Eur. 3rd Ed.  \r\n\r\n Cinchonae cortex         Cinchona bark              Ph. Eur. 3rd Ed.  \r\n\r\n Cinnamomi cortex         Cinnamon                   Ph. Eur. 3rd Ed.  \r\n\r\n  Cinnamon                Ceylon kanel               Ph. Eur. 3rd Ed.  \r\n\r\n  Cinnarizine             Cinnarizin                 Ph. Eur. 3rd Ed.  \r\n\r\n  Ciprofloxacin           Ciprofloxacin              Ph. Eur. 3rd Ed.  \r\n\r\n  Ciprofloxacin  \r\n\r\n  hydrochloride           Ciprofloxacinhydrochlorid  Ph. Eur. 3rd Ed.  \r\n\r\n Ciprofloxacin-  \r\n\r\n  hydrochlorid            Ciprofloxacin  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Cisapride               Cisaprid                   Ph. Eur. 3rd Ed.  \r\n\r\n  Cisplatin               Cisplatin                  Ph. Eur. 3rd Ed.  \r\n\r\n Citirizindihydrochlorid  Cetirizine  \r\n\r\n                          dihydrochloride            Ph. Eur. 3rd Ed.  \r\n\r\n  Citric acid, anhydrous  Citronsyre, vandfri        Ph. Eur. 3rd Ed.  \r\n\r\n  Citric acid,  \r\n\r\n  monohydrate             Citronsyremonohydrat       Ph. Eur. 3rd Ed.  \r\n\r\n Citronolie               Lemon oil                  Ph. Eur. 3rd Ed.  \r\n\r\n Citronsyre, vandfri      Citric acid, anhydrous     Ph. Eur. 3rd Ed.  \r\n\r\n Citronsyremonohydrat     Citric acid, monohydrate   Ph. Eur. 3rd Ed.  \r\n\r\n  Clindamycin  \r\n\r\n  hydrochloride           Clindamycinhydrochlorid    Ph. Eur. 3rd Ed.  \r\n\r\n  Clindamycin phosphate   Clindamycinphosphat        Ph. Eur. 3rd Ed.  \r\n\r\n Clindamycinhydrochlorid  Clindamycin hydrochloride  Ph. Eur. 3rd Ed.  \r\n\r\n Clindamycinphosphat      Clindamycin phosphate      Ph. Eur. 3rd Ed.  \r\n\r\n Clobetasonbutyrat        Clobetasone butyrate       Ph. Eur. 3rd Ed.  \r\n\r\n  Clobetasone butyrate    Clobetasonbutyrat          Ph. Eur. 3rd Ed.  \r\n\r\n  Clofibrate              Clofibrat                  Ph. Eur. 3rd Ed.  \r\n\r\n Clomifencitrat           Clomifene citrate          Ph. Eur. 3rd Ed.  \r\n\r\n  Clomifene citrate       Clomifencitrat             Ph. Eur. 3rd Ed.  \r\n\r\n  Clomipramine  \r\n\r\n  hydrochloride           Clomipraminhydrochlorid    Ph. Eur. 3rd Ed.  \r\n\r\n Clomipraminhydrochlorid  Clomipramine  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Clonazepam              Clonazepam                 Ph. Eur. 3rd Ed.  \r\n\r\n  Clonidine  \r\n\r\n  hydrochloride           Clonidinhydrochlorid       Ph. Eur. 3rd Ed.  \r\n\r\n Clonidinhydrochlorid     Clonidine hydrochloride    Ph. Eur. 3rd Ed.  \r\n\r\n  Clotrimazole            Clotrimazol                Ph. Eur. 3rd Ed.  \r\n\r\n  Clove                   Kryddernellike             Ph. Eur. 3rd Ed.  \r\n\r\n  Clove oil               Nellikeolie                Ph. Eur. 3rd Ed.  \r\n\r\n  Cloxacillin sodium      Cloxacillinnatrium         Ph. Eur. 3rd Ed.  \r\n\r\n Cloxacillinnatrium       Cloxacillin sodium         Ph. Eur. 3rd Ed.  \r\n\r\n  Cocaine hydrochloride   Cocainhydrochlorid         Ph. Eur. 3rd Ed.  \r\n\r\n Cocainhydrochlorid       Cocaine hydrochloride      Ph. Eur. 3rd Ed.  \r\n\r\n  Cod liver oil           Torskelevertran            DLS 97  \r\n\r\n  Codeine                 Codein                     Ph. Eur. 3rd Ed.  \r\n\r\n  Codeine phosphate  \r\n\r\n  hemihydrate             Codeinphosphathemihydrat   Ph. Eur. 3rd Ed.  \r\n\r\n  Codeine phosphate  \r\n\r\n  sesquihydrate           Codeinphosphatsesquihydrat Ph. Eur. 3rd Ed.  \r\n\r\n Codeinphosphathemihydrat Codeine phosphate  \r\n\r\n                          hemihydrate                Ph. Eur. 3rd Ed.  \r\n\r\n Codeinphosphatses-  \r\n\r\n  quihydrat               Codeine phosphate  \r\n\r\n                          sesquihydrate              Ph. Eur. 3rd Ed.  \r\n\r\n Coffein                  Caffeine                   Ph. Eur. 3rd Ed.  \r\n\r\n Coffeinmonohydrat        Caffeine monohydrate       Ph. Eur. 3rd Ed.  \r\n\r\n  Colchicine              Colchicin                  Ph. Eur. 3rd Ed.  \r\n\r\n  Colistimethate sodium   Colistimethatnatrium       Ph. Eur. 3rd Ed.  \r\n\r\n Colistimethatnatrium     Colistimethate sodium      Ph. Eur. 3rd Ed.  \r\n\r\n  Colistin sulphate       Colistinsulfat             Ph. Eur. 3rd Ed.  \r\n\r\n Colistinsulfat           Colistin sulphate          Ph. Eur. 3rd Ed.  \r\n\r\n  Copolyvidone            Copolyvidon                Ph. Eur. 3rd Ed.  \r\n\r\n  Copper sulphate  \r\n\r\n  pentahydrate            Kobbersulfatpentahydrat    Ph. Eur. 3rd Ed.  \r\n\r\n  Copper sulphate,  \r\n\r\n  anhydrous               Kobbersulfat, vandfri      Ph. Eur. 3rd Ed.  \r\n\r\n  Corticotropin           Corticotropin              Ph. Eur. 3rd Ed.  \r\n\r\n Cortisonacetat           Cortisone acetate          Ph. Eur. 3rd Ed.  \r\n\r\n  Cortisone acetate       Cortisonacetat             Ph. Eur. 3rd Ed.  \r\n\r\n  Croscarmellose sodium   Croscarmellosenatrium      Ph. Eur. 3rd Ed.  \r\n\r\n Croscarmellosenatrium    Croscarmellose sodium      Ph. Eur. 3rd Ed.  \r\n\r\n  Crospovidone            Crospovidon                Ph. Eur. 3rd Ed.  \r\n\r\n Cuprisulfat, vandfri     Copper sulphate,  \r\n\r\n                          anhydrous                  Ph. Eur. 3rd Ed.  \r\n\r\n Cuprisulfatpentahydrat   Copper sulphate  \r\n\r\n                          pentahydrate               Ph. Eur. 3rd Ed.  \r\n\r\n  Cyanocobalamin          Cyanocobalamin             Ph. Eur. 3rd Ed.  \r\n\r\n  Cyclizine hydrochloride Cyclizinhydrochlorid       Ph. Eur. 3rd Ed.  \r\n\r\n Cyclizinhydrochlorid     Cyclizine hydrochloride    Ph. Eur. 3rd Ed.  \r\n\r\n  Cyclopentolate  \r\n\r\n  hydrochloride           Cyclopentolathydrochlorid  Ph. Eur. 3rd Ed.  \r\n\r\n Cyclopentolat-  \r\n\r\n  hydrochlorid            Cyclopentolate  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Cyclophosphamide        Cyclophosphamid            Ph. Eur. 3rd Ed.  \r\n\r\n  Cyproheptadine  \r\n\r\n  hydrochloride           Cyproheptadinhydrochlorid  Ph. Eur. 3rd Ed.  \r\n\r\n Cyproheptadin-  \r\n\r\n  hydrochlorid            Cyproheptadine  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n Cyproteronacetat         Cyproterone acetate        Ph. Eur. 3rd Ed.  \r\n\r\n  Cyproterone acetate     Cyproteronacetat           Ph. Eur. 3rd Ed.  \r\n\r\n  Cysteine hydrochloride  Cysteinhydrochlorid-  \r\n\r\n  monohydrate             monohydrat                 Ph. Eur. 3rd Ed.  \r\n\r\n Cysteinhydrochlorid-  \r\n\r\n  monohydrat              Cysteine hydrochloride     Ph. Eur. 3rd Ed.  \r\n\r\n                          monohydrate  \r\n\r\n  Cystine                 Cystin                     Ph. Eur. 3rd Ed.  \r\n\r\n  Cytarabine              Cytarabin                  Ph. Eur. 3rd Ed.  \r\n\r\n  Dapsone                 Dapson                     Ph. Eur. 3rd Ed.  \r\n\r\n  Daunorubicin  \r\n\r\n  hydrochloride           Daunorubicinhydrochlorid   Ph. Eur. 3rd Ed.  \r\n\r\n Daunorubicinhydrochlorid Daunorubicin  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Deferoxamine mesilate   Deferoxaminmesilat         Ph. Eur. 3rd Ed.  \r\n\r\n Deferoxaminmesilat       Deferoxamine mesilate      Ph. Eur. 3rd Ed.  \r\n\r\n  Demeclocycline  \r\n\r\n  hydrochloride           Demeclocyclinhydrochlorid  Ph. Eur. 3rd Ed.  \r\n\r\n Demeclocyclin-  \r\n\r\n  hydrochlorid            Demeclocycline  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Desipramine  \r\n\r\n  hydrochloride           Desipraminhydrochlorid     Ph. Eur. 3rd Ed.  \r\n\r\n Desipraminhydrochlorid   Desipramine hydrochloride  Ph. Eur. 3rd Ed.  \r\n\r\n  Deslanoside             Deslanosid                 Ph. Eur. 3rd Ed.  \r\n\r\n  Desmopressin            Desmopressin               Ph. Eur. 3rd Ed.  \r\n\r\n Desoxycortonacetat       Desoxycortone acetate      Ph. Eur. 3rd Ed.  \r\n\r\n  Desoxycortone acetate   Desoxycortonacetat         Ph. Eur. 3rd Ed.  \r\n\r\n  Devil's claw root       Djævleklorod               Ph. Eur. 3rd Ed.  \r\n\r\n Dexamethasonacetat       Dexamethasone acetate      Ph. Eur. 3rd Ed.  \r\n\r\n  Dexamethasone           Dexamethason               Ph. Eur. 3rd Ed.  \r\n\r\n  Dexamethasone acetate   Dexamethasonacetat         Ph. Eur. 3rd Ed.  \r\n\r\n  Dexamethasone sodium  \r\n\r\n  phosphate               Dexamethasonnatrium-  \r\n\r\n                          phosphat                   Ph. Eur. 3rd Ed.  \r\n\r\n Dexamethasonnatrium-  \r\n\r\n  phosphat                Dexamethasone sodium  \r\n\r\n                          phosphate                  Ph. Eur. 3rd Ed.  \r\n\r\n  Dexpanthenol            Dexpanthenol               Ph. Eur. 3rd Ed.  \r\n\r\n  Dextran 40 for  \r\n\r\n  injection               Dextran 40 til  \r\n\r\n                          parenteralt brug           Ph. Eur. 3rd Ed.  \r\n\r\n Dextran 40 til  \r\n\r\n  parenteralt brug        Dextran 40 for injection   Ph. Eur. 3rd Ed.  \r\n\r\n  Dextran 60 for  \r\n\r\n  injection               Dextran 60 til  \r\n\r\n                          parenteralt brug           Ph. Eur. 3rd Ed.  \r\n\r\n Dextran 60 til  \r\n\r\n  parenteralt brug        Dextran 60 for injection   Ph. Eur. 3rd Ed.  \r\n\r\n  Dextran 70 for  \r\n\r\n  injection               Dextran 70 til  \r\n\r\n                          parenteralt brug           Ph. Eur. 3rd Ed.  \r\n\r\n Dextran 70 til  \r\n\r\n  parenteralt brug        Dextran 70 for injection   Ph. Eur. 3rd Ed.  \r\n\r\n  Dextromethorphan  \r\n\r\n  hydrobromide            Dextromethorphan-  \r\n\r\n                          hydrobromid                Ph. Eur. 3rd Ed.  \r\n\r\n Dextromethorphan-  \r\n\r\n  hydrobromid             Dextromethorphan  \r\n\r\n                          hydrobromide               Ph. Eur. 3rd Ed.  \r\n\r\n  Dextromoramide  \r\n\r\n  tartrate                Dextromoramidtartrat       Ph. Eur. 3rd Ed.  \r\n\r\n Dextromoramidtartrat     Dextromoramide tartrate    Ph. Eur. 3rd Ed.  \r\n\r\n  Dextropropoxyphene  \r\n\r\n  hydrochloride           Dextropropoxyphenhydro-  \r\n\r\n                          chlorid                    Ph. Eur. 3rd Ed.  \r\n\r\n Dextropropoxyphen-  \r\n\r\n  hydrochlorid            Dextropropoxyphene  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n Dextrose, anhydrous      Glucose, anhydrous         Ph. Eur. 3rd Ed.  \r\n\r\n  Diazepam                Diazepam                   Ph. Eur. 3rd Ed.  \r\n\r\n  Diazoxide               Diazoxid                   Ph. Eur. 3rd Ed.  \r\n\r\n  Dibutyl phthalate       Dibutylphthalat            Ph. Eur. 3rd Ed.  \r\n\r\n Dibutylphthalat          Dibutyl phthalate          Ph. Eur. 3rd Ed.  \r\n\r\n Dichlormethan            Methylene chloride         Ph. Eur. 3rd Ed.  \r\n\r\n  Diclofenac sodium       Diclofenacnatrium          Ph. Eur. 3rd Ed.  \r\n\r\n Diclofenacnatrium        Diclofenac sodium          Ph. Eur. 3rd Ed.  \r\n\r\n  Dicloxacillin sodium      Dicloxacillinnatrium     Ph. Eur. 3rd Ed.  \r\n\r\n Dicloxacillinnatrium     Dicloxacillin sodium       Ph. Eur. 3rd Ed.  \r\n\r\n  Dienestrol              Dienestrol                 Ph. Eur. 3rd Ed.  \r\n\r\n  Diethyl phthalate       Diethylphthalat            Ph. Eur. 3rd Ed.  \r\n\r\n Diethylcarbamazincitrat  Diethylcarbamazine  \r\n\r\n                          citrate                    Ph. Eur. 3rd Ed.  \r\n\r\n  Diethylcarbamazine  \r\n\r\n  citrate                 Diethylcarbamazincitrat    Ph. Eur. 3rd Ed.  \r\n\r\n Diethylphthalat          Diethyl phthalate          Ph. Eur. 3rd Ed.  \r\n\r\n  Diethylstilbestrol      Diethylstilbestrol         Ph. Eur. 3rd Ed.  \r\n\r\n  Diflunisal              Diflunisal                 Ph. Eur. 3rd Ed.  \r\n\r\n  Digitalis leaf          Digitalisblad              Ph. Eur. 3rd Ed.  \r\n\r\n Digitalis purpureae  \r\n\r\n  folium                  Digitalis leaf             Ph. Eur. 3rd Ed.  \r\n\r\n Digitalisblad            Digitalis leaf             Ph. Eur. 3rd Ed.  \r\n\r\n  Digitoxin               Digitoxin                  Ph. Eur. 3rd Ed.  \r\n\r\n  Digoxin                 Digoxin                    Ph. Eur. 3rd Ed.  \r\n\r\n  Dihydroergotamine  \r\n\r\n  mesilate                Dihydroergotaminmesilat    Ph. Eur. 3rd Ed.  \r\n\r\n  Dihydroergotamine  \r\n\r\n  tartrate                Dihydroergotamintartrat    Ph. Eur. 3rd Ed.  \r\n\r\n Dihydroergotaminmesilat  Dihydroergotamine  \r\n\r\n                          mesilate                   Ph. Eur. 3rd Ed.  \r\n\r\n Dihydroergotamintartrat  Dihydroergotamine  \r\n\r\n                          tartrate                   Ph. Eur. 3rd Ed.  \r\n\r\n  Dihydrostreptomycin  \r\n\r\n  sulphate                Dihydrostreptomycinsulfat  Ph. Eur. 3rd Ed.  \r\n\r\n Dihydrostreptomycin-  \r\n\r\n  sulfat                  Dihydrostreptomycin  \r\n\r\n                          sulphate                   Ph. Eur. 3rd Ed.  \r\n\r\n Dikaliumclorazepat       Dipotassium clorazepate    Ph. Eur. 3rd Ed.  \r\n\r\n Dikaliumphosphat         Dipotassium phosphate      Ph. Eur. 3rd Ed.  \r\n\r\n  Diltiazem  \r\n\r\n  hydrochloride           Diltiazemhydrochlorid      Ph. Eur. 3rd Ed.  \r\n\r\n Diltiazemhydrochlorid    hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Dimenhydrinate          Dimenhydrinat              Ph. Eur. 3rd Ed.  \r\n\r\n  Dimercaprol             Dimercaprol                Ph. Eur. 3rd Ed.  \r\n\r\n  Dimethyl sulfoxide      Dimethylsulfoxid           Ph. Eur. 3rd Ed.  \r\n\r\n Dimethylsulfoxid         Dimethyl sulfoxide         Ph. Eur. 3rd Ed.  \r\n\r\n  Dimeticone              Dimeticon                  Ph. Eur. 3rd Ed.  \r\n\r\n Dinatriumedetat          Disodium edetate           Ph. Eur. 3rd Ed.  \r\n\r\n Dinatriumphosphat-  \r\n\r\n  dihydrat                Disodium phosphate  \r\n\r\n                          dihydrate                  Ph. Eur. 3rd Ed.  \r\n\r\n Dinatriumphosphat-  \r\n\r\n  dodecahydrat            Disodium phosphate  \r\n\r\n                          dodecahydrate              Ph. Eur. 3rd Ed.  \r\n\r\n Dinitrogenoxid           Nitrous oxide              Ph. Eur. 3rd Ed.  \r\n\r\n  Diphenhydramine  \r\n\r\n  hydrochloride           Diphenhydraminhydro-  \r\n\r\n                          chlorid                    Ph. Eur. 3rd Ed.  \r\n\r\n Diphenhydraminhydro-  \r\n\r\n  chlorid                 Diphenhydramine  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Diphenoxylate  \r\n\r\n  hydrochloride           Diphenoxylathydrochlorid   Ph. Eur. 3rd Ed.  \r\n\r\n Diphenoxylathydro-  \r\n\r\n  chlorid                 Diphenoxylate  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Dipotassium  \r\n\r\n  clorazepate             Dikaliumclorazepat         Ph. Eur. 3rd Ed.  \r\n\r\n  Dipotassium phosphate   Dikaliumphosphat           Ph. Eur. 3rd Ed.  \r\n\r\n  Diprophylline           Diprophyllin               Ph. Eur. 3rd Ed.  \r\n\r\n  Disodium edetate        Dinatriumedetat            Ph. Eur. 3rd Ed.  \r\n\r\n  Disodium phosphate  \r\n\r\n  dihydrate               Dinatriumphosphatdihydrat  Ph. Eur. 3rd Ed.  \r\n\r\n  Disodium phosphate  \r\n\r\n  dodecahydrate           Dinatriumphosphatdodeca-  \r\n\r\n                          hydrat                     Ph. Eur. 3rd Ed.  \r\n\r\n  Disopyramide            Disopyramid                Ph. Eur. 3rd Ed.  \r\n\r\n  Disopyramide phosphate  Disopyramidphosphat        Ph. Eur. 3rd Ed.  \r\n\r\n Disopyramidphosphat      Disopyramide phosphate     Ph. Eur. 3rd Ed.  \r\n\r\n  Disulfiram              Disulfiram                 Ph. Eur. 3rd Ed.  \r\n\r\n  Dithranol               Dithranol                  Ph. Eur. 3rd Ed.  \r\n\r\n Djævleklorod             Devil's claw root          Ph. Eur. 3rd Ed.  \r\n\r\n  Domperidone             Domperidon                 Ph. Eur. 3rd Ed.  \r\n\r\n  Domperidone maleate     Domperidonmaleat           Ph. Eur. 3rd Ed.  \r\n\r\n Domperidonmaleat         Domperidone maleate        Ph. Eur. 3rd Ed.  \r\n\r\n  Dopamine hydrochloride  Dopaminhydrochlorid        Ph. Eur. 3rd Ed.  \r\n\r\n Dopaminhydrochlorid      Dopamine hydrochloride     Ph. Eur. 3rd Ed.  \r\n\r\n  Doxepine hydrochloride  Doxepinhydroklorid         Ph. Eur. 3rd Ed.  \r\n\r\n Doxepinhydroklorid       Doxepine hydrochloride     Ph. Eur. 3rd Ed.  \r\n\r\n  Doxorubicin  \r\n\r\n  hydrochloride           Doxorubicinhydrochlorid    Ph. Eur. 3rd Ed.  \r\n\r\n Doxorubicinhydrochlorid  Doxorubicin hydrochloride  Ph. Eur. 3rd Ed.  \r\n\r\n  Doxycycline             Doxycyclin                 Ph. Eur. 3rd Ed.  \r\n\r\n  Doxycycline hyclate     Doxycyclinhyclat           Ph. Eur. 3rd Ed.  \r\n\r\n Doxycyclinhyclat         Doxycycline hyclate        Ph. Eur. 3rd Ed.  \r\n\r\n  Droperidol              Droperidol                 Ph. Eur. 3rd Ed.  \r\n\r\n  Econazole nitrate       Econazolnitrat             Ph. Eur. 3rd Ed.  \r\n\r\n Econazolnitrat           Econazole nitrate          Ph. Eur. 3rd Ed.  \r\n\r\n Eddikesyre               Acetic acid, glacial       Ph. Eur. 3rd Ed.  \r\n\r\n  Emetine hydrochloride   Emetinhydrochloridhepta-  \r\n\r\n  heptahydrate            hydrat                     Ph. Eur. 3rd Ed.  \r\n\r\n  Emetine hydrochloride   Emetinhydrochloridpenta-  \r\n\r\n  pentahydrate            hydrat                     Ph. Eur. 3rd Ed.  \r\n\r\n Emetinhydrochlorid-  \r\n\r\n  heptahydrat             Emetine hydrochloride      Ph. Eur. 3rd Ed.  \r\n\r\n                          heptahydrate  \r\n\r\n Emetinhydrochlorid-  \r\n\r\n  pentahydrat             Emetine hydrochloride      Ph. Eur. 3rd Ed.  \r\n\r\n                          pentahydrate  \r\n\r\n  Enoxaparin sodium       Enoxaparinnatrium          Ph. Eur. 3rd Ed.  \r\n\r\n Enoxaparinnatrium        Enoxaparin sodium          Ph. Eur. 3rd Ed.  \r\n\r\n Ensianrod                Gentian root               Ph. Eur. 3rd Ed.  \r\n\r\n Ephedrin, vandfri        Ephedrine, anhydrous       Ph. Eur. 3rd Ed.  \r\n\r\n  Ephedrine hemihydrate   Ephedrinhemihydrat         Ph. Eur. 3rd Ed.  \r\n\r\n  Ephedrine hydrochloride Ephedrinhydrochlorid       Ph. Eur. 3rd Ed.  \r\n\r\n  Ephedrine  \r\n\r\n  hydrochloride, racemic  Ephedrinhydrochlorid,  \r\n\r\n                          racemisk                   Ph. Eur. 3rd Ed.  \r\n\r\n  Ephedrine, anhydrous    Ephedrin, vandfri          Ph. Eur. 3rd Ed.  \r\n\r\n Ephedrinhemihydrat       Ephedrine hemihydrate      Ph. Eur. 3rd Ed.  \r\n\r\n Ephedrinhydrochlorid     Ephedrine hydrochloride    Ph. Eur. 3rd Ed.  \r\n\r\n Ephedrinhydrochlorid,  \r\n\r\n  racemisk                Ephedrine hydrochloride,  \r\n\r\n                          racemic                    Ph. Eur. 3rd Ed.  \r\n\r\n  Ergocalciferol          Ergocalciferol             Ph. Eur. 3rd Ed.  \r\n\r\n  Ergometrine maleate     Ergometrinmaleat           Ph. Eur. 3rd Ed.  \r\n\r\n Ergometrinmaleat         Ergometrine maleate        Ph. Eur. 3rd Ed.  \r\n\r\n  Ergotamine tartrate     Ergotamintartrat           Ph. Eur. 3rd Ed.  \r\n\r\n Ergotamintartrat         Ergotamine tartrate        Ph. Eur. 3rd Ed.  \r\n\r\n  Erythromycin            Erythromycin               Ph. Eur. 3rd Ed.  \r\n\r\n  Erythromycin estolate   Erythromycinestolat        Ph. Eur. 3rd Ed.  \r\n\r\n  Erythromycin  \r\n\r\n  ethylsuccinate          Erythromycinethylsuccinat  Ph. Eur. 3rd Ed.  \r\n\r\n  Erythromycin  \r\n\r\n  lactobionate            Erythromycinlactobionat    Ph. Eur. 3rd Ed.  \r\n\r\n  Erythromycin stearate   Erythromycinstearat        Ph. Eur. 3rd Ed.  \r\n\r\n Erythromycinestolat      Erythromycin estolate      Ph. Eur. 3rd Ed.  \r\n\r\n Erythromycinethyl-  \r\n\r\n  succinat                Erythromycin  \r\n\r\n                          ethylsuccinate             Ph. Eur. 3rd Ed.  \r\n\r\n Erythromycinlactobionat  Erythromycin lactobionate  Ph. Eur. 3rd Ed.  \r\n\r\n Erythromycinstearat      Erythromycin stearate      Ph. Eur. 3rd Ed.  \r\n\r\n  Estradiol benzoate      Estradiolbenzoat           Ph. Eur. 3rd Ed.  \r\n\r\n  Estradiol hemihydrate   Estradiolhemihydrat        Ph. Eur. 3rd Ed.  \r\n\r\n Estradiolbenzoat         Estradiol benzoate         Ph. Eur. 3rd Ed.  \r\n\r\n Estradiolhemihydrat      Estradiol hemihydrate      Ph. Eur. 3rd Ed.  \r\n\r\n  Etacrynic acid          Etacrynsyre                Ph. Eur. 3rd Ed.  \r\n\r\n Etacrynsyre              Etacrynic acid             Ph. Eur. 3rd Ed.  \r\n\r\n  Ethambutol  \r\n\r\n  hydrochloride           Ethambutolhydrochlorid     Ph. Eur. 3rd Ed.  \r\n\r\n Ethambutolhydrochlorid   Ethambutol hydrochloride   Ph. Eur. 3rd Ed.  \r\n\r\n  Ethanol                 Ethanol                    DLS 97  \r\n\r\n Ether til anæstesi       Ether, anaesthetic         Ph. Eur. 3rd Ed.  \r\n\r\n  Ether, anaesthetic      Ether til anæstesi         Ph. Eur. 3rd Ed.  \r\n\r\n  Ethinylestradiol        Ethinylestradiol           Ph. Eur. 3rd Ed.  \r\n\r\n  Ethionamide             Ethionamid                 Ph. Eur. 3rd Ed.  \r\n\r\n  Ethisterone             Ethisteron                 Ph. Eur. 3rd Ed.  \r\n\r\n  Ethosuximide            Ethosuximid                Ph. Eur. 3rd Ed.  \r\n\r\n  Ethyl acetate           Ethylacetat                Ph. Eur. 3rd Ed.  \r\n\r\n  Ethyl parahydroxy-  \r\n\r\n  benzoate                Ethylparahydroxybenzoat    Ph. Eur. 3rd Ed.  \r\n\r\n Ethylacetat              Ethyl acetate              Ph. Eur. 3rd Ed.  \r\n\r\n  Ethylcellulose          Ethylcellulose             Ph. Eur. 3rd Ed.  \r\n\r\n  Ethylendiamine          Ethylendiamin              Ph. Eur. 3rd Ed.  \r\n\r\n  Ethylene glycol  \r\n\r\n  monostearate            Ethylenglycolmonostearat   Ph. Eur. 3rd Ed.  \r\n\r\n Ethylenglycolmonostearat Ethylene glycol  \r\n\r\n                          monostearate               Ph. Eur. 3rd Ed.  \r\n\r\n  Ethylmorphine  \r\n\r\n  hydrochloride           Ethylmorphinhydrochlorid   Ph. Eur. 3rd Ed.  \r\n\r\n Ethylmorphinhydrochlorid Ethylmorphine  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n Ethylparahydroxybenzoat  Ethyl parahydroxybenzoate  Ph. Eur. 3rd Ed.  \r\n\r\n  Etofylline              Etofyllin                  Ph. Eur. 3rd Ed.  \r\n\r\n  Etoposide               Etoposid                   Ph. Eur. 3rd Ed.  \r\n\r\n Eucalypti aetheroleum    Eucalyptus oil             Ph. Eur. 3rd Ed.  \r\n\r\n  Eucalyptus oil          Eukalyptusolie             Ph. Eur. 3rd Ed.  \r\n\r\n  Eugenol                 Eugenol                    Ph. Eur. 3rd Ed.  \r\n\r\n Eukalyptusolie            Eucalyptus oil            Ph. Eur. 3rd Ed.  \r\n\r\n  Famotidine               Famotidin                 Ph. Eur. 3rd Ed.  \r\n\r\n  Felodipine               Felodipin                 Ph. Eur. 3rd Ed.  \r\n\r\n  Fennel, bitter           Fennikel bitter           Ph. Eur. 3rd Ed.  \r\n\r\n  Fennel, sweet            Fennikel, sød             Ph. Eur. 3rd Ed.  \r\n\r\n Fennikel bitter           Fennel, bitter            Ph. Eur. 3rd Ed.  \r\n\r\n Fennikel, sød             Fennel, sweet             Ph. Eur. 3rd Ed.  \r\n\r\n  Fenoterol hydrobromide   Fenoterolhydrobromid      Ph. Eur. 3rd Ed.  \r\n\r\n Fenoterolhydrobromid      Fenoterol hydrobromide    Ph. Eur. 3rd Ed.  \r\n\r\n  Fentanyl citrate         Fentanylcitrat            Ph. Eur. 3rd Ed.  \r\n\r\n Fentanylcitrat            Fentanyl citrate          Ph. Eur. 3rd Ed.  \r\n\r\n Ferrofumarat              Ferrous fumarate          Ph. Eur. 3rd Ed.  \r\n\r\n Ferrogluconat             Ferrous gluconate         Ph. Eur. 3rd Ed.  \r\n\r\n Ferrosulfat               Ferrous sulphate          Ph. Eur. 3rd Ed.  \r\n\r\n  Ferrous fumarate         Ferrofumarat              Ph. Eur. 3rd Ed.  \r\n\r\n  Ferrous gluconate        Ferrogluconat             Ph. Eur. 3rd Ed.  \r\n\r\n  Ferrous sulphate         Ferrosulfat               Ph. Eur. 3rd Ed.  \r\n\r\n  Fibrin sealant kit       Fibrin vævsklæber         Ph. Eur. 3rd Ed.  \r\n\r\n Fibrin vævsklæber         Fibrin sealant kit        Ph. Eur. 3rd Ed.  \r\n\r\n  Flucloxacillin sodium    Flucloxacillinnatrium     Ph. Eur. 3rd Ed.  \r\n\r\n Flucloxacillinnatrium     Flucloxacillin sodium     Ph. Eur. 3rd Ed.  \r\n\r\n  Flucytosine              Flucytosin                Ph. Eur. 3rd Ed.  \r\n\r\n Fludrocortisonacetat      Fludrocortisone acetate   Ph. Eur. 3rd Ed.  \r\n\r\n  Fludrocortisone acetate  Fludrocortisonacetat      Ph. Eur. 3rd Ed.  \r\n\r\n  Flunitrazepam            Flunitrazepam             Ph. Eur. 3rd Ed.  \r\n\r\n Fluocinolonacetonid       Fluocinolone acetonide    Ph. Eur. 3rd Ed.  \r\n\r\n  Fluocinolone acetonide   Fluocinolonacetonid       Ph. Eur. 3rd Ed.  \r\n\r\n  Fluorouracil             Fluoruracil               Ph. Eur. 3rd Ed.  \r\n\r\n Fluoruracil               Fluorouracil              Ph. Eur. 3rd Ed.  \r\n\r\n  Fluoxetine  \r\n\r\n  hydrochloride            Fluoxetinhydrochlorid     Ph. Eur. 3rd Ed.  \r\n\r\n Fluoxetinhydrochlorid     Fluoxetine hydrochloride  Ph. Eur. 3rd Ed.  \r\n\r\n Fluphenazindecanoat       Fluphenazine decanoate    Ph. Eur. 3rd Ed.  \r\n\r\n  Fluphenazine decanoate   Fluphenazindecanoat       Ph. Eur. 3rd Ed.  \r\n\r\n  Fluphenazine enantate    Fluphenazinenantat        Ph. Eur. 3rd Ed.  \r\n\r\n  Fluphenazine  \r\n\r\n  hydrochloride            Fluphenazinhydrochlorid   Ph. Eur. 3rd Ed.  \r\n\r\n Fluphenazinenantat        Fluphenazine enantate     Ph. Eur. 3rd Ed.  \r\n\r\n Fluphenazinhydrochlorid   Fluphenazine  \r\n\r\n                           hydrochloride             Ph. Eur. 3rd Ed.  \r\n\r\n  Flurazepam  \r\n\r\n  monohydrochloride        Flurazepammono-  \r\n\r\n                           hydrochlorid              Ph. Eur. 3rd Ed.  \r\n\r\n Flurazepammono-  \r\n\r\n  hydrochlorid             Flurazepam  \r\n\r\n                           monohydrochloride         Ph. Eur. 3rd Ed.  \r\n\r\n Foeniculi amari fructus   Fennel, bitter            Ph. Eur. 3rd Ed.  \r\n\r\n Foeniculi dulcis fructus  Fennel, sweet             Ph. Eur. 3rd Ed.  \r\n\r\n  Folic acid               Folinsyre                 Ph. Eur. 3rd Ed.  \r\n\r\n Folinsyre                 Folic acid                Ph. Eur. 3rd Ed.  \r\n\r\n Folsyre                   Folic acid                Ph. Eur. 3rd Ed.  \r\n\r\n  Formaldehyde solution  \r\n\r\n  (35 per cent)           Formaldehydopløsning 35%   Ph. Eur. 3rd Ed.  \r\n\r\n Formaldehydopløsning 35% Formaldehyde solution  \r\n\r\n                          (35 per cent)              Ph. Eur. 3rd Ed.  \r\n\r\n  Framycetin sulphate     Framycetinsulfat           Ph. Eur. 3rd Ed.  \r\n\r\n Framycetinsulfat         Framycetin sulphate        Ph. Eur. 3rd Ed.  \r\n\r\n  Frangula bark           Frangulabark               Ph. Eur. 3rd Ed.  \r\n\r\n Frangulabark             Frangula bark              Ph. Eur. 3rd Ed.  \r\n\r\n Frangulae cortex         Frangula bark              Ph. Eur. 3rd Ed.  \r\n\r\n  Fructose                Fructose                   Ph. Eur. 3rd Ed.  \r\n\r\n  Fructose for injection  Fructose til parenteralt  \r\n\r\n                          brug                       DLS 97  \r\n\r\n Fructose til  \r\n\r\n  parenteralt brug        Fructose for injection     DLS 97  \r\n\r\n  Furosemide              Furosemid                  Ph. Eur. 3rd Ed.  \r\n\r\n  Fusidic acid            Fusidinsyre                Ph. Eur. 3rd Ed.  \r\n\r\n Fusidinsyre              Fusidic acid               Ph. Eur. 3rd Ed.  \r\n\r\n  Gallamine triethiodide  Gallamintriethiodid        Ph. Eur. 3rd Ed.  \r\n\r\n Gallamintriethiodid      Gallamine triethiodide     Ph. Eur. 3rd Ed.  \r\n\r\n  Gelatin                 Gelatine                   Ph. Eur. 3rd Ed.  \r\n\r\n  Gentamicin sulphate     Gentamicinsulfat           Ph. Eur. 3rd Ed.  \r\n\r\n Gentamicinsulfat         Gentamicin sulphate        Ph. Eur. 3rd Ed.  \r\n\r\n  Gentian root            Gentianrod                 Ph. Eur. 3rd Ed.  \r\n\r\n Gentianae radix          Gentian root               Ph. Eur. 3rd Ed.  \r\n\r\n Gentianrod               Gentian root               Ph. Eur. 3rd Ed.  \r\n\r\n  Glibenclamide           Glibenclamid               Ph. Eur. 3rd Ed.  \r\n\r\n  Glipizide               Glipizid                   Ph. Eur. 3rd Ed.  \r\n\r\n  Glucagon                Glucagon                   Ph. Eur. 3rd Ed.  \r\n\r\n  Glucose monohydrate     Glucosemonohydrat          Ph. Eur. 3rd Ed.  \r\n\r\n  Glucose, anhydrous      Glucose, vandfri           Ph. Eur. 3rd Ed.  \r\n\r\n Glucose, vandfri         Glucose, anhydrous         Ph. Eur. 3rd Ed.  \r\n\r\n Glucosemonohydrat        Glucose monohydrate        Ph. Eur. 3rd Ed.  \r\n\r\n  Glutamic acid           Glutaminsyre               Ph. Eur. 3rd Ed.  \r\n\r\n Glutaminsyre             Glutamic acid              Ph. Eur. 3rd Ed.  \r\n\r\n  Glutethimide            Glutethimid                Ph. Eur. 3rd Ed.  \r\n\r\n  Glycerol                Glycerol                   Ph. Eur. 3rd Ed.  \r\n\r\n  Glycerol (85 per cent)  Glycerol 85%               Ph. Eur. 3rd Ed.  \r\n\r\n Glycerol 85%             Glycerol (85 per cent)     Ph. Eur. 3rd Ed.  \r\n\r\n  Glycerol monostearate  \r\n\r\n  40-50                   Glycerolmonostearat 40-50  Ph. Eur. 3rd Ed.  \r\n\r\n  Glycerol triacetate     Glyceroltriacetat          Ph. Eur. 3rd Ed.  \r\n\r\n Glycerolmonostearat  \r\n\r\n  40-50                   Glycerol monostearate  \r\n\r\n                          40-50                      Ph. Eur. 3rd Ed.  \r\n\r\n Glyceroltriacetat        Glycerol triacetate        Ph. Eur. 3rd Ed.  \r\n\r\n  Glycine      Glycin     Ph. Eur. 3rd Ed.  \r\n\r\n  Glycopyrronii bromidum  Glycopyrroniumbromid       DLS 97  \r\n\r\n Glycopyrroniumbromid     Glycopyrronii bromidum     DLS 97  \r\n\r\n  Gonadorelin             Gonadorelin                Ph. Eur. 3rd Ed.  \r\n\r\n  Gonadotropin, chorionic Choriongonadotropin        Ph. Eur. 3rd Ed.  \r\n\r\n  Gonadotropin,  \r\n\r\n  equine serum for        Serumgonadotropin til dyr  Ph. Eur. 3rd Ed.  \r\n\r\n  veterinary use  \r\n\r\n  Gramicidin              Gramicidin                 Ph. Eur. 3rd Ed.  \r\n\r\n  Griseofulvin            Griseofulvin               Ph. Eur. 3rd Ed.  \r\n\r\n  Guaifenesin             Guaifenesin                Ph. Eur. 3rd Ed.  \r\n\r\n  Guanethidine  \r\n\r\n  monosulphate            Guanethidinmonosulfat      Ph. Eur. 3rd Ed.  \r\n\r\n Guanethidinmonosulfat    Guanethidine monosulphate  Ph. Eur. 3rd Ed.  \r\n\r\n  Guar galactomannan      Guar galactomannan         Ph. Eur. 3rd Ed.  \r\n\r\n Gult voks                Yellow beeswax             Ph. Eur. 3rd Ed.  \r\n\r\n  Haloperidol             Haloperidol                Ph. Eur. 3rd Ed.  \r\n\r\n  Halothane               Halothan                   Ph. Eur. 3rd Ed.  \r\n\r\n Hamamelidis folium       Hamamelis leaf             Ph. Eur. 3rd Ed.  \r\n\r\n  Hamamelis leaf          Hamamelisblad              Ph. Eur. 3rd Ed.  \r\n\r\n Hamamelisblad            Hamamelis leaf             Ph. Eur. 3rd Ed.  \r\n\r\n  Hard fat                Hårdfedt                   Ph. Eur. 3rd Ed.  \r\n\r\n Harpagophyti radix       Devil's claw root          Ph. Eur. 3rd Ed.  \r\n\r\n  Heparin calcium         Heparincalcium             Ph. Eur. 3rd Ed.  \r\n\r\n  Heparin sodium          Heparinnatrium             Ph. Eur. 3rd Ed.  \r\n\r\n Heparin, lavmolekylær    Heparins, low-molecular-  \r\n\r\n                          mass                       Ph. Eur. 3rd Ed.  \r\n\r\n Heparincalcium           Heparin calcium            Ph. Eur. 3rd Ed.  \r\n\r\n Heparinnatrium           Heparin sodium             Ph. Eur. 3rd Ed.  \r\n\r\n  Heparins, low-  \r\n\r\n  molecular-mass          Heparin, lavmolekylær      Ph. Eur. 3rd Ed.  \r\n\r\n  Hexobarbital            Hexobarbital               Ph. Eur. 3rd Ed.  \r\n\r\n Histamindihydrochlorid   Histamine dihydrochloride  Ph. Eur. 3rd Ed.  \r\n\r\n  Histamine  \r\n\r\n  dihydrochloride         Histamindihydrochlorid     Ph. Eur. 3rd Ed.  \r\n\r\n  Histamine phosphate     Histaminphosphat           Ph. Eur. 3rd Ed.  \r\n\r\n Histaminphosphat         Histamine phosphate        Ph. Eur. 3rd Ed.  \r\n\r\n  Histidine               Histidin                   Ph. Eur. 3rd Ed.  \r\n\r\n  Histidine hydrochloride Histidinhydrochlorid-  \r\n\r\n  monohydrate             monohydrat                 Ph. Eur. 3rd Ed.  \r\n\r\n Histidinhydrochlorid-  \r\n\r\n  monohydrat              Histidine hydrochloride    Ph. Eur. 3rd Ed.  \r\n\r\n                          monohydrate  \r\n\r\n  Homatropine  \r\n\r\n  hydrobromide            Homatropinhydrobromid      Ph. Eur. 3rd Ed.  \r\n\r\n  Homatropine  \r\n\r\n  methylbromide           Homatropinmethylbromid     Ph. Eur. 3rd Ed.  \r\n\r\n Homatropinhydrobromid    Homatropine hydrobromide   Ph. Eur. 3rd Ed.  \r\n\r\n Homatropinmethylbromid   Homatropine methylbromide  Ph. Eur. 3rd Ed.  \r\n\r\n Hvedestivelse            Wheat starch               Ph. Eur. 3rd Ed.  \r\n\r\n Hvidt voks               White beeswax              Ph. Eur. 3rd Ed.  \r\n\r\n  Hyalorunidase           Hyalorunidase              Ph. Eur. 3rd Ed.  \r\n\r\n  Hydralazine  \r\n\r\n  hydrochloride           Hydralazinhydrochlorid     Ph. Eur. 3rd Ed.  \r\n\r\n Hydralazinhydrochlorid   Hydralazine hydrochloride  Ph. Eur. 3rd Ed.  \r\n\r\n  Hydrochloric acid,  \r\n\r\n  concentrated            Saltsyre, koncentreret     Ph. Eur. 3rd Ed.  \r\n\r\n  Hydrochloric acid,  \r\n\r\n  dilute                  Saltsyre, fortyndet        Ph. Eur. 3rd Ed.  \r\n\r\n  Hydrochlorothiazide     Hydrochlorthiazid          Ph. Eur. 3rd Ed.  \r\n\r\n Hydrochlorthiazid        Hydrochlorothiazide        Ph. Eur. 3rd Ed.  \r\n\r\n Hydrocortisonacetat      Hydrocortisone acetate     Ph. Eur. 3rd Ed.  \r\n\r\n  Hydrocortisone          Hydrocortison              Ph. Eur. 3rd Ed.  \r\n\r\n  Hydrocortisone acetate  Hydrocortisonacetat        Ph. Eur. 3rd Ed.  \r\n\r\n  Hydrocortisone hydrogen  \r\n\r\n  succinate               Hydrocortisonhydrogen-  \r\n\r\n                          succinat                   Ph. Eur. 3rd Ed.  \r\n\r\n Hydrocortisonhydrogen-  \r\n\r\n  succinat                Hydrocortisone hydrogen  \r\n\r\n                          succinate                  Ph. Eur. 3rd Ed.  \r\n\r\n  Hydrogen peroxide  \r\n\r\n  solution                Hydrogenperoxid-diluendum  \r\n\r\n  (30 per cent)           30%                        Ph. Eur. 3rd Ed.  \r\n\r\n Hydrogenperoxid-  \r\n\r\n diluendum 30%            Hydrogen peroxide  \r\n\r\n                          solution                   Ph. Eur. 3rd Ed.  \r\n\r\n                          (30 per cent)  \r\n\r\n  Hydroxocobalamin  \r\n\r\n  acetate                 Hydroxocobalaminacetat     Ph. Eur. 3rd Ed.  \r\n\r\n  Hydroxocobalamin  \r\n\r\n  chloride                Hydroxocobalaminchlorid    Ph. Eur. 3rd Ed.  \r\n\r\n  Hydroxocobalamin  \r\n\r\n  sulphate                Hydroxocobalaminsulfat     Ph. Eur. 3rd Ed.  \r\n\r\n Hydroxocobalaminacetat   Hydroxocobalamin acetate   Ph. Eur. 3rd Ed.  \r\n\r\n Hydroxocobalaminchlorid  Hydroxocobalamin chloride  Ph. Eur. 3rd Ed.  \r\n\r\n Hydroxocobalaminsulfat   Hydroxocobalamin sulphate  Ph. Eur. 3rd Ed.  \r\n\r\n  Hydroxyethylcellulose   Hydroxyethylcellulose      Ph. Eur. 3rd Ed.  \r\n\r\n  Hydroxypropylcellulose  Hydroxypropylcellulose     Ph. Eur. 3rd Ed.  \r\n\r\n  Hydroxyzine  \r\n\r\n  hydrochloride           Hydroxyzinhydrochlorid     Ph. Eur. 3rd Ed.  \r\n\r\n Hydroxyzinhydrochlorid   Hydroxyzine hydrochloride  Ph. Eur. 3rd Ed.  \r\n\r\n Hyoscinbutylbromid       Hyoscine butylbromide      Ph. Eur. 3rd Ed.  \r\n\r\n  Hyoscine butylbromide   Hyoscinbutylbromid         Ph. Eur. 3rd Ed.  \r\n\r\n  Hyoscine hydrobromide   Hyoscinhydrobromid         Ph. Eur. 3rd Ed.  \r\n\r\n Hyoscinhydrobromid       Hyoscine hydrobromide      Ph. Eur. 3rd Ed.  \r\n\r\n Hyoscyami folium         Hyoscyamus leaf            Ph. Eur. 3rd Ed.  \r\n\r\n Hyoscyami pulvis  \r\n\r\n  normatus                Hyoscyamus,prepared        Ph. Eur. 3rd Ed.  \r\n\r\n  Hyoscyamine sulphate    Hyoscyaminsulfat           Ph. Eur. 3rd Ed.  \r\n\r\n Hyoscyaminsulfat         Hyoscyamine sulphate       Ph. Eur. 3rd Ed.  \r\n\r\n  Hyoscyamus leaf         Hyoskyamusblad             Ph. Eur. 3rd Ed.  \r\n\r\n  Hyoscyamus, prepared    Hyoskyamus,  \r\n\r\n                          standardiseret             Ph. Eur. 3rd Ed.  \r\n\r\n Hyoskyamus,  \r\n\r\n  standardiseret          Hyoscyamus, prepared       Ph. Eur. 3rd Ed.  \r\n\r\n Hyoskyamusblad           Hyoscyamus leaf            Ph. Eur. 3rd Ed.  \r\n\r\n Hørfrø                   Linseed                    Ph. Eur. 3rd Ed.  \r\n\r\n Hårdfedt                 Hard fat                   Ph. Eur. 3rd Ed.  \r\n\r\n  Ibuprofen               Ibuprofen                  Ph. Eur. 3rd Ed.  \r\n\r\n  Ichthammol              Ichthammol                 Ph. Eur. 3rd Ed.  \r\n\r\n  Idoxuridine             Idoxuridin                 Ph. Eur. 3rd Ed.  \r\n\r\n Iecoris aselli oleum     Cod liver oil              DLS 97  \r\n\r\n  Imipramine  \r\n\r\n  hydrochloride           Imipraminhydrochlorid      Ph. Eur. 3rd Ed.  \r\n\r\n Imipraminhydrochlorid    Imipramine hydrochloride   Ph. Eur. 3rd Ed.  \r\n\r\n  Indapamide              Indapamid                  Ph. Eur. 3rd Ed.  \r\n\r\n  Indometacin             Indometacin                Ph. Eur. 3rd Ed.  \r\n\r\n  Insulin                 Insulin                    Ph. Eur. 3rd Ed.  \r\n\r\n  Insulin, human          Insulin, humant            Ph. Eur. 3rd Ed.  \r\n\r\n  Iodine                  Iod                        Ph. Eur. 3rd Ed.  \r\n\r\n  Iohexol                 Iohexol                    Ph. Eur. 3rd Ed.  \r\n\r\n  Iopamidol               Iopamidol                  Ph. Eur. 3rd Ed.  \r\n\r\n  Iopanoic acid           Iopanoinsyre               Ph. Eur. 3rd Ed.  \r\n\r\n Iopanoinsyre             Iopanoic acid              Ph. Eur. 3rd Ed.  \r\n\r\n  Iotalamic acid          Iotalaminsyre              Ph. Eur. 3rd Ed.  \r\n\r\n Iotalaminsyre            Iotalamic acid             Ph. Eur. 3rd Ed.  \r\n\r\n  Ipecacuanha root        Ipecacuanharod             Ph. Eur. 3rd Ed.  \r\n\r\n  Ipecacuanha, prepared   Ipecacuanha,  \r\n\r\n                          standardiseret             Ph. Eur. 3rd Ed.  \r\n\r\n Ipecacuanha,  \r\n\r\n  standardiseret          Ipecacuanha, prepared      Ph. Eur. 3rd Ed.  \r\n\r\n Ipecacuanhae pulvis  \r\n\r\n  normatus                Ipecacuanha, prepared      Ph. Eur. 3rd Ed.  \r\n\r\n Ipecacuanhae radix       Ipecacuanha root           Ph. Eur. 3rd Ed.  \r\n\r\n Ipecacuanharod           Ipecacuanha root           Ph. Eur. 3rd Ed.  \r\n\r\n  Ipratropium bromide     Ipratropiniumbromid        Ph. Eur. 3rd Ed.  \r\n\r\n  Isoconazole             Isoconazol                 Ph. Eur. 3rd Ed.  \r\n\r\n  Isoconazole nitrate     Isoconazolnitrat           Ph. Eur. 3rd Ed.  \r\n\r\n Isoconazolnitrat         Isoconazole nitrate        Ph. Eur. 3rd Ed.  \r\n\r\n  Isoleucine              Isoleucin                  Ph. Eur. 3rd Ed.  \r\n\r\n  Isoniazid               Isoniazid                  Ph. Eur. 3rd Ed.  \r\n\r\n  Isoprenaline sulphate   Isoprenalinsulfat          Ph. Eur. 3rd Ed.  \r\n\r\n Isoprenalinsulfat        Isoprenaline sulphate      Ph. Eur. 3rd Ed.  \r\n\r\n  Isopropyl alcohol       Isopropylalkohol           Ph. Eur. 3rd Ed.  \r\n\r\n  Isopropyl myristate     Isopropylmyristat          Ph. Eur. 3rd Ed.  \r\n\r\n  Isopropyl palmitate     Isopropylpalmitat          Ph. Eur. 3rd Ed.  \r\n\r\n Isopropylalkohol         Isopropyl alcohol          Ph. Eur. 3rd Ed.  \r\n\r\n Isopropylmyristat        Isopropyl myristate        Ph. Eur. 3rd Ed.  \r\n\r\n Isopropylpalmitat        Isopropyl palmitate        Ph. Eur. 3rd Ed.  \r\n\r\n Isosorbiddinitrat,  \r\n\r\n  fortyndet               Isosorbide dinitrate,  \r\n\r\n                          diluted                    Ph. Eur. 3rd Ed.  \r\n\r\n  Isosorbide dinitrate,  \r\n\r\n  diluted                 Isosorbiddinitrat,  \r\n\r\n                          fortyndet                  Ph. Eur. 3rd Ed.  \r\n\r\n  Isosorbide mononitrate,  \r\n\r\n  diluted                 Isosorbidmononitrat,  \r\n\r\n                          fortyndet                  Ph. Eur. 3rd Ed.  \r\n\r\n Isosorbidmononitrat,  \r\n\r\n  fortyndet               Isosorbide mononitrate,  \r\n\r\n                          diluted                    Ph. Eur. 3rd Ed.  \r\n\r\n  Isotretinoin            Isotretinoin               Ph. Eur. 3rd Ed.  \r\n\r\n  Isoxsuprine  \r\n\r\n  hydrochloride           Isoxsuprinhydrochlorid     Ph. Eur. 3rd Ed.  \r\n\r\n Isoxsuprinhydrochlorid   Isoxsuprine hydrochloride  Ph. Eur. 3rd Ed.  \r\n\r\n Jordnødolie              Arachis oil                Ph. Eur. 3rd Ed.  \r\n\r\n Kaliumacetat             Potassium acetate          Ph. Eur. 3rd Ed.  \r\n\r\n Kaliumaluminiumsulfat    Alumen                     Ph. Eur. 3rd Ed.  \r\n\r\n Kaliumbromid             Potassium bromide          Ph. Eur. 3rd Ed.  \r\n\r\n Kaliumchlorid            Potassium chloride         Ph. Eur. 3rd Ed.  \r\n\r\n Kaliumcitrat             Potassium citrate          Ph. Eur. 3rd Ed.  \r\n\r\n Kaliumclavulanat         Potassium clavulanate      Ph. Eur. 3rd Ed.  \r\n\r\n Kaliumdihydrogenphosphat Potassium dihydrogen  \r\n\r\n                          phosphate                  Ph. Eur. 3rd Ed.  \r\n\r\n Kaliumhydrogencarbonat   Potassium hydrogen  \r\n\r\n                          carbonate                  Ph. Eur. 3rd Ed.  \r\n\r\n Kaliumhydroxid           Potassium hydroxide        Ph. Eur. 3rd Ed.  \r\n\r\n Kaliumiodid              Potassium iodide           Ph. Eur. 3rd Ed.  \r\n\r\n Kaliumpermanganat        Potassium permanganate     Ph. Eur. 3rd Ed.  \r\n\r\n Kaliumsorbat             Potassium sorbate          Ph. Eur. 3rd Ed.  \r\n\r\n Kamilleblomst            Matricaria flower          Ph. Eur. 3rd Ed.  \r\n\r\n Kamilleblomst, romersk   Chamomile flower, Roman    Ph. Eur. 3rd Ed.  \r\n\r\n  Kanamycin acid  \r\n\r\n  sulphate                Kanamycinsesquisulfat      Ph. Eur. 3rd Ed.  \r\n\r\n  Kanamycin monosulphate  Kanamycinmonosulfat        Ph. Eur. 3rd Ed.  \r\n\r\n Kanamycinmonosulfat      Kanamycin monosulphate     Ph. Eur. 3rd Ed.  \r\n\r\n Kanamycinsesquisulfat    Kanamycin acid sulphate    Ph. Eur. 3rd Ed.  \r\n\r\n  Kaolin, heavy           Kaolin, tung               Ph. Eur. 3rd Ed.  \r\n\r\n Kaolin, tung             Kaolin, heavy              Ph. Eur. 3rd Ed.  \r\n\r\n Kap-aloe                 Aloes, cape                Ph. Eur. 3rd Ed.  \r\n\r\n Kartoffelstivelse        Potato starch              Ph. Eur. 3rd Ed.  \r\n\r\n  Ketamine hydrochloride  Ketaminhydrochlorid        Ph. Eur. 3rd Ed.  \r\n\r\n Ketaminhydrochlorid      Ketamine hydrochloride     Ph. Eur. 3rd Ed.  \r\n\r\n  Ketoconazole            Ketoconazol                Ph. Eur. 3rd Ed.  \r\n\r\n  Ketoprofen              Ketoprofen                 Ph. Eur. 3rd Ed.  \r\n\r\n Kinabark                 Cinchona bark              Ph. Eur. 3rd Ed.  \r\n\r\n Kobbersulfat, vandfri    Copper sulphate,  \r\n\r\n                          anhydrous                  Ph. Eur. 3rd Ed.  \r\n\r\n Kobbersulfatpentahydrat  Copper sulphate  \r\n\r\n                          pentahydrate               Ph. Eur. 3rd Ed.  \r\n\r\n Kommen                   Caraway fruit              Ph. Eur. 3rd Ed.  \r\n\r\n Kryddernellike           Clove                      Ph. Eur. 3rd Ed.  \r\n\r\n Kul, aktivt              Charcoal, activated        Ph. Eur. 3rd Ed.  \r\n\r\n  Labetalol  \r\n\r\n  hydrochloride           Labetalolhydrochlorid      Ph. Eur. 3rd Ed.  \r\n\r\n Labetalolhydrochlorid    Labetalol hydrochloride    Ph. Eur. 3rd Ed.  \r\n\r\n Lacca                    Shellac                    Ph. Eur. 3nd Ed.  \r\n\r\n  Lactic acid             Mælkesyre                  Ph. Eur. 3rd Ed.  \r\n\r\n  Lactose monohydrate     Lactosemonohydrat          Ph. Eur. 3rd Ed.  \r\n\r\n  Lactose, anhydrous      Lactose, vandfri           Ph. Eur. 3rd Ed.  \r\n\r\n Lactose, vandfri         Lactose, anhydrous         Ph. Eur. 3rd Ed.  \r\n\r\n Lactosemonohydrat        Lactose monohydrate        Ph. Eur. 3rd Ed.  \r\n\r\n  Lactulose solution      Lactuloseopløsning         Ph. Eur. 3rd Ed.  \r\n\r\n Lactuloseopløsning       Lactulose solution         Ph. Eur. 3rd Ed.  \r\n\r\n Laevulose                Fructose                   Ph. Eur. 3rd Ed.  \r\n\r\n Lakridsrod, uskrællet    Liquorice root             Ph. Eur. 3rd Ed.  \r\n\r\n  Lanatoside C            Lanatosid C                Ph. Eur. 3rd Ed.  \r\n\r\n Lanolin                  Wool fat, hydrous          Ph. Eur. 3rd Ed.  \r\n\r\n Lanolin, hydrogeneret    Wool fat, hydrogenated     Ph. Eur. 3rd Ed.  \r\n\r\n Lanolin, vandfrit        Wool fat                   Ph. Eur. 3rd Ed.  \r\n\r\n Lanolinalkohol           Wool alcohols              Ph. Eur. 3rd Ed.  \r\n\r\n  Lemon oil               Citronolie                 Ph. Eur. 3rd Ed.  \r\n\r\n  Leucine                 Leucin                     Ph. Eur. 3rd Ed.  \r\n\r\n  Levamisole  \r\n\r\n  hydrochloride           Levamisolhydrochlorid      Ph. Eur. 3rd Ed.  \r\n\r\n Levamisolhydrochlorid    Levamisole hydrochloride   Ph. Eur. 3rd Ed.  \r\n\r\n  Levodopa                Levodopa                   Ph. Eur. 3rd Ed.  \r\n\r\n  Levomenthol             Levomenthol                Ph. Eur. 3rd Ed.  \r\n\r\n  Levomepromazine  \r\n\r\n  hydrochloride           Levomepromazin-  \r\n\r\n                          hydrochlorid               Ph. Eur. 3rd Ed.  \r\n\r\n  Levomepromazine  \r\n\r\n  maleate                 Levomepromazinmaleat       Ph. Eur. 3rd Ed.  \r\n\r\n Levomepromazin-  \r\n\r\n  hydrochlorid            Levomepromazine  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n Levomepromazinmaleat     Levomepromazine maleate    Ph. Eur. 3rd Ed.  \r\n\r\n  Levonorgestrel          Levonorgestrel             Ph. Eur. 3rd Ed.  \r\n\r\n  Levothyroxine sodium    Levothyroxinnatrium        Ph. Eur. 3rd Ed.  \r\n\r\n Levothyroxinnatrium      Levothyroxine sodium       Ph. Eur. 3rd Ed.  \r\n\r\n  Lidocaine               Lidocain                   Ph. Eur. 3rd Ed.  \r\n\r\n  Lidocaine  \r\n\r\n  hydrochloride           Lidocainhydrochlorid       Ph. Eur. 3rd Ed.  \r\n\r\n Lidocainhydrochlorid     Lidocaine hydrochloride    Ph. Eur. 3rd Ed.  \r\n\r\n  Lime flower             Lindeblomst                Ph. Eur. 3rd Ed.  \r\n\r\n Limonis aetherolum       Lemon oil                  Ph. Eur. 3rd Ed.  \r\n\r\n  Lincomycin  \r\n\r\n  hydrochloride           Lincomycinhydrochlorid     Ph. Eur. 3rd Ed.  \r\n\r\n Lincomycinhydrochlorid   Lincomycin hydrochloride   Ph. Eur. 3rd Ed.  \r\n\r\n  Lindane                 Lindan                     Ph. Eur. 3rd Ed.  \r\n\r\n Lindeblomst              Lime flower                Ph. Eur. 3rd Ed.  \r\n\r\n Lini semen               Linseed                    Ph. Eur. 3rd Ed.  \r\n\r\n  Linseed                 Hørfrø                     Ph. Eur. 3rd Ed.  \r\n\r\n  Liothyronine sodium     Liothyroninnatrium         Ph. Eur. 3rd Ed.  \r\n\r\n Liothyroninnatrium       Liothyronine sodium        Ph. Eur. 3rd Ed.  \r\n\r\n Liquiritiae radix        Liquorice root             Ph. Eur. 3rd Ed.  \r\n\r\n  Liquorice root          Lakridsrod, uskrællet      Ph. Eur. 3rd Ed.  \r\n\r\n  Lisinopril dihydrate    Lisinoprildihydrat         Ph. Eur. 3rd Ed.  \r\n\r\n Lisinoprildihydrat       Lisinopril dihydrate       Ph. Eur. 3rd Ed.  \r\n\r\n  Lithium carbonate       Lithiumcarbonat            Ph. Eur. 3rd Ed.  \r\n\r\n  Lithium citrate         Lithiumcitrat              Ph. Eur. 3rd Ed.  \r\n\r\n Lithiumcarbonat          Lithium carbonate          Ph. Eur. 3rd Ed.  \r\n\r\n Lithiumcitrat            Lithium citrate            Ph. Eur. 3rd Ed.  \r\n\r\n  Lomustine               Lomustin                   Ph. Eur. 3rd Ed.  \r\n\r\n  Loperamide  \r\n\r\n  hydrochloride           Loperamidhydrochlorid      Ph. Eur. 3rd Ed.  \r\n\r\n Loppefrø                 Psyllium seed              Ph. Eur. 3rd Ed.  \r\n\r\n  Lorazepam               Lorazepam                  Ph. Eur. 3rd Ed.  \r\n\r\n Luft, medicinsk          Air, compressed            DLS 97  \r\n\r\n  Lynestrenol             Lynestrenol                Ph. Eur. 3rd Ed.  \r\n\r\n  Lysine hydrochloride    Lysinhydrochlorid          Ph. Eur. 3rd Ed.  \r\n\r\n Lysinhydrochlorid        Lysine hydrochloride       Ph. Eur. 3rd Ed.  \r\n\r\n  Macrogol 1000           Macrogol 1000              Ph. Eur. 3rd Ed.  \r\n\r\n  Macrogol 1500           Macrogol 1500              Ph. Eur. 3rd Ed.  \r\n\r\n  Macrogol 20000          Macrogol 20000             Ph. Eur. 3rd Ed.  \r\n\r\n  Macrogol 300            Macrogol 300               Ph. Eur. 3rd Ed.  \r\n\r\n  Macrogol 3000           Macrogol 3000              Ph. Eur. 3rd Ed.  \r\n\r\n  Macrogol 35000          Macrogol 35000             Ph. Eur. 3rd Ed.  \r\n\r\n  Macrogol 400            Macrogol 400               Ph. Eur. 3rd Ed.  \r\n\r\n  Macrogol 4000           Macrogol 4000              Ph. Eur. 3rd Ed.  \r\n\r\n  Macrogol 6000           Macrogol 6000              Ph. Eur. 3rd Ed.  \r\n\r\n  Macrogol 7 glycerol  \r\n\r\n  cocoate                 Macrogol 7 glycerolcocoat  Ph. Eur. 3rd Ed.  \r\n\r\n Macrogol 7  \r\n\r\n  glycerolcocoat          Macrogol 7 glycerol  \r\n\r\n                          cocoate                    Ph. Eur. 3rd Ed.  \r\n\r\n  Macrogol cetostearyl  \r\n\r\n  ether                   Macrogolcetostearylether   Ph. Eur. 3rd Ed.  \r\n\r\n  Macrogol lauryl ether   Macrogollaurylether        Ph. Eur. 3rd Ed.  \r\n\r\n  Macrogol oleyl ether    Macrogololeylether         Ph. Eur. 3rd Ed.  \r\n\r\n Macrogolcetostearylether Macrogol cetostearyl  \r\n\r\n                          ether                      Ph. Eur. 3rd Ed.  \r\n\r\n Macrogollaurylether      Macrogol lauryl ether      Ph. Eur. 3rd Ed.  \r\n\r\n Macrogololeylether       Macrogol oleyl ether       Ph. Eur. 3rd Ed.  \r\n\r\n  Magnesium carbonate,  \r\n\r\n  heavy                   Magnesiumcarbonat, tungt   Ph. Eur. 3rd Ed.  \r\n\r\n  Magnesium carbonate,  \r\n\r\n  light                   Magnesiumcarbonat, let     Ph. Eur. 3rd Ed.  \r\n\r\n  Magnesium chloride  \r\n\r\n  hexahydrate             Magnesiumchloridhexahydrat Ph. Eur. 3rd Ed.  \r\n\r\n  Magnesium hydroxide     Magnesiumhydroxid          Ph. Eur. 3rd Ed.  \r\n\r\n  Magnesium oxide, heavy  Magnesiumoxid, tungt       Ph. Eur. 3rd Ed.  \r\n\r\n  Magnesium oxide, light  Magnesiumoxid, let         Ph. Eur. 3rd Ed.  \r\n\r\n  Magnesium stearate      Magnesiumstearat           Ph. Eur. 3rd Ed.  \r\n\r\n  Magnesium sulphate      Magnesiumsulfat            Ph. Eur. 3rd Ed.  \r\n\r\n  Magnesium trisilicate   Magnesiumtrisilicat        Ph. Eur. 3rd Ed.  \r\n\r\n Magnesiumcarbonat, let   Magnesium carbonate,  \r\n\r\n                          light                      Ph. Eur. 3rd Ed.  \r\n\r\n Magnesiumcarbonat, tungt Magnesium carbonate,  \r\n\r\n                          heavy                      Ph. Eur. 3rd Ed.  \r\n\r\n Magnesiumchlorid         Magnesium chloride  \r\n\r\n                          hexahydrate                Ph. Eur. 3rd Ed.  \r\n\r\n Magnesiumchlorid-  \r\n\r\n  hexahydrat              Magnesium chloride  \r\n\r\n                          hexahydrate                Ph. Eur. 3rd Ed.  \r\n\r\n Magnesiumhydroxid        Magnesium hydroxide        Ph. Eur. 3rd Ed.  \r\n\r\n Magnesiumoxid, let       Magnesium oxide, light     Ph. Eur. 3rd Ed.  \r\n\r\n Magnesiumoxid, tungt     Magnesium oxide, heavy     Ph. Eur. 3rd Ed.  \r\n\r\n Magnesiumstearat         Magnesium stearate         Ph. Eur. 3rd Ed.  \r\n\r\n Magnesiumsubcarbonat     Magnesium carbonate        Ph. Eur. 3rd Ed.  \r\n\r\n Magnesiumsulfat          Magnesium sulphate         Ph. Eur. 3rd Ed.  \r\n\r\n Magnesiumtrisilicat      Magnesium trisilicate      Ph. Eur. 3rd Ed.  \r\n\r\n  Maize starch            Majsstivelse               Ph. Eur. 3rd Ed.  \r\n\r\n Majsstivelse             Maize starch               Ph. Eur. 3rd Ed.  \r\n\r\n  Maleic acid             Maleinsyre                 Ph. Eur. 3rd Ed.  \r\n\r\n Maleinsyre               Maleic acid                Ph. Eur. 3rd Ed.  \r\n\r\n Mandelolie               Almond oil                 Ph. Eur. 3rd Ed.  \r\n\r\n Mandelolie, renset       Almond oil, refined        Ph. Eur. 3rd Ed.  \r\n\r\n  Mannitol                Mannitol                   Ph. Eur. 3rd Ed.  \r\n\r\n  Marshmallow root        Altæarod                   Ph. Eur. 3rd Ed.  \r\n\r\n  Matricaria flower       Kamilleblomst              Ph. Eur. 3rd Ed.  \r\n\r\n Matricariae flos         Matricaria flower          Ph. Eur. 3rd Ed.  \r\n\r\n Maydis amylum            Maize starch               Ph. Eur. 3rd Ed.  \r\n\r\n  Mebendazole             Mebendazol                 Ph. Eur. 3rd Ed.  \r\n\r\n  Meclozine  \r\n\r\n  hydrochloride           Meclozinhydrochlorid       Ph. Eur. 3rd Ed.  \r\n\r\n Meclozinhydrochlorid     Meclozine hydrochloride    Ph. Eur. 3rd Ed.  \r\n\r\n Medroxyprogesteron-  \r\n\r\n  acetat                  Medroxyprogesterone  \r\n\r\n                          acetate                    Ph. Eur. 3rd Ed.  \r\n\r\n  Medroxyprogesterone  \r\n\r\n  acetate                 Medroxyprogesteronacetat   Ph. Eur. 3rd Ed.  \r\n\r\n Melbærrisblad            Bearberry leaf             Ph. Eur. 3rd Ed.  \r\n\r\n  Menadione               Menadion                   Ph. Eur. 3rd Ed.  \r\n\r\n Menthae piperitae  \r\n\r\n  aetheroleum             Peppermint oil             Ph. Eur. 3rd Ed.  \r\n\r\n Menthae piperitae  \r\n\r\n  folium                  Peppermint leaf            Ph. Eur. 3rd Ed.  \r\n\r\n  Menthol, racemic        Menthol, racemisk          Ph. Eur. 3rd Ed.  \r\n\r\n Menthol, racemisk        Menthol, racemic           Ph. Eur. 3rd Ed.  \r\n\r\n  Meprobamate             Meprobamat                 Ph. Eur. 3rd Ed.  \r\n\r\n  Mepyramine maleate      Mepyraminmaleat            Ph. Eur. 3rd Ed.  \r\n\r\n Mepyraminmaleat          Mepyramine maleate         Ph. Eur. 3rd Ed.  \r\n\r\n  Mercaptopurine          Mercaptopurin              Ph. Eur. 3rd Ed.  \r\n\r\n  Mercuric chloride       Mercurichlorid             Ph. Eur. 3rd Ed.  \r\n\r\n Mercurichlorid           Mercuric chloride          Ph. Eur. 3rd Ed.  \r\n\r\n  Mestranol               Mestranol                  Ph. Eur. 3rd Ed.  \r\n\r\n  Metformin  \r\n\r\n  hydrochloride           Metforminhydrochlorid      Ph. Eur. 3rd Ed.  \r\n\r\n Metforminhydrochlorid    Metformin hydrochloride    Ph. Eur. 3rd Ed.  \r\n\r\n  Methacrylic acid-  \r\n\r\n acrylate copolymer       Methacrylsyre-acrylat  \r\n\r\n  (1:1) L 100             copolymer                  Ph. Eur. 3rd Ed.  \r\n\r\n                          (1:1) L100  \r\n\r\n  Methacrylic acid-  \r\n\r\n  acrylate copolymer      Methacrylsyre-acrylat  \r\n\r\n  (1:1) L100-55           copolymer                  Ph. Eur. 3rd Ed.  \r\n\r\n                          (1:1) L100-55  \r\n\r\n  Methacrylic acid-  \r\n\r\n  acrylate copolymer      Methacrylsyre-acrylat  \r\n\r\n  (1:2) S100              copolymer                  Ph. Eur. 3rd Ed.  \r\n\r\n                          (1:2) S100  \r\n\r\n  Methacrylic acid-  \r\n\r\n  acrylate copolymer      Methacrylsyre-acrylat  \r\n\r\n  dispersion 30 per cent  copolymer                  Ph. Eur. 3rd Ed.  \r\n\r\n  L30D                    dispersion 30% L30D  \r\n\r\n Methacrylsyre-acrylat  \r\n\r\n  copolymer               Methacrylic acid-  \r\n\r\n (1:1) L100               acrylate copolymer         Ph. Eur. 3rd Ed.  \r\n\r\n                          (1:1) L100  \r\n\r\n Methacrylsyre-acrylat  \r\n\r\n  copolymer               Methacrylic acid-  \r\n\r\n  (1:1) L100-55           acrylate copolymer         Ph. Eur. 3rd Ed.  \r\n\r\n                          (1:1) L100-55  \r\n\r\n Methacrylsyre-acrylat  \r\n\r\n  copolymer               Methacrylic acid-  \r\n\r\n  (1:2) S100              acrylate copolymer         Ph. Eur. 3rd Ed.  \r\n\r\n                          (1:2) S100  \r\n\r\n Methacrylsyre-acrylat  \r\n\r\n  copolymer               Methacrylic acid-  \r\n\r\n  dispersion 30% L300     acrylate copolymer         Ph. Eur. 3rd Ed.  \r\n\r\n                          dispersion 30 per cent  \r\n\r\n                          L30D  \r\n\r\n  Methadone  \r\n\r\n  hydrochloride           Methadonhydrochlorid       Ph. Eur. 3rd Ed.  \r\n\r\n Methadonhydrochlorid     Methadone hydrochloride    Ph. Eur. 3rd Ed.  \r\n\r\n  Methaqualone            Methaqualon                Ph. Eur. 3rd Ed.  \r\n\r\n  dl-Methionine           dl-Methionin               Ph. Eur. 3rd Ed.  \r\n\r\n  Methionine              Methionin                  Ph. Eur. 3rd Ed.  \r\n\r\n  Methotrexate            Methotrexat                Ph. Eur. 3rd Ed.  \r\n\r\n  Methyl  \r\n\r\n  parahydroxybenzoate     Methylparahydroxybenzoat   Ph. Eur. 3rd Ed.  \r\n\r\n  Methyl salicylate       Methylsalicylat            Ph. Eur. 3rd Ed.  \r\n\r\n Methylatropinbromid      Methylatropine bromide     Ph. Eur. 3rd Ed.  \r\n\r\n  Methylatropine bromide  Methylatropinbromid        Ph. Eur. 3rd Ed.  \r\n\r\n  Methylatropine nitrate  Methylatropinnitrat        Ph. Eur. 3rd Ed.  \r\n\r\n Methylatropinnitrat      Methylatropine nitrate     Ph. Eur. 3rd Ed.  \r\n\r\n  Methylcellulose         Methylcellulose            Ph. Eur. 3rd Ed.  \r\n\r\n Methylcellulose          Methylcellulose            Ph. Eur. 3rd Ed.  \r\n\r\n  Methyldopa              Methyldopa                 Ph. Eur. 3rd Ed.  \r\n\r\n Methylenchlorid          Methylene chloride         Ph. Eur. 3rd Ed.  \r\n\r\n  Methylene chloride      Methylenchlorid            Ph. Eur. 3rd Ed.  \r\n\r\n  Methylhydroxyethyl-  \r\n\r\n  cellulose               Methylhydroxyethyl-  \r\n\r\n                          cellulose                  Ph. Eur. 3rd Ed.  \r\n\r\n  Methylhydroxypropyl-  \r\n\r\n  cellulose               Methylhydroxypropyl-  \r\n\r\n                          cellulose                  Ph. Eur. 3rd Ed.  \r\n\r\n  Methylhydroxypropyl-  \r\n\r\n  cellulose               Methylhydroxypropyl-  \r\n\r\n  phthalate               cellulose-                 Ph. Eur. 3rd Ed.  \r\n\r\n                          phthalat  \r\n\r\n Methylparahydroxybenzoat Methyl parahydroxy-  \r\n\r\n                          benzoate                   Ph. Eur. 3rd Ed.  \r\n\r\n  Methylphenobarbital     Methylphenobarbital        Ph. Eur. 3rd Ed.  \r\n\r\n Methylprednisolonacetat  Methylprednisolone  \r\n\r\n                          acetate                    Ph. Eur. 3rd Ed.  \r\n\r\n  Methylprednisolone      Methylprednisolon          Ph. Eur. 3rd Ed.  \r\n\r\n  Methylprednisolone  \r\n\r\n  acetate                 Methylprednisolonacetat    Ph. Eur. 3rd Ed.  \r\n\r\n  Methylprednisolone  \r\n\r\n   hydrogen               Methylprednisolon-  \r\n\r\n  succinate               hydrogensuccinat           Ph. Eur. 3rd Ed.  \r\n\r\n Methylprednisolon-  \r\n\r\n  hydrogensuccinat        Methylprednisolone  \r\n\r\n                          hydrogen                   Ph. Eur. 3rd Ed.  \r\n\r\n                          succinate  \r\n\r\n Methylsalicylat          Methyl salicylate          Ph. Eur. 3rd Ed.  \r\n\r\n  Methyltestosterone      Methyltestosteron          Ph. Eur. 3rd Ed.  \r\n\r\n  Methylthioninium  \r\n\r\n  chloride for            Methylthioniniumchlorid  \r\n\r\n  external use            til                        Ph. Eur. 3rd Ed.  \r\n\r\n                          udvortes anvendelse  \r\n\r\n Methylthioniniumchlorid  \r\n\r\n  til                     Methylthioninium chloride  \r\n\r\n  udvortes anvendelse     for                        Ph. Eur. 3rd Ed.  \r\n\r\n udvortes anvendelse      external use  \r\n\r\n  Metoclopramide  \r\n\r\n  hydrochloride           Metoclopramidhydrochlorid  Ph. Eur. 3rd Ed.  \r\n\r\n Metoclopramidhydro-  \r\n\r\n chlorid                  Metoclopramide  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Metoprolol tartrate     Metoprololtartrat          Ph. Eur. 3rd Ed.  \r\n\r\n Metoprololtartrat        Metoprolol tartrate        Ph. Eur. 3rd Ed.  \r\n\r\n  Metrifonate             Metrifonat                 Ph. Eur. 3rd Ed.  \r\n\r\n  Metrizoic acid          Metrizoinsyre              DLS 97  \r\n\r\n Metrizoinsyre            Metrizoic acid             DLS 97  \r\n\r\n Metronidazolbenzoat      Metronidazole benzoate     Ph. Eur. 3rd Ed.  \r\n\r\n  Metronidazole           Metronidazol               Ph. Eur. 3rd Ed.  \r\n\r\n  Metronidazole benzoate  Metronidazolbenzoat        Ph. Eur. 3rd Ed.  \r\n\r\n  Mexiletine  \r\n\r\n  hydrochloride           Mexiletinhydrochlorid      Ph. Eur. 3rd Ed.  \r\n\r\n Mexiletinhydrochlorid    Mexiletine hydrochloride   Ph. Eur. 3rd Ed.  \r\n\r\n  Mianserin  \r\n\r\n  hydrochloride           Mianserinhydrochlorid      Ph. Eur. 3rd Ed.  \r\n\r\n Mianserinhydrochlorid    Mianserin hydrochloride    Ph. Eur. 3rd Ed.  \r\n\r\n  Miconazole              Miconazol                  Ph. Eur. 3rd Ed.  \r\n\r\n  Miconazole nitrate      Miconazolnitrat            Ph. Eur. 3rd Ed.  \r\n\r\n Miconazolnitrat          Miconazole nitrate         Ph. Eur. 3rd Ed.  \r\n\r\n  Midazolam               Midazolam                  Ph. Eur. 3rd Ed.  \r\n\r\n  Minocycline  \r\n\r\n  hydrochloride           Minocyclinhydrochlorid     Ph. Eur. 3rd Ed.  \r\n\r\n Minocyclinhydrochlorid   Minocycline hydrochloride  Ph. Eur. 3rd Ed.  \r\n\r\n  Minoxidil               Minoxidil                  Ph. Eur. 3rd Ed.  \r\n\r\n  Morphine hydrochloride  Morphinhydrochlorid        Ph. Eur. 3rd Ed.  \r\n\r\n Morphinhydrochlorid      Morphine hydrochloride     Ph. Eur. 3rd Ed.  \r\n\r\n Mælkesyre                Lactic acid                Ph. Eur. 3rd Ed.  \r\n\r\n  Nadroparin calcium      Nadroparincalcium          Ph. Eur. 3rd Ed.  \r\n\r\n Nadroparincalcium        Nadroparin calcium         Ph. Eur. 3rd Ed.  \r\n\r\n  Nalidixic acid          Nalidixinsyre              Ph. Eur. 3rd Ed.  \r\n\r\n Nalidixinsyre            Nalidixic acid             Ph. Eur. 3rd Ed.  \r\n\r\n  Naloxone  \r\n\r\n  hydrochloride           Naloxonhydrochlorid        Ph. Eur. 3rd Ed.  \r\n\r\n Naloxonhydrochlorid      Naloxone hydrochloride     Ph. Eur. 3rd Ed.  \r\n\r\n  Naphazoline  \r\n\r\n  hydrochloride           Naphazolinhydrochlorid     Ph. Eur. 3rd Ed.  \r\n\r\n  Naphazoline nitrate     Naphazolinnitrat           Ph. Eur. 3rd Ed.  \r\n\r\n Naphazolinhydrochlorid   Naphazoline hydrochloride  Ph. Eur. 3rd Ed.  \r\n\r\n Naphazolinnitrat         Naphazoline nitrate        Ph. Eur. 3rd Ed.  \r\n\r\n  Naproxen                Naproxen                   Ph. Eur. 3rd Ed.  \r\n\r\n Natriumacetat            Sodium acetate             Ph. Eur. 3rd Ed.  \r\n\r\n Natriumalginat           Sodium alginate            Ph. Eur. 3rd Ed.  \r\n\r\n Natriumamidotrizoat      Sodium amidotrizoate       Ph. Eur. 3rd Ed.  \r\n\r\n Natriumbenzoat           Sodium benzoate            Ph. Eur. 3rd Ed.  \r\n\r\n Natriumbromid            Sodium bromide             Ph. Eur. 3rd Ed.  \r\n\r\n Natriumcalciumedetat     Sodium calcium edetate     Ph. Eur. 3rd Ed.  \r\n\r\n Natriumcarbonat,  \r\n\r\n  vandfri                 Sodium carbonate,  \r\n\r\n                          anhydrous                  Ph. Eur. 3rd Ed.  \r\n\r\n Natriumcarbonatdeca-  \r\n\r\n  hydrat                  Sodium carbonate  \r\n\r\n                          decahydrate                Ph. Eur. 3rd Ed.  \r\n\r\n Natriumcarbonat-  \r\n\r\n  monohydrat              Sodium carbonate  \r\n\r\n                          monohydrate                Ph. Eur. 3rd Ed.  \r\n\r\n Natriumcetostearylsulfat Sodium cetostearyl  \r\n\r\n                          sulphate                   Ph. Eur. 3rd Ed.  \r\n\r\n Natriumchlorid           Sodium chloride            Ph. Eur. 3rd Ed.  \r\n\r\n Natriumcitrat            Sodium citrate             Ph. Eur. 3rd Ed.  \r\n\r\n Natriumcromoglicat       Sodium cromoglicate        Ph. Eur. 3rd Ed.  \r\n\r\n Natriumcyclamat          Sodium cyclamate           Ph. Eur. 3rd Ed.  \r\n\r\n Natriumdihydrogen-  \r\n\r\n phosphat-                Sodium dihydrogen  \r\n\r\n dihydrat                 phosphate                  Ph. Eur. 3rd Ed.  \r\n\r\n                          dihydrate  \r\n\r\n Natriumedetat            Disodium edetate           Ph. Eur. 3rd Ed.  \r\n\r\n Natriumfluorid           Sodium fluoride            Ph. Eur. 3rd Ed.  \r\n\r\n Natriumfusidat           Sodium fusidate            Ph. Eur. 3rd Ed.  \r\n\r\n Natriumhydrogencarbonat  Sodium hydrogen carbonate  Ph. Eur. 3rd Ed.  \r\n\r\n Natriumhydroxid          Sodium hydroxide           Ph. Eur. 3rd Ed.  \r\n\r\n Natriumiodid             Sodium iodide              Ph. Eur. 3rd Ed.  \r\n\r\n Natriumlactatopløsning   Sodium lactate solution    Ph. Eur. 3rd Ed.  \r\n\r\n Natriumlaurylsulfat      Sodium lauryl sulphate     Ph. Eur. 3rd Ed.  \r\n\r\n Natriummetabisulfit      Sodium metabisulphite      Ph. Eur. 3rd Ed.  \r\n\r\n Natriumnitroprussid      Sodium nitroprusside       Ph. Eur. 3rd Ed.  \r\n\r\n Natriumpicosulfat        Sodium picosulfate         Ph. Eur. 3rd Ed.  \r\n\r\n Natriumpyrosulfit        Sodium metabisulphite      Ph. Eur. 3rd Ed.  \r\n\r\n Natriumsalicylat         Sodium salicylate          Ph. Eur. 3rd Ed.  \r\n\r\n Natriumstivelses-  \r\n\r\n  glycollat (type A)      Sodium starch glycollate  \r\n\r\n                          (type A)                   Ph. Eur. 3rd Ed.  \r\n\r\n Natriumstivelses-  \r\n\r\n  glycollat (type B)      Sodium starch glycollate  \r\n\r\n                          (type B)                   Ph. Eur. 3rd Ed.  \r\n\r\n Natriumsulfat, vandfrit  Sodium sulphate,  \r\n\r\n                          anhydrous                  Ph. Eur. 3rd Ed.  \r\n\r\n Natriumsulfatdecahydrat  Sodium sulphate  \r\n\r\n                          decahydrate                Ph. Eur. 3rd Ed.  \r\n\r\n Natriumsulfit, vandfri   Sodium sulphite,  \r\n\r\n                          anhydrous                  Ph. Eur. 3rd Ed.  \r\n\r\n Natriumsulfitheptahydrat Sodium sulphite  \r\n\r\n                          heptahydrate               Ph. Eur. 3rd Ed.  \r\n\r\n Natriumthiosulfat        Sodium thiosulphate        Ph. Eur. 3rd Ed.  \r\n\r\n Natriumvalproat          Sodium valproate           Ph. Eur. 3rd Ed.  \r\n\r\n Nellikeolie              Clove oil                  Ph. Eur. 3rd Ed.  \r\n\r\n  Neomycin sulphate       Neomycinsulfat             Ph. Eur. 3rd Ed.  \r\n\r\n Neomycinsulfat           Neomycin sulphate          Ph. Eur. 3rd Ed.  \r\n\r\n Neostigminbromid         Neostigmine bromide        Ph. Eur. 3rd Ed.  \r\n\r\n  Neostigmine bromide     Neostigminbromid           Ph. Eur. 3rd Ed.  \r\n\r\n  Neostigmine  \r\n\r\n  metilsulfate            Neostigminmetilsulfat      Ph. Eur. 3rd Ed.  \r\n\r\n Neostigminmetilsulfat    Neostigmine metilsulfate   Ph. Eur. 3rd Ed.  \r\n\r\n  Nicethamide             Nicethamid                 Ph. Eur. 3rd Ed.  \r\n\r\n Niclosamid, vandfri      Niclosamide, anhydrous     Ph. Eur. 3rd Ed.  \r\n\r\n  Niclosamide  \r\n\r\n  monohydrate             Niclosamidmonohydrat       Ph. Eur. 3rd Ed.  \r\n\r\n  Niclosamide, anhydrous  Niclosamid, vandfri        Ph. Eur. 3rd Ed.  \r\n\r\n Niclosamidmonohydrat     Niclosamide monohydrate    Ph. Eur. 3rd Ed.  \r\n\r\n  Nicotinamide            Nicotinamid                Ph. Eur. 3rd Ed.  \r\n\r\n  Nicotinic acid          Nicotinsyre                Ph. Eur. 3rd Ed.  \r\n\r\n Nicotinsyre              Nicotinic acid             Ph. Eur. 3rd Ed.  \r\n\r\n  Nifedipine              Nifedipin                  Ph. Eur. 3rd Ed.  \r\n\r\n  Nitrazepam              Nitrazepam                 Ph. Eur. 3rd Ed.  \r\n\r\n  Nitrofural              Nitrofural                 Ph. Eur. 3rd Ed.  \r\n\r\n  Nitrofurantoin          Nitrofurantoin             Ph. Eur. 3rd Ed.  \r\n\r\n  Nitrous oxide           Dinitrogenoxid             Ph. Eur. 3rd Ed.  \r\n\r\n  Noradrenaline  \r\n\r\n  hydrochloride           Noradrenalinhydrochlorid   Ph. Eur. 3rd Ed.  \r\n\r\n  Noradrenaline tartrate  Noradrenalintartrat        Ph. Eur. 3rd Ed.  \r\n\r\n Noradrenalinhydrochlorid Noradrenaline  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n Noradrenalintartrat      Noradrenaline tartrate     Ph. Eur. 3rd Ed.  \r\n\r\n Norethisteronacetat      Norethisterone acetate     Ph. Eur. 3rd Ed.  \r\n\r\n  Norethisterone          Norethisteron              Ph. Eur. 3rd Ed.  \r\n\r\n  Norethisterone acetate  Norethisteronacetat        Ph. Eur. 3rd Ed.  \r\n\r\n  Norgestrel              Norgestrel                 Ph. Eur. 3rd Ed.  \r\n\r\n  Nortriptyline  \r\n\r\n  hydrochloride           Nortriptylinhydrochlorid   Ph. Eur. 3rd Ed.  \r\n\r\n Nortriptylinhydrochlorid Nortriptyline  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Noscapine               Noscapin                   Ph. Eur. 3rd Ed.  \r\n\r\n  Noscapine  \r\n\r\n  hydrochloride           Noscapinhydrochlorid       Ph. Eur. 3rd Ed.  \r\n\r\n Noscapinhydrochlorid     Noscapine hydrochloride    Ph. Eur. 3rd Ed.  \r\n\r\n  Nystatin                Nystatin                   Ph. Eur. 3rd Ed.  \r\n\r\n  Octyldodecanol          Octyldodecanol             Ph. Eur. 3rd Ed.  \r\n\r\n  Oleic acid              Oliesyre                   Ph. Eur. 3rd Ed.  \r\n\r\n Oliesyre                 Oleic acid                 Ph. Eur. 3rd Ed.  \r\n\r\n Olivae oleum             Olive oil                  Ph. Eur. 3rd Ed.  \r\n\r\n  Olive oil               Olivenolie                 Ph. Eur. 3rd Ed.  \r\n\r\n Olivenolie               Olive oil                  Ph. Eur. 3rd Ed.  \r\n\r\n  Omeprazole              Omeprazol                  Ph. Eur. 3rd Ed.  \r\n\r\n  Omeprazole sodium       Omeprazolnatrium           Ph. Eur. 3rd Ed.  \r\n\r\n Omeprazolnatrium         Omeprazole sodium          Ph. Eur. 3rd Ed.  \r\n\r\n Opium crudum             Opium, raw                 Ph. Eur. 3rd Ed.  \r\n\r\n  Opium, raw              Opium, rå                  Ph. Eur. 3rd Ed.  \r\n\r\n Opium, rå                Opium, raw                 Ph. Eur. 3rd Ed.  \r\n\r\n  Orciprenaline sulphate  Orciprenalinsulfat         Ph. Eur. 3rd Ed.  \r\n\r\n Orciprenalinsulfat       Orciprenaline sulphate     Ph. Eur. 3rd Ed.  \r\n\r\n Oryzae amylum            Rice starch                Ph. Eur. 3rd Ed.  \r\n\r\n  Ouabain                 Ouabain                    Ph. Eur. 3rd Ed.  \r\n\r\n  Oxazepam                Oxazepam                   Ph. Eur. 3rd Ed.  \r\n\r\n  Oxprenolol  \r\n\r\n  hydrochloride           Oxprenololhydrochlorid     Ph. Eur. 3rd Ed.  \r\n\r\n Oxprenololhydrochlorid   Oxprenolol hydrochloride   Ph. Eur. 3rd Ed.  \r\n\r\n  Oxygen                  Oxygen                     Ph. Eur. 3rd Ed.  \r\n\r\n  Oxymetazoline  \r\n\r\n  hydrochloride           Oxymetazolinhydrochlorid   Ph. Eur. 3rd Ed.  \r\n\r\n  Oxyphenbutazone         Oxyphenbutazon             Ph. Eur. 3rd Ed.  \r\n\r\n  Oxytetracycline         Oxytetracyclin             Ph. Eur. 3rd Ed.  \r\n\r\n  Oxytetracycline  \r\n\r\n  hydrochloride           Oxytetracyclinhydrochlorid Ph. Eur. 3rd Ed.  \r\n\r\n Oxytetracyclin-  \r\n\r\n  hydrochlorid            Oxytetracycline  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Oxytocin                Oxytocin                   Ph. Eur. 3rd Ed.  \r\n\r\n  Oxytocin concentrated  \r\n\r\n  solution                Oxytocinopløsning,  \r\n\r\n                          koncentreret               Ph. Eur. 3rd Ed.  \r\n\r\n Oxytocinopløsning,  \r\n\r\n  koncentreret            Oxytocin concentrated  \r\n\r\n                          solution                   Ph. Eur. 3rd Ed.  \r\n\r\n  Pancreas powder         Pankreaspulver             Ph. Eur. 3rd Ed.  \r\n\r\n  Pancuronium bromide     Pancuroniumbromid          Ph. Eur. 3rd Ed.  \r\n\r\n Pancuroniumbromid        Pancuronium bromide        Ph. Eur. 3rd Ed.  \r\n\r\n Pankreaspulver           Pancreas powder            Ph. Eur. 3rd Ed.  \r\n\r\n  Papaverine  \r\n\r\n  hydrochloride           Papaverinhydrochlorid      Ph. Eur. 3rd Ed.  \r\n\r\n Papaverinhydrochlorid    Papaverine hydrochloride   Ph. Eur. 3rd Ed.  \r\n\r\n  Paracetamol             Paracetamol                Ph. Eur. 3rd Ed.  \r\n\r\n Paraffin                 Paraffin, hard             Ph. Eur. 3rd Ed.  \r\n\r\n  Paraffin, hard          Paraffin                   Ph. Eur. 3rd Ed.  \r\n\r\n  Paraffin, light liquid  Paraffinolie, tynd         Ph. Eur. 3rd Ed.  \r\n\r\n  Paraffin, liquid        Paraffinolie               Ph. Eur. 3rd Ed.  \r\n\r\n Paraffinolie             Paraffin, liquid           Ph. Eur. 3rd Ed.  \r\n\r\n Paraffinolie, tynd       Paraffin, light liquid     Ph. Eur. 3rd Ed.  \r\n\r\n  Paraldehyde             Paraldehyd                 Ph. Eur. 3rd Ed.  \r\n\r\n Pebermynteblad           Peppermint leaf            Ph. Eur. 3rd Ed.  \r\n\r\n Pebermynteolie           Peppermint oil             Ph. Eur. 3rd Ed.  \r\n\r\n  Penicillamine           Penicillamin               Ph. Eur. 3rd Ed.  \r\n\r\n Pentamidindiisetionat    Pentamidine diisetionate   Ph. Eur. 3rd Ed.  \r\n\r\n  Pentamidine  \r\n\r\n  diisetionate            Pentamidindiisetionat      Ph. Eur. 3rd Ed.  \r\n\r\n  Pentazocine lactate     Pentazocinlactat           DLS 97  \r\n\r\n Pentazocinlactat         Pentazocine lactate        DLS 97  \r\n\r\n  Pentobarbital           Pentobarbital              Ph. Eur. 3rd Ed.  \r\n\r\n  Pentobarbital sodium    Pentobarbitalnatrium       Ph. Eur. 3rd Ed.  \r\n\r\n Pentobarbitalnatrium     Pentobarbital sodium       Ph. Eur. 3rd Ed.  \r\n\r\n  Pentoxifylline          Pentoxifyllin              Ph. Eur. 3rd Ed.  \r\n\r\n  Peppermint leaf         Pebermynteblad             Ph. Eur. 3rd Ed.  \r\n\r\n  Peppermint oil          Pebermynteolie             Ph. Eur. 3rd Ed.  \r\n\r\n Pepsin                   Pepsin powder              Ph. Eur. 3rd Ed.  \r\n\r\n  Pepsin powder           Pepsin                     Ph. Eur. 3rd Ed.  \r\n\r\n  Perphenazine            Perphenazin                Ph. Eur. 3rd Ed.  \r\n\r\n  Peru balsam             Perubalsam                 Ph. Eur. 3rd Ed.  \r\n\r\n  Pethidine hydrochloride Pethidinhydrochlorid       Ph. Eur. 3rd Ed.  \r\n\r\n Pethidinhydrochlorid     Pethidine hydrochloride    Ph. Eur. 3rd Ed.  \r\n\r\n  Phenacetin              Phenacetin                 Ph. Eur. 3rd Ed.  \r\n\r\n  Phenazone               Phenazon                   Ph. Eur. 3rd Ed.  \r\n\r\n  Phenobarbital           Phenobarbital              Ph. Eur. 3rd Ed.  \r\n\r\n  Phenobarbital sodium    Phenobarbitalnatrium       Ph. Eur. 3rd Ed.  \r\n\r\n Phenobarbitalnatrium     Phenobarbital sodium       Ph. Eur. 3rd Ed.  \r\n\r\n  Phenol                  Phenol                     Ph. Eur. 3rd Ed.  \r\n\r\n  Phenolsulfonphthalein   Phenolsulfonphthalein      Ph. Eur. 3rd Ed.  \r\n\r\n  Phenoxyethanol          Phenoxyethanol             Ph. Eur. 3rd Ed.  \r\n\r\n  Phenoxymethylpenicillin Phenoxymethylpenicillin    Ph. Eur. 3rd Ed.  \r\n\r\n  Phenoxymethylpenicillin Phenoxymethylpenicillin-  \r\n\r\n  potassium               kalium                     Ph. Eur. 3rd Ed.  \r\n\r\n Phenoxymethylpenicillin-  \r\n\r\n  kalium                  Phenoxymethylpenicillin    Ph. Eur. 3rd Ed.  \r\n\r\n                          potassium  \r\n\r\n  Phentolamine mesilate   Phentolaminmesilat         Ph. Eur. 3rd Ed.  \r\n\r\n Phentolaminmesilat       Phentolamine mesilate      Ph. Eur. 3rd Ed.  \r\n\r\n  Phenylalanine           Phenylalanin               Ph. Eur. 3rd Ed.  \r\n\r\n  Phenylbutazone          Phenylbutazon              Ph. Eur. 3rd Ed.  \r\n\r\n  Phenylephrine           Phenylephrin               Ph. Eur. 3rd Ed.  \r\n\r\n  Phenylephrine  \r\n\r\n  hydrochloride           Phenylephrinhydrochlorid   Ph. Eur. 3rd Ed.  \r\n\r\n Phenylephrinhydrochlorid Phenylephrine  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n Phenylmercuriborat       Phenylmercuric borate      Ph. Eur. 3rd Ed.  \r\n\r\n  Phenylmercuric borate   Phenylmercuriborat         Ph. Eur. 3rd Ed.  \r\n\r\n  Phenylmercuric nitrate  Phenylmercurinitrat        Ph. Eur. 3rd Ed.  \r\n\r\n Phenylmercurinitrat      Phenylmercuric nitrate     Ph. Eur. 3rd Ed.  \r\n\r\n  Phenylpropanolamine  \r\n\r\n  hydrochloride           Phenylpropanolamin-  \r\n\r\n                          hydrochlorid               Ph. Eur. 3rd Ed.  \r\n\r\n Phenylpropanolamin-  \r\n\r\n  hydrochlorid            Phenylpropanolamine  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Phenytoin sodium        Phenytoinnatrium           Ph. Eur. 3rd Ed.  \r\n\r\n Phenytoinnatrium         Phenytoin sodium           Ph. Eur. 3rd Ed.  \r\n\r\n  Pholcodine              Pholcodin                  Ph. Eur. 3rd Ed.  \r\n\r\n  Phosphoric acid,  \r\n\r\n  concentrated            Phosphorsyre, koncentreret Ph. Eur. 3rd Ed.  \r\n\r\n  Phosphoric acid, dilute Phosphorsyre, fortyndet    Ph. Eur. 3rd Ed.  \r\n\r\n Phosphorsyre, fortyndet  Phosphoric acid, dilute    Ph. Eur. 3rd Ed.  \r\n\r\n Phosphorsyre,  \r\n\r\n  koncentreret            Phosphoric acid,  \r\n\r\n                          concentrated               Ph. Eur. 3rd Ed.  \r\n\r\n  Phthalylsulfathiazole   Phthalylsulfathiazol       Ph. Eur. 3rd Ed.  \r\n\r\n  Physostigmine  \r\n\r\n  salicylate              Physostigminsalicylat      Ph. Eur. 3rd Ed.  \r\n\r\n  Physostigmine sulphate  Physostigminsulfat         Ph. Eur. 3rd Ed.  \r\n\r\n Physostigminsalicylat    Physostigmine salicylate   Ph. Eur. 3rd Ed.  \r\n\r\n Physostigminsulfat       Physostigmine sulphate     Ph. Eur. 3rd Ed.  \r\n\r\n  Phytomenadione          Phytomenadion              Ph. Eur. 3rd Ed.  \r\n\r\n Pigæbleblad              Stramonium leaf            Ph. Eur. 3rd Ed.  \r\n\r\n  Pilocarpine  \r\n\r\n  hydrochloride           Pilocarpinhydrochlorid     Ph. Eur. 3rd Ed.  \r\n\r\n  Pilocarpine nitrate     Pilocarpinnitrat           Ph. Eur. 3rd Ed.  \r\n\r\n Pilocarpinhydrochlorid   Pilocarpine hydrochloride  Ph. Eur. 3rd Ed.  \r\n\r\n Pilocarpinnitrat         Pilocarpine nitrate        Ph. Eur. 3rd Ed.  \r\n\r\n  Pindolol                Pindolol                   Ph. Eur. 3rd Ed.  \r\n\r\n Piperazinadipat          Piperazine adipate         Ph. Eur. 3rd Ed.  \r\n\r\n Piperazincitrat          Piperazine citrate         Ph. Eur. 3rd Ed.  \r\n\r\n  Piperazine adipate      Piperazinadipat            Ph. Eur. 3rd Ed.  \r\n\r\n  Piperazine citrate      Piperazincitrat            Ph. Eur. 3rd Ed.  \r\n\r\n  Piperazine hydrate      Piperazinhydrat            Ph. Eur. 3rd Ed.  \r\n\r\n Piperazinhydrat          Piperazine hydrate         Ph. Eur. 3rd Ed.  \r\n\r\n  Piroxicam               Piroxicam                  Ph. Eur. 3rd Ed.  \r\n\r\n  Pivampicillin           Pivampicillin              Ph. Eur. 3rd Ed.  \r\n\r\n  Plasma for  \r\n\r\n  fractionation, human    Plasma til fraktionering,  \r\n\r\n                          humant                     DLS 97  \r\n\r\n Plasma til  \r\n\r\n  fraktionering, humant   Plasma for fractionation,  \r\n\r\n                          human                      DLS 97  \r\n\r\n Polyacrylat 30%,  \r\n\r\n  dispergeret             Polyacrylate dispersion  \r\n\r\n                          30 per cent                Ph. Eur. 3rd Ed.  \r\n\r\n  Polyacrylate  \r\n\r\n  dispersion 30  \r\n\r\n  per cent                Polyacrylat 30%,  \r\n\r\n                          dispergeret                Ph. Eur. 3rd Ed.  \r\n\r\n Polygalae radix          Senega root                Ph. Eur. 3rd Ed.  \r\n\r\n Polymyxin B sulfat       Polymyxin B sulphate       Ph. Eur. 3rd Ed.  \r\n\r\n  Polymyxin B sulphate    Polymyxin B sulfat         Ph. Eur. 3rd Ed.  \r\n\r\n  Polysorbate 20          Polysorbat 20              Ph. Eur. 3rd Ed.  \r\n\r\n  Polysorbate 60          Polysorbat 60              Ph. Eur. 3rd Ed.  \r\n\r\n  Polysorbate 80          Polysorbat 80              Ph. Eur. 3rd Ed.  \r\n\r\n Polyvidon                Povidone                   Ph. Eur. 3rd Ed.  \r\n\r\n Polyvinylpyrrolidon      Povidone                   Ph. Eur. 3rd Ed.  \r\n\r\n  Potassium acetate       Kaliumacetat               Ph. Eur. 3rd Ed.  \r\n\r\n  Potassium bromide       Kaliumbromid               Ph. Eur. 3rd Ed.  \r\n\r\n  Potassium chloride      Kaliumchlorid              Ph. Eur. 3rd Ed.  \r\n\r\n  Potassium citrate       Kaliumcitrat               Ph. Eur. 3rd Ed.  \r\n\r\n  Potassium clavulanate   Kaliumclavulanat           Ph. Eur. 3rd Ed.  \r\n\r\n  Potassium dihydrogen  \r\n\r\n  phosphate               Kaliumdihydrogenphosphat   Ph. Eur. 3rd Ed.  \r\n\r\n  Potassium hydrogen  \r\n\r\n  carbonate               Kaliumhydrogencarbonat     Ph. Eur. 3rd Ed.  \r\n\r\n  Potassium hydroxide     Kaliumhydroxid             Ph. Eur. 3rd Ed.  \r\n\r\n  Potassium iodide        Kaliumiodid                Ph. Eur. 3rd Ed.  \r\n\r\n  Potassium permanganate  Kaliumpermanganat          Ph. Eur. 3rd Ed.  \r\n\r\n  Potassium sorbate       Kaliumsorbat               Ph. Eur. 3rd Ed.  \r\n\r\n  Potato starch           Kartoffelstivelse          Ph. Eur. 3rd Ed.  \r\n\r\n Povidon                  Povidone                   Ph. Eur. 3rd Ed.  \r\n\r\n Povidon, ioderet         Povidone, iodinated        Ph. Eur. 3rd Ed.  \r\n\r\n  Povidone                Povidon                    Ph. Eur. 3rd Ed.  \r\n\r\n  Povidone, iodinated     Povidon, ioderet           Ph. Eur. 3rd Ed.  \r\n\r\n  Praziquantel            Praziquantel               Ph. Eur. 3rd Ed.  \r\n\r\n  Prazosin hydrochloride  Prazosinhydrochlorid       Ph. Eur. 3rd Ed.  \r\n\r\n Prazosinhydrochlorid     Prazosin hydrochloride     Ph. Eur. 3rd Ed.  \r\n\r\n Prednisolonacetat        Prednisolone acetate       Ph. Eur. 3rd Ed.  \r\n\r\n  Prednisolone            Prednisolon                Ph. Eur. 3rd Ed.  \r\n\r\n  Prednisolone acetate    Prednisolonacetat          Ph. Eur. 3rd Ed.  \r\n\r\n  Prednisolone pivalate   Prednisolonpivalat         Ph. Eur. 3rd Ed.  \r\n\r\n  Prednisolone sodium  \r\n\r\n  phosphate               Prednisolonnatriumphosphat Ph. Eur. 3rd Ed.  \r\n\r\n Prednisolonnatrium-  \r\n\r\n  phosphat                Prednisolone sodium  \r\n\r\n                          phosphate                  Ph. Eur. 3rd Ed.  \r\n\r\n Prednisolonpivalat       Prednisolone pivalate      Ph. Eur. 3rd Ed.  \r\n\r\n  Prednisone              Prednison                  Ph. Eur. 3rd Ed.  \r\n\r\n  Primaquine diphosphate  Primaquinphosphat          Ph. Eur. 3rd Ed.  \r\n\r\n Primaquinphosphat        Primaquine diphosphate     Ph. Eur. 3rd Ed.  \r\n\r\n  Primidone               Primidon                   Ph. Eur. 3rd Ed.  \r\n\r\n  Probenecid              Probenecid                 Ph. Eur. 3rd Ed.  \r\n\r\n  Procainamide  \r\n\r\n  hydrochloride           Procainamidhydrochlorid    Ph. Eur. 3rd Ed.  \r\n\r\n Procainamidhydrochlorid  Procainamide  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Procaine hydrochloride  Procainhydrochlorid        Ph. Eur. 3rd Ed.  \r\n\r\n Procainhydrochlorid      Procaine hydrochloride     Ph. Eur. 3rd Ed.  \r\n\r\n  Prochlorperazine  \r\n\r\n  maleate                 Prochlorperazinmaleat      Ph. Eur. 3rd Ed.  \r\n\r\n Prochlorperazinmaleat    Prochlorperazine maleate   Ph. Eur. 3rd Ed.  \r\n\r\n  Progesterone            Progesteron                Ph. Eur. 3rd Ed.  \r\n\r\n  Proline                 Prolin                     Ph. Eur. 3rd Ed.  \r\n\r\n  Promethazine  \r\n\r\n  hydrochloride           Promethazinhydrochlorid    Ph. Eur. 3rd Ed.  \r\n\r\n Promethazinhydrochlorid  Promethazine  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n Propanthelinbromid       Propantheline bromide      Ph. Eur. 3rd Ed.  \r\n\r\n  Propantheline bromide   Propanthelinbromid         Ph. Eur. 3rd Ed.  \r\n\r\n  Propranolol  \r\n\r\n  hydrochloride           Propranololhydroclorid     Ph. Eur. 3rd Ed.  \r\n\r\n Propranololhydroclorid   Propranolol hydrochloride  Ph. Eur. 3rd Ed.  \r\n\r\n  Propyl gallate          Propylgallat               Ph. Eur. 3rd Ed.  \r\n\r\n  Propyl parahydroxy-  \r\n\r\n  benzoate                Propylparahydroxybenzoat   Ph. Eur. 3rd Ed.  \r\n\r\n  Propylene glycol        Propylenglycol             Ph. Eur. 3rd Ed.  \r\n\r\n  Propylene glycol  \r\n\r\n  monostearate            Propylenglycolmonostearat  Ph. Eur. 3rd Ed.  \r\n\r\n Propylenglycol-  \r\n\r\n  monostearat             Propylene glycol  \r\n\r\n                          monostearate               Ph. Eur. 3rd Ed.  \r\n\r\n Propylgallat             Propyl gallate             Ph. Eur. 3rd Ed.  \r\n\r\n Propylparahydroxybenzoat Propyl parahydroxy-  \r\n\r\n                          benzoate                   Ph. Eur. 3rd Ed.  \r\n\r\n  Propylthiouracil        Propylthiouracil           Ph. Eur. 3rd Ed.  \r\n\r\n  Propyphenazone          Propyphenazon              Ph. Eur. 3rd Ed.  \r\n\r\n  Protamine hydrochloride Protaminhydrochlorid       Ph. Eur. 3rd Ed.  \r\n\r\n  Protamine sulphate      Protaminsulfat             Ph. Eur. 3rd Ed.  \r\n\r\n Protaminhydrochlorid     Protamine hydrochloride    Ph. Eur. 3rd Ed.  \r\n\r\n Protaminsulfat           Protamine sulphate         Ph. Eur. 3rd Ed.  \r\n\r\n  Protirelin              Protirelin                 Ph. Eur. 3rd Ed.  \r\n\r\n Protirelin               Protirelin                 Ph. Eur. 3rd Ed.  \r\n\r\n  Proxyphylline           Proxyphyllin               Ph. Eur. 3rd Ed.  \r\n\r\n Psyllii semen            Psyllium seed              Ph. Eur. 3rd Ed.  \r\n\r\n  Psyllium seed           Psylliumfrø                Ph. Eur. 3rd Ed.  \r\n\r\n Psylliumfrø              Psyllium seed              Ph. Eur. 3rd Ed.  \r\n\r\n Purshianabark            Cascara                    Ph. Eur. 3rd Ed.  \r\n\r\n  Pyrazinamide            Pyrazinamid                Ph. Eur. 3rd Ed.  \r\n\r\n  Pyridoxine  \r\n\r\n  hydrochloride           Pyridoxinhydrochlorid      Ph. Eur. 3rd Ed.  \r\n\r\n Pyridoxinhydrochlorid    Pyridoxine hydrochloride   Ph. Eur. 3rd Ed.  \r\n\r\n  Pyrimethamine           Pyrimethamin               Ph. Eur. 3rd Ed.  \r\n\r\n  Quinidine sulphate      Quinidinsulfat             Ph. Eur. 3rd Ed.  \r\n\r\n Quinidinsulfat           Quinidine sulphate         Ph. Eur. 3rd Ed.  \r\n\r\n  Quinine hydrochloride   Quininhydrochlorid         Ph. Eur. 3rd Ed.  \r\n\r\n  Quinine sulphate        Quininsulfat               Ph. Eur. 3rd Ed.  \r\n\r\n Quininhydrochlorid       Quinine hydrochloride      Ph. Eur. 3rd Ed.  \r\n\r\n Quininsulfat             Quinine sulphate           Ph. Eur. 3rd Ed.  \r\n\r\n Rabarberrod              Rhubarb                    Ph. Eur. 3rd Ed.  \r\n\r\n  Ranitidine  \r\n\r\n  hydrochloride           Ranitidinhydrochlorid      Ph. Eur. 3rd Ed.  \r\n\r\n Ranitidinhydrochlorid    Ranitidine hydrochloride   Ph. Eur. 3rd Ed.  \r\n\r\n Ratanhiae radix          Rhatany root               Ph. Eur. 3rd Ed.  \r\n\r\n Ratanjerod               Rhatany root               Ph. Eur. 3rd Ed.  \r\n\r\n  Reserpine               Reserpin                   Ph. Eur. 3rd Ed.  \r\n\r\n  Resorcinol              Resorcinol                 Ph. Eur. 3rd Ed.  \r\n\r\n Rhamni purshianae  \r\n\r\n  cortex                  Cascara                    Ph. Eur. 3rd Ed.  \r\n\r\n  Rhatany root            Ratanjerod                 Ph. Eur. 3rd Ed.  \r\n\r\n Rhei radix               Rhubarb                    Ph. Eur. 3rd Ed.  \r\n\r\n  Rhubarb                 Rabarberrod                Ph. Eur. 3rd Ed.  \r\n\r\n  Riboflavine             Riboflavin                 Ph. Eur. 3rd Ed.  \r\n\r\n  Riboflavine sodium  \r\n\r\n  phosphate               Riboflavinnatriumphosphat  Ph. Eur. 3rd Ed.  \r\n\r\n Riboflavinnatrium-  \r\n\r\n  phosphat                Riboflavine sodium  \r\n\r\n                          phosphate                  Ph. Eur. 3rd Ed.  \r\n\r\n  Rice starch             Risstivelse                Ph. Eur. 3rd Ed.  \r\n\r\n Ricini oleum             Castor oil                 Ph. Eur. 3rd Ed.  \r\n\r\n Ricinusolie              Castor oil                 Ph. Eur. 3rd Ed.  \r\n\r\n Ricinusolie,  \r\n\r\n  polyoxyleret            Castor oil, polyoxyl       Ph. Eur. 3rd Ed.  \r\n\r\n Ricinusolie,  \r\n\r\n  polyoxyleret,           Castor oil, polyoxyl  \r\n\r\n  hydrogeneret            hydrogenated               Ph. Eur. 3rd Ed.  \r\n\r\n  Rifampicin              Rifampicin                 Ph. Eur. 3rd Ed.  \r\n\r\n  Rifamycin sodium        Rifamycinnatrium           Ph. Eur. 3rd Ed.  \r\n\r\n Rifamycinnatrium         Rifamycin sodium           Ph. Eur. 3rd Ed.  \r\n\r\n Risstivelse              Rice starch                Ph. Eur. 3rd Ed.  \r\n\r\n Romersk kamilleblomst    Chamomile flower, Roman    Ph. Eur. 3rd Ed.  \r\n\r\n  Roxithromycin           Roxithromycin              Ph. Eur. 3rd Ed.  \r\n\r\n  Saccharin               Saccharin                  Ph. Eur. 3rd Ed.  \r\n\r\n  Saccharin sodium        Saccharinnatrium           Ph. Eur. 3rd Ed.  \r\n\r\n Saccharinnatrium         Saccharin sodium           Ph. Eur. 3rd Ed.  \r\n\r\n Saccharose               Sucrose                    Ph. Eur. 3rd Ed.  \r\n\r\n  Salbutamol              Salbutamol                 Ph. Eur. 3rd Ed.  \r\n\r\n  Salbutamol sulphate     Salbutamolsulfat           Ph. Eur. 3rd Ed.  \r\n\r\n Salbutamolsulfat         Salbutamol sulphate        Ph. Eur. 3rd Ed.  \r\n\r\n  Salicylic acid          Salicylsyre                Ph. Eur. 3rd Ed.  \r\n\r\n Salicylsyre              Salicylic acid             Ph. Eur. 3rd Ed.  \r\n\r\n Saltsyre, fortyndet      Hydrochloric acid, dilute  Ph. Eur. 3rd Ed.  \r\n\r\n Saltsyre, koncentreret   Hydrochloric acid,  \r\n\r\n                          concentrated               Ph. Eur. 3rd Ed.  \r\n\r\n Scopolaminbutylbromid    Hyoscine butylbromide      Ph. Eur. 3rd Ed.  \r\n\r\n Scopolaminhydrobromid    Hyoscine hydrobromide      Ph. Eur. 3rd Ed.  \r\n\r\n Selendisulfid            Selenium disulphide        Ph. Eur. 3rd Ed.  \r\n\r\n  Selenium disulphide     Selendisulfid              Ph. Eur. 3rd Ed.  \r\n\r\n  Senega root             Senegarod                  Ph. Eur. 3rd Ed.  \r\n\r\n Senegarod                Senega root                Ph. Eur. 3rd Ed.  \r\n\r\n  Senna leaf              Sennesblad                 Ph. Eur. 3rd Ed.  \r\n\r\n  Senna pods,  \r\n\r\n  Alexandrian             Alexandrinsk sennesbælg    Ph. Eur. 3rd Ed.  \r\n\r\n  Senna pods,  \r\n\r\n  Tinnevelly              Tinnevelly-sennesbælg      Ph. Eur. 3rd Ed.  \r\n\r\n Sennae folium            Senna leaf                 Ph. Eur. 3rd Ed.  \r\n\r\n Sennae fructus  \r\n\r\n  acutifoliae             Senna pods, Alexandrian    Ph. Eur. 3rd Ed.  \r\n\r\n Sennae fructus  \r\n\r\n  angustifoliae           Senna pods, Tinnevelly     Ph. Eur. 3rd Ed.  \r\n\r\n Sennesblad               Senna leaf                 Ph. Eur. 3rd Ed.  \r\n\r\n Sennesbælg,  \r\n\r\n  Alexandrinsk            Senna pods, Alexandrian    Ph. Eur. 3rd Ed.  \r\n\r\n Sennesbælg, Tinnevelly   Senna pods, Tinnevelly     Ph. Eur. 3rd Ed.  \r\n\r\n  Serine                  Serin                      Ph. Eur. 3rd Ed.  \r\n\r\n  Sertaconazole nitrate   Sertaconazolnitrat         Ph. Eur. 3rd Ed.  \r\n\r\n Sertaconazolnitrat       Sertaconazole nitrate      Ph. Eur. 3rd Ed.  \r\n\r\n Serumgonadotropin til  \r\n\r\n  dyr                     Gonadotropin, equine  \r\n\r\n                          serum for                  Ph. Eur. 3rd Ed.  \r\n\r\n                          veterinary use  \r\n\r\n  Sesame oil              Sesamolie                  Ph. Eur. 3rd Ed.  \r\n\r\n Sesami oleum             Sesame oil                 Ph. Eur. 3rd Ed.  \r\n\r\n Sesamolie                Sesame oil                 Ph. Eur. 3rd Ed.  \r\n\r\n  Shellac                 Shellac                    Ph. Eur. 3rd Ed.  \r\n\r\n  Silica, colloidal  \r\n\r\n  anhydrous               Silica, kolloid vandfri    Ph. Eur. 3rd Ed.  \r\n\r\n  Silica, colloidal  \r\n\r\n  hydrated                Silica, kolloid            Ph. Eur. 3rd Ed.  \r\n\r\n Silica, kolloid          Silica, colloidal  \r\n\r\n                          hydrated                   Ph. Eur. 3rd Ed.  \r\n\r\n Silica, kolloid vandfri  Silica, colloidal  \r\n\r\n                          anhydrous                  Ph. Eur. 3rd Ed.  \r\n\r\n  Silver nitrate          Sølvnitrat                 Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium acetate          Natriumacetat              Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium alginate         Natriumalginat             Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium amidotrizoate    Natriumamidotrizoat        Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium benzoate         Natriumbenzoat             Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium bromide          Natriumbromid              Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium calcium edetate  Natriumcalciumedetat       Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium carbonate  \r\n\r\n  decahydrate             Natriumcarbonatdecahydrat  Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium carbonate  \r\n\r\n  monohydrate             Natriumcarbonatmonohydrat  Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium carbonate,  \r\n\r\n  anhydrous               Natriumcarbonat, vandfri   Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium cetostearyl  \r\n\r\n  sulphate                Natriumcetostearylsulfat   Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium chloride         Natriumchlorid             Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium citrate          Natriumcitrat              Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium cromoglicate     Natriumcromoglicat         Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium cyclamate        Natriumcyclamat            Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium dihydrogen  \r\n\r\n  phosphate               Natriumdihydrogenphosphat- Ph. Eur. 3rd Ed.  \r\n\r\n  dihydrate               dihydrat  \r\n\r\n  Sodium fluoride         Natriumfluorid             Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium fusidate         Natriumfusidat             Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium hydrogen  \r\n\r\n  carbonate               Natriumhydrogencarbonat    Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium hydroxide        Natriumhydroxid            Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium iodide           Natriumiodid               Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium lactate  \r\n\r\n  solution                Natriumlactatopløsning     Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium lauryl sulphate  Natriumlaurylsulfat        Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium metabisulphite   Natriummetabisulfit        Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium nitroprusside    Natriumnitroprussid        Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium picosulfate      Natriumpicosulfat          Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium salicylate       Natriumsalicylat           Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium starch  \r\n\r\n  glycollate (type A)     Natriumstivelsesglycollat  \r\n\r\n                          (type A)                   Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium starch  \r\n\r\n  glycollate (type B)     Natriumstivelsesglycollat  \r\n\r\n                          (type B)                   Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium sulphate  \r\n\r\n  decahydrate             Natriumsulfatdecahydrat    Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium sulphate,  \r\n\r\n  anhydrous               Natriumsulfat, vandfrit    Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium sulphite  \r\n\r\n  heptahydrate            Natriumsulfitheptahydrat   Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium sulphite,  \r\n\r\n  anhydrous               Natriumsulfit, vandfri     Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium thiosulphate     Natriumthiosulfat          Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium valproate        Natriumvalproat            Ph. Eur. 3rd Ed.  \r\n\r\n Sojae oleum              Soya-bean oil              Ph. Eur. 3rd Ed.  \r\n\r\n Sojaolie                 Soya-bean oil              Ph. Eur. 3rd Ed.  \r\n\r\n Solani amylum            Potato starch              Ph. Eur. 3rd Ed.  \r\n\r\n  Somatostatin            Somatostatin               Ph. Eur. 3rd Ed.  \r\n\r\n  Somatropin              Somatropin                 Ph. Eur. 3rd Ed.  \r\n\r\n  Somatropin bulk  \r\n\r\n  solution                Somatropinopløsning        Ph. Eur. 3rd Ed.  \r\n\r\n  Sorbic acid             Sorbinsyre                 Ph. Eur. 3rd Ed.  \r\n\r\n Sorbinsyre               Sorbic acid                Ph. Eur. 3rd Ed.  \r\n\r\n  Sorbitan laurate        Sorbitanlaurat             Ph. Eur. 3rd Ed.  \r\n\r\n  Sorbitan oleate         Sorbitanoleat              Ph. Eur. 3rd Ed.  \r\n\r\n  Sorbitan palmitate      Sorbitanpalmitat           Ph. Eur. 3rd Ed.  \r\n\r\n  Sorbitan stearate       Sorbitanstearat            Ph. Eur. 3rd Ed.  \r\n\r\n  Sorbitan trioleate      Sorbitantrioleat           Ph. Eur. 3rd Ed.  \r\n\r\n Sorbitanlaurat           Sorbitan laurate           Ph. Eur. 3rd Ed.  \r\n\r\n Sorbitanoleat            Sorbitan oleate            Ph. Eur. 3rd Ed.  \r\n\r\n Sorbitanpalmitat         Sorbitan palmitate         Ph. Eur. 3rd Ed.  \r\n\r\n Sorbitanstearat          Sorbitan stearate          Ph. Eur. 3rd Ed.  \r\n\r\n Sorbitantrioleat         Sorbitan trioleate         Ph. Eur. 3rd Ed.  \r\n\r\n  Sorbitol                Sorbitol                   Ph. Eur. 3rd Ed.  \r\n\r\n  Sorbitol 70 per cent    Sorbitolopløsning 70%,     Ph. Eur. 3rd Ed.  \r\n\r\n  (crystallising)         krystalliserende  \r\n\r\n  Sorbitol 70 per cent    Sorbitolopløsning 70%,     Ph. Eur. 3rd Ed.  \r\n\r\n  (non-crystallising)     ikke-krystalliserende  \r\n\r\n Sorbitolopløsning 70%,   Sorbitol 70 per cent       Ph. Eur. 3rd Ed.  \r\n\r\n ikke-krystalliserende    (non-crystallising)  \r\n\r\n Sorbitolopløsning 70%,   Sorbitol 70 per cent       Ph. Eur. 3rd Ed.  \r\n\r\n krystalliserende         (crystallising)  \r\n\r\n  Soya-bean oil           Sojaolie                   Ph. Eur. 3rd Ed.  \r\n\r\n  Spectinomycin  \r\n\r\n  hydrochloride           Spectinomycinhydrochlorid  Ph. Eur. 3rd Ed.  \r\n\r\n Spectinomycin-  \r\n\r\n  hydrochlorid            Spectinomycin  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Spiramycin              Spiramycin                 Ph. Eur. 3rd Ed.  \r\n\r\n Spiritus fortis          Alcohol 96 per cent        DLS 97  \r\n\r\n  Spironolactone          Spironolacton              Ph. Eur. 3rd Ed.  \r\n\r\n Sprit, stærk             Alcohol 96 per cent        DLS 97  \r\n\r\n  Star anise              Stjerneanis                Ph. Eur. 3rd Ed.  \r\n\r\n  Stearyl alcohol         Stearylalkohol             Ph. Eur. 3rd Ed.  \r\n\r\n Stearylalkohol           Stearyl alcohol            Ph. Eur. 3rd Ed.  \r\n\r\n Sterilt vand             Sterilised water           DLS 97  \r\n\r\n Stjerneanis              Star anise                 Ph. Eur. 3rd Ed.  \r\n\r\n Stramonii folium         Stramonium leaf            Ph. Eur. 3rd Ed.  \r\n\r\n Stramonii pulvis  \r\n\r\n  normatus                Stramonium, prepared       Ph. Eur. 3rd Ed.  \r\n\r\n  Stramonium leaf         Stramoniumblad             Ph. Eur. 3rd Ed.  \r\n\r\n  Stramonium, prepared    Stramonium,  \r\n\r\n                          standardiseret             Ph. Eur. 3rd Ed.  \r\n\r\n Stramonium,  \r\n\r\n  standardiseret          Stramonium, prepared       Ph. Eur. 3rd Ed.  \r\n\r\n Stramoniumblad           Stramonium leaf            Ph. Eur. 3rd Ed.  \r\n\r\n  Streptokinase           Streptokinase              Ph. Eur. 3rd Ed.  \r\n\r\n Streptokinase            Streptokinase              Ph. Eur. 3rd Ed.  \r\n\r\n  Streptomycin sulphate   Streptomycinsulfat         Ph. Eur. 3rd Ed.  \r\n\r\n Streptomycinsulfat       Streptomycin sulphate      Ph. Eur. 3rd Ed.  \r\n\r\n  Succinylsulfathiazole   Succinylsulfathiazol       Ph. Eur. 3rd Ed.  \r\n\r\n  Sucrose                 Saccharose                 Ph. Eur. 3rd Ed.  \r\n\r\n  Sulfacetamide sodium    Sulfacetamidnatrium        Ph. Eur. 3rd Ed.  \r\n\r\n Sulfacetamidnatrium      Sulfacetamide sodium       Ph. Eur. 3rd Ed.  \r\n\r\n  Sulfadiazine            Sulfadiazin                Ph. Eur. 3rd Ed.  \r\n\r\n  Sulfadimidine           Sulfadimidin               Ph. Eur. 3rd Ed.  \r\n\r\n  Sulfadoxine             Sulfadoxin                 Ph. Eur. 3rd Ed.  \r\n\r\n  Sulfafurazole           Sulfafurazol               Ph. Eur. 3rd Ed.  \r\n\r\n  Sulfamerazine           Sulfamerazin               Ph. Eur. 3rd Ed.  \r\n\r\n  Sulfamethizole          Sulfamethizol              Ph. Eur. 3rd Ed.  \r\n\r\n  Sulfamethoxazole        Sulfamethoxazol            Ph. Eur. 3rd Ed.  \r\n\r\n  Sulfamethoxypyridazine  Sulfamethoxypuridazin      Ph. Eur. 3rd Ed.  \r\n\r\n  Sulfasalazine           Sulfasalazin               Ph. Eur. 3rd Ed.  \r\n\r\n  Sulfathiazole           Sulfathiazol               Ph. Eur. 3rd Ed.  \r\n\r\n  Sulfinpyrazone          Sulfinpyrazon              Ph. Eur. 3rd Ed.  \r\n\r\n  Sulfisomidine           Sulfisomidin               Ph. Eur. 3rd Ed.  \r\n\r\n  Sulindac                Sulindac                   Ph. Eur. 3rd Ed.  \r\n\r\n  Sulphur for external  \r\n\r\n  use                     Svovl til udvortes brug    Ph. Eur. 3rd Ed.  \r\n\r\n  Sulpiride               Sulpirid                   Ph. Eur. 3rd Ed.  \r\n\r\n  Suxamethonium chloride  Suxamethoniumchlorid       Ph. Eur. 3rd Ed.  \r\n\r\n Suxamethoniumchlorid     Suxamethonium chloride     Ph. Eur. 3rd Ed.  \r\n\r\n Svovl til udvortes brug  Sulphur for external use   Ph. Eur. 3rd Ed.  \r\n\r\n Sølvnitrat               Silver nitrate             Ph. Eur. 3rd Ed.  \r\n\r\n  Talc                    Talcum                     Ph. Eur. 3rd Ed.  \r\n\r\n  Tamoxifen citrate       Tamoxifencitrat            Ph. Eur. 3rd Ed.  \r\n\r\n Tamoxifencitrat          Tamoxifen citrate          Ph. Eur. 3rd Ed.  \r\n\r\n  Tartaric acid           Vinsyre                    Ph. Eur. 3rd Ed.  \r\n\r\n  Temazepam               Temazepam                  Ph. Eur. 3rd Ed.  \r\n\r\n  Tenoxicam               Tenoxicam                  Ph. Eur. 3rd Ed.  \r\n\r\n  Terbutaline sulphate    Terbutalinsulfat           Ph. Eur. 3rd Ed.  \r\n\r\n Terbutalinsulfat         Terbutaline sulphate       Ph. Eur. 3rd Ed.  \r\n\r\n  Terfenadine             Terfenadin                 Ph. Eur. 3rd Ed.  \r\n\r\n  Testosterone enantate   Testosteronenantat         Ph. Eur. 3rd Ed.  \r\n\r\n  Testosterone propionate Testosteronpropionat       Ph. Eur. 3rd Ed.  \r\n\r\n Testosteronenantat       Testosterone enantate      Ph. Eur. 3rd Ed.  \r\n\r\n Testosteronpropionat     Testosterone propionate    Ph. Eur. 3rd Ed.  \r\n\r\n  Tetracaine  \r\n\r\n  hydrochloride           Tetracainhydrochlorid      Ph. Eur. 3rd Ed.  \r\n\r\n Tetracainhydrochlorid    Tetracaine hydrochloride   Ph. Eur. 3rd Ed.  \r\n\r\n  Tetracosactide          Tetracosactid              Ph. Eur. 3rd Ed.  \r\n\r\n  Tetracycline            Tetracyclin                Ph. Eur. 3rd Ed.  \r\n\r\n  Tetracycline  \r\n\r\n  hydrochloride           Tetracyclinhydrochlorid    Ph. Eur. 3rd Ed.  \r\n\r\n Tetracyclinhydrochlorid  Tetracycline  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Theobromine             Theobromin                 Ph. Eur. 3rd Ed.  \r\n\r\n Theophyllin og           Theophylline and  \r\n\r\n ethylendiamin            ethylenediamine            Ph. Eur. 3rd Ed.  \r\n\r\n Theophyllin og           Theophylline and  \r\n\r\n                          ethylendiamine             Ph. Eur. 3rd Ed.  \r\n\r\n ethylendiaminhydrat      hydrate  \r\n\r\n  Theophylline            Theophyllin                Ph. Eur. 3rd Ed.  \r\n\r\n  Theophylline and  \r\n\r\n  ethylendiamine          Theophyllin og             Ph. Eur. 3rd Ed.  \r\n\r\n  hydrate                 ethylendiaminhydrat  \r\n\r\n  Theophylline and  \r\n\r\n  ethylenediamine         Theophyllin og             Ph. Eur. 3rd Ed.  \r\n\r\n                          ethylendiamin  \r\n\r\n  Theophylline  \r\n\r\n  monohydrate             Theophyllinmonohydrat      Ph. Eur. 3rd Ed.  \r\n\r\n Theophyllinmonohydrat    Theophylline monohydrate   Ph. Eur. 3rd Ed.  \r\n\r\n  Thiamine hydrochloride  Thiaminhydrochlorid        Ph. Eur. 3rd Ed.  \r\n\r\n  Thiamine nitrate        Thiaminnitrat              Ph. Eur. 3rd Ed.  \r\n\r\n Thiaminhydrochlorid      Thiamine hydrochloride     Ph. Eur. 3rd Ed.  \r\n\r\n Thiaminnitrat            Thiamine nitrate           Ph. Eur. 3rd Ed.  \r\n\r\n  Thiamphenicol           Thiamphenicol              Ph. Eur. 3rd Ed.  \r\n\r\n  Thiopental sodium and   Thiopentalnatrium og       Ph. Eur. 3rd Ed.  \r\n\r\n  sodium carbonate        natriumcarbonat  \r\n\r\n Thiopentalnatrium og     Thiopental sodium and      Ph. Eur. 3rd Ed.  \r\n\r\n natriumcarbonat          sodium carbonate  \r\n\r\n  Thioridazine  \r\n\r\n  hydrochloride           Thioridazinhydrochlorid    Ph. Eur. 3rd Ed.  \r\n\r\n Thioridazinhydrochlorid  Thioridazine  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Threonine               Threonin                   Ph. Eur. 3rd Ed.  \r\n\r\n  Thyme                   Timian                     Ph. Eur. 3rd Ed.  \r\n\r\n Thymi herba              Thyme                      Ph. Eur. 3rd Ed.  \r\n\r\n  Thymol                  Thymol                     Ph. Eur. 3rd Ed.  \r\n\r\n  Tiabendazole            Tiabendazol                Ph. Eur. 3rd Ed.  \r\n\r\n  Tiaprofenic acid        Tiaprofensyre              Ph. Eur. 3rd Ed.  \r\n\r\n Tiaprofensyre            Tiaprofenic acid           Ph. Eur. 3rd Ed.  \r\n\r\n  Ticarcillin sodium      Ticarcillinnatrium         Ph. Eur. 3rd Ed.  \r\n\r\n Ticarcillinnatrium       Ticarcillin sodium         Ph. Eur. 3rd Ed.  \r\n\r\n  Ticlopidine  \r\n\r\n  hydrochloride           Ticlopidinhydrochlorid     Ph. Eur. 3rd Ed.  \r\n\r\n Ticlopidinhydrochlorid   Ticlopidine hydrochloride  Ph. Eur. 3rd Ed.  \r\n\r\n Tiliae flos              Lime flower                Ph. Eur. 3rd Ed.  \r\n\r\n Timian                   Thyme                      Ph. Eur. 3rd Ed.  \r\n\r\n  Timolol maleate         Timololmaleat              Ph. Eur. 3rd Ed.  \r\n\r\n Timololmaleat            Timolol maleate            Ph. Eur. 3rd Ed.  \r\n\r\n  Tinidazole              Tinidazol                  Ph. Eur. 3rd Ed.  \r\n\r\n Tinnevelly-sennesbælg    Senna pods, Tinnevelly     Ph. Eur. 3rd Ed.  \r\n\r\n Titandioxid              Titanium dioxide           Ph. Eur. 3rd Ed.  \r\n\r\n  Titanium dioxide        Titandioxid                Ph. Eur. 3rd Ed.  \r\n\r\n  Tobramycin              Tobramycin                 Ph. Eur. 3rd Ed.  \r\n\r\n  Alpha-Tocopherol        Alpha-Tocopherol           Ph. Eur. 3rd Ed.  \r\n\r\n  Alpha-Tocopherol  \r\n\r\n  acetate                 Alpha-Tocopherolacetat     Ph. Eur. 3rd Ed.  \r\n\r\n  Alpha-Tocopherol  \r\n\r\n  acetate concentrate     Alpha-Tocopherolacetat-  \r\n\r\n   (powder form)          trituration                Ph. Eur. 3rd Ed.  \r\n\r\n Alpha-Tocopherolacetat   Alpha-Tocopherol acetate   Ph. Eur. 3rd Ed.  \r\n\r\n Alpha-Tocopherolacetat-  \r\n\r\n  trituration             Alpha-Tocopherol acetate  \r\n\r\n                          concentrate                Ph. Eur. 3rd Ed.  \r\n\r\n                          (powder form)  \r\n\r\n  Tolbutamide             Tolbutamid                 Ph. Eur. 3rd Ed.  \r\n\r\n  Tolnaftate              Tolnaftat                  Ph. Eur. 3rd Ed.  \r\n\r\n Torskelevertran          Cod liver oil              DLS 97  \r\n\r\n  Tragacanth              Tragant                    Ph. Eur. 3rd Ed.  \r\n\r\n Tragacantha              Tragacanth                 Ph. Eur. 3rd Ed.  \r\n\r\n Tragant                  Tragacanth                 Ph. Eur. 3rd Ed.  \r\n\r\n  Tranexamic acid         Tranexamsyre               Ph. Eur. 3rd Ed.  \r\n\r\n Tranexamsyre             Tranexamic acid            Ph. Eur. 3rd Ed.  \r\n\r\n  Tretinoin               Tretinoin                  Ph. Eur. 3rd Ed.  \r\n\r\n Tricalciumphosphat       Calcium phosphate          Ph. Eur. 3rd Ed.  \r\n\r\n  Trifluoperazine  \r\n\r\n  hydrochloride           Trifluoperazinhydrochlorid Ph. Eur. 3rd Ed.  \r\n\r\n Trifluoperazin-  \r\n\r\n  hydrochlorid            Trifluoperazine  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n Triglycerider,  \r\n\r\n  middelkædelængde        Triglycerides,  \r\n\r\n                          medium-chain               Ph. Eur. 3rd Ed.  \r\n\r\n  Triglycerides,  \r\n\r\n  medium-chain            Triglycerider,  \r\n\r\n                          middelkædelængde           Ph. Eur. 3rd Ed.  \r\n\r\n  Trimethadione           Trimethadion               Ph. Eur. 3rd Ed.  \r\n\r\n  Trimethoprim            Trimethoprim               Ph. Eur. 3rd Ed.  \r\n\r\n  Trimipramine maleate    Trimipraminmaleat          Ph. Eur. 3rd Ed.  \r\n\r\n Trimipraminmaleat        Trimipramine maleate       Ph. Eur. 3rd Ed.  \r\n\r\n Tritici amylum           Wheat starch               Ph. Eur. 3rd Ed.  \r\n\r\n  Trometamol              Trometamol                 Ph. Eur. 3rd Ed.  \r\n\r\n  Tropicamide             Tropicamid                 Ph. Eur. 3rd Ed.  \r\n\r\n  Trypsin                 Trypsin                    Ph. Eur. 3rd Ed.  \r\n\r\n  Tuberculin purified  \r\n\r\n  protein                 Tuberculin, bovin (PPD),  \r\n\r\n  derivate, bovine        renset                     Ph. Eur. 3rd Ed.  \r\n\r\n  Tuberculin purified  \r\n\r\n  protein                 Tuberculin, (PPD),  \r\n\r\n  derivative for human    renset                     Ph. Eur. 3rd Ed.  \r\n\r\n  use  \r\n\r\n  Tuberculin purified  \r\n\r\n  protein                 Tuberculin, aviær (PPD),  \r\n\r\n  derivative, avian       renset                     Ph. Eur. 3rd Ed.  \r\n\r\n Tuberculin, (PPD),  \r\n\r\n  renset                  Tuberculin purified  \r\n\r\n                          protein                    Ph. Eur. 3rd Ed.  \r\n\r\n                          derivative for human use  \r\n\r\n Tuberculin, aviær  \r\n\r\n  (PPD), renset           Tuberculin purified  \r\n\r\n                          protein                    Ph. Eur. 3rd Ed.  \r\n\r\n                          derivative, avian  \r\n\r\n Tuberculin, bovin  \r\n\r\n  (PPD), renset           Tuberculin purified  \r\n\r\n                          protein                    Ph. Eur. 3rd Ed.  \r\n\r\n                          derivate, bovine  \r\n\r\n  Tuberculin, old, for  \r\n\r\n  human use               Alttuberculin              Ph. Eur. 3rd Ed.  \r\n\r\n Tubocurarinchlorid       Tubocurarine chloride      Ph. Eur. 3rd Ed.  \r\n\r\n  Tubocurarine chloride   Tubocurarinchlorid         Ph. Eur. 3rd Ed.  \r\n\r\n  Tyrosine                Tyrosin                    Ph. Eur. 3rd Ed.  \r\n\r\n Tørstetræbark            Frangula bark              Ph. Eur. 3rd Ed.  \r\n\r\n  Undecylenic acid        Undecylensyre              Ph. Eur. 3rd Ed.  \r\n\r\n Undecylensyre            Undecylenic acid           Ph. Eur. 3rd Ed.  \r\n\r\n  Urea                    Urea                       Ph. Eur. 3rd Ed.  \r\n\r\n  Urofollitropin          Urofollitropin             Ph. Eur. 3rd Ed.  \r\n\r\n  Urokinase               Urokinase                  Ph. Eur. 3rd Ed.  \r\n\r\n Uvae ursi folium         Bearberry leaf             Ph. Eur. 3rd Ed.  \r\n\r\n  Valerian root           Valerianerod               Ph. Eur. 3rd Ed.  \r\n\r\n Valerianae radix         Valerian root              Ph. Eur. 3rd Ed.  \r\n\r\n Valerianerod             Valerian root              Ph. Eur. 3rd Ed.  \r\n\r\n  Valine                  Valin                      Ph. Eur. 3rd Ed.  \r\n\r\n  Vancomycin  \r\n\r\n  hydrochloride           Vancomycinhydrochlorid     Ph. Eur. 3rd Ed.  \r\n\r\n Vancomycinhydrochlorid   Vancomycin hydrochloride   Ph. Eur. 3rd Ed.  \r\n\r\n Vand til  \r\n\r\n  injektionsvæsker        Water for injections       Ph. Eur. 3rd Ed.  \r\n\r\n Vand, renset             Water, purified            Ph. Eur. 3rd Ed.  \r\n\r\n Vand, sterilt            Water, sterilised          DLS 97  \r\n\r\n  Vanillin                Vanillin                   Ph. Eur. 3rd Ed.  \r\n\r\n  Verapamil  \r\n\r\n  hydrochloride           Verapamilhydrochlorid      Ph. Eur. 3rd Ed.  \r\n\r\n Verapamilhydrochlorid    Verapamil hydrochloride    Ph. Eur. 3rd Ed.  \r\n\r\n  Vinblastine sulphate    Vinblastinsulfat           Ph. Eur. 3rd Ed.  \r\n\r\n Vinblastinsulfat         Vinblastine sulphate       Ph. Eur. 3rd Ed.  \r\n\r\n  Vincristine sulphate    Vincristinsulfat           Ph. Eur. 3rd Ed.  \r\n\r\n Vincristinsulfat         Vincristine sulphate       Ph. Eur. 3rd Ed.  \r\n\r\n Vinsyre                  Tartaric acid              Ph. Eur. 3rd Ed.  \r\n\r\n  Vitamin A  \r\n\r\n  concentrate,  \r\n\r\n  synthetic               Vitamin A diluendum        Ph. Eur. 3rd Ed.  \r\n\r\n  (oily form)  \r\n\r\n  Vitamin A concentrate,  \r\n\r\n  synthetic               Vitamin A trituration      Ph. Eur. 3rd Ed.  \r\n\r\n  (powder form)  \r\n\r\n  Vitamin A concentrate,  \r\n\r\n  synthetic               Vitamin A diluendum,       Ph. Eur. 3rd Ed.  \r\n\r\n  (water-dispersible      vanddispergibel  \r\n\r\n  form)  \r\n\r\n Vitamin A diluendum      Vitamin A concentrate,  \r\n\r\n                          synthetic                  Ph. Eur. 3rd Ed.  \r\n\r\n                          (oily form)  \r\n\r\n Vitamin A diluendum,     Vitamin A concentrate,  \r\n\r\n vanddispergibel          synthetic                  Ph. Eur. 3rd Ed.  \r\n\r\n                          (water-dispersible form)  \r\n\r\n Vitamin A trituration    Vitamin A concentrate,  \r\n\r\n                          synthetic                  Ph. Eur. 3rd Ed.  \r\n\r\n                          (powder form)  \r\n\r\n Vitamin B12              Cyanocobalamine            Ph. Eur. 3rd Ed.  \r\n\r\n Vitamin B1               Thiamine hydrochloride     Ph. Eur. 3rd Ed.  \r\n\r\n Vitamin B2               Riboflavine                Ph. Eur. 3rd Ed.  \r\n\r\n Vitamin B6               Pyridoxine hydrochloride   Ph. Eur. 3rd Ed.  \r\n\r\n Vitamin C                Ascorbic acid              Ph. Eur. 3rd Ed.  \r\n\r\n Vitamin D2               Ergocalciferol             Ph. Eur. 3rd Ed.  \r\n\r\n Vitamin D3               Cholecalciferol            Ph. Eur. 3rd Ed.  \r\n\r\n Vitamin E                Alpha-Tocopherole acetate  Ph. Eur. 3rd Ed.  \r\n\r\n Vitamin K                Phytomenadione             Ph. Eur. 3rd Ed.  \r\n\r\n  Warfarin sodium         Warfarinnatrium            Ph. Eur. 3rd Ed.  \r\n\r\n  Warfarin sodium  \r\n\r\n  clathrate               Warfarinnatriumclathrat    Ph. Eur. 3rd Ed.  \r\n\r\n Warfarinnatrium          Warfarin sodium            Ph. Eur. 3rd Ed.  \r\n\r\n Warfarinnatriumclathr    Warfarin sodium clathrate  Ph. Eur. 3rd Ed.  \r\n\r\n  Water for injections    Vand til injektionsvæsker  Ph. Eur. 3rd Ed.  \r\n\r\n  Water, purified         Vand, renset               Ph. Eur. 3rd Ed.  \r\n\r\n  Water, sterilised       Vand, sterilt              DLS 97  \r\n\r\n  Wheat starch            Hvedestivelse              Ph. Eur. 3rd Ed.  \r\n\r\n  White beeswax           Hvidt voks                 Ph. Eur. 3rd Ed.  \r\n\r\n  Wool alcohols           Lanolinalkohol             Ph. Eur. 3rd Ed.  \r\n\r\n  Wool fat                Lanolin, vandfrit          Ph. Eur. 3rd Ed.  \r\n\r\n  Wool fat, hydrogenated  Lanolin, hydrogeneret      Ph. Eur. 3rd Ed.  \r\n\r\n  Wool fat, hydrous       Lanolin                    Ph. Eur. 3rd Ed.  \r\n\r\n  Xylometazoline  \r\n\r\n  hydrochloride           Xylometazolinhydrochlorid  Ph. Eur. 3rd Ed.  \r\n\r\n Xylometazolin-  \r\n\r\n  hydrochlorid            Xylometazoline  \r\n\r\n                          hydrochloride              Ph. Eur. 3rd Ed.  \r\n\r\n  Yellow beeswax          Gult voks                  Ph. Eur. 3rd Ed.  \r\n\r\n  Zidovudine              Zidovudin                  Ph. Eur. 3rd Ed.  \r\n\r\n  Zinc chloride           Zinkchlorid                Ph. Eur. 3rd Ed.  \r\n\r\n  Zinc oxide              Zinkoxid                   Ph. Eur. 3rd Ed.  \r\n\r\n  Zinc stearate           Zinkstearat                Ph. Eur. 3rd Ed.  \r\n\r\n  Zinc sulphate           Zinksulfat                 Ph. Eur. 3rd Ed.  \r\n\r\n  Zinc undecylenate       Zinkundecylenat            Ph. Eur. 3rd Ed.  \r\n\r\n Zinkchlorid              Zinc chloride              Ph. Eur. 3rd Ed.  \r\n\r\n Zinkoxid                 Zinc oxide                 Ph. Eur. 3rd Ed.  \r\n\r\n Zinkstearat              Zinc stearate              Ph. Eur. 3rd Ed.  \r\n\r\n Zinksulfat               Zinc sulphate              Ph. Eur. 3rd Ed.  \r\n\r\n Zinkundecylenat          Zinc undecylenate          Ph. Eur. 3rd Ed.  \r\n\r\n  Zopiclone               Zopiclon                   Ph. Eur. 3rd Ed.  \r\n\r\n</PRE>  \r\n\r\n<P> <B>STANDARDER FOR RÅVARER</B>  </P>  \r\n\r\n<P>AIR, COMPRESSED </P>  \r\n\r\n<P>Luft, medicinsk </P>  \r\n\r\n<P>Aer Medicinalis </P>  \r\n\r\n<P>DEFINITION </P>  \r\n\r\n<P>Prepared by compressing atmospheric air. It contains not less than 19.0  \r\n\r\n and not more than 23.0 per cent <I>V/V</I> of oxygen (O2-Mr 32.00), about 78  \r\n\r\n per cent  <I>V/V</I> of nitrogen (N2-Mr 28.01) and up to 1 per cent  \r\n\r\n<I>V/V</I> of other gases, mainly argon (Ar-Mr 39.95). Mean Mr 29. </P>  \r\n\r\n<P>CHARACTERS </P>  \r\n\r\n<P>A colourless, odourless gas. The mass of 1 l is 1.29 g (1 bar, 0 graderC).  \r\n\r\n At 20 graderC and a pressure of 1 bar, 1 volume dissolves in about 50 volumes  \r\n\r\n of water. </P>  \r\n\r\n<P>IDENTIFICATION </P>  \r\n\r\n<P>A. It complies with the test for Carbon dioxide (see Tests). </P>  \r\n\r\n<P>B. It complies with the Assay. </P>  \r\n\r\n<P>C. Nitric acid R is poured over copper turnings. The gas developed is  \r\n\r\n collected in an inverted test tube over water until the test tube is half  \r\n\r\n filled. When the gas to be examined is led into the test tube brownishred  \r\n\r\n fumes are immediately formed. </P>  \r\n\r\n<P>TESTS </P>  \r\n\r\n<P> <B>Oil, volatile hydrocarbons</B> Determined by a suitable method (e.g.  \r\n\r\n by the use of Drager-Tube,, type Oil 10/a-P) it contains not more than 0.3  \r\n\r\n mg/(m3.) </P>  \r\n\r\n<P> <B>Sulfur dioxide</B> Determined by a suitable method (e.g. by the use of  \r\n\r\n Drager-Tube, type Sulphur Dioxide 1/a) it contains not more than 0.0005 per  \r\n\r\n cent <I>V/V</I> . </P>  \r\n\r\n<P> <B>Nitrogen dioxide</B> Determined by a suitable method (e.g. by the use  \r\n\r\n of Drager-Tube, type Nitrogen Dioxide 0.5/c) it contains not more than 0.0005  \r\n\r\n per cent <I>V/V</I> . </P>  \r\n\r\n<P> <B>Nitrogen oxides</B> Determined by a suitable method (e.g. by the use  \r\n\r\n of Drager-Tube, type Nitrous Fumes 2/a) it contains not more than 0.0025 per  \r\n\r\n cent <I>V/V</I> . </P>  \r\n\r\n<P> <B>Carbon monoxide</B> Determined by a suitable method (e.g. by the use  \r\n\r\n of Drager-Tube, type Carbon Monoxide 0.001%/a) it contains not more than  \r\n\r\n 0.003 per cent <I>V/V</I> . </P>  \r\n\r\n<P> <B>Carbon dioxide</B> Determined by a suitable method (e.g. by the use of  \r\n\r\n Drager-Tupe, type Carbon Dioxide 100/a) it contains not more than 0.04 per  \r\n\r\n cent <I>V/V</I> . </P>  \r\n\r\n<P> <B>Water</B> Compressed air stored in compressed-gas bottles (max.  \r\n\r\n pressure 200 bar): Determined by a suitable method (e.g. by use of a Shaw  \r\n\r\n Mini Hygrometer (Shaw, Rawson Road, Westgate, Bradford, England)) it contains  \r\n\r\n not more than 30 mg/(m3). </P>  \r\n\r\n<P>Compressed air stored and delivered in low-pressure systems: The content  \r\n\r\n is sufficiently low to ensure that the pressure dew point is not exceeded at  \r\n\r\n any point throughout the system (e.g. not more than 700 mg/(m3) at 7 bar at  \r\n\r\n temperatures above 0 graderC). </P>  \r\n\r\n<P>ASSAY </P>  \r\n\r\n<P>Use a gas burette (1 in Figure) of 100 ml capacity having at its upper end  \r\n\r\n a two-way capillary tap (A) connected to two capillaries a and b. Capillary b  \r\n\r\n is connected by suitable means to the capillary of a gas pipette (2 in  \r\n\r\n Figure). The lower end of the gas burette is connected to a reservoir by  \r\n\r\n rubber tubing. The lower tube of the gas burette is graduated in 0.2 ml  \r\n\r\n between 75 and 101 ml, the distance between the graduations being not less  \r\n\r\n than 2 mm. </P>  \r\n\r\n<P>The gas cylinder is kept at room temperature for not less than 6 hours  \r\n\r\n before performing the analysis. The apparatus must be in temperature  \r\n\r\n equilibrium with the surrounding air. </P>  \r\n\r\n<P>Fill the gas pipette with the absorption liquid, a 150 g/l solution of  \r\n\r\n pyrogallol-R in 5M potassium hydroxide until it reaches the lower part of the  \r\n\r\n upper bulb. Fill the gas burette and the reservoir with an appropriate volume  \r\n\r\n of the deplacement liquid, either mercury or a 22 g/l solution of sodium  \r\n\r\n chloride R saturated with the gas to be examined. By raising and lowering the  \r\n\r\n reservoir and by opening and closing the tap it is ensured that capillary a  \r\n\r\n is filled with the displacement liquid and capillary b is filled with the  \r\n\r\n absorption liquid. 100 ml (+/-0.2 ml) of the gas to be examined is introduced  \r\n\r\n into the gas burette through capillary a. During the measurement the  \r\n\r\n displacement liquid is kept at the same level in the gas burette and in the  \r\n\r\n reservoir. The gas is displaced into the gas pipette and the absorption  \r\n\r\n liquid is swirled gently. After standing for 5 min. the non-absorbed gas is  \r\n\r\n returned into the burette and its volume measured. The non-absorbed gas is  \r\n\r\n then displaced into the pipette returned into the burette and its volume  \r\n\r\n measured again.This sequence of operations is repeated until the volume of  \r\n\r\n non-absorbed gas remains constant. The non-absorbed volume is between 77.0 ml  \r\n\r\n and 81.0 ml. </P>  \r\n\r\n<P><IMG SRC=\"/image.aspx?id=83706&img=CR43116_1.gif\" ALIGN=\"middle\" WIDTH=\"235\" HEIGHT=\"85 BORDER=\"no\" ALT=\"DUMMY.GIF billedet er ikke indlagt onMouseOver=\"self.status='DUMMY.GIF billedet er ikke indlagt'; return true\"\"> </P>  \r\n\r\n<P>Rekommanderet af NLN som nordisk lægemiddelstandard. </P>  \r\n\r\n<P>ALCOHOL </P>  \r\n\r\n<P>Alkohol </P>  \r\n\r\n<P>Alcohol </P>  \r\n\r\n<P>DEFINITION </P>  \r\n\r\n<P>Alcohol is a mixture of ethanol and water. It contains 98.0 to 102.0 per  \r\n\r\n cent of the declared content of ethanol (C2H6O). </P>  \r\n\r\n<P>CHARACTERS </P>  \r\n\r\n<P>It has the characters described in the monograph Ethanol. </P>  \r\n\r\n<P>IDENTIFICATION </P>  \r\n\r\n<P>It complies with identification tests A, C and D prescribed in the  \r\n\r\n monograph Ethanol and with a test for relative density with limits that  \r\n\r\n correspond to 98.0 to 102.0 per cent of the declared content of ethanol. </P>  \r\n\r\n<P>TESTS </P>  \r\n\r\n<P>It complies with the tests in the monograph Ethanol. </P>  \r\n\r\n<P>STORAGE </P>  \r\n\r\n<P>Store in an airtight container protected from light. </P>  \r\n\r\n<P>LABELLING </P>  \r\n\r\n<P>The label on the container states as part of the name of the article its  \r\n\r\n content to the nearest whole number of ethanol in per cent <I>V/V </I>  .  \r\n\r\n</P>  \r\n\r\n<P> <B>ALCOHOL 96 PER CENT Sprit, stærk</B>  </P>  \r\n\r\n<P>Spiritus fortis </P>  \r\n\r\n<P>DEFINITION </P>  \r\n\r\n<P>Alcohol 96 per cent is a mixture of ethanol and water. It contains not  \r\n\r\n less than 92.6 per cent <I>m/m</I> (95.1 per cent <I>V/V</I> ) and not more  \r\n\r\n than 95.2 per cent <I>m/m</I> (96.9 per cent <I>V/V</I> ) of ethanol. </P>  \r\n\r\n<P>CHARACTERS </P>  \r\n\r\n<P>It has the characters described in the monograph Ethanol. </P>  \r\n\r\n<P>IDENTIFICATION </P>  \r\n\r\n<P>It complies with identification tests A, C and D prescribed in the  \r\n\r\n monograph Ethanol and with the following test: </P>  \r\n\r\n<P>B. Relative density (Ph. Eur. 3rd Ed., 2.2.5) 0.804 to 0.811. </P>  \r\n\r\n<P>TESTS </P>  \r\n\r\n<P>It complies with the tests prescribed in the monograph Ethanol. </P>  \r\n\r\n<P>STORAGE </P>  \r\n\r\n<P>Store in an airtight container, protected from light. </P>  \r\n\r\n<P>Rekommanderet af NLN som nordisk lægemiddelstandard. </P>  \r\n\r\n<P>CHLORMEZANONE </P>  \r\n\r\n<P>Chlormezanon </P>  \r\n\r\n<P>Chlormezanonum </P>  \r\n\r\n<P>C11H12ClNO3S Mr 273.7 </P>  \r\n\r\n<P>DEFINITION </P>  \r\n\r\n<P>Chlormezanone contains not less than 97.0 per cent and not more than the  \r\n\r\n equivalent of 101.0 per cent of 2-(4-chlorophenyl) tetrahydro-3-methyl-4  \r\n\r\n<I>H</I> 1,3-thiazin-4-one-1,1-dioxide, calculated with reference to the  \r\n\r\n dried substance. </P>  \r\n\r\n<P>CHARACTERS </P>  \r\n\r\n<P>A white crystalline powder, practically insoluble in water and in ether,  \r\n\r\n soluble in chloroform, slightly soluble in alcohol. </P>  \r\n\r\n<P>IDENTIFICATION </P>  \r\n\r\n<P>A. Melting point (Ph. Eur. 3rd Ed., 2.2.14) 111 graderC to 115 graderC.  \r\n\r\n</P>  \r\n\r\n<P>B. Examine by infrared absorption spectrophotometry (Ph. Eur. 3rd Ed.,  \r\n\r\n 2.2.24), comparing with the spectrum obtained with chlormezanone NRP. </P>  \r\n\r\n<P>TESTS </P>  \r\n\r\n<P> <B>Related substances</B> Examine by thin-layer chromatography (Ph. Eur.  \r\n\r\n 3rd Ed., 2.2.27) using silica gel GF254R as the coating substance. </P>  \r\n\r\n<P> <I>Test solution</I> Dissolve 1.0 g of the substance to be examined in  \r\n\r\n chloroform R and dilute to 10 ml with the same solvent. </P>  \r\n\r\n<P> <I>Reference solution</I> Dilute 1 ml of the test solution to 100 ml with  \r\n\r\n chloroform R. </P>  \r\n\r\n<P>Apply separately to the plate 10 microl of each solution. Develop over a  \r\n\r\n path of 15 cm using a mixture of 70 volumes of toluene R and 30 volumes of  \r\n\r\n acetone R. Allow the plate to dry in air and examine in ultraviolet light at  \r\n\r\n 254 nm. Any spot in the chromatogram obtained with the test solution, apart  \r\n\r\n from the principal spot, is not more intense than the spot in the  \r\n\r\n chromatogram obtained with the reference solution (1 per cent). </P>  \r\n\r\n<P> <B>Heavy metals</B> (Ph. Eur. 3rd Ed., 2.4.8) 2.0 g complies with limit  \r\n\r\n test C for heavy metals (10 ppm). Prepare the standard using 2 ml of lead  \r\n\r\n standard solution (10 ppm Pb) R. </P>  \r\n\r\n<P> <B>Loss on drying</B> (Ph. Eur. 3rd Ed., 2.2.32) Not more than 0.5 per  \r\n\r\n cent, determined on 0.500 g by drying in vacuo at 70 graderC. </P>  \r\n\r\n<P> <B>Sulphated ash</B> (Ph. Eur. 3rd Ed., 2.4.14) Not more than 0.1 per  \r\n\r\n cent, determined on 1.0 g. </P>  \r\n\r\n<P>ASSAY </P>  \r\n\r\n<P>Dissolve 0.1000 g in methanol R and dilute to 100.0 ml with the same  \r\n\r\n solvent. Dilute 10.0 ml of this solution to 100.0 ml with methanol R. Dilute  \r\n\r\n 10.0 ml of this solution to 100.0 ml with methanol R. Prepare a standard  \r\n\r\n solution in the same conditions using 0.1000 g of chlormezanone NRP. Measure  \r\n\r\n the absorbance (Ph. Eur. 3rd Ed., 2.2.25) of the two solutions at the maximum  \r\n\r\n at 227 nm using methanol R as compensation liquid. </P>  \r\n\r\n<P>Calculate the content of C11H12ClNO3S from the absorbances measured and  \r\n\r\n the concentrations of the solutions. </P>  \r\n\r\n<P>Rekommanderet af NLN som nordisk lægemiddelstandard. </P>  \r\n\r\n<P> <B>COD LIVER OIL </B></P>  \r\n\r\n<P>Torskelevertran </P>  \r\n\r\n<P>Iecoris aselli oleum </P>  \r\n\r\n<P>DEFINITION </P>  \r\n\r\n<P>Cod liver oil is the purified fatty oil obtained from the fresh liver of  \r\n\r\n cod and other <I>Gadus</I> species, solid substances being removed by  \r\n\r\n cooling. It contains not less than 200 microg (666 I.U.) of vitamin A per  \r\n\r\n gram and not less than 2 microg (80 I.U.) of vitamin D3 per gram. </P>  \r\n\r\n<P>CHARACTERS </P>  \r\n\r\n<P>A clear, yellowish, viscous liquid, almost odourless, practically  \r\n\r\n insoluble in water, slightly soluble in alcohol, miscible with ether and with  \r\n\r\n light petroleum. </P>  \r\n\r\n<P>IDENTIFICATION </P>  \r\n\r\n<P>A. In the assay for vitamin A, the test solution shows an absorption  \r\n\r\n maximum (Ph. Eur. 3rd Ed., 2.2.25) at 325 nm +/- 2 nm. </P>  \r\n\r\n<P>B. In the assay for vitamin D3, test solution (a) gives a peak  \r\n\r\n corresponding to the peak of cholecalciferol obtained from the reference  \r\n\r\n solution. </P>  \r\n\r\n<P>TESTS </P>  \r\n\r\n<P> <B>Colour</B> Not more intensely coloured than a reference solution  \r\n\r\n prepared in the following manner: To 1.5 ml of red primary solution add 12.5  \r\n\r\n ml of yellow primary solution and dilute to 50 ml with 1 per cent <I>m/V </I>  \r\n\r\n hydrochloric acid solution (Method II, Ph. Eur. 3rd Ed., 2.2.25). </P>  \r\n\r\n<P> <B>Relative density</B> (Ph. Eur. 3rd Ed., 2.2.5) 0.918 to 0.930. </P>  \r\n\r\n<P> <B>Acid value</B> (Ph. Eur. 3rd Ed., 2.5.1) Dissolve 5.0 g in the  \r\n\r\n prescribed mixture of solvents. The acid value is not more than 2.0. </P>  \r\n\r\n<P> <B>Anisidine value</B> (see Annex) Not more than 20. </P>  \r\n\r\n<P> <B>Iodine value</B> (Ph. Eur. 3rd Ed., 2.5.4) 150 to 180. </P>  \r\n\r\n<P> <B>Peroxide value</B> (Ph. Eur. 3rd Ed., 2.5.5) Not more than 10. </P>  \r\n\r\n<P> <B>Saponification value</B> (Ph. Eur. 3rd Ed., 2.5.6) 180 to 192,  \r\n\r\n determined on 2.0 g. </P>  \r\n\r\n<P> <B>Unsaponifiable matter</B> (Ph. Eur. 3rd Ed., 2.5.7) Not more than 1.5  \r\n\r\n per cent <I>m/m</I> , determined on 10.0 g. </P>  \r\n\r\n<P> <B>Aldehydes</B> Shake 1.0 ml in a test tube (16 mm x 160 mm) with 10.0  \r\n\r\n ml of hydrochloric acid R for 30 s. Add 0.1 ml of 50 g/l solution of  \r\n\r\n phloroglucinol R in alcohol R, shake again for 30 s and centrifuge for 2 min  \r\n\r\n (3000 rpm). The clear supernatant is not more intensely coloured than a  \r\n\r\n reference solution prepared in the following manner: To 1.2 ml of red primary  \r\n\r\n solution add 0.2 ml of blue primary solution and 0.3 ml of yellow primary  \r\n\r\n solution and dilute to 10 ml with 10 g/l hydrochloric acid solution (Method  \r\n\r\n I, Ph. Eur. 3rd Ed., 2.2.2). </P>  \r\n\r\n<P> <B>Stearin</B> 10 ml remains clear after cooling in an ice bath for 5 h.  \r\n\r\n</P>  \r\n\r\n<P> <B>Mercury</B> Not more than 0.2 ppm, determined by atomic absorption  \r\n\r\n spectrophotometry (Method I, Ph. Eur. 3rd Ed., 2.2.23). </P>  \r\n\r\n<P> <I>Test solution</I> Digest 1.0 g of the substance to be examined in a  \r\n\r\n mixture of 12.0 ml of nitric acid and 5.0 ml of perchloric acid. Perform the  \r\n\r\n digestion in a borosilicate glass tube about 30 cm high with a volume of  \r\n\r\n about 75 ml. Heat the glass tube in a heater block according to the  \r\n\r\n time/temperature program shown below. Cool and dilute to 25.0 ml with  \r\n\r\n distilled water. </P>  \r\n\r\n<PRE>  \r\n\r\n                            Temperature        Ramp*        Time  \r\n\r\n Step                       graderC         hour    min  hour    min  \r\n\r\n ---------------------------------------------------------------------  \r\n\r\n 1                            50                     15   1      00  \r\n\r\n 2                            70                     15   1      45  \r\n\r\n 3                           100                     15   1      45  \r\n\r\n 4                           120                     15   1      15  \r\n\r\n 5                           138             1       15   1      00  \r\n\r\n 6                           150             1       30   1      30  \r\n\r\n 7                           160                     45          45  \r\n\r\n 8                           180                     15   2      00  \r\n\r\n ---------------------------------------------------------------------  \r\n\r\n</PRE>  \r\n\r\n<P>time of temperature rise between each step. </P>  \r\n\r\n<P> <I>Reference solutions</I> Prepare the reference solutions using mercury  \r\n\r\n standard solution (10 ppm) and diluting with a 2 per cent <I>V/V </I>  \r\n\r\n  solution of nitric acid. </P>  \r\n\r\n<P>The test may be carried out using a device for continuous generation of  \r\n\r\n mercury. The test solution is added to the device at a flow rate of 7 ml/min,  \r\n\r\n sodium borohydride solution is added at a flow rate of 1 ml/min and a 180 g/l  \r\n\r\n solution of hydrochloric acid at a flow rate of 1 ml/min. Pass through the  \r\n\r\n device a stream of nitrogen as carrier gas. Measure the absorbance at 253.7  \r\n\r\n nm using a mercury hollow-cathode lamp as radiation source and, as  \r\n\r\n atomisation device, a flameless system whereby the mercury can be entrained  \r\n\r\n in the form of cold vapours. </P>  \r\n\r\n<P>ASSAY </P>  \r\n\r\n<P> <B>Vitamin A</B>  <I>Carry out the operations as rapidly as possible,  \r\n\r\n avoiding exposure to actinic light and air</I> . </P>  \r\n\r\n<P>Examine by ultraviolet absorption spectrophotometry (Ph. Eur. 3rd Ed.,  \r\n\r\n 2.2.25). </P>  \r\n\r\n<P> <I>Test solution</I> To 1.00 g of substance to be examined, add in a  \r\n\r\n round-bottom flask 30 ml of ethanol R and 3 ml of a freshly prepared 50 per  \r\n\r\n cent <I>m/m</I> solution of potassium hydroxide R. Boil under reflux in a  \r\n\r\n stream of nitrogen R for 30 min. Cool rapidly and add 30 ml of water R.  \r\n\r\n Extract with 50 ml of ether R. Repeat extraction twice. Wash the combined  \r\n\r\n ether layers with four quantities, each of 50 ml, of water R, mixing very  \r\n\r\n cautiously during the two first washes to avoid the formation of emulsions.  \r\n\r\n Dry and filter the combined ether layers, and evaporate to dryness under a  \r\n\r\n gentle current of nitrogen R. Dissolve the residue in sufficient 2-propanol  \r\n\r\n R1 to give an expected concentration of vitamin A equivalent to 3 microg to 5  \r\n\r\n microg per ml. </P>  \r\n\r\n<P>Determine the absorbances of the resulting solution at the wavelengths 310  \r\n\r\n nm, 325 nm and 334 nm with a suitable spectrophotometer in 1 cm specially  \r\n\r\n matched cells, using 2-propanol R1 as the blank. </P>  \r\n\r\n<P> <I>Calculation</I>  </P>  \r\n\r\n<P>Calculate the content af vitamin A, as all-trans retinol, in microg per  \r\n\r\n gram from the expression. </P>  \r\n\r\n<PRE>  \r\n\r\n             0.549  \r\n\r\n A325   x --------- x    1000  \r\n\r\n               m  \r\n\r\n A325   = the observed absorbance at 325 nm  \r\n\r\n  m     = the mass of the substance to be examined in the test  \r\n\r\n    solution, in grams per 100 ml.  \r\n\r\n</PRE>  \r\n\r\n<P>The expression above can only be used if A325 has a value not more than  \r\n\r\n (A325)/0.970 where (A325) is the corrected absorbance at 325 nm and is given  \r\n\r\n by the equation: </P>  \r\n\r\n<UL CLASS=PLAIN-LIST>  \r\n\r\n<LI>(A325) = 6.815 A325 - 2.555 A310 - 4.260 A334 </LI>  \r\n\r\n</UL>  \r\n\r\n<P>A designates the absorbance at the wavelength indicated by the subscript.  \r\n\r\n</P>  \r\n\r\n<P>Where A325 has a value more than (A325)/0.970 apply the following  \r\n\r\n expression for calculation of the vitamin A content: </P>  \r\n\r\n<PRE>  \r\n\r\n               0.549  \r\n\r\n   (A325)  x  ------- x  1000  \r\n\r\n                 m  \r\n\r\n</PRE>  \r\n\r\n<P> <B>Vitamin D3</B>  <I>Carry out the operations as rapidly as possible,  \r\n\r\n avoiding exposure to actinic light and air</I> . </P>  \r\n\r\n<P>Examine by liquid chromatography (Ph. Eur. 3rd Ed., 2.2.29). </P>  \r\n\r\n<P> <I>Internal standard solution</I> Dissolve 0.50 mg of ergocalciferol CRS  \r\n\r\n in 100 ml of hexane R for spektrophotometry. </P>  \r\n\r\n<P> <I>Test solution (a)</I> To 4.00 g of the substance to be examined add in  \r\n\r\n a round-bottom flask 60 ml of ethanol R, 5 ml of sodium ascorbate solution R  \r\n\r\n and 30 ml of a freshly prepared 50 per cent <I>m/m</I>  solution of potassium  \r\n\r\n hydroxide R. Reflux in a water bath at 50 graderC for 12 min under constant  \r\n\r\n stirring. Cool and dilute with 30 ml of water R and 10 ml of alcohol R.  \r\n\r\n Extract with 50 ml of pentane R for spectrophotometry. Repeat the extraction  \r\n\r\n twice. Wash the combined pentane layers with two quantities, each of 50 ml,  \r\n\r\n of a solution containing 30 g/l of potassium hydroxide R in alcohol (10 per  \r\n\r\n cent <I>V/V</I> ), and then wash with succesive quantities, each of 50 ml, of  \r\n\r\n water R until the last washing is neutral to phenolphthalein. Dry and filter  \r\n\r\n the combined pentane layers and evaporate to dryness under a gentle current  \r\n\r\n of nitrogen R at a temperature not exceeding 40 graderC. Dissolve the residue  \r\n\r\n in 1.5 ml of the mobile phase prescribed under <I>Purification</I> . </P>  \r\n\r\n<P> <I>Test solution (b)</I> To 4.00 g of the substance to be examined add  \r\n\r\n 2.0 ml (V 3) of internal standard solution, evaporate the solvent under a  \r\n\r\n gentle current of nitrogen R at a temperature not exceeding 40 graderC, and  \r\n\r\n proceed as described for test solution (a). </P>  \r\n\r\n<P> <I>Reference solution</I> Dissolve 0.50 mg of ergocalciferol CRS and 0.50  \r\n\r\n mg of cholecalciferol CRS in 100 ml of hexane R for spectrophotometry. </P>  \r\n\r\n<P> <I>Purification</I>  </P>  \r\n\r\n<P>The chromatographic procedure may be carried out using: </P>  \r\n\r\n<P>- a stainless steel column 0.25 m long and 4.6 mm in internal diameter  \r\n\r\n packed with cyanosilyl silica gel for chromatography (10 microm), <I>e.g.</I>  \r\n\r\n R-Sil CN 10 microm Alltech: </P>  \r\n\r\n<P>- as mobile phase a mixture of 98.4 volumes of hexane R for  \r\n\r\n spectrophotometry and 1.6 volumes of isoamyl alcohol R at a flow rate of 1.1  \r\n\r\n ml per minute: </P>  \r\n\r\n<P>- as detector a spectrophotometer set at 265 nm. </P>  \r\n\r\n<P>Inject 350 microl of the reference solution onto the column. Collect the  \r\n\r\n eluate 1 min before and until 1 min after the retention time of  \r\n\r\n cholecalciferol, into a ground glas stoppered tube containing 1 ml of a 0.1  \r\n\r\n per cent <I>m/V</I> solution of butylhydroxytoluene R in hexane R for  \r\n\r\n spectrophotometry. Repeat the procedure with test solutions (a) and (b),  \r\n\r\n respectively. Evaporate under a gentle current of nitrogen R the three  \r\n\r\n eluates obtained from the reference solution and test solutions (a) and (b),  \r\n\r\n respectively, to dryness at a temperature not exceeding 40 graderC. Dissolve  \r\n\r\n each of the three residues in 1.5 ml of acetonitrile R for spectrophotometry.  \r\n\r\n</P>  \r\n\r\n<P> <I>Determination</I>  </P>  \r\n\r\n<P>The chromatographic procedure may be carried out using: </P>  \r\n\r\n<P>- a stainless steel column 0.15 m long and 4.6 mm in internal diameter  \r\n\r\n packed with octadecylsilyl silica gel for chromatography R (5 microm),  \r\n\r\n<I>e.g.</I> Spherisorb ODS 5 microm: </P>  \r\n\r\n<P>- a mixture of 0.2 g of phosphoric acid R and 99.8 volumes of a 96 per  \r\n\r\n cent V/V solution of acetonitrile R for spectrophotometry as mobile phase at  \r\n\r\n a flow rate of 1.0 ml per minute: </P>  \r\n\r\n<P>- spectrophotometer set at 265 nm as detector. </P>  \r\n\r\n<P>Inject two times onto the column, aliquots not exceeding 200 microl of  \r\n\r\n each of the three solutions obtained under  <I>purification</I> . </P>  \r\n\r\n<P>The test is only valid if the chromatogram obtained with the reference  \r\n\r\n solution shows two peaks corresponding to ergocalciferol and cholecalciferol  \r\n\r\n with a resolution greater than 1.4. </P>  \r\n\r\n<P> <I>Calculation</I>  </P>  \r\n\r\n<P>Calculate the content of vitamin D3 in microg per gram from the  \r\n\r\n expression: </P>  \r\n\r\n<PRE>  \r\n\r\n     m 1     V 1     m 3    1      A 2     A 4  \r\n\r\n    ---  x ----- x ----- x --- x ----- x ------ x  V 3 x 1000  \r\n\r\n      V 1    m 2    V 2     m 4    A 1     A 3  \r\n\r\n  m 1    =    mass of cholecalciferol CRS in the reference solution in  \r\n\r\n              milligrams:  \r\n\r\n  m 2    =    mass of ergocalciferol CRS in the reference solution in  \r\n\r\n              milligrams:  \r\n\r\n  m 3    =    mass of ergocalciferol CRS in the internal standard  \r\n\r\n              solution in  milligrams:  \r\n\r\n  m 4    =    mass of the substance to be examined in test solution  \r\n\r\n              (b) in grams:  \r\n\r\n  V 1    =    volume of reference solution (100 ml):  \r\n\r\n  V 2    =    volume of internal standard solution (100 ml):  \r\n\r\n  V 3    =    volume of internal standard solution used for the  \r\n\r\n              preparation of test solution (b):  \r\n\r\n  A 1    =    peak area (or height) for cholecalciferol in the  \r\n\r\n              chromatogram obtained with the reference solution:  \r\n\r\n  A 2    =    peak area (or height) for ergocalciferol in the  \r\n\r\n              chromatogram obtained with the reference solution:  \r\n\r\n  A 3    =    peak area (or height) for ergocalciferol in the  \r\n\r\n              chromatogram obtained with the test solution (b):  \r\n\r\n              correct, if necessary, for any peak of related  \r\n\r\n              substances with retention time corresponding to  \r\n\r\n              ergocalciferol, in the chromatogram obtained with  \r\n\r\n              test solution (a):  \r\n\r\n  A 4    =    peak area (or height) for cholecalciferol in the  \r\n\r\n              chromatogram obtained with the test solution (b).  \r\n\r\n</PRE>  \r\n\r\n<P>STORAGE </P>  \r\n\r\n<P>Store in a airtight and well-filled container, protected from light at 8  \r\n\r\n graderC to 15 graderC. </P>  \r\n\r\n<P>REAGENTS </P>  \r\n\r\n<P> <B>Nitric acid</B> corresponding to the Suprapur quality from Merck. </P>  \r\n\r\n<P> <B>Perchloric acid</B> corresponding to the Suprapur quality from Merck.  \r\n\r\n</P>  \r\n\r\n<P> <B>Mercury standard solution (10 ppm)</B> Immediately before use, dilute  \r\n\r\n with a 2 per cent <I>V/V</I> solution of nitric acid to 100 times its volume  \r\n\r\n a solution containing mercuric nitrate R equivalent to 1.708 g Hg(NO3)2,H2O  \r\n\r\n in 1000.0 ml of a 2 per cent <I>V/V</I> solution of nitric acid. </P>  \r\n\r\n<P> <B>Sodium borohydride solution</B> Dissolve 0.3 g of sodium borohydride  \r\n\r\n in a 5 g/l solution of sodium hydroxide R and dilute to 100.0 ml with the  \r\n\r\n same solvent. </P>  \r\n\r\n<P> <B>Sodium borohydride</B> Na(BH4) (Mr 37.83) </P>  \r\n\r\n<P>Hygroscopic, cubic crystals containing at least 97 per cent <I>m/m</I> of  \r\n\r\n Na(BH4). Store protected from moisture. </P>  \r\n\r\n<P> <B>Hydrochloric acid</B> correponding to the Suprapur quality from Merck.  \r\n\r\n</P>  \r\n\r\n<P>ANNEX </P>  \r\n\r\n<P> <B>Anisidine value</B>  </P>  \r\n\r\n<P>The anisidine value is defined as 100 times the optical density measured  \r\n\r\n in a 1 cm cell of a solution containing 1 g of the oil in 100 ml of a mixture  \r\n\r\n of solvent and reagent according to the method described below. </P>  \r\n\r\n<P> <I>Carry out the operations as rapidly as possible, avoiding exposure to  \r\n\r\n actinic light</I> . </P>  \r\n\r\n<P> <I>Test solution (a)</I> Dissolve 0.500 g of the substance to be examined  \r\n\r\n in trimethylpentane R and dilute to 25.0 ml with the same solvent. </P>  \r\n\r\n<P> <I>Test solution (b)</I> To 5.0 ml of test solution (a) add 1.0 ml of a  \r\n\r\n 0.25 per cent <I>m/V</I> solution of <I>p</I> -anisidine in glacial acetic  \r\n\r\n acid R, shake and keep in the dark. </P>  \r\n\r\n<P> <I>Reference solution</I> To 5.0 ml of trimethylpentane R add 1.0 ml of a  \r\n\r\n 0.25 per cent <I>m/V</I> solution of <I>p</I> -anisidine in glacial acetic  \r\n\r\n acid R, shake and keep in the dark. </P>  \r\n\r\n<P>Measure the absorbance of test solution (a) at 350 nm using  \r\n\r\n trimethylpentane R as a blank. Measure the absorbance of test solution (b) at  \r\n\r\n 350 nm exactly 10 min after its preparation, using the reference solution as  \r\n\r\n a blank. </P>  \r\n\r\n<P>Calculate the anisidine value from the expression: </P>  \r\n\r\n<PRE>  \r\n\r\n        25 x (1.2  A s -  A b)  \r\n\r\n        ----------------------  \r\n\r\n                   m  \r\n\r\n  A s    =    the absorbance of test solution (b) at 350 nm:  \r\n\r\n  A b    =    the absorbance of test solution (a) at 350 nm:  \r\n\r\n  m      =    mass of the substance to be examined in test  \r\n\r\n              solution (a) in grams.  \r\n\r\n</PRE>  \r\n\r\n<P>REAGENTS </P>  \r\n\r\n<P> <B></B> <I>p-Anisidine</I>  - C7H9NO (Mr 123.16). 4-methoxyaniline.  \r\n\r\n Creamcoloured crystals, sparingly soluble in water, soluble in ethanol. It  \r\n\r\n contains at least 97 per cent <I>m/m</I> of C7H9NO. </P>  \r\n\r\n<P>Caution: skin irritant, sensitizer. </P>  \r\n\r\n<P>Store protected from light at 0 graderC to 4 graderC. </P>  \r\n\r\n<P>On storage, <I>p</I> -anisidine tends to darken as a result of oxidation.  \r\n\r\n A discoloured reagent can be reduced and decolorized in the following way:  \r\n\r\n Dissolve 20 g of <I>p</I> -anisidine in 500 ml of water at 75 graderC. Add 1  \r\n\r\n g of sodium sulphite R and 10 g of activated charcoal and stir for 5 min.  \r\n\r\n Filter, cool the filtrate to about 0 graderC and allow to stand at this  \r\n\r\n temperature for at least 4 h. Filter off the crystals, wash with a small  \r\n\r\n quantity of water at a temperature of about 0 graderC and dry the crystals in  \r\n\r\n a vacuum desiccator. </P>  \r\n\r\n<P>Rekommanderet af NLN som nordisk lægemiddelstandard. </P>  \r\n\r\n<P>ETHANOL </P>  \r\n\r\n<P>Ethanol </P>  \r\n\r\n<P> <B>CH3CH2OH</B>  </P>  \r\n\r\n<P>Ethanolum C2H6O </P>  \r\n\r\n<P>DEFINITION </P>  \r\n\r\n<P>Ethanol contains not less than 98.8 per cent <I>m/m</I> (99.3 per cent  \r\n\r\n<I>V/V</I> ) and not more than 100.0 per cent <I>m/m</I> (100.0 per cent  \r\n\r\n<I>V/V</I> ) of ethanol (C2H6O). </P>  \r\n\r\n<P>CHARACTERS </P>  \r\n\r\n<P>A colourless, clear, mobile and volatile liquid, with a characteristic  \r\n\r\n odour. It burns with a blue, smokeless flame. Miscible with water and with  \r\n\r\n ether. </P>  \r\n\r\n<P>IDENTIFICATION </P>  \r\n\r\n<P>A. Distillation range (Ph. Eur. 3rd Ed., 2.2.11): 78 graderC to 79.5  \r\n\r\n graderC. </P>  \r\n\r\n<P>B. Relative density (Ph. Eur. 3rd Ed., 2.2.5): 0.790 to 0.794. </P>  \r\n\r\n<P>C. Mix 0.1 ml with 1 ml of a 10 g/l solution of potassium permanganate R  \r\n\r\n and 0.2 ml of dilute sulphuric acid R in a 10 ml beaker. Cover the beaker  \r\n\r\n immediately with a filter paper moistened with a recently prepared solution  \r\n\r\n containing 0.1 g of sodium nitroprusside R and 0.5 g of piperazine hydrate R  \r\n\r\n in 5 ml of water R. After a few minutes an intense blue colour appears on the  \r\n\r\n paper and becomes paler after 10 min to 15 min. </P>  \r\n\r\n<P>D. Dilute 1 ml to 100 ml with water R. To 5 ml of the dilution add 3 ml of  \r\n\r\n dilute sodium hydroxide solution R then slowly add 2 ml of 0.05 M iodine. The  \r\n\r\n odour of iodoform develops and a yellow precipitate forms within 10 min. </P>  \r\n\r\n<P>TESTS </P>  \r\n\r\n<P> <B>Appearance</B> It is not more opalescent than water (Ph. Eur. 3rd Ed.,  \r\n\r\n 2.2.1) and not more intensely coloured than water (Ph. Eur. 3rd Ed., Method  \r\n\r\n II, 2.2.2). Dilute 1.0 ml to 20 ml with water. After standing for 5 min., the  \r\n\r\n dilution is not more opalescent than water (Ph. Eur. 3rd Ed., 2.2.1). </P>  \r\n\r\n<P> <B>Acidity or alkalinity</B> To 5 ml add 5 ml of carbon dioxide-free  \r\n\r\n water R and 0.1 ml of phenolphthalein solution R. The solution is colourless.  \r\n\r\n Add 0.20 ml of 0.01 M sodium hydroxide R. The solution is red. Add 0.30 ml of  \r\n\r\n 0.01 M hydrochloric acid R. The solution is colourless. Add 0.2 ml of methyl  \r\n\r\n red solution R. The solution is red or orange. </P>  \r\n\r\n<P> <B>Aldehydes and ketones</B> Heat 125 ml of hydroxylamine hydrochloride  \r\n\r\n solution R2 in a conical flask under a reflux condenser, on a water-bath, for  \r\n\r\n 30 min: cool and if necessary add sufficient 0.05 N sodium hydroxide to  \r\n\r\n restore the green colour. Transfer 50 ml of this solution to a similar  \r\n\r\n conical flask, add 25 ml of the substance to be examined and heat under a  \r\n\r\n reflux condenser, on a water-bath, for 10 min. Cool and titrate with 0.05 M  \r\n\r\n sodium hydroxide until the colour matches that of the remainder of the  \r\n\r\n hydroxylamine hydrochloride solution. Not more than 0.9 ml of 0.05 M sodium  \r\n\r\n hydroxide is required. (100 ppm, calculated as acetaldehyde). </P>  \r\n\r\n<P> <B>Methanol, higher alcohols and esters</B> Examine by gas chromatography  \r\n\r\n (Ph. Eur. 3rd Ed., 2.2.28). </P>  \r\n\r\n<P> <I>Test solution (a)</I> The substance to be examined. </P>  \r\n\r\n<P> <I>Test solution (b)</I> Dilute 100 microl of methyl ethyl ketone R to  \r\n\r\n 50.0 ml with the substance to be examined. Dilute 5.0 ml of this solution to  \r\n\r\n 50.0 ml with the substance to be examined. </P>  \r\n\r\n<P> <I>Reference solution</I> Dilute 100 microl of methyl ethyl ketone R and  \r\n\r\n 250 microl of anhydrous methanol R to 50.0 ml with the substance to be  \r\n\r\n examined. Dilute 5.0 ml of this solution to 50.0 ml with the substance to be  \r\n\r\n examined. </P>  \r\n\r\n<P>The chromatographic procedure may be carried out using: </P>  \r\n\r\n<P>- a glass column 1.8 m long and 2 mm in internal diameter packed with  \r\n\r\n ethylbenzene divinylbenzene copolymer (125 microm to 150 microm) R (e.g.  \r\n\r\n Porapak Q). </P>  \r\n\r\n<P>- nitrogen for chromatography R as the carrier gas, at a flow rate of 30  \r\n\r\n ml per minute, </P>  \r\n\r\n<P>- a flame-ionisation detector. </P>  \r\n\r\n<P>Maintain the temperature of the column at 120 graderC for 16 min, then  \r\n\r\n raise the temperature at a rate of 8 graderC per minute to 240 graderC and  \r\n\r\n maintain at 240 graderC for 16 min. Maintain the temperature of the injection  \r\n\r\n port at 200 graderC and that of the detector at 250 graderC. </P>  \r\n\r\n<P>Inject 1 microl of test solution (a) and at least three times 1 microl of  \r\n\r\n test solution (b) and of the reference solution, alternating the order of  \r\n\r\n injections. Check that the chromatogram obtained with the test solution (a)  \r\n\r\n does not show a peak at a retention tR the same as that of the peak  \r\n\r\n corresponding to methyl ethyl ketone in the chromatogram obtained with test  \r\n\r\n solution (b). Carry out under the same conditions a blank chromatography  \r\n\r\n before each test. </P>  \r\n\r\n<P>The areas of the peaks corresponding to methanol in the chromatograms  \r\n\r\n obtained with test solution (b) and the reference solution are to be  \r\n\r\n corrected in relation to the areas of the peaks corresponding to methyl ethyl  \r\n\r\n ketone in the chromatograms obtained with test solution (b) and the reference  \r\n\r\n solution. </P>  \r\n\r\n<P>Calculate the percentage <I>(V/V)</I> content of methanol using the  \r\n\r\n expression: </P>  \r\n\r\n<PRE>  \r\n\r\n                           b  \r\n\r\n                         ------------- - per cent  \r\n\r\n                         20 ( a - b )  \r\n\r\n  a =  area of the peak corresponding to methanol in the  \r\n\r\n       chromatogram obtained with the reference solution,  \r\n\r\n  b =  area of the peak corresponding to methanol in  \r\n\r\n       the chromatogram obtained with test solution (b).  \r\n\r\n</PRE>  \r\n\r\n<P>Maximum content: 0.06 per cent <I>V/V</I> of methanol. </P>  \r\n\r\n<P>In the chromatogram obtained with test solution (b) recorded for 3.5 times  \r\n\r\n the retention time of the internal standard, the total area of the peaks  \r\n\r\n corresponding to the substance with a retention tR greater than that of  \r\n\r\n ethanol is not greater than the area of the peak corresponding to methyl  \r\n\r\n ethyl ketone (0.02 per cent <I>V/V</I> ). </P>  \r\n\r\n<P> <B>Benzene and other UV-absorbing compounds</B> Examined between 235 mm  \r\n\r\n and 275 nm, the absorbance (Ph. Eur. 3rd Ed., 2.2.25) measured in a 5 cm cell  \r\n\r\n using water as the compensation liquid is not greater than 0.50 at 240 nm,  \r\n\r\n 0.30 in the interval between 250 nm and 260 nm and 0.15 at 270 nm. </P>  \r\n\r\n<P>If benzene is present, maxima occur at about 249 nm, 254 nm and 261 nm.  \r\n\r\n Draw a perpendicular through the maximum at 254 nm and draw a line between  \r\n\r\n the minima at about 253 nm and 259 nm. The difference between the absorbance  \r\n\r\n at the maximum at about 254 nm and the absorbance at the intercept of the  \r\n\r\n perpendicular with the line joining the minima is not greater than 0.045 (5  \r\n\r\n ppm benzene). </P>  \r\n\r\n<P> <B>Chlorides</B> (Ph. Eur. 3rd Ed., 2.4.4) 4 ml diluted to 15 ml with  \r\n\r\n water complies with the limit test for chlorides (1.5 ppm). Prepare the  \r\n\r\n standard using a mixture of 1 ml of chloride standard solution (5 ppm Cl) R  \r\n\r\n and 14 ml of water. </P>  \r\n\r\n<P> <B>Heavy metals</B> (Ph. Eur. 3rd Ed., 2.4.8) 12 ml of a solution  \r\n\r\n prepared by evaporating 50 ml on a water-bath to 5 ml and diluting to 25 ml  \r\n\r\n with water complies with limit test A for heavy metals (0.3 ppm). Prepare the  \r\n\r\n standard using a mixture of 5 ml of lead standard solution (1 ppm Pb) R and 5  \r\n\r\n ml of water R. </P>  \r\n\r\n<P> <B>Residue on evaporation</B> Evaporate 100 ml on water-bath and dry in  \r\n\r\n an oven at 100 graderC to 105 graderC. The residue weighs not more than 2 mg  \r\n\r\n (0.002 per cent <I>m/V</I> ). </P>  \r\n\r\n<P>STORAGE </P>  \r\n\r\n<P>Store in an airtight container, protected from light. </P>  \r\n\r\n<P>Rekommanderet af NLN som nordisk lægemiddelstandard. </P>  \r\n\r\n<P> <B>FRUCTOSE FOR PARENTERAL USE </B></P>  \r\n\r\n<P>Fructose til injektion </P>  \r\n\r\n<P>Fructosum ad usum parenterale </P>  \r\n\r\n<P>Fructose til parenteralt brug skal foruden de nedennævnte prøver opfylde  \r\n\r\n de angivne kvalitetskrav i monografien for fructose i Ph. Eur. 3rd Ed.,  \r\n\r\n herunder de anførte prøver. </P>  \r\n\r\n<P> <B>Pyrogener:</B> Skal holde prøven &#187;Pyrogens&#171;, Ph. Eur. 3rd  \r\n\r\n Ed., 2.6.8. Prøveopløsningen, hvis koncentration skal være 50 mg/ml,  \r\n\r\n fremstilles med sterilt vand. Ved afprøvningen injiceres 10 ml prøveopløsning  \r\n\r\n pr. kg legemsvægt. </P>  \r\n\r\n<P>alpha <B>-1,6-Glucaner:</B> Skal holde prøven, &#187;Test for  \r\n\r\n alpha-1,6-glucans&#171;, DLS, sektion 1. Prøveopløsningen, hvis koncentration  \r\n\r\n skal være 100 mg/ml, fremstilles med isotonisk natriumchloridopløsning. </P>  \r\n\r\n<P> <B>GLYCOPYRRONIUM BROMIDE </B></P>  \r\n\r\n<P>Glopyrroniumbromid </P>  \r\n\r\n<P><IMG SRC=\"/image.aspx?id=83706&img=1.gif\" ALIGN=\"middle\" WIDTH=\"235\" HEIGHT=\"85 BORDER=\"no\" ALT=\"DUMMY.GIF billedet er ikke indlagt onMouseOver=\"self.status='DUMMY.GIF billedet er ikke indlagt'; return true\"\"> </P>  \r\n\r\n<PRE>  \r\n\r\n Glycopyrronii bromidum  \r\n\r\n C19H28BrNO3                                 Mr 398.3  \r\n\r\n</PRE>  \r\n\r\n<P>DEFINITION </P>  \r\n\r\n<P>Glycopyrronium bromide contains not less than 99.0 per cent and not more  \r\n\r\n than the equivalent of 101.0 per cent of  \r\n\r\n (3RS)-3-((RS)-(2-cyclopentyl-2-hydroxy-2- </P>  \r\n\r\n<P>phenylacetyl)oxy)-1,1-dimethyl-pyrr olidinium bromide, calculated with  \r\n\r\n reference to the dried substance. </P>  \r\n\r\n<P>CHARACTERS </P>  \r\n\r\n<P>A white, crystalline powder, freely soluble in water and in alcohol, very  \r\n\r\n slightly soluble in ether. </P>  \r\n\r\n<P>IDENTIFICATION </P>  \r\n\r\n<P>A. Melting point (Ph. Eur. 3rd Ed., 2.2.14) 193 graderC to 198 graderC.  \r\n\r\n</P>  \r\n\r\n<P>B. Examine by infrared absorption spectrophometry (Ph. Eur. 3rd Ed.,  \r\n\r\n 2.2.24) compairing with the spectrum obtained with glycopyrronium bromide  \r\n\r\n NRP. </P>  \r\n\r\n<P>C. It gives reaction (a) of bromides (Ph. Eur. 3rd Ed., 2.3.1). </P>  \r\n\r\n<P>TESTS </P>  \r\n\r\n<P> <B>Solution S</B> Dissolve 0.5 g in water R and dilute to 25 ml with the  \r\n\r\n same solvent. </P>  \r\n\r\n<P> <B>Appearance of solution</B> Solution S is clear (Ph. Eur. 3rd Ed.,  \r\n\r\n 2.2.1) and colourless (Ph. Eur. 3rd Ed., Method II, 2.2.2). </P>  \r\n\r\n<P> <B>Acidity or alkalinity</B> To 10 ml of solution S add 0.05 ml of  \r\n\r\n phenolphthalein solution R1. The solution is colourless. Not more than 0.2 ml  \r\n\r\n of 0.01 M sodium hydroxide is required to change the colour of the indicator  \r\n\r\n to pink. Add 0.4 ml of 0.01 M hydrochloric acid and 0.05 ml of methyl red  \r\n\r\n solution R. The solution is red or orange. </P>  \r\n\r\n<P> <B>Related substances</B> Examine by thin layer chromatography (Ph. Eur.  \r\n\r\n 3rd Ed., 2.2.27) using silica gel G R as the coating substance. </P>  \r\n\r\n<P> <I>Test solution</I> Dissolve 0.25 g of the substance to be examined in  \r\n\r\n alcohol R and dilute to 5 ml with the same solvent. </P>  \r\n\r\n<P> <I>Reference solution</I> Dilute 0.5 ml of the test solution to 100 ml  \r\n\r\n with alcohol R. </P>  \r\n\r\n<P>Apply separately to the plate 5 microl of each solution and develop over a  \r\n\r\n path of 15 cm using a mixture of 10 volumes of anhydrous formic acid R, 16  \r\n\r\n volumes of water and 74 volumes of ethyl acetate R. Dry the plate at 100  \r\n\r\n graderC to 105 graderC for 15 min. Allow to cool and spray with dilute  \r\n\r\n potassium iodobismuthate solution R until the spots appear. Any spot in the  \r\n\r\n chromatogram obtained with the test solution, apart from the principal spot,  \r\n\r\n is not more intense than the spot in the chromatogram obtained with the  \r\n\r\n reference solution (0.5 per cent) </P>  \r\n\r\n<P> <B>Loss of drying</B> (Ph. Eur. 3rd Ed., 2.2.32) Not more than 0.5 per  \r\n\r\n cent, determined on 1.000 g by drying at 100 graderC to 105 graderC for 3  \r\n\r\n hours. </P>  \r\n\r\n<P> <B>Sulphated ash</B> (Ph. Eur. 3rd Ed., 2.4.14) Not more than 0.1 per  \r\n\r\n cent, determined on 1.0 g. </P>  \r\n\r\n<P>ASSAY </P>  \r\n\r\n<P>Dissolve 0.300 g in a mixture of 40 ml of acetic anhydride R and 10 ml of  \r\n\r\n anhydrous acetic acid R. Titrate with 0.1M perchloric acid, determining the  \r\n\r\n end-point potentiometrically (Ph. Eur. 3rd Ed., 2.2.20.). </P>  \r\n\r\n<P>1 ml of 0.1 M perchloric acid is equivalent to 39.83 mg of C19H28BrNO3.  \r\n\r\n</P>  \r\n\r\n<P>STORAGE </P>  \r\n\r\n<P>Store in a well-closed container. </P>  \r\n\r\n<P>Rekommanderet af NLN som nordisk lægemiddelstandard. </P>  \r\n\r\n<P> <B>METRIZOIC ACID </B></P>  \r\n\r\n<P>Metrizoinsyre </P>  \r\n\r\n<P><IMG SRC=\"/image.aspx?id=83706&img=1.gif\" ALIGN=\"middle\" WIDTH=\"235\" HEIGHT=\"85 BORDER=\"no\" ALT=\"DUMMY.GIF billedet er ikke indlagt onMouseOver=\"self.status='DUMMY.GIF billedet er ikke indlagt'; return true\"\"> </P>  \r\n\r\n<P>Acidum metrizoicum </P>  \r\n\r\n<P>C12H11I3N2O4 Mr 628 </P>  \r\n\r\n<P>DEFINITION </P>  \r\n\r\n<P>Metrizoic acid contains not less than 98.0 per cent and not more than the  \r\n\r\n equivalent of 102.0 per cent of  \r\n\r\n 3-acetamido-2,4,6-triiodo-5-(N-methylacetamido) benzoic acid, calculated with  \r\n\r\n reference to the dried substance. </P>  \r\n\r\n<P>CHARACTERS </P>  \r\n\r\n<P>A white or almost white, crystalline powder, very slightly soluble in  \r\n\r\n water, slightly soluble in alcohol, practically insoluble in ether. It  \r\n\r\n dissolves in solutions of alkali hydroxides and alkali carbonates. </P>  \r\n\r\n<P>IDENTIFICATION </P>  \r\n\r\n<P>Examine by infrared absorption spectrophotometry (Ph. Eur. 3rd Ed.,  \r\n\r\n 2.2.24), comparingwith the spectrum obtained with metrizoic acid NRP. </P>  \r\n\r\n<P>TESTS </P>  \r\n\r\n<P> <B>Appearance of solution</B> Dissolve 0.20 g in a mixture of 5 ml of  \r\n\r\n dilute sodium hydroxide solution R and 5 ml of water R. The solution is clear  \r\n\r\n (Ph. Eur. 3rd Ed., 2.2.1) and colourless (Ph. Eur. 3rd Ed., Method II,  \r\n\r\n 2.2.2). </P>  \r\n\r\n<P> <B>pH</B> (Ph. Eur. 3rd Ed., 2.2.3) Suspend 0.40 g in 20 ml of water R  \r\n\r\n and boil for 1 min. Cool the suspension under stirring and filter. The pH of  \r\n\r\n the filtrate is between 2.7 and 3.0. </P>  \r\n\r\n<P> <B>Related substances</B> Examine by liquid chromatography (Ph. Eur. 3rd  \r\n\r\n Ed., 2.2.29). </P>  \r\n\r\n<P> <I>Test solution</I> Dissolve 25.0 mg of the substance to be examined in  \r\n\r\n a mixture of 0.05 ml of 1 M sodium hydroxide and 10 ml of water R and dilute  \r\n\r\n to 100.0 ml with water R. </P>  \r\n\r\n<P> <I>Reference solution (a)</I> Dissolve 25.0 mg of metrizoic acid NRP in a  \r\n\r\n mixture of 0.05 ml of 1 M sodium hydroxide and 10 ml of water R and dilute to  \r\n\r\n 100.0 ml with water R. </P>  \r\n\r\n<P> <I>Reference solution (b)</I> Dissolve 25.0 mg of diatrizoic acid in a  \r\n\r\n mixture of 0.05 ml of 1 M sodium hydroxide and 10 ml of water R and dilute to  \r\n\r\n 100.0 ml with water R. </P>  \r\n\r\n<P> <I>Reference solution (c)</I> Dilute 1.0 ml of reference solution (b) to  \r\n\r\n 100.0 ml with water R. </P>  \r\n\r\n<P> <I>Reference solution (d)</I> Dilute 1.0 ml of the test solution to 100.0  \r\n\r\n ml with water R. Dilute 3.0 ml of this solution to 10.0 ml with water R. </P>  \r\n\r\n<P> <I>Reference solution (e)</I> Mix 1 ml of reference solution (a) with 1  \r\n\r\n ml of reference solution (b). </P>  \r\n\r\n<P>The chromatographic procedure may be carried out using: </P>  \r\n\r\n<P>- a stainless steel column 25 cm long and 4.6 mm in internal diameter  \r\n\r\n packed with octadecylsilyl silicagel for chromatography R (5-10 microm): </P>  \r\n\r\n<P>- as the mobile phase at a flow rate of 1.3 ml per minute a mixture of 30  \r\n\r\n volumes of methanol R and 70 volumes of a 0.01 M solution of  \r\n\r\n tetrabutylammonium chloride adjusted to pH 6 to 7 by the addition of dilute  \r\n\r\n ammonia R1: </P>  \r\n\r\n<P>- as the detector a spectrophotometer set at 240 nm: </P>  \r\n\r\n<P>- a loop injector. </P>  \r\n\r\n<P>Inject separately 10 microl of each solution and continue the  \r\n\r\n chromatography for 4 times the retention time of the main peak. In the  \r\n\r\n chromatogram obtained with the test solution the area of the peak  \r\n\r\n corresponding to diatrizoic acid is not greater than that in the chromatogram  \r\n\r\n obtained with reference solution (c) (1 per cent) and the area of any other  \r\n\r\n peak apart from the principal peak, is not greater than that in the  \r\n\r\n chromatogram obtained with reference solution (d) (0.3 per cent). The test is  \r\n\r\n not valid unless in the chromatogram obtained with reference solution (e) the  \r\n\r\n resolution between the two peaks is greater than 1.5. </P>  \r\n\r\n<P> <B>Free aromatic amines</B>  <I>Protect the solutions from bright  \r\n\r\n light</I> . Dissolve 50 mg in 1.0 ml of 0.1 M sodium hydroxide, add 1.0 ml of  \r\n\r\n a 2.5 g/l solution of sodium nitrite R and 1.0 ml of 5 M hydrochloric acid:  \r\n\r\n let stand for 4 min, then shake vigorously for 10 s. After 1 min add 1.0 ml  \r\n\r\n of a 25 g/l solution of ammonium sulphamate R. After 2 min add 7.0 ml of  \r\n\r\n water R, filter and add 1.0 ml of a 10 g/l solution of naphtylethylenediamine  \r\n\r\n dihydrochloride R. Measure the absorbance at 500 nm after 2 min: the  \r\n\r\n absorbance is not greater than 0.02. </P>  \r\n\r\n<P> <B>Inorganic iodide</B> Not more than 20 ppm. Dissolve 2.50 g in 5 ml of  \r\n\r\n 1 M sodium hydroxide and dilute to 10 ml with water R. Add dropwise dilute  \r\n\r\n nitric acid R until the precipitation is complete, then add 3 ml of dilute  \r\n\r\n nitric acid R. Filter and wash the precipitate with 5 ml of water R. Collect  \r\n\r\n the filtrate and washings. Add 1 ml of dilute hydrogen peroxide solution R  \r\n\r\n and 1 ml of methylene chloride R and shake. The lower layer is not more  \r\n\r\n intensely coloured than a reference solution prepared simultaneously and in  \r\n\r\n the same manner using a mixture of 5 ml of iodide standard solution (10 ppm  \r\n\r\n I), 3 ml of dilute nitric acid R and 15 ml of water R. </P>  \r\n\r\n<P> <B>Methanol</B> Examine by gas chromatography (Ph. Eur. 3rd Ed., 2.2.28).  \r\n\r\n</P>  \r\n\r\n<P> <I>Test solution</I> Dissolve 1.0 g of the substance to be examined in a  \r\n\r\n mixture of 0.5 ml of 5 M sodium hydroxide and 2 ml of water R, and adjust the  \r\n\r\n pH to 7.0 to 7.5 by the addition of 1 M hydrochloric acid: dilute with water  \r\n\r\n R to 5.0 ml. </P>  \r\n\r\n<P> <I>Reference solution</I> Dilute 2.0 g of methanol R to 100.0 ml with  \r\n\r\n water R: dilute 1.0 ml of the resulting solution to 1000.0 ml with water R.  \r\n\r\n</P>  \r\n\r\n<P>The chromatographic procedure may be carried out using: </P>  \r\n\r\n<P>- a glass column 2 m long and 2 mm in internal diameter, packed with  \r\n\r\n porous polymer beads (e.g. Porapak Q 150-180 mesh). </P>  \r\n\r\n<P>- nitrogen for chromatography R as carrier gas at a flow rate of 25 ml per  \r\n\r\n min. </P>  \r\n\r\n<P>- a flame-ionisation detector. </P>  \r\n\r\n<P>Maintain the temperature of the column at 50 graderC, that of the  \r\n\r\n injection port at 150 graderC and that of the detector at 150 graderC. Inject  \r\n\r\n 5 microl of each solution. </P>  \r\n\r\n<P>In the chromatogram obtained with the test solution the peak area due to  \r\n\r\n methanol is not greater than the peak area due to methanol in the  \r\n\r\n chromatogram obtained with the reference solution. </P>  \r\n\r\n<P> <B>Heavy metals</B> (Ph. Eur. 3rd Ed., 2.4.8) 1.0 g complies with limit  \r\n\r\n test C for heavy metals (20 ppm). Prepare the standard using 2 ml of lead  \r\n\r\n standard solution (10 ppm Pb) R. </P>  \r\n\r\n<P> <B>Loss on drying</B> (Ph. Eur. 3rd Ed., 2.2.32). Not more than 0.5 per  \r\n\r\n cent, determined on 1.000 g by drying in an oven at 100 graderC to 105  \r\n\r\n graderC. </P>  \r\n\r\n<P> <B>Sulphated ash</B> (Ph. Eur. 3rd Ed., 2.4.14). Not more than 0.1 per  \r\n\r\n cent, determined on 1.0 g. </P>  \r\n\r\n<P>ASSAY </P>  \r\n\r\n<P>To 0.150 g in a glass-stoppered 250 ml flask add 18 ml of dilute sodium  \r\n\r\n hydroxide solution R, 12 ml of water R, 0.5 g of powdered zink R and a few  \r\n\r\n glass beads. Boil under a reflux condenser for 30 min. Allow to cool and  \r\n\r\n rinse the condenser with 20 ml of water R. Filter and wash the filter with  \r\n\r\n several quantities of water R. Collect the filtrate and washings. Add 5 ml of  \r\n\r\n glacial acetic acid R and titrate immediately with 0.1 M silver nitrate,  \r\n\r\n determining the end-point potentiometrically, using a silver electrode as  \r\n\r\n indicator electrode and a mercurous sulphate electrode as comparison  \r\n\r\n electrode (Ph. Eur. 3rd Ed., 2.2.20). </P>  \r\n\r\n<P>1 ml of 0.1 M silver nitrate is equivalent to 20.93 mg of C12H11I3N2O4.  \r\n\r\n</P>  \r\n\r\n<P>STORAGE </P>  \r\n\r\n<P>Store protected from light. </P>  \r\n\r\n<P>REAGENTS </P>  \r\n\r\n<P> <B>Diatrizoic acid </B>  \r\n\r\n  C11H9I3N2O4(Mr614).3,5-Diacetamido-2,4,6-triiodo-benzoic acid. </P>  \r\n\r\n<P>White crystals, hygroscopic, very slightly soluble in water, slightly  \r\n\r\n soluble in ethanol, practically insoluble in ether. </P>  \r\n\r\n<P>A 1 per cent: about 560 at 238 nm, determined in ethanol and calculated  \r\n\r\n with dollarj' </P>  \r\n\r\n<P>1 cm reference to the anhydrous substance. </P>  \r\n\r\n<P>Store protected from light. </P>  \r\n\r\n<P> <B>Iodide Standard solution (10 ppm I) </B></P>  \r\n\r\n<P>Immediately before use, dilute with water R to 100 times its volume a  \r\n\r\n solution containing potassium iodide equivalent to 0.131 g of KI in 100.0 ml.  \r\n\r\n</P>  \r\n\r\n<P> <B>Tetrabutylammonium chloride</B> C16H36ClN, H2O (Mr295.9) </P>  \r\n\r\n<P>Slightly coloured crystals, hygroscopic, very soluble in water, freely  \r\n\r\n soluble in ethanol. </P>  \r\n\r\n<P>Rekommanderet af NLN som nordisk lægemiddelstandard. </P>  \r\n\r\n<P> <B>PENTAZOCINE LACTATE </B></P>  \r\n\r\n<P>Pentazocinlactat </P>  \r\n\r\n<P><IMG SRC=\"/image.aspx?id=83706&img=1.gif\" ALIGN=\"middle\" WIDTH=\"235\" HEIGHT=\"85 BORDER=\"no\" ALT=\"DUMMY.GIF billedet er ikke indlagt onMouseOver=\"self.status='DUMMY.GIF billedet er ikke indlagt'; return true\"\"> </P>  \r\n\r\n<P>Pentazocini lactats </P>  \r\n\r\n<P>C22H33NO4 Mr 375.5 </P>  \r\n\r\n<P>DEFINITION </P>  \r\n\r\n<P>Pentazocine lactate contains not less than 98.5 per cent and not more than  \r\n\r\n the equivalent of 101.0 per cent of (2R, 6R,  \r\n\r\n 11R)-1,2,3,4,5,6-hexahydro-8-hydroxy-6,11-dimethyl-3- </P>  \r\n\r\n<P>(3-methylbut-2-enyl)-2, 6-methano-3-benzazocinum (RS)lactate, calculated  \r\n\r\n with reference to the dried substance. </P>  \r\n\r\n<P>CHARACTERS </P>  \r\n\r\n<P>A white or almost white powder, soluble in water, alcohol and chloroform,  \r\n\r\n very slightly soluble in ether. </P>  \r\n\r\n<P>It melts at about 165 graderC. </P>  \r\n\r\n<P>IDENTIFICATION </P>  \r\n\r\n<P>A. Examine by infrared absorption spectrophotometry (Ph. Eur. 3rd Ed.,  \r\n\r\n 2.2.24) comparing with the spectrum obtained with pentazocine lactate NRP.  \r\n\r\n</P>  \r\n\r\n<P>TESTS </P>  \r\n\r\n<P> <B>Solution S</B> With the aid of gentle heating, dissolve 0.80 g in 40  \r\n\r\n ml of water. </P>  \r\n\r\n<P> <B>Appearance of solution</B> Solution S is clear (Ph. Eur. 3rd Ed.,  \r\n\r\n 2.2.1) and not more intensely coloured than reference solution B8 (Ph. Eur.  \r\n\r\n 3rd Ed., Method II, 2.2.2). </P>  \r\n\r\n<P> <B>Acidity or alkalinity</B> To 10 ml of solution S add 0.2 ml of 0.01 M  \r\n\r\n sodium hydroxide. The pH of the mixture is not less than 6.5. Add 0.4 ml of  \r\n\r\n 0.01 M hydrochloric acid. The pH of the mixture is not more than 6.5. </P>  \r\n\r\n<P> <B>Related substances</B> Examine by thin layer chromatography (Ph. Eur.  \r\n\r\n 3rd Ed., 2.2.27.), using silica gel GF254R as the coating substance. </P>  \r\n\r\n<P> <I>Test solution</I> Dissolve 0.10 g of the substance to be examined in  \r\n\r\n alcohol R and dilute to 10 ml with the same solvent. </P>  \r\n\r\n<P> <I>Reference solution</I> Dilute 1 ml of the test solution to 50 ml with  \r\n\r\n alcohol R. </P>  \r\n\r\n<P>Apply separately to the plate 10 microl of each solution. Develop over a  \r\n\r\n path of 10 cm using af mixture of 3 volumes of isopropylamine, 3 volumes of  \r\n\r\n methanol R and 94 volumes of chloroform R. Allow the plate to dry in air and  \r\n\r\n examine in ultraviolet light at 254 mm. In the chromatogram obtained with the  \r\n\r\n test solution at most one spot, apart from the principal spot, may be present  \r\n\r\n and is not more intense than the spot in the chromatopgram obtained with the  \r\n\r\n reference solution. </P>  \r\n\r\n<P> <B>Chlorides</B> (Ph. Eur. 3rd Ed., 2.4.4) 15 ml of solutions S complies  \r\n\r\n with the limit test for chlorides (175 ppm). </P>  \r\n\r\n<P> <B>Heavy metals</B> (Ph. Eur. 3rd Ed., 2.4.8) 0.25 g complies with limit  \r\n\r\n test C for heavy metals (60 ppm). Prepare the standard using 1.5 ml of lead  \r\n\r\n standard solution (10 ppm Pb) R. </P>  \r\n\r\n<P> <B>Loss of drying</B> (Ph. Eur. 3rd Ed., 2.2.32) Not more than 0.5 per  \r\n\r\n cent, determined on 1.000 g by drying in an oven at 100 graderC to 105  \r\n\r\n graderC. </P>  \r\n\r\n<P> <B>Sulphated ash</B> (Ph. Eur. 3rd Ed., 2.4.14) Not more than 0.1 per  \r\n\r\n cent, determined on 1.0 g. </P>  \r\n\r\n<P>ASSAY </P>  \r\n\r\n<P>Dissolve 0.300 g in 30 ml of anhydrous acetic acid R and add 30 ml of  \r\n\r\n dioxan R. Titrate with 0.1 M perchloric acid, using 0.1 ml of crystal violet  \r\n\r\n solution R as indicator, until a blue colour is obtained. dollarR9st'1 ml of  \r\n\r\n 0.1 M perchloric acid is equivalent to 37.55 mg of C2H33NO4. </P>  \r\n\r\n<P>STORAGE </P>  \r\n\r\n<P>Store protected from light. </P>  \r\n\r\n<P>REAGENTS </P>  \r\n\r\n<P>Isopropylamine C3H9N (Mr 59.1). 2-aminopropan. </P>  \r\n\r\n<P>A clear, colourless, volatile liquid. </P>  \r\n\r\n<PRE>  \r\n\r\n       20  \r\n\r\n      d----: about 0.69         bp: about 33  graderC.  \r\n\r\n       20  \r\n\r\n</PRE>  \r\n\r\n<P>Rekommanderet af NLN som nordisk lægemiddelstandard. </P>  \r\n\r\n<P> <B>PLASMA FOR FRACTIONATION, HUMAN </B></P>  \r\n\r\n<P>Plasma til fraktionering, humant </P>  \r\n\r\n<P>Plasma humanum ad seperationem </P>  \r\n\r\n<P>Plasma til fraktionering skal opfylde de i Ph. Eur. 3rd Ed. angivne  \r\n\r\n kvalitetskrav i monografien &#187;Human plasma for fractionation&#171; og de  \r\n\r\n anførte donortests skal udføres i overensstemmelse med de af  \r\n\r\n Sundhedsstyrelsen fastsatte regler for undersøgelse af donorblod for syfilis,  \r\n\r\n hepatitis B overfladeantigen, HIV antistoffer (type 1 og type 2), HTLV  \r\n\r\n antistoffer (type I/II) og hepatitis C antistof. </P>  \r\n\r\n<P> <B>WATER, STERILISED </B></P>  \r\n\r\n<P>Vand, sterilt </P>  \r\n\r\n<P>Aqua sterilisata </P>  \r\n\r\n<P>Vand, sterilt, skal opfylde de angivne krav for <B>Sterilised water for  \r\n\r\n injections</B> i monografien <B>Water for injections</B> i Ph. Eur. 3rd Ed.  \r\n\r\n<B>SEKTION 3</B>  </P>  \r\n\r\n<P> <B>FREMSTILLING AF LÆGEMIDLER</B>  </P>  \r\n\r\n<P>Produktion, kontrol og lagerhold af lægemidler skal finde sted i  \r\n\r\n overensstemmelse med de regler, der er angivet i nærværende kapitel, samt de  \r\n\r\n regler, der måtte være anført i de tilhørende lægemiddelformstandarder. </P>  \r\n\r\n<P> <B>PRODUKTION </B></P>  \r\n\r\n<P>Råvarer </P>  \r\n\r\n<P>Råvarekvalitet </P>  \r\n\r\n<P>Når det af en monografi for en råvare i den Europæiske Farmakope eller i  \r\n\r\n DLS fremgår, at der stilles specielle krav til renhed ved anvendelse til  \r\n\r\n bestemte lægemiddelformer, skal en sådan råvare anvendes til fremstilling af  \r\n\r\n lægemidler tilhørende disse. </P>  \r\n\r\n<P>Lægemiddelstof </P>  \r\n\r\n<P>Det skal ved fremstilling af et lægemiddel tilstræbes, at det får et  \r\n\r\n indhold af lægemiddelstof, der er i overensstemmelse med lægemidlets  \r\n\r\n deklaration. Såfremt lægemiddelstoffet består af en råvare, hvor det  \r\n\r\n kvantitative indhold kan variere betydeligt, skal der ved fremstillingen  \r\n\r\n tages højde for resultatet, der er opnået ved den kvantitative bestemmelse af  \r\n\r\n den aktuelt anvendte batch af råvaren. </P>  \r\n\r\n<P>Hjælpestoffer </P>  \r\n\r\n<P> <B>Vand til fortynding af hæmodialysekoncentrater</B>  </P>  \r\n\r\n<P>Til fortynding af hæmodialysekoncentrater skal anvendes vand af  \r\n\r\n tilfredsstillende kvalitet. Det anbefales at bruge en kvalitet svarende til  \r\n\r\n monografien &#187;Haemodialysis solutions, concentrated, water for  \r\n\r\n diluting&#171;, Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P> <B>Farvestoffer</B>  </P>  \r\n\r\n<P>Lægemidler må, jvf. EF-direktiv 94/36/EC farves med de farvestoffer, der  \r\n\r\n er optaget i nedenstående fortegnelse over godkendte farvestoffer. </P>  \r\n\r\n<P>Farvestofferne riboflavin, aktivt kul, calciumcarbonat og titandioxid skal  \r\n\r\n opfylde de kvalitetskrav, der fremgår af de i DLS bekendtgjorte  \r\n\r\n råvarestandarder. De øvrige farvestoffer skal opfylde de krav til identitet  \r\n\r\n og renhed, der fremgår af den gældende fortegnelse over godkendte  \r\n\r\n tilsætningsstoffer til levnedsmidler (Positivlisten), Levnedsmiddelstyrelsen.  \r\n\r\n</P>  \r\n\r\n<P> <B>Fortegnelse over godkendte farvestoffer</B>  </P>  \r\n\r\n<PRE>  \r\n\r\n  EF-nr.          Navn  \r\n\r\n E 100            Gurkemejefarve (Curcumin)  \r\n\r\n E 101            Riboflavin  \r\n\r\n E 102            Tartrazin  \r\n\r\n E 104            Quinolingult  \r\n\r\n E 110            Sunset Yellow FCF  \r\n\r\n E 120            Carminer  \r\n\r\n E 122            Azorubin  \r\n\r\n E 123            Amaranth  \r\n\r\n E 124            Ponceau 4 R  \r\n\r\n E 127            Erythrosin  \r\n\r\n E 128            Rød 2G  \r\n\r\n E 129            Allura Rød AC  \r\n\r\n E 131            Patent Blue V  \r\n\r\n E 132            Indigotin I, Indigotin carmine  \r\n\r\n E 133            Brilliant blå FCF  \r\n\r\n E 140            Chlorophyll  \r\n\r\n E 141            Chlorophyll- og chlorophyllin-kobber-kompleks  \r\n\r\n E 142            Green S  \r\n\r\n E 150            Karamel, ammonieret karamel og ammonieret,  \r\n\r\n                  sulfiteret karamel  \r\n\r\n E 151            Black PN  \r\n\r\n E 153            Aktivt kul (Carbo medicinalis vegetabilis)  \r\n\r\n E 154            Brun FK  \r\n\r\n E 155            Brun HT  \r\n\r\n E 160            Carotenoider  \r\n\r\n            a.    Alpha-, Beta-, Gamma-Caroten  \r\n\r\n            b.    Annattoekstrakter  \r\n\r\n            c.    Capsanthin  \r\n\r\n            d.    Lycopen  \r\n\r\n            e.    Beta-Apo-8'-carotenal (C 30)  \r\n\r\n            f.    Beta-Apo-8'-carotensyre (C 30), ethylester  \r\n\r\n E 161            Xanthophyller  \r\n\r\n            b.    Lutein  \r\n\r\n            g.    Canthaxanthin  \r\n\r\n E 162            Rødbedefarve (Betaniner)  \r\n\r\n E 163            Drueskalsfarve (Anthocyaniner)  \r\n\r\n E 170            Calciumcarbonat  \r\n\r\n E 171            Titandioxid  \r\n\r\n E 172            Jernoxider og jernhydroxider  \r\n\r\n E 173            Aluminium  \r\n\r\n E 174            Sølv  \r\n\r\n E 175            Guld  \r\n\r\n E 180            Litholrubin BK  Konserveringsstoffer  \r\n\r\n</PRE>  \r\n\r\n<P>Konservering af lægemidler kan ske under anvendelse af sådanne  \r\n\r\n konserveringsstoffer, for hvilke der er bekendtgjort en standard i DLS, eller  \r\n\r\n som er optaget i den gældende fortegnelse over godkendte tilsætningsstoffer  \r\n\r\n til levnedsmidler (Positivlisten), Levnedsmiddelstyrelsen. Det skal i det  \r\n\r\n enkelte tilfælde sikres, at den benyttede art og koncentration af  \r\n\r\n konserveringsstof udøver en tilstrækkelig konserverende effekt i henhold til  \r\n\r\n Ph. Eur. 3rd Ed., 5.1.3. &#187;Efficacy of antimicrobial preservation&#171;.  \r\n\r\n</P>  \r\n\r\n<P> <B>Aromastoffer</B>  </P>  \r\n\r\n<P>Til smagskorrigering og aromatisering af lægemidler skal de begrænsninger,  \r\n\r\n der er anført i Sundhedsministeriets bekendtgørelse om aromaer m.m., der må  \r\n\r\n anvendes til levnedsmidler, respekteres. </P>  \r\n\r\n<P>Emballage </P>  \r\n\r\n<P>(Se iøvrigt Standard Termer for beholdere, lukker mv.). </P>  \r\n\r\n<P> <B>Glasbeholdere</B>  </P>  \r\n\r\n<P>Glasbeholdere beregnet til lægemidler til parenteralt brug skal medmindre  \r\n\r\n andet er fastsat opfylde de i Ph. Eur. 3rd Ed., 3.2.1. angivne kvalitetskrav.  \r\n\r\n</P>  \r\n\r\n<P>Glasbeholdere, hvori øjenbadevande samt vandige øjendråber og øredråber  \r\n\r\n som led i deres fremstilling varmebehandles, skal medmindre andet er fastsat  \r\n\r\n opfylde de i Ph. Eur. 3rd Ed., 3.2.1. under &#187;Glass containers for  \r\n\r\n pharmaceutical use&#171; angivne kvalitetskrav for glas af type I. </P>  \r\n\r\n<P>Glasbeholdere beregnet til lægemidler bestående af vandige opløsninger til  \r\n\r\n anden anvendelse skal medmindre andet er fastsat opfylde de i Ph. Eur. 3rd  \r\n\r\n Ed., 3.2.1. under &#187;Glass containers for pharmaceutical use&#171; angivne  \r\n\r\n kvalitetskrav for glas af type III. </P>  \r\n\r\n<P> <B>Plastbeholdere</B>  </P>  \r\n\r\n<P>Plastbeholdere og lukkemidler af plast skal fremstilles og kontrolleres i  \r\n\r\n henhold til de i Ph. Eur. 3rd Ed., 3.2.2. angivne retningslinjer. </P>  \r\n\r\n<P>Plastbeholdere til blod og blodfraktioner skal medmindre andet er fastsat  \r\n\r\n opfylde de i Ph. Eur. 3rd Ed., 3.2.3. angivne kvalitetskrav. </P>  \r\n\r\n<P>Plastbeholdere til vandige opløsninger til intravenøs infusion skal  \r\n\r\n opfylde de i Ph. Eur. 3rd Ed., 3.2.8. angivne kvalitetskrav. </P>  \r\n\r\n<P>Plastmaterialer af blødgjort polyvinylchlorid beregnet til fremstilling af  \r\n\r\n beholdere til blod og blodfraktioner og til vandige opløsninger til  \r\n\r\n intravenøs infusion skal medmindre andet er fastsat opfylde de i Ph. Eur. 3rd  \r\n\r\n Ed., 3.1.1. angivne kvalitetskrav. </P>  \r\n\r\n<P>Plastmaterialer af polyolefin beregnet til fremstilling af beholdere til  \r\n\r\n lægemidler skal med mindre andet er fastsat opfylde de i Ph. Eur. 3rd Ed.  \r\n\r\n 3.1.3. angivne kvalitetskrav. </P>  \r\n\r\n<P>Plastmaterialer af polyethylen LD beregnet til fremstilling af beholdere  \r\n\r\n til præparater til parenteralt brug og øjenpræparater skal medmindre andet er  \r\n\r\n fastsat opfylde de i Ph. Eur. 3rd Ed., 3.1.4. angivne kvalitetskrav. </P>  \r\n\r\n<P>Plastmaterialer af polyethylen HD og polypropylen beregnet til  \r\n\r\n fremstilling af beholdere til præparater til parenteralt brug skal medmindre  \r\n\r\n andet er fastsat opfylde de i Ph. Eur. 3rd Ed., 3.1.5. henholdsvis 3.1.6.  \r\n\r\n angivne kvalitetskrav. </P>  \r\n\r\n<P>Plastmaterialer af ethylenvinylacetat copolymer beregnet til fremstilling  \r\n\r\n af beholdere til præparater til total parenteral ernæring skal - medmindre  \r\n\r\n andet er fastsat - opfylde de i Ph. Eur. 3rd Ed., 3.1.7. angivne  \r\n\r\n kvalitetskrav. </P>  \r\n\r\n<P> <B>Siliconeolier</B>  </P>  \r\n\r\n<P>Siliconeolier, der anvendes som smøremidler, skal opfylde de i Ph. Eur.  \r\n\r\n 3rd Ed., 3.1.8. angivne kvalitetskrav. </P>  \r\n\r\n<P> <B>Siliconelukker</B>  </P>  \r\n\r\n<P>Siliconeelastomerer, der anvendes til lukkemidler, skal opfylde de i Ph.  \r\n\r\n Eur. 3rd Ed., 3.1.9. angivne kvalitetskrav. </P>  \r\n\r\n<P> <B>Gummilukker</B>  </P>  \r\n\r\n<P>Gummilukker til vandige præparater til parenteralt brug skal opfylde de i  \r\n\r\n Ph. Eur. 3rd Ed., 3.2.9. angivne kvalitetskrav. </P>  \r\n\r\n<P> <B>Aerosolbeholdere</B>  </P>  \r\n\r\n<P>Beholdere, beregnet til at indeholde lægemidler under tryk, skal opfylde  \r\n\r\n de angivne kvalitetskrav i monografien &#187;Pressurised Pharmaceutical  \r\n\r\n Preparations&#171; i Ph. Eur. 3rd Ed. kvalitetskrav. </P>  \r\n\r\n<P> <B>Mellemprodukter</B>  </P>  \r\n\r\n<P> <B>Ekstrakter</B>  </P>  \r\n\r\n<P>Mellemprodukter, som er drogeudtræk, produceret med flygtige  \r\n\r\n opløsningsmidler, inddampet til en vis konsistens og eventuelt indstillet på  \r\n\r\n foreskreven styrke, betegnes ekstrakter. Ekstrakter er koncentrerede  \r\n\r\n tilberedninger og kan være flydende (tynde ekstrakter, fluidekstrakter),  \r\n\r\n tyktflydende (tykke ekstrakter, bløde ekstrakter) eller faste (tørre  \r\n\r\n ekstrakter). </P>  \r\n\r\n<P>Ekstrakter skal opfylde kravene i monografien &#187;Extracts&#171; i Ph.  \r\n\r\n Eur. 3rd Ed. </P>  \r\n\r\n<P> <B>Tinkturer</B>  </P>  \r\n\r\n<P>Mellemprodukter, som er flydende, spritholdige drogeudtræk, betegnes  \r\n\r\n tinkturer. </P>  \r\n\r\n<P>Tinkturer skal opfylde kravene i monografien &#187;Tinctures&#171; i Ph.  \r\n\r\n Eur. 3rd Ed. </P>  \r\n\r\n<P>Lægemidler </P>  \r\n\r\n<P>Sterile og aseptisk fremstillede lægemidler </P>  \r\n\r\n<P>Sterile og aseptisk fremstillede lægemidler skal steriliseres i henhold  \r\n\r\n til de i Ph. Eur. 3rd Ed. 5.1.1. &#187;Methods of preparation of sterile  \r\n\r\n products&#171; angivne retningslinier. De til validering af  \r\n\r\n sterilisationsprocessen anvendte biologiske indikatorer i henhold til Ph.  \r\n\r\n Eur. 3rd Ed., 5.1.2. &#187;Biological indicators for the verification of  \r\n\r\n sterilisation procedures&#171; kan rekvireres fra Statens Seruminstitut,  \r\n\r\n Artillerivej 5, 2300 København S. </P>  \r\n\r\n<P>Pyrogenfrie lægemidler </P>  \r\n\r\n<P>Når det af en lægemiddelformstandard fremgår, at et præparat skal  \r\n\r\n fremstilles under anvendelse af arbejdsmetoder, der tilsigter fremstilling af  \r\n\r\n pyrogenfrie præparater, samtidig med at det af samme lægemiddelformstandard  \r\n\r\n fremgår, at præparatet skal opfylde prøven for pyrogener, skal der så vidt  \r\n\r\n muligt anvendes råvarer, der opfylder en prøve for pyrogener. </P>  \r\n\r\n<P>For en sådan råvare, for hvilken det af en monografi i den Europæiske  \r\n\r\n Farmakope fremgår, at nationale myndigheder kan kræve, at &#187;Test for  \r\n\r\n pyrogens&#171; Ph. Eur. 3rd Ed., 2.6.8. er opfyldt, udgør denne prøve en del  \r\n\r\n af den i DLS bekendtgjorte standard, og råvaren skal mærkes i  \r\n\r\n overensstemmelse hermed. </P>  \r\n\r\n<P>Endotoxinfrie lægemidler </P>  \r\n\r\n<P>Når det af en lægemiddelformstandard fremgår, at et præparat skal  \r\n\r\n fremstilles under anvendelse af arbejdsmetoder, der tilsigter fremstilling af  \r\n\r\n præparater med lavt indhold af bakterielle endotoxiner, skal der så vidt  \r\n\r\n muligt anvendes råvarer, der opfylder en prøve for bakterielle endotoxiner.  \r\n\r\n</P>  \r\n\r\n<P>Når det samtidig af lægemiddelsformstandarden fremgår, at præparatet skal  \r\n\r\n opfylde prøven for bakterielle endotoxiner anbefales det, at det beskrevne i  \r\n\r\n &#187;Test for bacterial endotoxins: Guidelines&#171; i monografien  \r\n\r\n &#187;Bacterial endotoxins&#171; i Ph. Eur. 3rd Ed. 2.6.14. følges. </P>  \r\n\r\n<P>Ikke-sterile lægemidler </P>  \r\n\r\n<P>Ikke-sterile lægemidler skal fremstilles under tilfredsstillende  \r\n\r\n hygiejniske forhold, og de indgående råvarer skal være af tilfredsstillende  \r\n\r\n mikrobiologisk kvalitet. </P>  \r\n\r\n<P>Med mindre der i lægemiddelmonografien er anført krav til mikrobiologisk  \r\n\r\n kvalitet, skal fremstillingen ske under forhold, der sikrer, at det færdige  \r\n\r\n lægemiddel overholder det angivne i &#187;Krav til lægemidlers mikrobielle  \r\n\r\n renhed&#171; kategori 3, i DLS, sektion 1. For lægemidler der udelukkende  \r\n\r\n består af råvarer af vegetabilsk eller animalsk oprindelse (droger), er det  \r\n\r\n dog tilstrækkeligt, at disse overholder krav angivet under kategori 4. </P>  \r\n\r\n<P>Det er ikke tilladt ved fremstilling af lægemidler at benytte  \r\n\r\n lægemiddelstoffer eller hjælpestoffer af vegetabilsk oprindelse, som har  \r\n\r\n været behandlet med ethylenoxid. </P>  \r\n\r\n<P>Når det af en monografi for en råvare i den Europæiske Farmakope fremgår,  \r\n\r\n at nationale myndigheder kan stille krav vedrørende et højest tilladt antal  \r\n\r\n af mikroorganismer eller fravær af specifikke mikroorganismer, udgør de  \r\n\r\n pågældende prøver en del af den i DLS bekendtgjorte standard for råvaren.  \r\n\r\n</P>  \r\n\r\n<P>Pesticidrester </P>  \r\n\r\n<P>Når der er mulighed for at et lægemiddel, der helt eller delvist består af  \r\n\r\n råvarer af vegetabilsk eller animalsk oprindelse, kan indeholde rester af  \r\n\r\n pesticider eller andre bekæmpelsesmidler, skal lægemidlet opfylde de i Ph.  \r\n\r\n Eur. 3rd Ed. 2.8.13. angivne kvalitetskrav. </P>  \r\n\r\n<P>Homøopatiske lægemidler </P>  \r\n\r\n<P>Homøopatiske lægemidler skal fremstilles og deklareres som beskrevet i Ph.  \r\n\r\n Eur. 3rd Ed. &#187;Homoeopathic Preparations&#171;. </P>  \r\n\r\n<P> <B>KONTROL</B>  </P>  \r\n\r\n<P>Lægemiddelstof </P>  \r\n\r\n<P>Det kvantitative indhold af lægemiddelstof i et lægemiddel må på  \r\n\r\n fremstillingstidspunktet sædvanligvis højst afvige 5% fra det deklarerede.  \r\n\r\n</P>  \r\n\r\n<P>På grundlag af holdbarhedsundersøgelser vil en større afvigelse,  \r\n\r\n sædvanligvis indtil 10% for den nedre grænse, som følge af nedbrydning inden  \r\n\r\n for opbevaringstiden kunne godkendes. </P>  \r\n\r\n<P>Faktisk indhold </P>  \r\n\r\n<P>Det gennemsnitlige indhold af lægemidlet i forbrugerpakningen skal være  \r\n\r\n tilstrækkeligt til, at det deklarerede indhold (antal, masse eller volumen)  \r\n\r\n kan udtages under anvendelse af sædvanlig teknik. </P>  \r\n\r\n<P>Mikrobiel renhed </P>  \r\n\r\n<P>Ved udførelse af prøven &#187;Sterility&#171; i Ph. Eur. 3rd Ed., 2.6.1.  \r\n\r\n skal der tages hensyn til, om der i lægemidlet kan forekomme mikroorganismer,  \r\n\r\n som udviser forsinket fremvækst. I bekræftende fald skal der anvendes en  \r\n\r\n længere inkubationstid end 7 dage. </P>  \r\n\r\n<P>Dosisvariation </P>  \r\n\r\n<P>Kvalitetskrav vedrørende dosisvariation, &#187;Uniformity of content of  \r\n\r\n singledose preparations&#171; i Ph. Eur. 3rd Ed., 2.9.6., gælder ikke  \r\n\r\n multivitamin- og sporstofpræparater. </P>  \r\n\r\n<P> <B>LAGERHOLD</B>  </P>  \r\n\r\n<P>Opbevaringsbetingelser </P>  \r\n\r\n<P> <B>Opbevaring ved almindelig temperatur</B> skal finde sted ved 15-25  \r\n\r\n graderC. </P>  \r\n\r\n<P> <B>Opbevaring på svalt sted</B> skal finde sted ved 8-15 graderC. </P>  \r\n\r\n<P> <B>Opbevaring på koldt sted</B> skal finde sted ved 2-8 graderC. </P>  \r\n\r\n<P> <B>Opbevaring i frossen tilstand</B> skal finde sted ved højst 10  \r\n\r\n graderC. </P>  \r\n\r\n<P> <B>Radioaktive lægemidler</B> skal opbevares i overensstemmelse med de  \r\n\r\n bestemmelser, der er fastsat i monografien &#187;Radiopharmaceutical  \r\n\r\n Preparations&#171; Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P> <B>Sterile og aseptisk fremstillede lægemidler</B> skal opbevares i  \r\n\r\n beholdere eller forbrugeremballage, som beskytter mod mikrobiel forurening:  \r\n\r\n salver skal, når det er muligt, opbevares i tuber. </P>  \r\n\r\n<P>Opbevaringstid </P>  \r\n\r\n<P>Ved beregning af udløbsdatoen for den enkelte batch af et lægemiddel skal  \r\n\r\n fremstillingsdatoen fastsættes på samme måde i forhold til tidspunktet for  \r\n\r\n batchens tilberedning, som det blev gjort i den for Sundhedsstyrelsen  \r\n\r\n forelagte holdbarhedsdokumentation for lægemidlet. </P>  \r\n\r\n<P>Den fastsatte opbevaringstid kan ikke forlænges ved sval eller kold  \r\n\r\n opbevaring af lægemidlet. </P>  \r\n\r\n<P>Den maksimale opbevaringstid, der kan godkendes, er 5 år. </P>  \r\n\r\n<P> <B>FREMSTILLING AF MAGISTRELLE LÆGEMIDLER</B>  </P>  \r\n\r\n<P>Lægemidler, som fremstilles på apotek til den enkelte patient under  \r\n\r\n angivelse af deklaration og uden anden form for navneangivelse (jfr. § 11,  \r\n\r\n stk. 3 i lov om lægemidler), skal produceres, kontrolleres og lagerholdes i  \r\n\r\n overensstemmelse med de for lægemidler iøvrigt gældende regler, herunder de  \r\n\r\n tilhørende lægemiddelformstandarder, idet dog de i nærværende kapitel optagne  \r\n\r\n<I>bestemmelser skal</I> iagttages. De i det følgende givne  \r\n\r\n<I>anvisninger</I> kan benyttes som vejledning ved den magistrelle  \r\n\r\n fremstilling af lægemidler. </P>  \r\n\r\n<P> <B>PRODUKTION</B>  </P>  \r\n\r\n<P>Ved produktion af et magistrelt lægemiddel skal der tages hensyn til de  \r\n\r\n tilgængelige oplysninger om råvarernes uforligelighed, tekniske egenskaber og  \r\n\r\n retningslinier for deres varmebehandling samt andre forhold af betydning for  \r\n\r\n deres anvendelse, som er relevante for det pågældende lægemiddel. Der skal  \r\n\r\n også tages hensyn til de tilgængelige oplysninger om fremstillingsmåden for  \r\n\r\n tilsvarende lægemidler. </P>  \r\n\r\n<P>Foruden tidligere officielle monografisamlinger kan værker som <I>The  \r\n\r\n Pharmaceutical Codex</I> , 12th Ed., The Pharmaceutical Press, London 1994 og  \r\n\r\n<I>Martindale: The Extra Pharmacopoeia</I> , 31st Ed., The Pharmaceutical  \r\n\r\n Press, London 1996, benyttes som kilde. </P>  \r\n\r\n<P>Råvarer </P>  \r\n\r\n<P>Ved fremstilling af magistrelle lægemidler skal der, medmindre særlige  \r\n\r\n forhold tilsiger andet, anvendes råvarer, der opfylder de i DLS bekendtgjorte  \r\n\r\n standarder. I tilfælde af at en standard ikke er bekendtgjort i DLS, påhviler  \r\n\r\n det fremstilleren at anvende en råvare af egnet kvalitet. Der kan i den  \r\n\r\n sammenhæng først og fremmest tages hensyn til standarder bekendtgjort i  \r\n\r\n tidligere udgaver af DLS, dernæst til standarder optaget i gældende udgaver  \r\n\r\n af udenlandske farmakopeer og endelig til standarder optaget i ældre danske  \r\n\r\n monografisamlinger. </P>  \r\n\r\n<P>En farmaceutisk specialitet må kun anvendes til fremstilling af et  \r\n\r\n magistrelt lægemiddel, når dette udtrykkelig er forlangt ved ordinationen.  \r\n\r\n</P>  \r\n\r\n<P>Ordineres et magistrelt lægemiddel under anvendelse af navnet på en  \r\n\r\n farmaceutisk specialitet eller et i en tidligere officiel monografisamling  \r\n\r\n beskrevet lægemiddel, men i afvigende styrke, skal det magistrelle lægemiddel  \r\n\r\n fremstilles under anvendelse af samme lægemiddelstof, som indgår i den  \r\n\r\n pågældende farmaceutiske specialitet eller i det i en monografisamling  \r\n\r\n beskrevne lægemiddel. Der skal lægges samme relation til grund mellem  \r\n\r\n styrkeangivelsen i navnet og den i lægemidlet indgående mængde  \r\n\r\n lægemiddelstof, som er anvendt i den farmaceutiske specialitet eller det i  \r\n\r\n monografisamlingen beskrevne tilsvarende lægemiddel. </P>  \r\n\r\n<P>Ordineres et lægemiddel fremstillet uden tilsætning af  \r\n\r\n konserveringsmiddel, skal der ses bort fra eventuelle bestemmelser om  \r\n\r\n konservering i den tilhørende lægemiddelformstandard. </P>  \r\n\r\n<P>Ved fremstilling af magistrelle lægemidler skal der så vidt muligt  \r\n\r\n anvendes de almindeligst benyttede hjælpestoffer. Visse magistrelle  \r\n\r\n lægemidler skal, som det fremgår i efterfølgende tillæg til de tilhørende  \r\n\r\n lægemiddelformstandarder, fortrinsvis fremstilles under anvendelse af  \r\n\r\n bestemte hjælpestoffer eller mellemprodukter. </P>  \r\n\r\n<P>Magistrelle lægemidler, der er ordineret som opløsninger i vand, sprit  \r\n\r\n eller olie, skal fremstilles som opløsninger i henholdsvis renset vand, stærk  \r\n\r\n sprit eller jordnødolie. </P>  \r\n\r\n<P>Findelingsgraden af et lægemiddelstof, der skal anvendes ved magistrel  \r\n\r\n fremstilling, skal være sådan, at det sikres at produktet opnår de ønskede  \r\n\r\n tekniske egenskaber. F.eks. skal der ved tabletfremstilling anvendes en  \r\n\r\n findelingsgrad af lægemiddelstoffet, som sikrer en tilfredsstillende  \r\n\r\n dosisvariation og udløsningshastighed. </P>  \r\n\r\n<P> <I>Findelingsgraden</I> af en råvare, der skal anvendes ved magistrel  \r\n\r\n fremstilling, udtrykkes ved angivelse af sigtenummeret svarende til  \r\n\r\n maskeåbningen i microm i den sigte (Ph. Eur. 3rd Ed., 2.1.4.), som stoffet  \r\n\r\n lige netop er i stand til at passere. Angives en råvare at have en vis  \r\n\r\n findelingsgrad, skal mindst 97% af råvaren kunne passere den til  \r\n\r\n findelingsgraden svarende sigte. </P>  \r\n\r\n<P>Mellemprodukter </P>  \r\n\r\n<P>Det er ved fremstilling af magistrelle lægemidler tilladt at anvende  \r\n\r\n mellemprodukter, når den tilsigtede virkning af lægemidlerne ikke påvirkes  \r\n\r\n heraf. Ordineres et mellemprodukt som et lægemiddel, skal det håndteres,  \r\n\r\n herunder benævnes, i overensstemmelse med den relevante  \r\n\r\n lægemiddelformstandard. </P>  \r\n\r\n<P> <B>Aromatisk vand</B>  </P>  \r\n\r\n<P>Mellemprodukter, som er opløsninger af æteriske olier eller andre  \r\n\r\n aromastoffer i vand, betegnes aromatiske vande. </P>  \r\n\r\n<P>Sædvanligvis fremstilles aromatiske vande med anvendelse af 0,05% æterisk  \r\n\r\n olie. Aromatiske vande skal konserveres med 0,1% parahydroxybenzoat i form af  \r\n\r\n methylparahydroxybenzoat eller en blanding af methylparahydroxybenzoat og  \r\n\r\n propylparahydroxybenzoat (8:2). </P>  \r\n\r\n<P>Et aromatisk vand skal fremstilles på følgende måde: </P>  \r\n\r\n<P>Den æteriske olie rystes kraftigt med den fornødne mængde lunkent vand,  \r\n\r\n der forud har været opvarmet til kogning. I stedet for frisk kogt vand kan  \r\n\r\n anvendes frisk destilleret vand, såfremt dette er af en passende hygiejnisk  \r\n\r\n kvalitet. Blandingen hensættes ved almindelig temperatur 1 døgn under jævnlig  \r\n\r\n omrystning, hvorefter den filtreres gennem et filter, der forud er fugtet med  \r\n\r\n vand, idet det først filtrerede gentagne gange hældes tilbage på filteret.  \r\n\r\n Til filtratet sættes konserveringsmidlet i form af et diluendum på 10% i  \r\n\r\n stærk sprit. </P>  \r\n\r\n<P>Aromatiske vande er klare eller opalescerende og må kun lugte og smage af  \r\n\r\n de æteriske olier eller aromastoffer, hvormed de er fremstillet. </P>  \r\n\r\n<P>Aromatiske vande skal opbevares i vel tillukkede beholdere, beskyttet mod  \r\n\r\n lyset på svalt sted. </P>  \r\n\r\n<P> <B>Dekokt</B>  </P>  \r\n\r\n<P>Mellemprodukter, som er drogeudtræk, fremstillet ved overhældning af  \r\n\r\n drogen med vand og påfølgende opvarmning i vandbad, betegnes dekokter. </P>  \r\n\r\n<P>Sædvanligvis fremstilles af 1 del droge 10 dele dekokt. </P>  \r\n\r\n<P>Et dekokt fremstilles sædvanligvis på følgende måde: </P>  \r\n\r\n<P>Den findelte droge overhældes med den for fremstillingen af den pågældende  \r\n\r\n mængde dekokt nødvendige mængde vand, og blandingen opvarmes i en tillukket  \r\n\r\n beholder i vandbad under jævnlig omrøring. Opvarmningen fortsættes 30  \r\n\r\n minutter, efter at blandingen har nået 90 graderC, hvorefter den koleres og  \r\n\r\n presses svagt. Er mængden af udtræk mindre end fornødent, blandes remanensen  \r\n\r\n med så meget kogende vand, at der efter fornyet udpresning opnås den fornødne  \r\n\r\n mængde udtræk. Det samlede udtræk hensættes til bundfældning, dekanteres og  \r\n\r\n koleres. </P>  \r\n\r\n<P>Dekokter må ikke opbevares. </P>  \r\n\r\n<P> <B>Diluendum</B>  </P>  \r\n\r\n<P>Mellemprodukter, som er stamopløsninger af råvarer eller flydende  \r\n\r\n drogeudtræk af angiven styrke, betegnes diluenda. </P>  \r\n\r\n<P>Det kvantitative indhold af lægemiddelstof i et diluendum må højst afvige  \r\n\r\n 5% fra det tilstræbte. </P>  \r\n\r\n<P> <B>Infus</B>  </P>  \r\n\r\n<P>Mellemprodukter, som er drogeudtræk, fremstillet ved overhældning af  \r\n\r\n drogen med kogende vand og påfølgende henstand, betegnes infuser. </P>  \r\n\r\n<P>Sædvanligvis fremstilles af 1 del droge 10 dele infus. </P>  \r\n\r\n<P>Et infus fremstilles sædvanligvis på følgende måde: </P>  \r\n\r\n<P>Den findelte droge overhældes med sin lige vægtmængde vand og hensættes 15  \r\n\r\n minutter. Efter tilsætning af så meget kogende vand, at man kan forvente at  \r\n\r\n opnå den fornødne mængde infus, hensættes blandingen i en tillukket beholder  \r\n\r\n 30 minutter under jævnlig omrøring, hvorefter den koleres og presses svagt.  \r\n\r\n Er mængden af udtræk mindre end fornødent, blandes remanensen med så meget  \r\n\r\n kogende vand, at der efter fornyet presning opnås den fornødne mængde udtræk.  \r\n\r\n Det samlede udtræk hensættes til bundfældning, dekanteres og koleres. </P>  \r\n\r\n<P>Infuser må ikke opbevares. </P>  \r\n\r\n<P> <B>Slim</B>  </P>  \r\n\r\n<P>Mellemprodukter, som er mere eller mindre tyktflydende, kolloide  \r\n\r\n opløsninger af gummiarter, planteslim eller andre kolloider, betegnes slim.  \r\n\r\n</P>  \r\n\r\n<P>Slim skal konserveres med 0,1% parahydroxybenzoat i form af  \r\n\r\n methylparahydroxybenzoat eller en blanding af methylparahydroxybenzoat og  \r\n\r\n propylparahydroxybenzoat (8:2), tilsat i form af et diluendum på 10% i stærk  \r\n\r\n sprit. </P>  \r\n\r\n<P>Slim fremstilles i almindelighed med vand, undertiden med tilsætning af  \r\n\r\n andre væsker som glycerol eller sprit. </P>  \r\n\r\n<P> <B>Sur frugtsaft</B>  </P>  \r\n\r\n<P>Mellemprodukter, som er udpres af friske frugter, befriet for indhold af  \r\n\r\n pectin, betegnes sure frugtsafter. </P>  \r\n\r\n<P>Sure frugtsafter skal konserveres med 0,1% kaliumsorbat. </P>  \r\n\r\n<P>En sur frugtsaft skal fremstilles på følgende måde: </P>  \r\n\r\n<P>Den friske, fuldmodne frugt knuses, og den knuste bærmasse underkastes en  \r\n\r\n behandling, f.eks. ved gæring eller med pectinspaltende enzymer, indtil 10 ml  \r\n\r\n saft efter sammenrystning med 5 ml stærk sprit og henstand 2 minutter ikke  \r\n\r\n indeholder luftblærer. Saften fraskilles ved presning, konserveres og  \r\n\r\n hensættes til bundfældning og klaring. </P>  \r\n\r\n<P>Sure frugtsafter skal ved anvendelsen være klare. </P>  \r\n\r\n<P>Sure frugtsafter skal opbevares i vel tillukkede, helt fyldte beholdere på  \r\n\r\n svalt sted. </P>  \r\n\r\n<P> <B>Syrup</B>  </P>  \r\n\r\n<P>Mellemprodukter, som er stærkt sukkerholdige opløsninger, betegnes  \r\n\r\n syruper. </P>  \r\n\r\n<P>Syruper, der indeholder drogeudtræk, skal konserveres med 0,1%  \r\n\r\n parahydroxybenzoat i form af methylparahydroxybenzoat eller en blanding af  \r\n\r\n methylparahydroxybenzoat og propylparahydroxybenzoat (8:2), tilsat i form af  \r\n\r\n et diluendum på 10% i stærk sprit. </P>  \r\n\r\n<P>Syruper, der indeholder i forvejen konserverede drogeudpres, skal ikke  \r\n\r\n konserveres yderligere. </P>  \r\n\r\n<P>En syrup skal fremstilles på følgende måde: </P>  \r\n\r\n<P>Til den klare væske, der indgår i syrupen, sættes saccharosen og eventuelt  \r\n\r\n konserveringsmiddel. Saccharosen opløses under omrøring, og opløsningen gives  \r\n\r\n et opkog eller koges forsigtigt, til eventuel sprit er fjernet, tilsættes så  \r\n\r\n meget kogende vand, at syrupens masse bliver som tilsigtet, skummes om  \r\n\r\n fornødent og koleres eller filtreres. </P>  \r\n\r\n<P>Syruper skal så vidt muligt være klare. </P>  \r\n\r\n<P>Syruper skal opbevares i vel tillukkede flasker på svalt sted. </P>  \r\n\r\n<P> <B>Trituration</B>  </P>  \r\n\r\n<P>Mellemprodukter, som er udrivninger af et eller flere lægemiddelstoffer  \r\n\r\n med faste, flydende eller salveagtige hjælpestoffer, betegnes triturationer.  \r\n\r\n</P>  \r\n\r\n<P>Ved fremstilling af pulverformede triturationer af råvarer, der er giftige  \r\n\r\n stoffer, skal såvel lægemiddelstof som udrivningsmiddel (lactose eller,  \r\n\r\n såfremt denne er uforligelig med lægemiddelstoffet, et egnet indifferent  \r\n\r\n hjælpestof) anvendes i en findelingsgrad, svarende til sigte 125. </P>  \r\n\r\n<P>Det kvantitative indhold af lægemiddelstof i en trituration må højst  \r\n\r\n afvige 5% fra det tilstræbte. </P>  \r\n\r\n<P>Isotoniske vandige opløsninger </P>  \r\n\r\n<P>En vandig væske kan sædvanligvis gøres isotonisk ved at tilsættes  \r\n\r\n natriumchlorid i en sådan mængde, som kan beregnes ud fra tallene i  \r\n\r\n nedenstående tabel. For stoffer, som udfældes af natriumchlorid, er i  \r\n\r\n tabellen angivet den tilsvarende mængde natriumsulfatdecahydrat: visse  \r\n\r\n øjendråber gøres isotoniske ved hjælp af kaliumnitrat. </P>  \r\n\r\n<P>En 0,9% natriumchloridopløsning, en 1,6% kaliumnitratopløsning og en 3,9%  \r\n\r\n natriumsulfatdecahydratopløsning er isotoniske med væv, blod og tårevæske og  \r\n\r\n har en frysepunktsænkning på 0,52 graderC. </P>  \r\n\r\n<P>Ved fremstilling af magistrelle øjenbadevande eller øjendråber er det  \r\n\r\n sædvanligvis ikke nødvendigt at korrigere for den isotoniændring, som det  \r\n\r\n konserverende stof medfører. </P>  \r\n\r\n<P> <B>Isotonitabel</B>  </P>  \r\n\r\n<P>I <I>kolonne I</I> er angivet det antal g natriumchlorid, som 1 g af det  \r\n\r\n pågældende stof erstatter i osmotisk henseende. Ved hjælp af disse værdier  \r\n\r\n beregnes, hvor mange g natriumchlorid som må tilsættes, for at en opløsning  \r\n\r\n skal blive isotonisk (svare til 0,9% natriumchloridopløsning). </P>  \r\n\r\n<P> <I>Eksempel</I> : Pethidininjektionsvæske 2% 20 ml. </P>  \r\n\r\n<P>20 ml isotonisk natriumchloridopløsning svarer til 0,180 g NaCl </P>  \r\n\r\n<P>0,4 g pethidinhydrochlorid svarer til 0,4 30 0,19 = 0,076 g NaCl </P>  \r\n\r\n<P>Der må tilsættes 0,180-0,076 = 0,104 g NaCl </P>  \r\n\r\n<P>I <I>kolonne II</I> er angivet det antal g vand, som 1 g af det pågældende  \r\n\r\n stof må opløses i for at give en isotonisk opløsning. </P>  \r\n\r\n<P>Lægemidlet indstilles på ønsket styrke ved yderligere tilsætning af  \r\n\r\n isotonisk væske. Til injektionsvæsker anvendes sædvanligvis 0,9%  \r\n\r\n natriumchloridopløsning som fortyndingsmiddel. </P>  \r\n\r\n<P> <I>Eksempel</I> : Cocainøjendråber 1% 10 g. </P>  \r\n\r\n<P>Øjendråberne skal indeholde 0,1 g cocainhydrochlorid, 0,1 30 15 = 1,5 g  \r\n\r\n sterilt vand, konserveringsmiddel samt steril 0,9% natriumchloridopløsning  \r\n\r\n til en samlet vægt af 10 g. </P>  \r\n\r\n<PRE>  \r\n\r\n        I       II  \r\n\r\n Ascorbinsyre                                 0,18      19  \r\n\r\n Adrenalintartrat                             0,16      17  \r\n\r\n Alun                                         0,15      16  \r\n\r\n Aminoacridiniumchlorid                       0,17      18  \r\n\r\n Ammoniumchlorid                              1,13     125  \r\n\r\n Amobarbitalnatrium                           0,25      27  \r\n\r\n Amphetaminsulfat                             0,21      22  \r\n\r\n Antazolinhydrochlorid                        0,22      23  \r\n\r\n Apomorphinhydrochlorid                       0,14      15  \r\n\r\n Atropinsulfat                                0,10      10  \r\n\r\n Bacitracin 0-5%                              0,04       3  \r\n\r\n Barbitalnatrium                              0,29      31  \r\n\r\n Benzalkoniumchlorid                          0,03       3  \r\n\r\n Benzylalkohol                                0,16      17  \r\n\r\n Benzylpenicillinnatrium                      0,16      17  \r\n\r\n Borax 0-1,0%                                 0,43      47  \r\n\r\n Borax over 1,0%                              0,36      39  \r\n\r\n Borsyre                                      0,48      52  \r\n\r\n Calciumchlorid hexahydrat                    0,36      39  \r\n\r\n Calciumgluconat                              0,14      15  \r\n\r\n Calciumlactatpentahydrat                     0,21      22  \r\n\r\n Calciumlevulat                               0,26      28  \r\n\r\n Calciumpantothenat                           0,17      18  \r\n\r\n Carbacholchlorid                             0,33      36  \r\n\r\n Cetrimid 0-5,0%                              0,08       8  \r\n\r\n Chinidinsulfat                               0,10      10  \r\n\r\n Chininhydrochlorid                           0,12      12  \r\n\r\n Chloramin                                    0,22      23  \r\n\r\n Chloramphenicol                              0,10      10  \r\n\r\n Chlorhexidinacetat                           0,18 2)   19  \r\n\r\n Chlorbutanolhemihydrat                       0,24      26  \r\n\r\n Chlorpromazinhydrochlorid 0-2,0%             0,08       8  \r\n\r\n Chlorpromazinhydrochlorid 2,1-4,0%           0,05       5  \r\n\r\n Chlorpromazinhydrochlorid 4,1-5,0%           0,03       2  \r\n\r\n Cholinhydrogentartrat                        0,23      25  \r\n\r\n Cinchocainhydrochlorid 0-3,0%                0,12      12  \r\n\r\n Cinchocainhydrochlorid 3,1-5,0%              0,08       8  \r\n\r\n Cinchocainhydrochlorid 5,1-8,0%              0,06       6  \r\n\r\n Citronsyremonohydrat                         0,16      17  \r\n\r\n Cobaltochlorid                               0,36      39  \r\n\r\n Cocainhydrochlorid                           0,14      15  \r\n\r\n Codeinhydrochlorid                           0,15      16  \r\n\r\n Codeinphosphatsesquihydrat                   0,12      12  \r\n\r\n Coffein                                      0,08       8  \r\n\r\n Coffeinnatriumbenzoat                        0,24      26  \r\n\r\n Cuprisulfat 0-4%                             0,15      16  \r\n\r\n Cuprisulfat over 4,0%                        0,13      13  \r\n\r\n Dexpanthenol                                 0,17      18  \r\n\r\n Dihydrostreptomycinsulfat                    0,05       5  \r\n\r\n Dinatriumphosphatdihydrat                    0,40      43  \r\n\r\n Diphenhydraminhydrochlorid 0-2,0%            0,24      26  \r\n\r\n Diphenhydraminhydrochlorid 2,1-4,0%          0,19      20  \r\n\r\n Diphenhydraminhydrochlorid over 4,0%         0,17      18  \r\n\r\n Diprophyllin 0-5,0%                          0,09       9  \r\n\r\n Diprophyllin over 5,0%                       0,08       8  \r\n\r\n Ephedrinhydrochlorid                         0,28      30  \r\n\r\n Ergometrinmaleat                             0,12      12  \r\n\r\n Ergotamintartrat                             0,07       7  \r\n\r\n Ethylendiaminhydrat                          0,44      48  \r\n\r\n Ethylmorphinhydrochlorid                     0,15      16  \r\n\r\n Euflavin 0-3,0%                              0,09       9  \r\n\r\n Ferrolactat                                  0,21      22  \r\n\r\n Fluoresceinnatrium                           0,28      30  \r\n\r\n Fructose                                     0,18      19  \r\n\r\n Glucose, vandfri                             0,18      19  \r\n\r\n Glucosemonohydrat                            0,16      17  \r\n\r\n Glycerol                                     0,41      44  \r\n\r\n Glycerol (85%)                               0,35      38  \r\n\r\n Hexobarbitalnatrium                          0,24      26  \r\n\r\n Histamindihydrochlorid                       0,40      43  \r\n\r\n Histaminphosphat                             0,23      25  \r\n\r\n Homatropinhydrobromid                        0,16      17  \r\n\r\n Hydromorphoniumchlorid 0-2,0%                0,20      21  \r\n\r\n Hydromorphoniumchlorid 2,1-4,0%              0,16      17  \r\n\r\n Hydromorphoniumchlorid over 4,0%             0,15      16  \r\n\r\n Hyoscyaminhydrobromid 0-2,0%                 0,18      19  \r\n\r\n Hyoscyaminhydrobromid 2,1-4,0%               0,16      17  \r\n\r\n Hyoscyaminhydro    bromid over 4,0%          0,14      15  \r\n\r\n Hyoscyaminsulfat 0-5,0%                      0,12      12  \r\n\r\n Isoniazid                                    0,22      23  \r\n\r\n Kaliumantimontartrat 0-2,0%                  0,16      17  \r\n\r\n Kaliumantimontartrat 2,1-4,0%                0,13      13  \r\n\r\n Kaliumantimontartrat over 4,0%               0,11      11  \r\n\r\n Kaliumchlorid                                0,76      83  \r\n\r\n Kaliumiodid                                  0,35      38  \r\n\r\n Kaliumnitrat                                 0,56      61  \r\n\r\n Kaliumpermanganat                            0,39      42  \r\n\r\n Lactosemonohydrat                            0,09       9  \r\n\r\n Lidocainhydrochlorid                         0,21      22  \r\n\r\n Magnesiumchlorid                             0,45      49  \r\n\r\n Magnesiumsulfat                              0,14      15  \r\n\r\n Mannitol                                     0,18      19  \r\n\r\n Menadionnatriumbisulfit                      0,18      19  \r\n\r\n Mepyraminmaleat 0-2,0%                       0,15      16  \r\n\r\n Mepyraminmaleat 2,1-4,0%                     0,11      11  \r\n\r\n Mepyraminmaleat 4,1-6,0%                     0,09       9  \r\n\r\n Merbromin 0-3,0%                             0,12      12  \r\n\r\n Merbromin 3,1-5,0%                           0,10      10  \r\n\r\n Mercurichlorid                               0,10      10  \r\n\r\n Metamizolnatrium                             0,19      20  \r\n\r\n Methadonhydrochlorid 0-2,0%                  0,16      17  \r\n\r\n Methadonhydrochlorid 2,1-4,0%                0,13      13  \r\n\r\n Methadonhydrochlorid 4,1-6,0%                0,12      12  \r\n\r\n Methylatropinbromid                          0,13      13  \r\n\r\n Methylatropinnitrat                          0,14      15  \r\n\r\n Methylscopolaminnitrat                       0,13      13  \r\n\r\n Methylthioniniumchlorid                      0,05 3)    5  \r\n\r\n Morphinhydrochlorid                          0,14      15  \r\n\r\n Mælkesyre                                    0,40      43  \r\n\r\n Naphazolinhydrochlorid                       0,24      26  \r\n\r\n Natriumacetat                                0,45      49  \r\n\r\n Natriumbenzoat                               0,40      43  \r\n\r\n Natriumcalciumedetat                         0,21      22  \r\n\r\n Natriumchlorid                               1,00     110  \r\n\r\n Natriumcitrat                                0,30      32  \r\n\r\n Natriumdihydrogenphosphatdihydrat            0,33      36  \r\n\r\n Natriumedetat                                0,20      21  \r\n\r\n Natriumhydrogencarbonat                      0,65      71  \r\n\r\n Natriumiodid                                 0,38      41  \r\n\r\n Natriumnitrat                                0,84      92  \r\n\r\n Natriumpropionat                             0,61      67  \r\n\r\n Natriumpyrosulfit                            0,66      72  \r\n\r\n Natrium    riboflavinphosphat                0,08       8  \r\n\r\n Natriumsalicylat                             0,36      39  \r\n\r\n Natriumsulfatdecahydrat                      0,24      26  \r\n\r\n Natriumthiosulfat                            0,30      32  \r\n\r\n Neomycinsulfat 0-5,0%                        0,09       9  \r\n\r\n Neostigminbromid                             0,19      20  \r\n\r\n Nicethamid                                   0,15      16  \r\n\r\n Nicotinamid                                  0,21      22  \r\n\r\n Nicotinsyre                                  0,25      27  \r\n\r\n Noradrenalintartrat                          0,16      17  \r\n\r\n Noscapinhydrochlorid                         0,07       7  \r\n\r\n Ouabain                                      0,04       3  \r\n\r\n Oxedrintartrat                               0,15      16  \r\n\r\n Oxichinolinsulfat 0-2,0%                     0,17      18  \r\n\r\n Oxichinolinsulfat 2,1-4,0%                   0,13      13  \r\n\r\n Oxichinolinsulfat 4,1-6,0%                   0,11      11  \r\n\r\n Oxytetracyclinhydrochlorid 0-3,0%            0,09       9  \r\n\r\n Papaverinhydrochlorid                        0,11      11  \r\n\r\n Papaverinsulfat                              0,03 4)    2  \r\n\r\n Pentetrazol                                  0,19      20  \r\n\r\n Pentobarbitalnatrium                         0,23      25  \r\n\r\n Pethidinhydrochlorid                         0,19      20  \r\n\r\n Phenazon                                     0,13      13  \r\n\r\n Phenethanol                                  0,26      28  \r\n\r\n Phenobarbitalnatrium                         0,23      25  \r\n\r\n Phenol                                       0,33      36  \r\n\r\n Phenylephrin                                 0,31      33  \r\n\r\n Physostigminsalicylat                        0,16      17  \r\n\r\n Pilocarpinchlorid                            0,22      23  \r\n\r\n Pilocarpinnitrat                             0,20      21  \r\n\r\n Polymyxin B sulfat 0-5,0%                    0,05       5  \r\n\r\n Procainamidchlorid                           0,18      19  \r\n\r\n Procainhydrochlorid                          0,18      19  \r\n\r\n Promethazinhydrochlorid 0-2,0%               0,14      15  \r\n\r\n Promethazinhydrochlorid 2,1-4,0%             0,10      10  \r\n\r\n Promethazinhydrochlorid 4,1-5,0%             0,08       8  \r\n\r\n Propylenglycol                               0,45      49  \r\n\r\n Pyridoxinhydrochlorid 0-2,0%                 0,34      37  \r\n\r\n Pyridoxinhydrochlorid over 2,0%              0,30      32  \r\n\r\n Resorcinol                                   0,27      29  \r\n\r\n Saccharose                                   0,10      10  \r\n\r\n Saltsyre, fortyndet                          0,12      12  \r\n\r\n Scopolaminhydrobromid                        0,11      11  \r\n\r\n Sorbitol                                     0,16      17  \r\n\r\n Sprit, stærk                                 0,65      71  \r\n\r\n Streptomycinsulfat                           0,06       6  \r\n\r\n Strychninnitrat                              0,12      12  \r\n\r\n Sulfadimidinnatrium                          0,18      19  \r\n\r\n Sulfathiazolnatrium                          0,19      20  \r\n\r\n Suxamethoniumchlorid                         0,20      21  \r\n\r\n Sølvnitrat                                   0,33 1)   36  \r\n\r\n Tannin                                       0,03       2  \r\n\r\n Tetracainhydrochlorid 0-3,0%                 0,16      17  \r\n\r\n Tetracainhydrochlorid 3,1-5,0%               0,13      13  \r\n\r\n Tetracainhydrochlorid 5,1-6,0%               0,11      11  \r\n\r\n Tetracainnitrat                              0,23 5)   25  \r\n\r\n Tetracyclinhydrochlorid 0-3,0%               0,11      11  \r\n\r\n Theophyllinmonohydrat                        0,09       9  \r\n\r\n Thiaminhydrochlorid                          0,22      23  \r\n\r\n Tolazoliniumchlorid                          0,31      33  \r\n\r\n Trimethadion                                 0,21      22  \r\n\r\n Venal kaliumsulfat                           0,43      47  \r\n\r\n Vinsyre                                      0,23      25  \r\n\r\n Zinksulfat                                   0,12      12  \r\n\r\n ---------------------------------------------------------------------  \r\n\r\n</PRE>  \r\n\r\n<UL CLASS=PLAIN-LIST>  \r\n\r\n<LI>1) 0,33 g natriumchlorid svarer til 0,59 g kaliumnitrat </LI>  \r\n\r\n<LI>2) 0,18 g natriumchlorid svarer til 0,40 g natriumacetat </LI>  \r\n\r\n<LI>3) 0,05 g natriumchlorid svarer til 0,18 g natriumsulfatdecahydrat </LI>  \r\n\r\n<LI>4) 0,03 g natriumchlorid svarer til 0,11 g natriumsulfatdecahydrat </LI>  \r\n\r\n<LI>5) 0,23 g natriumchlorid svarer til 0,42 g kaliumnitrat </LI>  \r\n\r\n</UL>  \r\n\r\n<P>Tillæg til lægemiddelformstandarder </P>  \r\n\r\n<P>Ved fremstilling af magistrelle lægemidler skal de regler, der fremgår af  \r\n\r\n de tilhørende lægemiddelformstandarder, suppleres eller tilpasses i  \r\n\r\n overensstemmelse med efterfølgende bestemmelser og anvisninger. </P>  \r\n\r\n<P> <B>Afdelte pulvere</B>  </P>  \r\n\r\n<P>Magistrelle afdelte pulvere skal veje mindst 500 mg. Afdelte pulvere  \r\n\r\n indeholdende lægemiddelstof i mindre mængde tilsættes lactose eller andet  \r\n\r\n indifferent hjælpestof, således at det enkelte pulvers masse bliver 500 mg.  \r\n\r\n</P>  \r\n\r\n<P>Ved magistrel fremstilling af afdelte pulvere skal, hvis en råvare  \r\n\r\n optræder i kvaliteter med forskellig densitet, vælges den kvalitet, som har  \r\n\r\n den mindste densitet. </P>  \r\n\r\n<P> <B>Creme </B>  </P>  \r\n\r\n<P>Magistrelle cremer fremstilles, når intet andet er ordineret, med følgende  \r\n\r\n cremegrundlag: </P>  \r\n\r\n<PRE>  \r\n\r\n  Basiscreme  \r\n\r\n       Polysorbat 80 ..................................   5 g  \r\n\r\n  I    Cetylan ........................................  50 g  \r\n\r\n       Paraffinolie ...................................  50 g  \r\n\r\n       Glycerolmonostearat 40-50 ......................  60 g  \r\n\r\n       Methylparahydroxybenzoat  ......................   1 g  \r\n\r\n  II   Glycerol 85% ...................................  40 g  \r\n\r\n       Sorbitol .......................................  70 g  \r\n\r\n       Vand, renset ................................... 724 g  \r\n\r\n                                                       ------  \r\n\r\n                                                       1000 g  \r\n\r\n</PRE>  \r\n\r\n<P>I sammensmeltes ved ca. 70 graderC, og II, der forud er opvarmet til  \r\n\r\n kogning og derefter afkølet til 65-70 graderC, tilblandes under omrøring.  \r\n\r\n Blandingen omrøres jævnligt under afkølingen. </P>  \r\n\r\n<P>Blandingen af I og II tåler varmebehandling ved 100 graderC i 20 minutter.  \r\n\r\n</P>  \r\n\r\n<P>Hvid creme. </P>  \r\n\r\n<P>Ved fremstilling af magistrelle cremer skal faste stoffer, der ikke  \r\n\r\n opløses fuldstændig i cremegrundlaget, umiddelbart før anvendelsen sigtes  \r\n\r\n gennem sigte 125. </P>  \r\n\r\n<P>Magistrelle cremer, der skal konserveres (emulsionscremer, der indeholder  \r\n\r\n mere end 20% vand), kan konserveres med 0,1% parahydroxybenzoat i form af  \r\n\r\n methylparahydroxybenzoat eller en blanding af methylparahydroxybenzoat og  \r\n\r\n propylparahydroxybenzoat (8:2), eventuelt tilsat i form af et diluendum på  \r\n\r\n 10% i stærk sprit. </P>  \r\n\r\n<P> <B>Dråber</B>  </P>  \r\n\r\n<P>Magistrelle dråber, der skal konserveres, kan konserveres med 0,1%  \r\n\r\n parahydroxybenzoat i form af methylparahydroxybenzoat eller en blanding af  \r\n\r\n methylparahydroxybenzoat og propylparahydroxybenzoat (8:2), eventuelt tilsat  \r\n\r\n i form af et diluendum på 10% i stærk sprit: eller med 0,05% kaliumsorbat.  \r\n\r\n</P>  \r\n\r\n<P> <B>Gel</B>  </P>  \r\n\r\n<P>Magistrelle geler, der skal konserveres, kan konserveres med 0,1%  \r\n\r\n parahydroxybenzoat i form af methylparahydroxybenzoat eller en blanding af  \r\n\r\n methylparahydroxybenzoat og propylparahydroxybenzoat (8:2), eventuelt tilsat  \r\n\r\n i form af et diluendum på 10% i stærk sprit. </P>  \r\n\r\n<P> <B>Injektionsvæske</B>  </P>  \r\n\r\n<P>Magistrelle injektionsvæsker, der ordineres i enkeltdosis-beholdere med et  \r\n\r\n deklareret volumen på indtil 20 ml, skal være tilsat følgende overskud af  \r\n\r\n injektionsvæske, beregnet i forhold til det nominelle volumen: </P>  \r\n\r\n<PRE>  \r\n\r\n                           indtil 0,75 ml 20%  \r\n\r\n over 0,75 ml              indtil 7,5  ml 10%  \r\n\r\n                           over   7,5  ml  5%  \r\n\r\n</PRE>  \r\n\r\n<P>Magistrelle injektionsvæsker, der skal konserveres, kan konserveres med 1%  \r\n\r\n benzylalkohol, 0,5% phenol, 0,1% chlorcresol eller 0,1%  \r\n\r\n methylparahydroxybenzoat. </P>  \r\n\r\n<P> <B>Liniment</B>  </P>  \r\n\r\n<P>Magistrelle linimenter, der skal konserveres (slim), kan konserveres med  \r\n\r\n 0,1% parahydroxybenzoat i form af methylparahydroxybenzoat eller en blanding  \r\n\r\n af methylparahydroxybenzoat og propylparahydroxybenzoat (8:2), eventuelt  \r\n\r\n tilsat i form af et diluendum på 10% i stærk sprit. </P>  \r\n\r\n<P> <B>Mikstur</B>  </P>  \r\n\r\n<P>Magistrelle miksturer, der skal konserveres, kan konserveres med 0,1%  \r\n\r\n parahydroxybenzoat i form af methylparahydroxybenzoat eller en blanding af  \r\n\r\n methylparahydroxybenzoat og propylparahydroxybenzoat (8:2), eventuelt tilsat  \r\n\r\n i form af et diluendum på 10% i stærk sprit: eller med 0,05% kaliumsorbat.  \r\n\r\n</P>  \r\n\r\n<P> <B>Næsedråber</B>  </P>  \r\n\r\n<P>Magistrelle næsedråber, der skal konserveres, kan konserveres med 0,01%  \r\n\r\n benzalkoniumchlorid + 0,05% natriumedetat. </P>  \r\n\r\n<P> <B>Pudder</B>  </P>  \r\n\r\n<P>Ved magistrel fremstilling af pudder skal, hvis en råvare optræder i  \r\n\r\n kvaliteter med forskellig densitet, vælges den kvalitet, som har den mindste  \r\n\r\n densitet. </P>  \r\n\r\n<P> <B>Pulver</B>  </P>  \r\n\r\n<P>Ved magistrel fremstilling af pulver skal, hvis en råvare optræder i  \r\n\r\n kvaliteter med forskellig densitet, vælges den kvalitet, som har den mindste  \r\n\r\n densitet. </P>  \r\n\r\n<P> <B>Salve</B>  </P>  \r\n\r\n<P>Magistrelle salver fremstilles, når intet andet er ordineret, med følgende  \r\n\r\n salvegrundlag: </P>  \r\n\r\n<PRE>  \r\n\r\n  Basissalve  \r\n\r\n I    Polyethylen .............................................. 100 g  \r\n\r\n II   Paraffinolie ............................................. 900 g  \r\n\r\n                                                                ------  \r\n\r\n                                                                1000 g  \r\n\r\n</PRE>  \r\n\r\n<P>I opløses i II ved opvarmning til ca. 110 graderC under omrøring, og  \r\n\r\n opløsningen afkøles frivilligt til ca. 90 graderC. Herefter afkøles  \r\n\r\n blandingen med hastigheden ca. 2 graderC pr. minut under omrøring i egnet  \r\n\r\n apparatur. </P>  \r\n\r\n<P>Opløsningen af I i II tåler varmebehandling ved 140 graderC i 3 timer.  \r\n\r\n</P>  \r\n\r\n<P>Hvid, halvgennemskinnelig salve. </P>  \r\n\r\n<P>Ved fremstilling af magistrelle salver skal faste stoffer, der ikke  \r\n\r\n opløses fuldstændig i salvegrundlaget, umiddelbart før anvendelsen sigtes  \r\n\r\n gennem sigte 125. </P>  \r\n\r\n<P>Magistrelle salver, der skal konserveres (emulsionssalver, der indeholder  \r\n\r\n mere end ca. 20% vand), kan konserveres med 0,1% parahydroxybenzoat i form af  \r\n\r\n methylparahydroxybenzoat eller en blanding af methylparahydroxybenzoat og  \r\n\r\n propylparahydroxybenzoat (8:2), eventuelt tilsat i form af et diluendum på  \r\n\r\n 10% i stærk sprit. </P>  \r\n\r\n<P> <B>Suppositorier</B>  </P>  \r\n\r\n<P>Magistrelle suppositorier fremstilles, når ikke andet er ordineret, med  \r\n\r\n hårdfedt som grundmasse og fortrinsvis ved støbning. </P>  \r\n\r\n<P>Faste stoffer, der er uopløselige i grundmassen, skal umiddelbart før  \r\n\r\n anvendelsen sigtes gennem sigte 125. </P>  \r\n\r\n<P>Til fremstilling af suppositorier med et lavt indhold af lægemiddelstof  \r\n\r\n (10 mg og derunder) er det tilladt at anvende dette i form af en trituration  \r\n\r\n med lactose. </P>  \r\n\r\n<P>Suppositorier, fremstillet med en grundmasse på fedtbasis, skal opbevares  \r\n\r\n på svalt sted. </P>  \r\n\r\n<P> <B>Tabletter</B>  </P>  \r\n\r\n<P>Ved magistrel fremstilling af ikke-overtrukne tabletter skal det i  \r\n\r\n tabellen angivne system følges i størst mulig udstrækning. </P>  \r\n\r\n<PRE>  \r\n\r\n Indhold af       Diameter       Tilstræbt       Grænser for  \r\n\r\n lægemiddelstof                  bruttomasse     bruttomasse  \r\n\r\n     mg             mm             mg ca.            mg  \r\n\r\n ---------------------------------------------------------------------  \r\n\r\n       0-  50        6             100             90-110  \r\n\r\n      51- 100        8             180            160-200  \r\n\r\n     101- 250       10             350            325-375  \r\n\r\n     251- 350       12             450            400-500  \r\n\r\n     351- 450       12             550            500-600  \r\n\r\n     451- 550       13,5           650            600-700  \r\n\r\n     551- 650       13,5           750            700-800  \r\n\r\n     651-1200       15     delelig med 25 (eks.: 950-1050)  \r\n\r\n ---------------------------------------------------------------------  \r\n\r\n</PRE>  \r\n\r\n<P>Tabletterne skal så vidt muligt fremstilles i cirkelrund form med plane  \r\n\r\n flader og skrå kant. Cirkelrunde tabletter med diameter 8-13,5 mm skal være  \r\n\r\n forsynet med delekærv. Tabletter med diameter 6 mm må ikke forsynes med  \r\n\r\n delekærv. Foreskrives tabletter, der indeholder 50 mg lægemiddelstof eller  \r\n\r\n derunder, forsynet med delekærv, skal tabletterne fremstilles med diameter 8  \r\n\r\n mm (tilstræbt bruttomasse 180 mg). </P>  \r\n\r\n<P>Ved magistrel fremstilling af tabletter skal, hvis en råvare optræder i  \r\n\r\n kvaliteter med forskellig densitet, vælges den kvalitet, som har størst  \r\n\r\n densitet. </P>  \r\n\r\n<P>Lægemiddelstoffer, hvis opløselighed i vand er mindre end ca. 3 mg per ml,  \r\n\r\n skal, medmindre nedennævnte metode A anvendes, opfylde følgende prøve for  \r\n\r\n partikelstørrelse: </P>  \r\n\r\n<P>Lægemiddelstoffet fordeles i en væske med gode dispergeringsegenskaber,  \r\n\r\n hvori stoffet ikke opløses. Ved mikroskopisk undersøgelse af suspension  \r\n\r\n svarende til 10 microg af den faste fase må højst findes 20 partikler, hvis  \r\n\r\n største dimension overstiger 25 microm, og heraf må højst 2 overstige 50  \r\n\r\n microm, medens ingen partiklers største dimension må overstige 90 microm.  \r\n\r\n</P>  \r\n\r\n<P>Ved fremstilling af tabletter med et lavt indhold (5 mg og derunder) af  \r\n\r\n lægemiddelstof kan blandingen af lægemiddelstof og hjælpestoffer fremstilles  \r\n\r\n efter en af de nedenfor angivne metoder, idet metode A bør anvendes, når  \r\n\r\n indholdet af lægemiddelstof er 1 mg og derunder. </P>  \r\n\r\n<P> <I>Metode A</I> : Lægemiddelstoffet opløses, om fornødent ved svag  \r\n\r\n opvarmning, i et egnet flygtigt opløsningsmiddel, hvorefter den for  \r\n\r\n tabletfremstillingen nødvendige mængde lactose (som mindst udgør 60% af den  \r\n\r\n tilstræbte bruttomasse) gennemfugtes med opløsningen, idet der skylles efter  \r\n\r\n 2 gange, hver gang med ca. 10% af den anvendte mængde opløsningsmiddel.  \r\n\r\n Blandingen omrøres, til den er ensartet fugtet, og hensættes under omrøring,  \r\n\r\n til den er tør. Efter sigtning (sigte 180) tilblandes stivelse og eventuelle  \r\n\r\n andre stoffer, og blandingen sigtes. </P>  \r\n\r\n<P> <I>Metode B</I> : Lægemiddelstoffet (sigte 125) udrives med den for  \r\n\r\n tabletfremstillingen nødvendige mængde lactose (sigte 125), og blandingen  \r\n\r\n sigtes. Stivelse og eventuelle andre stoffer tilblandes, og blandingen  \r\n\r\n sigtes. </P>  \r\n\r\n<P> <B>Vagitorier</B>  </P>  \r\n\r\n<P>Magistrelle vagitorier, der fremstilles ved støbning, fremstilles som  \r\n\r\n anført for suppositorier. </P>  \r\n\r\n<P> <B>Øjenbadevand, øjendråber og øredråber</B>  </P>  \r\n\r\n<P>Magistrelle øjenbadevande, samt vandige øjendråber og øredråber skal  \r\n\r\n underkastes en varmebehandling ved den højeste temperatur, det pågældende  \r\n\r\n lægemiddel må udsættes for: hvis lægemidlet fremstilles <I>ex tempore</I> ,  \r\n\r\n er det i stedet for varmebehandling dog tilladt at anvende filtrering gennem  \r\n\r\n bakterieretentivt filter, f.eks. et membranfilter med porevidde 0,22 microm.  \r\n\r\n</P>  \r\n\r\n<P>Magistrelle øjenbadevande og øjendråber, der skal konserveres, kan  \r\n\r\n konserveres med 0,5% phenethanol eller med 0,01% benzalkoniumchlorid + 0,05%  \r\n\r\n natriumedetat. </P>  \r\n\r\n<P>Magistrelle øredråber, der skal konserveres, kan konserveres med 0,5%  \r\n\r\n phenethanol. </P>  \r\n\r\n<P>Diluenda og opløsningsmidler til fremstilling af øjenbadevande, øjendråber  \r\n\r\n eller øredråber, der har været underkastet en varmebehandling i  \r\n\r\n opbevaringsbeholderne, må opbevares i indtil 2 år, såfremt beholderne er  \r\n\r\n forsynet med tætsluttende lukke. Når en beholder er anbrudt, må indholdet  \r\n\r\n højst opbevares 1 måned: denne begrænsning gælder ikke for diluenda af  \r\n\r\n konserveringsstoffer og af lægemiddelstoffer med tilstrækkelig baktericid  \r\n\r\n virkning. På koldt sted må opbevaring kun finde sted i ikke anbrudt beholder  \r\n\r\n med tætsluttende lukke. </P>  \r\n\r\n<P> <B>Øjensalve</B>  </P>  \r\n\r\n<P>Magistrelle øjensalver fremstilles, når intet andet er ordineret, med  \r\n\r\n følgende øjensalvegrundlag: </P>  \r\n\r\n<PRE>  \r\n\r\n  Basisøjensalve  \r\n\r\n I   Paraffinolie ....................................... 200 g  \r\n\r\n II  Vaselin ............................................ 800 g  \r\n\r\n                                                         ------  \r\n\r\n                                                         1000 g  \r\n\r\n</PRE>  \r\n\r\n<P>II smeltes på vandbad, I tilsættes, og blandingen afkøles under omrøring.  \r\n\r\n</P>  \r\n\r\n<P>Varmebehandles ved 140 graderC i 3 timer. </P>  \r\n\r\n<P>Gul salve. </P>  \r\n\r\n<P>Ved fremstilling af magistrelle øjensalver skal faste stoffer, der ikke  \r\n\r\n opløses fuldstændigt i salvegrundlaget, umiddelbart før anvendelsen sigtes  \r\n\r\n gennem sigte 125. </P>  \r\n\r\n<P> <B>KONTROL</B>  </P>  \r\n\r\n<P>Almindelige bestemmelser </P>  \r\n\r\n<P>I medfør af § 24 stk. 1 i Sundhedsstyrelsens bekendtgørelse nr. 968 af 13.  \r\n\r\n december 1993, som ændret ved bekendtgørelse nr. 642 af 24. juli 1995 om god  \r\n\r\n fremstillings- og distributionspraksis for lægemidler er magistrelle  \r\n\r\n lægemidler fritaget for prøveudtagning og afprøvning i de tilfælde, hvor der  \r\n\r\n kun fremstilles en enkelt eller nogle få pakninger. </P>  \r\n\r\n<P>I de tilfælde, hvor magistrelle lægemidler fremstilles i større partier  \r\n\r\n (f.eks. flere end 10 enkeltpakninger), skal færdigvaren underkastes  \r\n\r\n prøveudtagning og afprøvning i overensstemmelse med præparatets  \r\n\r\n specifikationer. Fremstilleren af magistrelle lægemidler skal selv fastlægge  \r\n\r\n specifikationerne, og som hovedregel bør færdigvarekontrollen inkludere  \r\n\r\n identifikation og kvantitativ bestemmelse af det eller de enkelte  \r\n\r\n lægemiddelstoffer. </P>  \r\n\r\n<P>Lægemiddelstof </P>  \r\n\r\n<P>Det kvantitative indhold af lægemiddelstof i et magistrelt lægemiddel må  \r\n\r\n højst afvige 10% fra det deklarerede. </P>  \r\n\r\n<P> <B>LAGERHOLD</B>  </P>  \r\n\r\n<P>Opbevaringsbetingelser </P>  \r\n\r\n<P> <B>Opbevaring i vel tillukket beholder</B> skal foretages således, at  \r\n\r\n indholdet på betryggende måde er beskyttet mod forvitring, fordampning eller  \r\n\r\n mod fri tilgang af luftens fugtighed, oxygen og carbondioxid m.v. </P>  \r\n\r\n<P> <B>Opbevaring i lufttæt tillukket beholder</B> skal foretages således, at  \r\n\r\n luftudveksling med omgivelserne er udelukket. </P>  \r\n\r\n<P> <B>Opbevaring over tørremiddel</B> skal foretages i vel tillukket  \r\n\r\n beholder eller skab, hvori der er anbragt et egnet tørremiddel. </P>  \r\n\r\n<P> <B>Opbevaring beskyttet mod lyset</B> skal ske enten på et for lys  \r\n\r\n utilgængeligt sted eller i beholder eller pakning af et sådant materiale, at  \r\n\r\n kortbølget, ultraviolet lys absorberes tilstrækkeligt til at beskytte  \r\n\r\n indholdet mod nedbrydning eller forandring forårsaget af et sådant lys, eller  \r\n\r\n i pakning beskyttet af en yderpakning som giver en sådan beskyttelse. </P>  \r\n\r\n<P> <B>Opbevaring udelukket fra lyset</B> skal foretages i beholder eller  \r\n\r\n pakning, som er uigennemtrængelig for lys. </P>  \r\n\r\n<P>Opbevaringstid </P>  \r\n\r\n<P>Magistrelle lægemidlers opbevaringstid fastsættes på grundlag af en  \r\n\r\n holdbarhedsdokumentation eller en farmaceutisk faglig vurdering.  \r\n\r\n Opbevaringstiden må højst fastsættes til 2 år, medmindre Sundhedsstyrelsen på  \r\n\r\n grundlag af resultaterne af udførte holdbarhedsforsøg har givet tilladelse  \r\n\r\n til en længere opbevaringstid. </P>  \r\n\r\n<P> <B>INTRODUKTION TIL FORTEGNELSE OVER STANDARDER FOR LÆGEMIDDELFORMER SAMT  \r\n\r\n TERMER, DER KAN BENYTTES TIL MÆRKNING</B>  </P>  \r\n\r\n<P>Introduktion </P>  \r\n\r\n<P>De i dette afsnit beskrevne standarder og termer er baseret på dokumentet  \r\n\r\n<B>Standard Terms for Pharmaceutical Forms, Routes of Administration and  \r\n\r\n Containers,</B> der er vedtaget af den europæiske Farmakopekommission og er  \r\n\r\n publiceret i et særnummer af Pharmeuropa (oktober 1996). Disse standarder og  \r\n\r\n termer forventes sat i kraft i alle EU medlemslande 1. januar 1997, for nye  \r\n\r\n ansøgninger. I skrivende stund er den endelige afgørelse ikke truffet, men  \r\n\r\n når det sker, vil det blive publiceret i Statstidende og i fagpresse, ligesom  \r\n\r\n brancheorganisationerne vil blive underrettet. </P>  \r\n\r\n<P>Liste for standarder og termer </P>  \r\n\r\n<P>Listen er en alfabetisk fortegnelse over de engelske betegnelser og  \r\n\r\n tilsvarende danske oversættelse af både lægemiddelformstandarder og termer  \r\n\r\n til mærkningsbrug. En standard for en lægemiddelform er i fortegnelsen anført  \r\n\r\n ved en engelsk titel, et fastsat dansk navn og en henvisning til den engelske  \r\n\r\n titel på monografien for lægemiddelformen i Ph. Eur. 3rd Ed. eller en  \r\n\r\n standard i DLS 97, afhængig af hvor denne er optrykt. Såvel titlen som  \r\n\r\n henvisningen er i fortegnelsen anført med halvfed skrifttype. Termer der kan  \r\n\r\n anvendes til mærkning vil være mærket med , ved disse er der ikke henvisning  \r\n\r\n til en monografi, idet samtlige referencer er til DLS 97. Ved henvisning til  \r\n\r\n DLS 97 forstås her henvisning til afsnittet om standarder for  \r\n\r\n lægemiddelformer, samt termer der kan benyttes til mærkning. Nogle af  \r\n\r\n henvisningerne til standarder optaget i DLS 97 er efterfulgt af en angivelse  \r\n\r\n på en lægemiddelformstandard i parentes. Dette skyldes, at  \r\n\r\n lægemiddelformstandarderne er slået sammen, hvis der kun er tale om forskelle  \r\n\r\n i lægemiddelformernes fysiske form. </P>  \r\n\r\n<P>Søgeord </P>  \r\n\r\n<P>I første spalte i fortegnelsen er angivet samtlige standarders titler,  \r\n\r\n termers engelske titler, og de fastsatte danske navne i alfabetisk orden som  \r\n\r\n søgeord. Det danske navn vil dog ikke optræde i første spalte, hvis  \r\n\r\n standardens titel og det danske navn er identisk. Til titlen på en standard  \r\n\r\n eller en term i fortegnelsens første spalte svarer det fastsatte danske navn  \r\n\r\n i anden spalte, eller omvendt. Tredje spalte indeholder en henvisning til  \r\n\r\n titlen på den monografi i Ph. Eur. 3rd Ed. eller DLS 97, hvori standarden  \r\n\r\n forekommer. </P>  \r\n\r\n<P> <B>FORTEGNELSE OVER STANDARDER FOR LÆGEMIDDELFORMER SAMT TERMER DER KAN  \r\n\r\n BENYTTES TIL MÆRKNING</B>  </P>  \r\n\r\n<PRE>  \r\n\r\n Badeadditiv              Bath additive              DLS 97  \r\n\r\n  Bath additive           Badeadditiv                DLS 97  \r\n\r\n  Bladder irrigation      Blæreskyllevæske           Preparations  \r\n\r\n                                                     for irrigation  \r\n\r\n Blæreskyllevæske         Bladder irrigation         Preparations for  \r\n\r\n                                                     irrigation  \r\n\r\n  Bolus                   Boli                       DLS 97  \r\n\r\n Brusegranulat            Effervescent granules      Granules  \r\n\r\n Brusepulver              Effervescent powder        Oral powders  \r\n\r\n Brusetabletter           Effervescent tablet        Tablets  \r\n\r\n  Cachet                  Oblatkapsler               DLS 97  \r\n\r\n  Capsule                 Kapsler                    DLS 97  \r\n\r\n  Capsule, hard           Kapsler, hårde             Capsules  \r\n\r\n  Capsule, soft           Kapsler, bløde             Capsules  \r\n\r\n  Chewable tablet         Tyggetabletter             Tablets  \r\n\r\n  Coated tablet           Overtrukne tabletter       DLS 97  \r\n\r\n  Collodion               Kollodium                  DLS 97  \r\n\r\n  Compressed lozenge      Sugetabletter              Tablets  \r\n\r\n  Concentrate for  \r\n\r\n  haemodialysis           Hæmodialysekoncentrat      Solutions for  \r\n\r\n  solution                                           haemodialysis  \r\n\r\n  Concentrate for rectal  \r\n\r\n  solution                Rektalvæskekoncentrat      Rectal  \r\n\r\n                                                     preparations  \r\n\r\n  Concentrate for  \r\n\r\n  solution for            Koncentrat til  \r\n\r\n  infusion                infusionsvæske,            Parenteral  \r\n\r\n                          opløsning                  preparations  \r\n\r\n  Concentrate for  \r\n\r\n  solution for            Koncentrat til  \r\n\r\n  injection               injektionsvæske,           Parenteral  \r\n\r\n                          opløsning                  preparations  \r\n\r\n  Cream                   Creme                      Topical semi-  \r\n\r\n                                                     solid  \r\n\r\n                                                     preparations  \r\n\r\n Creme                    Cream                      Topical semi-  \r\n\r\n                                                     solid  \r\n\r\n                                                     preparations  \r\n\r\n  Cutaneous emulsion      Liniment, emulsion         Liquids for  \r\n\r\n                                                     cutaneous  \r\n\r\n                                                     application  \r\n\r\n  Cutaneous foam          Kutan skum                 Liquids for  \r\n\r\n                                                     cutaneous  \r\n\r\n                                                     application  \r\n\r\n  Cutaneous liquid        Liniment                   DLS 97  \r\n\r\n  Cutaneous paste         Pasta                      Topical semi-  \r\n\r\n                                                     solid  \r\n\r\n                                                     preparations  \r\n\r\n  Cutaneous powder        Pudder                     Topical powders  \r\n\r\n  Cutaneous solution      Liniment, opløsning        Liquids for  \r\n\r\n                                                     cutaneuos  \r\n\r\n                                                     application  \r\n\r\n  Cutaneous spray         Kutan spray                DLS 97  \r\n\r\n  Cutaneous spray, powder Kutan spray, pulver        DLS 97  \r\n\r\n                                                     (Kutan spray)  \r\n\r\n  Cutaneous spray,  \r\n\r\n  solution                Kutan spray, opløsning     DLS 97 (Kutan  \r\n\r\n                                                     spray)  \r\n\r\n  Cutaneous spray,  \r\n\r\n  suspension              Kutan spray, suspension    DLS 97 (Kutan  \r\n\r\n                                                     spray)  \r\n\r\n  Cutaneous stick         Kutan stift                Sticks  \r\n\r\n  Cutaneous suspension    Liniment, suspension       Liquids for  \r\n\r\n                                                     cutaneous  \r\n\r\n                                                     application  \r\n\r\n  Dental emulsion         Dentalemulsion             Liquids for  \r\n\r\n                                                     cutaneous  \r\n\r\n                                                     application  \r\n\r\n  Dental gel              Dentalgel                  Topical semi-  \r\n\r\n                                                     solid  \r\n\r\n                                                     preparations  \r\n\r\n  Dental liquid           Dentalvæske                DLS 97  \r\n\r\n  Dental powder           Dentalpulver               DLS 97  \r\n\r\n  Dental solution         Dentalopløsning            Liquids for  \r\n\r\n                                                     cutaneous  \r\n\r\n                                                     application  \r\n\r\n  Dental stick            Dentalstift                Sticks  \r\n\r\n  Dental suspension       Dentalsuspension           Liquids for  \r\n\r\n                                                     cutaneous  \r\n\r\n                                                     application  \r\n\r\n Dentalemulsion           Dental emulsion            Liquids for  \r\n\r\n                                                     cutaneous  \r\n\r\n                                                     application  \r\n\r\n Dentalgel                Dental gel                 Topical semi-  \r\n\r\n                                                     solid  \r\n\r\n                                                     preparations  \r\n\r\n Dentalopløsning          Dental solution            Liquids for  \r\n\r\n                                                     cutaneous  \r\n\r\n                                                     application  \r\n\r\n Dentalpulver             Dental powder              DLS 97  \r\n\r\n Dentalstift              Dental stick               Sticks  \r\n\r\n Dentalsuspension         Dental suspension          Liquids for  \r\n\r\n                                                     cutaneous  \r\n\r\n                                                     application  \r\n\r\n Dentalvæske              Dental liquid              DLS 97  \r\n\r\n Depotgranulat            Prolonged release  \r\n\r\n                          granules                   DLS 97  \r\n\r\n Depotkapsler             Prolonged release capsule  DLS 97  \r\n\r\n Depotkapsler, bløde      Prolonged release  \r\n\r\n                          capsule, soft              DLS 97  \r\n\r\n                                                     (Depotkapsler)  \r\n\r\n Depotkapsler, hårde      Prolonged release  \r\n\r\n                          capsule, hard              DLS 97  \r\n\r\n                                                     (Depotkapsler)  \r\n\r\n Depotplastre             Transdermal patch          DLS 97  \r\n\r\n Depottabletter           Prolonged release tablet   Tablets  \r\n\r\n Depotøjendråber          Eye drops, prolonged  \r\n\r\n                          release                    DLS 97  \r\n\r\n Dispergible tabletter    Dispersible tablet         Tablets  \r\n\r\n  Dispersible tablet      Dispergible tabletter      Tablets  \r\n\r\n Dråber                   Oral drops                 DLS 97  \r\n\r\n Dråber, emulsion         Oral drops, emulsion       Liquids for  \r\n\r\n                                                     oral use  \r\n\r\n Dråber, opløsning        Oral drops, solution       Liquids for oral  \r\n\r\n                                                     use  \r\n\r\n Dråber, suspension       Oral drops, suspension     Liquids for oral  \r\n\r\n                                                     use  \r\n\r\n  Ear cream               Ørecreme                   Ear preparations  \r\n\r\n  Ear drops               Øredråber                  DLS 97  \r\n\r\n  Ear drops, emulsion     Øredråber, emulsion        Ear preparations  \r\n\r\n  Ear drops, solution     Øredråber, opløsning       Ear preparations  \r\n\r\n  Ear drops, suspension   Øredråber, suspension      Ear preparations  \r\n\r\n  Ear gel                 Øregel                     Ear preparations  \r\n\r\n  Ear ointment            Øresalve                   Ear preparations  \r\n\r\n  Ear powder              Ørepudder                  Ear preparations  \r\n\r\n  Ear spray               Ørespray                   DLS 97  \r\n\r\n  Ear spray, emulsion     Ørespray, emulsion         Ear preparations  \r\n\r\n  Ear spray, solution     Ørespray, opløsning        Ear preparations  \r\n\r\n  Ear spray, suspension   Ørespray, suspension       Ear preparations  \r\n\r\n  Ear stick               Ørestift                   Sticks  \r\n\r\n  Ear tampon              Øretampon                  Ear preparations  \r\n\r\n  Ear wash                Øreskyllevæske             DLS 97  \r\n\r\n  Ear wash, emulsion      Øreskyllevæske, emulsion   Ear preparations  \r\n\r\n  Ear wash, solution      Øreskyllevæske, opløsning  Ear preparations  \r\n\r\n  Effervescent granules   Brusegranulat              Granules  \r\n\r\n  Effervescent powder     Brusepulver                Oral powders  \r\n\r\n  Effervescent tablet     Brusetabletter             Tablets  \r\n\r\n  Effervescent vaginal  \r\n\r\n  tablet                  Vagitorier, hurtigt  \r\n\r\n                          henfaldende                DLS 97  \r\n\r\n  Emulsion for infusion   Infusionsvæske, emulsion   Parenteral  \r\n\r\n                                            reparations  \r\n\r\n  Emulsion for injection  Injektionsvæske, emulsion  Parenteral  \r\n\r\n                                                     preparations  \r\n\r\n  Endocervical gel        Endocervikalgel            DLS 97  \r\n\r\n Endocervikalgel          Endocervical gel           DLS 97  \r\n\r\n Endotracheopulmonal  \r\n\r\n  instillations-          Endotracheopulmonary  \r\n\r\n  væske**                 instillation               DLS 97  \r\n\r\n Endotracheopulmonal  \r\n\r\n  instillations-          Endotracheopulmonary  \r\n\r\n  væske, opløsning        instillation,              DLS 97  \r\n\r\n                          solution                   (Endotracheopul-  \r\n\r\n                                                     monal  \r\n\r\n                                                     instillations-  \r\n\r\n                                                     væske)  \r\n\r\n Endotracheopulmonal  \r\n\r\n  instillations-          Endotracheopulmonary  \r\n\r\n  væske, pulver og        instillation,              DLS 97  \r\n\r\n  solvens til opløs-      powder and solvent  \r\n\r\n  ning                    for solution  \r\n\r\n Endotracheopulmonal                                 DLS 97  \r\n\r\n instillations-           Endotracheopulmonary  \r\n\r\n væske, pulver til        instillation, powder  \r\n\r\n opløsning                for solution  \r\n\r\n Endotracheopulmonal      Endotracheopulmonary       DLS 97(Endo-  \r\n\r\n instillations-           instillation,              tracheopulmonial  \r\n\r\n væske, suspension        suspension                 installations-  \r\n\r\n                                                     væske)  \r\n\r\n  Endotracheopulmonary  \r\n\r\n  instillation **         Endotracheopulmonal  \r\n\r\n                          instillations-             DLS 97  \r\n\r\n                          væske  \r\n\r\n  Endotracheopulmonary  \r\n\r\n  instillation,           Endotracheopulmonal  \r\n\r\n  powder and solvent      instillations-             DLS 97  \r\n\r\n  for solution            væske, pulver og solvens  \r\n\r\n                          til opløsning  \r\n\r\n  Endotracheopulmonary  \r\n\r\n  instillation,           Endotracheopulmonal  \r\n\r\n  powder for solution     instillations-             DLS 97  \r\n\r\n                          væske, pulver til  \r\n\r\n                          opløsning  \r\n\r\n  Endotracheopulmonary  \r\n\r\n  instillation,           Endotracheopulmonal  \r\n\r\n  solution                instillations-             DLS 97  \r\n\r\n                          væske, opløsning           (Endotracheo-  \r\n\r\n                                                     pulmonal  \r\n\r\n                                                     instillations-  \r\n\r\n                                                     væske)  \r\n\r\n  Endotracheopulmonary  \r\n\r\n  instillation,           Endotracheopulmonal  \r\n\r\n  suspension              instillations-             DLS 97  \r\n\r\n                          væske, suspension          (Endotracheo-  \r\n\r\n                                                     pulmonal  \r\n\r\n Enterogranulat           Gastro-resistant granules  DLS 97  \r\n\r\n Enterokapsler            Gastro-resistant capsule   DLS 97  \r\n\r\n Enterokapsler, bløde     Gastro-resistant capsule,  \r\n\r\n                          soft                       DLS 97  \r\n\r\n                                                     (Enterokapsler)  \r\n\r\n Enterokapsler, hårde     Gastro-resistant capsule,  \r\n\r\n                          hard                       DLS 97  \r\n\r\n                                                     (Enterokapsler)  \r\n\r\n Enterotabletter          Gastro-resistant tablet    DLS 97  \r\n\r\n  Eye cream               Øjencreme                  Eye preparations  \r\n\r\n  Eye drops               Øjendråber                 DLS 97  \r\n\r\n  Eye drops, powder and  \r\n\r\n  solvent                 Pulver og solvens til  \r\n\r\n  for solution            øjendråber,                DLS 97 (Pulver  \r\n\r\n                          opløsning                  og solvens til  \r\n\r\n                                                     øjendråber)  \r\n\r\n  Eye drops, powder and  \r\n\r\n  solvent                 Pulver og solvens til  \r\n\r\n  for suspension          øjendråber,                 DLS 97 (Pulver  \r\n\r\n    og  \r\n\r\n                          suspension                  solvens til  \r\n\r\n                                                      øjendråber)  \r\n\r\n  Eye drops, prolonged  \r\n\r\n  release                 Depotøjendråber             DLS 97  \r\n\r\n  Eye drops, solution     Øjendråber, opløsning       Eye prepara-  \r\n\r\n                                                     tions  \r\n\r\n  Eye drops, solvent for  Solvens til rekonstitution  \r\n\r\n  reconstitution          af                         DLS 97  \r\n\r\n                          øjendråber  \r\n\r\n  Eye drops, suspension   Øjendråber, suspension     Eye preparations  \r\n\r\n  Eye gel                 Øjengel                    Eye preparations  \r\n\r\n  Eye lotion              Øjenbadevand               Eye preparations  \r\n\r\n  Eye lotion, solvent for Solvens til rekonsti-  \r\n\r\n  reconstitution          tution af                  DLS 97  \r\n\r\n  reconstitution          øjenbadevand  \r\n\r\n  Eye ointment            Øjensalve                  Eye preparations  \r\n\r\n  Film coated tablet      Filmovertrukne tabletter   Tablets  \r\n\r\n Filmovertrukne tabletter Film coated tablet         Tablets  \r\n\r\n  Gargle                  Gurglevand                 DLS 97  \r\n\r\n  Gargle, powder for  \r\n\r\n  solution                Pulver til gurglevand,  \r\n\r\n                          opløsning                  DLS 97  \r\n\r\n  Gargle, tablet for  \r\n\r\n  solution                Tabletter til gurglevand,  \r\n\r\n                          opløsning                  DLS 97  \r\n\r\n  Gastro-resistant  \r\n\r\n  capsule                 Enterokapsler              DLS 97  \r\n\r\n  Gastro-resistant  \r\n\r\n  capsule, hard           Enterokapsler, hårde       DLS 97  \r\n\r\n                                                    (Enterokapsler)  \r\n\r\n  Gastro-resistant  \r\n\r\n  capsule, soft           Enterokapsler, bløde       DLS 97  \r\n\r\n                                                     (Enterokapsler)  \r\n\r\n  Gastro-resistant  \r\n\r\n  granules                Enterogranulat             DLS 97  \r\n\r\n  Gastro-resistant tablet Enterotabletter            DLS 97  \r\n\r\n  Gastroenteral emulsion  Gastroenteral væske,  \r\n\r\n                          emulsion                   DLS 97  \r\n\r\n                                                     (Gastroenteral  \r\n\r\n                                                     væske)  \r\n\r\n  Gastroenteral liquid    Gastroenteral væske        DLS 97  \r\n\r\n  Gastroenteral solution  Gastroenteral væske,  \r\n\r\n                          opløsning                  DLS 97  \r\n\r\n                                                     (Gastroenteral  \r\n\r\n                                                     væske)  \r\n\r\n  Gastroenteral  \r\n\r\n  suspension              Gastroenteral væske,  \r\n\r\n                          suspension                 DLS 97  \r\n\r\n                                                     (Gastroenteral  \r\n\r\n                                                     væske)  \r\n\r\n Gastroenteral væske      Gastroenteral liquid       DLS 97  \r\n\r\n Gastroenteral væske,  \r\n\r\n  emulsion                Gastroenteral emulsion     DLS 97  \r\n\r\n                                                     (Gastroenteral  \r\n\r\n                                                     væske)  \r\n\r\n Gastroenteral væske,  \r\n\r\n  opløsning               Gastroenteral solution     DLS 97  \r\n\r\n                                                     (Gastroenteral  \r\n\r\n                                                     væske)  \r\n\r\n Gastroenteral væske,  \r\n\r\n  suspension              Gastroenteral suspension   DLS 97  \r\n\r\n                                                     (Gastroenteral  \r\n\r\n                                                     væske)  \r\n\r\n  Gel                     Gel                        Topical semi-  \r\n\r\n                                                     solid  \r\n\r\n                                                     preparations  \r\n\r\n  Gingival gel            Tandkødsgel                DLS 97  \r\n\r\n  Gingival paste          Tandkødspasta              DLS 97  \r\n\r\n  Gingival solution       Tandkødsopløsning          DLS 97  \r\n\r\n Granulat                 Granules                   DLS 97  \r\n\r\n Granulat med  \r\n\r\n  modificeret udløsning   Modified release granules  DLS 97  \r\n\r\n Granulat til mikstur,  \r\n\r\n  opløsning               Granules for oral  \r\n\r\n                          solution                   Liquids  \r\n\r\n                                                     for oral use  \r\n\r\n Granulat til mikstur,  \r\n\r\n  suspension              Granules for oral  \r\n\r\n                          suspension                 Liquids for oral  \r\n\r\n                                                     use  \r\n\r\n Granulat til syrup       Granules for syrup         Liquids for oral  \r\n\r\n                                                     use  \r\n\r\n  Granules                Granulat                   DLS 97  \r\n\r\n  Granules for oral  \r\n\r\n  solution                Granulat til mikstur,  \r\n\r\n                          opløsning                  Liquids  \r\n\r\n                                                     for oral use  \r\n\r\n  Granules for oral  \r\n\r\n  suspension              Granulat til mikstur,  \r\n\r\n                          suspension                 Liquids for oral  \r\n\r\n                                                     use  \r\n\r\n  Granules for syrup      Granulat til syrup         Liquids for oral  \r\n\r\n                                                     use  \r\n\r\n Gurglevand               Gargle                     DLS 97  \r\n\r\n  Herbal tea              Urtete                     DLS 97  \r\n\r\n Hæmodialysekoncentrat    Concentrate for  \r\n\r\n                          haemodialysis              Solutions for  \r\n\r\n                          solution                   haemodialysis  \r\n\r\n Hæmodialysevæske         Solution for  \r\n\r\n                          haemodialysis              Solutions for  \r\n\r\n                                                     haemodialysis  \r\n\r\n Hæmofiltreringsvæske     Solution for  \r\n\r\n                          haemofiltration            Solutions for  \r\n\r\n                                                     heamofiltration  \r\n\r\n  Implant                 Implantat                  DLS 97  \r\n\r\n Implantat                Implant                    DLS 97  \r\n\r\n  Implantation chain      Kæde til implantation      DLS 97  \r\n\r\n                                                     (Implantat)  \r\n\r\n  Implantation tablet     Tabletter til implantation DLS 97  \r\n\r\n                                                     (Implantat)  \r\n\r\n  Impregnated dressing    Imprægneret gaze           DLS 97  \r\n\r\n Imprægneret gaze         Impregnated dressing       DLS 97  \r\n\r\n  Infusion                Infusionsvæske             DLS 97  \r\n\r\n Infusionsvæske           Infusion                   DLS 97  \r\n\r\n Infusionsvæske, emulsion Emulsion for infusion      Parenteral  \r\n\r\n                                                     preparations  \r\n\r\n Infusionsvæske,  \r\n\r\n  opløsning               Solution for infusion      Parenteral  \r\n\r\n                                                     preparations  \r\n\r\n  Inhalation emulsion     Inhalationsvæske til  \r\n\r\n                          nebulisator,               Preparations  \r\n\r\n                          emulsion                   for inhalation  \r\n\r\n  Inhalation gas          Inhalationsgas             DLS 97  \r\n\r\n  Inhalation liquid       Inhalationsvæske til  \r\n\r\n                          nebulisator                DLS 97  \r\n\r\n  Inhalation powder       Inhalationspulver          Preparations for  \r\n\r\n                                                     inhalation  \r\n\r\n  Inhalation powder       Inhalationspulver          DLS 97  \r\n\r\n  Inhalation powder,  \r\n\r\n  hard capsule            Inhalationspulver i  \r\n\r\n                          kapsler                    Preparations for  \r\n\r\n                                                     inhalation  \r\n\r\n  Inhalation powder,  \r\n\r\n  pre-dispensed           Inhalationspulver, afdelt  Preparations for  \r\n\r\n                                                     inhalation  \r\n\r\n  Inhalation solution     Inhalationsvæske til  \r\n\r\n                          nebulisator,               Preparations for  \r\n\r\n                          opløsning                  inhalation  \r\n\r\n  Inhalation suspension   Inhalationsvæske til  \r\n\r\n                          nebulisator,               Preparations for  \r\n\r\n                          suspension                 inhalation  \r\n\r\n  Inhalation vapour       Inhalationsdamp            DLS 97  \r\n\r\n  Inhalation vapour,  \r\n\r\n  liquid                  Væske til inhalationsdamp  Preparations for  \r\n\r\n                                                     inhalation  \r\n\r\n  Inhalation vapour,  \r\n\r\n  ointment                Salve til inhalationsdamp  Preparations for  \r\n\r\n                                                     inhalation  \r\n\r\n  Inhalation vapour,  \r\n\r\n  solution                Opløsning til  \r\n\r\n                          inhalationsdamp            Preparations for  \r\n\r\n                                                     inhalation  \r\n\r\n  Inhalation vapour,  \r\n\r\n  tablet                  Tabletter til  \r\n\r\n                          inhalationsdamp            Preparations for  \r\n\r\n                                                     inhalation  \r\n\r\n Inhalationsdamp          Inhalation vapour          DLS 97  \r\n\r\n Inhalationsgas           Inhalation gas             DLS 97  \r\n\r\n Inhalationspulver        Inhalation powder          Preparations for  \r\n\r\n                                                     inhalation  \r\n\r\n Inhalationspulver i  \r\n\r\n  kapsler                 Inhalation powder, hard  \r\n\r\n                          capsule                    Preparations for  \r\n\r\n                                                     inhalation  \r\n\r\n Inhalationspulver        Inhalation powder          DLS 97  \r\n\r\n Inhalationspulver,  \r\n\r\n  afdelt                  Inhalation powder,  \r\n\r\n                          pre-dispensed              Preparations for  \r\n\r\n                                                     inhalation  \r\n\r\n Inhalationsspray         Pressurised inhalation     DLS 97  \r\n\r\n Inhalationsspray,  \r\n\r\n  emulsion                Pressurised inhalation,  \r\n\r\n                          emulsion                   Preparations for  \r\n\r\n                                                     inhalation  \r\n\r\n Inhalationsspray,  \r\n\r\n  opløsning               Pressurised inhalation,  \r\n\r\n                          solution                   Preparations for  \r\n\r\n                                                     inhalation  \r\n\r\n Inhalationsspray,  \r\n\r\n  suspension              Pressurised inhalation,  \r\n\r\n                          suspension                 Preparations for  \r\n\r\n                                                     inhalation  \r\n\r\n Inhalationsvæske til  \r\n\r\n  nebulisator             Inhalation liquid          DLS 97  \r\n\r\n Inhalationsvæske til  \r\n\r\n  nebulisator,            Inhalation emulsion        Preparations for  \r\n\r\n  emulsion                                           inhalation  \r\n\r\n Inhalationsvæske til  \r\n\r\n  nebulisator,            Inhalation solution        Preparations for  \r\n\r\n  opløsning                                          inhalation  \r\n\r\n Inhalationsvæske til  \r\n\r\n  nebulisator,            Inhalation suspension      Preparations for  \r\n\r\n  suspension                                         inhalation  \r\n\r\n  Injection               Injektionsvæske            DLS 97  \r\n\r\n Injektionsvæske          Injection                  DLS 97  \r\n\r\n Injektionsvæske,  \r\n\r\n  emulsion                Emulsion for injection     Parenteral  \r\n\r\n                                                     preparations  \r\n\r\n Injektionsvæske,  \r\n\r\n  opløsning               Solution for injection     Parenteral  \r\n\r\n                                                     preparations  \r\n\r\n Injektionsvæske,  \r\n\r\n  suspension              Suspension for injection   Parenteral  \r\n\r\n                                                     preparations  \r\n\r\n Intramammarier           Intramammary               DLS 97  \r\n\r\n  Intramammary            Intramammarier             DLS 97  \r\n\r\n  Intrauterine device     Intrauterint indlæg        DLS 97  \r\n\r\n Intrauterint indlæg      Intrauterine device        DLS 97  \r\n\r\n  Irrigation solution     Skyllevæske                Preparations  \r\n\r\n                                                     for irrigation  \r\n\r\n Kapsler med  \r\n\r\n  modificeret udløsning   Modified release capsule   Capsules  \r\n\r\n Kapsler                  Capsule                    DLS 97  \r\n\r\n Kapsler, bløde           Capsule, soft              Capsules  \r\n\r\n Kapsler, hårde           Capsule, hard              Capsules  \r\n\r\n Kollodium                Collodion                  DLS 97  \r\n\r\n Koncentrat til  \r\n\r\n  infusionsvæske,         Concentrate for solution  \r\n\r\n  opløsning               for                        Parenteral  \r\n\r\n                          infusion                   preparations  \r\n\r\n Koncentrat til  \r\n\r\n  injektionsvæske,        Concentrate for solution  \r\n\r\n  opløsning                injection        for      Parenteral  \r\n\r\n                                                     preparations  \r\n\r\n Kutan skum               Cutaneous foam             Liquids for  \r\n\r\n                                                     cutaneous  \r\n\r\n                                                     application  \r\n\r\n Kutan spray              Cutaneous spray            DLS 97  \r\n\r\n Kutan spray, opløsning   Cutaneous spray, solution  DLS 97  \r\n\r\n                                                     (Kutan spray)  \r\n\r\n Kutan spray, pulver      Cutaneous spray, powder    DLS 97  \r\n\r\n                                                     (Kutan spray)  \r\n\r\n Kutan spray, suspension  Cutaneous spray,  \r\n\r\n                          suspension                 DLS 97  \r\n\r\n                                                     (Kutan spray)  \r\n\r\n Kutan stift              Cutaneous stick            Sticks  \r\n\r\n Kæde til implantation    Implantation chain         DLS 97  \r\n\r\n                                                     (Implantat)  \r\n\r\n Liniment                 Cutaneous liquid           DLS 97  \r\n\r\n Liniment, emulsion       Cutaneous emulsion         Liquids for  \r\n\r\n                                                     cutaneous  \r\n\r\n                                                     application  \r\n\r\n Liniment, opløsning      Cutaneous solution         Liquids for  \r\n\r\n                                                     cutaneuos  \r\n\r\n                                                     application  \r\n\r\n Liniment, suspension     Cutaneous suspension       Liquids for  \r\n\r\n                                                     cutaneous  \r\n\r\n                                                     application  \r\n\r\n  Lozenge                 Pastiller                  Tablets  \r\n\r\n Maveskyllevæske          Stomach irrigation         Preparations for  \r\n\r\n                                                     irrigation  \r\n\r\n  Medicated chewing-gum   Medicinsk tyggegummi       DLS 97  \r\n\r\n  Medicated premixes      Premix                     DLS 97  \r\n\r\n Medicinsk tyggegummi     Medicated chewing-gum      DLS 97  \r\n\r\n Mikstur                  Oral liquid                DLS 97  \r\n\r\n Mikstur, emulsion        Oral emulsion              Liquids for oral  \r\n\r\n                                                     use  \r\n\r\n Mikstur, opløsning       Oral solution              Liquids for oral  \r\n\r\n                                                     use  \r\n\r\n Mikstur, suspension      Oral suspension            Liquids for oral  \r\n\r\n                                                     use  \r\n\r\n  Modified release  \r\n\r\n  capsule                 Kapsler med modificeret  \r\n\r\n                          udløsning                  Capsules  \r\n\r\n  Modified release  \r\n\r\n  granules                Granulat med modificeret  \r\n\r\n                          udløsning                  DLS 97  \r\n\r\n  Modified release tablet Tabletter med modificeret  \r\n\r\n                          udløsning                  DLS 97  \r\n\r\n  Mouth wash              Mundskyllevæske            DLS 97  \r\n\r\n  Mouth wash, tablet for  \r\n\r\n  solution                Tabletter til  \r\n\r\n                          mundskyllevæske,           DLS 97  \r\n\r\n                          opløsning  \r\n\r\n  Muco-adhesive buccal  \r\n\r\n  tablet                  Resoribletter,  \r\n\r\n                          slimhindefæstnende         Tablets  \r\n\r\n Mundhuledråber           Oromucosal drops           DLS 97  \r\n\r\n Mundhulegel              Oromucosal gel             DLS 97  \r\n\r\n Mundhulekapsler          Oromucosal capsule         DLS 97  \r\n\r\n Mundhulepasta            Oromucosal paste           DLS 97  \r\n\r\n Mundhulespray, opløsning Oromucosal spray,  \r\n\r\n                          solution                   DLS 97  \r\n\r\n Mundhulevæske            Oromucosal liquid          DLS 97  \r\n\r\n Mundhulevæske, opløsning Oromucosal solution        DLS 97  \r\n\r\n                                                     (Mundhulevæske)  \r\n\r\n Mundhulevæske,  \r\n\r\n  suspension              Oromucosal suspension      DLS 97  \r\n\r\n                                                     (Mundhulevæske)  \r\n\r\n Mundskyllevæske          Mouth wash                 DLS 97  \r\n\r\n  Nasal cream             Næsecreme                  Nasal  \r\n\r\n                                                     preparations  \r\n\r\n  Nasal drops             Næsedråber                 DLS 97  \r\n\r\n  Nasal drops, emulsion   Næsedråber, emulsion       Nasal  \r\n\r\n                                                     preparations  \r\n\r\n  Nasal drops, solution   Næsedråber, opløsning      Nasal  \r\n\r\n                                                     preparations  \r\n\r\n  Nasal drops, suspension Næsedråber, suspension     Nasal  \r\n\r\n                                                     preparations  \r\n\r\n  Nasal gel               Næsegel                    Nasal  \r\n\r\n                                                     preparations  \r\n\r\n  Nasal ointment          Næsesalve                  Nasal  \r\n\r\n                                                     preparations  \r\n\r\n  Nasal powder            Næsepudder                 Nasal  \r\n\r\n                                                     preparations  \r\n\r\n  Nasal spray             Næsespray                  DLS 97  \r\n\r\n  Nasal spray, emulsion   Næsespray, emulsion        Nasal  \r\n\r\n                                                     preparations  \r\n\r\n  Nasal spray, solution   Næsespray, opløsning       Nasal  \r\n\r\n                                                     preparations  \r\n\r\n  Nasal spray,  \r\n\r\n  suspension              Næsespray, suspension      Nasal  \r\n\r\n                                                     preparations  \r\n\r\n  Nasal stick             Næsestift                  Nasal  \r\n\r\n                                                     preparations  \r\n\r\n  Nasal wash              Næseskyllevæske            Nasal  \r\n\r\n                                                     preparations  \r\n\r\n Næsecreme                Nasal cream                Nasal  \r\n\r\n                                                     preparations  \r\n\r\n Næsedråber               Nasal drops                DLS 97  \r\n\r\n Næsedråber, emulsion     Nasal drops, emulsion      Nasal  \r\n\r\n                                                     preparations  \r\n\r\n Næsedråber, opløsning    Nasal drops, solution      Nasal  \r\n\r\n                                                     preparations  \r\n\r\n Næsedråber, suspension   Nasal drops, suspension    Nasal  \r\n\r\n                                                     preparations  \r\n\r\n Næsegel                  Nasal gel                  Nasal  \r\n\r\n                                                     preparations  \r\n\r\n Næsepudder               Nasal powder               Nasal  \r\n\r\n                                                     preparations  \r\n\r\n Næsesalve                Nasal ointment             Nasal  \r\n\r\n                                                     preparations  \r\n\r\n Næseskyllevæske          Nasal wash                 Nasal  \r\n\r\n                                                     preparations  \r\n\r\n Næsespray                Nasal spray                DLS 97  \r\n\r\n Næsespray, emulsion      Nasal spray, emulsion      Nasal  \r\n\r\n                                                     preparations  \r\n\r\n Næsespray, opløsning     Nasal spray, solution      Nasal  \r\n\r\n                                                     preparations  \r\n\r\n Næsespray, suspension    Nasal spray, suspension    Nasal  \r\n\r\n                                                     preparations  \r\n\r\n Næsestift                Nasal stick                Nasal  \r\n\r\n                                                     preparations  \r\n\r\n Oblatkapsler             Cachet                     DLS 97  \r\n\r\n  Ointment                Salve                      Topical semi-  \r\n\r\n                                                     solid  \r\n\r\n Omslag                   Poultice                   DLS 97  \r\n\r\n  Ophthalmic insert       Øjenlamel                  Eye  \r\n\r\n                                                     preparations  \r\n\r\n Opløselige tabletter     Soluble tablet             Tablets  \r\n\r\n Opløsning til  \r\n\r\n  inhalationsdamp         Inhalation vapour,  \r\n\r\n                          solution                   Preparations  \r\n\r\n                                                     for inhalation  \r\n\r\n Opløsning til  \r\n\r\n  iontoforese             Solution for  \r\n\r\n                          iontophoresis              DLS 97  \r\n\r\n  Oral drops              Dråber                     DLS 97  \r\n\r\n  Oral drops, emulsion    Dråber, emulsion           Liquids for oral  \r\n\r\n                                                     use  \r\n\r\n  Oral drops, solution    Dråber, opløsning          Liquids for oral  \r\n\r\n                                                     use  \r\n\r\n  Oral drops, suspension  Dråber, suspension         Liquids for oral  \r\n\r\n                                                     use  \r\n\r\n  Oral emulsion           Mikstur, emulsion          Liquids for oral  \r\n\r\n                                                     use  \r\n\r\n  Oral gel                Oral gel                   Topical semi-  \r\n\r\n                                                     solid  \r\n\r\n                                                     Preparations  \r\n\r\n  Oral liquid             Mikstur                    DLS 97  \r\n\r\n  Oral lyophilisate       Smeltetabletter            DLS 97  \r\n\r\n  Oral powder             Pulver                     Oral Powders  \r\n\r\n  Oral solution           Mikstur, opløsning         Liquids for oral  \r\n\r\n                                                     use  \r\n\r\n  Oral suspension         Mikstur, suspension        Liquids for oral  \r\n\r\n                                                     use  \r\n\r\n Organopbevaringsvæske    Solution for organ  \r\n\r\n                          preservations              DLS 97  \r\n\r\n  Oromucosal capsule      Mundhulekapsler            DLS 97  \r\n\r\n  Oromucosal drops        Mundhuledråber             DLS 97  \r\n\r\n  Oromucosal gel          Mundhulegel                DLS 97  \r\n\r\n  Oromucosal liquid       Mundhulevæske              DLS 97  \r\n\r\n  Oromucosal paste        Mundhulepasta              DLS 97  \r\n\r\n  Oromucosal solution     Mundhulevæske, opløsning   DLS 97  \r\n\r\n                                                     (Mundhulevæske)  \r\n\r\n  Oromucosal spray,  \r\n\r\n  solution                Mundhulespray, opløsning   DLS 97  \r\n\r\n  Oromucosal suspension   Mundhulevæske, suspension  DLS 97  \r\n\r\n                                                     (Mundhulevæske)  \r\n\r\n Overtrukne tabletter     Coated tablet              DLS 97  \r\n\r\n Pasta                    Cutaneous paste            Topical semi-  \r\n\r\n                                                     solid  \r\n\r\n                                                     preparations  \r\n\r\n Pastiller                Lozenge                    Tablets  \r\n\r\n Peritonealdialysevæske   Solution for peritoneal  \r\n\r\n                          dialysis                   Solutions  \r\n\r\n                                                     for peritoneal  \r\n\r\n                                                     dialysis  \r\n\r\n  Pessary                 Vagitorier                 Vaginal  \r\n\r\n                                                     preparations  \r\n\r\n  Pessary                 Vagitorier                 DLS 97  \r\n\r\n  Poultice                Omslag                     DLS 97  \r\n\r\n  Powder and solvent for  Pulver og solvens til  \r\n\r\n  endocervical gel        endocervikalgel            DLS 97  \r\n\r\n  Powder and solvent for  \r\n\r\n  oral                    Pulver og solvens til  \r\n\r\n  solution                mikstur,                   Liquids  \r\n\r\n                          opløsning                  for oral use  \r\n\r\n  Powder and solvent for  \r\n\r\n  oral                    Pulver og solvens til  \r\n\r\n  suspension              mikstur,                   Liquids  \r\n\r\n                          suspension                 for oral use  \r\n\r\n  Powder and solvent for  \r\n\r\n  solution                Pulver og solvens til      Parenteral  \r\n\r\n  for infusion            infusionsvæske,            preparations  \r\n\r\n                          opløsning  \r\n\r\n  Powder and solvent for  \r\n\r\n  solution                Pulver og solvens til      Parenteral  \r\n\r\n  for injection           injektionsvæske,           preparations  \r\n\r\n                          opløsning  \r\n\r\n  Powder and solvent for  \r\n\r\n  suspension              Pulver og solvens til      Parenteral  \r\n\r\n   for injection          injektionsvæske,           preparations  \r\n\r\n                          suspension  \r\n\r\n  Powder for bladder  \r\n\r\n  irrigation              Pulver til blæreskylle-  \r\n\r\n                          væske                      Preparations for  \r\n\r\n                                                     irrigation  \r\n\r\n  Powder for infusion     Pulver til infusionsvæske  DLS 97  \r\n\r\n  Powder for injection    Pulver til injektionsvæske DLS 97  \r\n\r\n  Powder for oral  \r\n\r\n  solution                Pulver til mikstur,  \r\n\r\n                          opløsning                  Liquids for  \r\n\r\n                                                     oral use  \r\n\r\n  Powder for oral  \r\n\r\n  suspension              Pulver til mikstur,  \r\n\r\n                          suspension                 Liquids  \r\n\r\n                                                     for oral use  \r\n\r\n  Powder for rectal  \r\n\r\n  solution                Pulver til rektalvæske,  \r\n\r\n                          opløsning                  Rectal  \r\n\r\n                                                     preparations  \r\n\r\n  Powder for rectal  \r\n\r\n  suspension              Pulver til rektalvæske,  \r\n\r\n                          suspension                 Rectal  \r\n\r\n                                                     preparations  \r\n\r\n  Powder for solution  \r\n\r\n  for infusion            Pulver til infusionsvæske, Parenteral  \r\n\r\n                          opløsning                  preparations  \r\n\r\n  Powder for solution for  \r\n\r\n  injection               Pulver til  \r\n\r\n                          injektionsvæske,           Parenteral  \r\n\r\n                          opløsning                  preparations  \r\n\r\n  Powder for suspension  \r\n\r\n  for injection           Pulver til  \r\n\r\n                          injektionsvæske,           Parenteral  \r\n\r\n                          suspension                 preparations  \r\n\r\n  Powder for syrup        Pulver til syrup           Liquids for oral  \r\n\r\n                                                     use  \r\n\r\n Premix                   Medicated premixes         DLS 97  \r\n\r\n  Pressurised inhalation  Inhalationsspray           DLS 97  \r\n\r\n  Pressurised  \r\n\r\n  inhalation, emulsion    Inhalationsspray,  \r\n\r\n                          emulsion                   Preparations for  \r\n\r\n                                                     inhalation  \r\n\r\n  Pressurised  \r\n\r\n  inhalation, solution    Inhalationsspray,  \r\n\r\n                          opløsning                  Preparations for  \r\n\r\n                                                     inhalation  \r\n\r\n  Pressurised  \r\n\r\n  inhalation, suspension  Inhalationsspray,  \r\n\r\n                          suspension                 Preparations for  \r\n\r\n                                                     inhalation  \r\n\r\n  Prolonged release  \r\n\r\n  capsule                 Depotkapsler               DLS 97  \r\n\r\n  Prolonged release  \r\n\r\n  capsule, hard           Depotkapsler, hårde        DLS 97  \r\n\r\n                                                     (Depotkapsler)  \r\n\r\n  Prolonged release  \r\n\r\n  capsule, soft           Depotkapsler, bløde        DLS 97  \r\n\r\n                                                     (Depotkapsler)  \r\n\r\n  Prolonged release  \r\n\r\n  granules                Depotgranulat              DLS 97  \r\n\r\n  Prolonged release  \r\n\r\n  tablet                  Depottabletter             Tablets  \r\n\r\n Pudder                   Cutaneous powder           Topical powders  \r\n\r\n Pulver                   Oral powder                Oral Powders  \r\n\r\n Pulver og solvens til    Powder and solvent for  \r\n\r\n infusionsvæske,          solution                   Parenteral  \r\n\r\n opløsning                for infusion               preparations  \r\n\r\n Pulver og solvens til    Powder and solvent for  \r\n\r\n injektionsvæske,         solution                   Parenteral  \r\n\r\n opløsning                for injektion              preparations  \r\n\r\n Pulver og solvens til    Powder and solvent for  \r\n\r\n injektionsvæske,         suspension                 Parenteral  \r\n\r\n suspension               for injektion              preparations  \r\n\r\n Pulver og solvens til  \r\n\r\n  endocervikal-           Powder and solvent for     DLS 97  \r\n\r\n  gel                     endocervical gel  \r\n\r\n Pulver og solvens til  \r\n\r\n  mikstur,                Powder and solvent for  \r\n\r\n  opløsning               oral solution              Liquids  \r\n\r\n                                                     for oral use  \r\n\r\n Pulver og solvens til  \r\n\r\n  mikstur,                Powder and solvent for  \r\n\r\n  suspension              oral suspension            Liquids  \r\n\r\n                                                     for oral use  \r\n\r\n Pulver og solvens til  \r\n\r\n  øjendråber,             Eye drops, powder and  \r\n\r\n  opløsning               solvent for solution       DLS 97  \r\n\r\n                                                     (Pulver og  \r\n\r\n                                                     solvens til  \r\n\r\n                                                     øjendråber)  \r\n\r\n Pulver og solvens til  \r\n\r\n  øjendråber,             Eye drops, powder and  \r\n\r\n  suspension              solvent for suspension     DLS 97  \r\n\r\n                                                     (Pulver og  \r\n\r\n    solvens  \r\n\r\n                                                     til  \r\n\r\n                                                     øjendråber)  \r\n\r\n Pulver til  \r\n\r\n  blæreskyllevæske        Powder for bladder  \r\n\r\n                          irrigation                 Preparations for  \r\n\r\n                                                     irrigation  \r\n\r\n Pulver til gurglevand,  \r\n\r\n  opløsning               Gargle, powder for  \r\n\r\n                          solution                   DLS 97  \r\n\r\n Pulver til  \r\n\r\n  infusionsvæske          Powder for infusion        DLS 97  \r\n\r\n Pulver til  \r\n\r\n  infusionsvæske,         Powder for solution for  \r\n\r\n  opløsning               infusion                   Parenteral  \r\n\r\n                                                     preparations  \r\n\r\n Pulver til  \r\n\r\n  injektionsvæske         Powder for injection       DLS 97  \r\n\r\n Pulver til  \r\n\r\n  injektionsvæske,        Powder for solution for  \r\n\r\n  opløsning               injection                  Parenteral  \r\n\r\n                                                     preparations  \r\n\r\n Pulver til  \r\n\r\n  injektionsvæske,        Powder for suspension for  \r\n\r\n  suspension              injection                  Parenteral  \r\n\r\n                                                     preparations  \r\n\r\n Pulver til mikstur,  \r\n\r\n  opløsning               Powder for oral solution   Liquids for  \r\n\r\n                                                     oral use  \r\n\r\n Pulver til mikstur,  \r\n\r\n  suspension              Powder for oral  \r\n\r\n                          suspension                 Liquids  \r\n\r\n                                                     for oral use  \r\n\r\n Pulver til rektalvæske,  \r\n\r\n  opløsning               Powder for rectal  \r\n\r\n                          solution                   Rectal  \r\n\r\n                                                     preparations  \r\n\r\n Pulver til  \r\n\r\n  rektalvæske, suspension Powder for rectal  \r\n\r\n                          suspension                 Rectal  \r\n\r\n                                                     preparations  \r\n\r\n Pulver til syrup         Powder for syrup           Liquids for  \r\n\r\n                                                     oral use  \r\n\r\n Radioaktiv  \r\n\r\n  mærkningsopløsning      Radiopharmaceutical  \r\n\r\n                          precursor                  DLS 97  \r\n\r\n  Radionuclide generator  Radionuklidgenerator       DLS 97  \r\n\r\n Radionuklidgenerator     Radionuclide generator     DLS 97  \r\n\r\n  Radiopharmaceutical  \r\n\r\n  precursor               Radioaktiv  \r\n\r\n                          mærkningsopløsning         DLS 97  \r\n\r\n  Rectal capsule          Rektalkapsler              Rectal  \r\n\r\n                                                     preparations  \r\n\r\n  Rectal cream            Rektalcreme                Rectal  \r\n\r\n                                                     preparations  \r\n\r\n  Rectal emulsion         Rektalvæske, emulsion      Rectal  \r\n\r\n                                                     preparations  \r\n\r\n  Rectal foam             Rektalskum                 Rectal  \r\n\r\n                                                     preparations  \r\n\r\n  Rectal gel              Rektalgel                  Rectal  \r\n\r\n                                                     preparations  \r\n\r\n  Rectal liquid           Rektalvæske                DLS 97  \r\n\r\n  Rectal ointment         Rektalsalve                Rectal  \r\n\r\n                                                     preparations  \r\n\r\n  Rectal solution         Rektalvæske, opløsning     Rectal  \r\n\r\n                                                     preparations  \r\n\r\n  Rectal suspension       Rektalvæske, suspension    Rectal  \r\n\r\n                                                     preparations  \r\n\r\n  Rectal tampon           Rektaltampon               Rectal  \r\n\r\n                                                     preparations  \r\n\r\n Rektalcreme              Rectal cream               Rectal  \r\n\r\n                                                     preparations  \r\n\r\n Rektalgel                Rectal gel                 Rectal  \r\n\r\n                                                     preparations  \r\n\r\n Rektalkapsler            Rectal capsule             Rectal  \r\n\r\n                                                     preparations  \r\n\r\n Rektalsalve              Rectal ointment            Rectal  \r\n\r\n                                                     preparations  \r\n\r\n Rektalskum               Rectal foam                Rectal  \r\n\r\n                                                     preparations  \r\n\r\n Rektaltampon             Rectal tampon              Rectal  \r\n\r\n                                                     preparations  \r\n\r\n Rektalvæske              Rectal liquid              DLS 97  \r\n\r\n Rektalvæske, emulsion    Rectal emulsion            Rectal  \r\n\r\n                                                     preparations  \r\n\r\n Rektalvæske, opløsning   Rectal solution            Rectal  \r\n\r\n                                                     preparations  \r\n\r\n Rektalvæske, suspension  Rectal suspension          Rectal  \r\n\r\n                                                     preparations  \r\n\r\n Rektalvæskekoncentrat    Concentrate for rectal  \r\n\r\n                          solution                   Rectal  \r\n\r\n                                                     preparations  \r\n\r\n Resoribletter,  \r\n\r\n  slimhindefæstnende      Muco-adhesive buccal  \r\n\r\n                          tablet                     Tablets  \r\n\r\n Resoribletter,  \r\n\r\n  sublinguale             Sublingual tablet          Tablets  \r\n\r\n Salve                    Ointment                   Topical semi-  \r\n\r\n                                                     solid  \r\n\r\n                                                     preparations  \r\n\r\n Salve til  \r\n\r\n  inhalationsdamp         Inhalation vapour,  \r\n\r\n                          ointment                   Preparations  \r\n\r\n                                                     for inhalation  \r\n\r\n  Sealant                 Vævsklæber                 DLS 97  \r\n\r\n  Shampoo                 Shampoo                    Liquids for  \r\n\r\n                                                     cutaneous  \r\n\r\n                                                     application  \r\n\r\n Skyllevæske              Irrigation solution        Preparations for  \r\n\r\n                                                     irrigation  \r\n\r\n Smeltetabletter          Oral lyophilisate          DLS 97  \r\n\r\n  Soluble tablet          Opløselige tabletter       Tablets  \r\n\r\n  Solution for  \r\n\r\n  haemodialysis           Hæmodialysevæske           Solutions for  \r\n\r\n                                                     haemodialysis  \r\n\r\n  Solution for  \r\n\r\n  haemofiltration         Hæmofiltreringsvæske       Solutions for  \r\n\r\n                                                     heamofiltration  \r\n\r\n  Solution for infusion   Infusionsvæske, opløsning  Parenteral  \r\n\r\n                                                     preparations  \r\n\r\n  Solution for injection  Injektionsvæske, opløsning Parenteral  \r\n\r\n                                                     preparations  \r\n\r\n  Solution for  \r\n\r\n  iontophoresis           Opløsning til iontoforese  DLS 97  \r\n\r\n  Solution for organ  \r\n\r\n  preservations           Organopbevaringsvæske      DLS 97  \r\n\r\n  Solution for peritoneal  \r\n\r\n  dialysis                Peritonealdialysevæske     Solutions  \r\n\r\n                                                     for peritoneal  \r\n\r\n                                                     dialysis  \r\n\r\n Solvens til  \r\n\r\n  parenteralt brug        Solvent for parenteral  \r\n\r\n                          use                        DLS 97  \r\n\r\n Solvens til  \r\n\r\n  rekonstitution af       Eye lotion, solvent for    DLS 97  \r\n\r\n  øjenbadevand            reconstitution  \r\n\r\n Solvens til  \r\n\r\n  rekonstitution af       Eye drops, solvent for     DLS 97  \r\n\r\n  øjendråber              reconstitution  \r\n\r\n  Solvent for  \r\n\r\n  parenteral use          Solvens til parenteralt  \r\n\r\n                          brug                       DLS 97  \r\n\r\n  Stomach irrigation      Maveskyllevæske            Preparations  \r\n\r\n                                                     for irrigation  \r\n\r\n  Sublingual tablet       Resoribletter, sublinguale Tablets  \r\n\r\n Sugetabletter            Compressed lozenge         Tablets  \r\n\r\n Suppositorier            Suppository                Rectal  \r\n\r\n                                                     preparations  \r\n\r\n  Suppository             Suppositorier              Rectal  \r\n\r\n                                                     preparations  \r\n\r\n  Suspension for  \r\n\r\n  injection               Injektionsvæske,  \r\n\r\n                          suspension                 Parenteral  \r\n\r\n                                                     preparations  \r\n\r\n  Syrup                   Syrup                      Liquids for oral  \r\n\r\n                                                     use  \r\n\r\n Sårstift                 Wound stick                Sticks  \r\n\r\n  Tablet                  Tabletter                  Tablets  \r\n\r\n  Tablet for rectal  \r\n\r\n  solution                Tabletter til rektalvæske, Rectal  \r\n\r\n                          opløsning                  preparations  \r\n\r\n  Tablet for rectal  \r\n\r\n  suspension              Tabletter til rektalvæske, Rectal  \r\n\r\n                          suspension                 preparations  \r\n\r\n  Tablet for vaginal  \r\n\r\n  solution                Tabletter til  \r\n\r\n                          vaginalskyllevæske,        DLS 97  \r\n\r\n                          opløsning  \r\n\r\n  Tablet                  Tabletter                  DLS 97  \r\n\r\n Tabletter med  \r\n\r\n  modificeret udløsning   Modified release tablet    DLS 97  \r\n\r\n Tabletter til  \r\n\r\n  gurglevand, opløsning   Gargle, tablet for  \r\n\r\n                          solution                   DLS 97  \r\n\r\n Tabletter til  \r\n\r\n  implantation            Implantation tablet        DLS 97  \r\n\r\n                                                     (Implantat)  \r\n\r\n Tabletter til  \r\n\r\n  inhalationsdamp         Inhalation vapour, tablet  Preparations  \r\n\r\n                                                     for inhalation  \r\n\r\n Tabletter til  \r\n\r\n  mundskyllevæske,        Mouth wash, tablet for  \r\n\r\n  opløsning               solution                   DLS 97  \r\n\r\n Tabletter til  \r\n\r\n  rektalvæske,            Tablet for rectal  \r\n\r\n  opløsning               solution                   Rectal  \r\n\r\n                                                     preparations  \r\n\r\n Tabletter til  \r\n\r\n  rektalvæske,            Tablet for rectal  \r\n\r\n  suspension              suspension                 Rectal  \r\n\r\n                                                     preparations  \r\n\r\n Tabletter til  \r\n\r\n  vaginalskyllevæske,     Tablet for vaginal  \r\n\r\n  opløsning               solution                   DLS 97  \r\n\r\n Tandkødsgel              Gingival gel               DLS 97  \r\n\r\n Tandkødsopløsning        Gingival solution          DLS 97  \r\n\r\n Tandkødspasta            Gingival paste             DLS 97  \r\n\r\n Tandpasta                Toothpaste                 Topical semi-  \r\n\r\n                                                     solid  \r\n\r\n                                                     preparations  \r\n\r\n  Toothpaste              Tandpasta                  Topical semi-  \r\n\r\n                                                     solid  \r\n\r\n                                                     preparations  \r\n\r\n  Transdermal patch       Depotplastre               DLS 97  \r\n\r\n Tyggetabletter           Chewable tablet            Tablets  \r\n\r\n  Urethral gel            Uretralgel                 Topical semi-  \r\n\r\n                                                     solid  \r\n\r\n                                                     preparations  \r\n\r\n  Urethral stick          Uretralstift               Sticks  \r\n\r\n Uretralgel               Urethral gel               Topical semi-  \r\n\r\n                                                     solid  \r\n\r\n                                                     preparations  \r\n\r\n Uretralstift             Urethral stick             Sticks  \r\n\r\n Urtete                   Herbal tea                 DLS 97  \r\n\r\n Uteritorier              Uteritory                  DLS 97  \r\n\r\n  Uteritory               Uteritorier                DLS 97  \r\n\r\n  Vaginal capsule         Vaginalkapsler             DLS 97  \r\n\r\n  Vaginal capsule, hard   Vaginalkapsler, hårde      Vaginal  \r\n\r\n                                                     preparations  \r\n\r\n  Vaginal capsule, soft   Vaginalkapsler, bløde      Vaginal  \r\n\r\n                                                     preparations  \r\n\r\n  Vaginal cream           Vaginalcreme               DLS 97  \r\n\r\n  Vaginal device          Vaginalindlæg              DLS 97  \r\n\r\n  Vaginal emulsion        Vaginalskyllevæske,  \r\n\r\n                          emulsion                   DLS 97  \r\n\r\n                                                     (Vaginalskylle-  \r\n\r\n                                                     væske)  \r\n\r\n  Vaginal foam            Vaginalskum                Vaginal  \r\n\r\n                                                     preparations  \r\n\r\n  Vaginal gel             Vaginalgel                 DLS 97  \r\n\r\n  Vaginal liquid          Vaginalskyllevæske         DLS 97  \r\n\r\n  Vaginal ointment        Vaginalsalve               DLS 97  \r\n\r\n  Vaginal solution        Vaginalskyllevæske,  \r\n\r\n                          opløsning                  DLS 97  \r\n\r\n                                                     (Vaginalskylle-  \r\n\r\n                                                     væske)  \r\n\r\n  Vaginal suspension      Vaginalskyllevæske,  \r\n\r\n                          suspension                 DLS 97  \r\n\r\n                                                     (Vaginalskylle-  \r\n\r\n                                                     væske)  \r\n\r\n  Vaginal tablet          Vaginaltabletter           Vaginal  \r\n\r\n                                                     preparations  \r\n\r\n  Vaginal tampon          Vaginaltampon              Vaginal  \r\n\r\n                                                     preparations  \r\n\r\n Vaginalcreme             Vaginal cream              DLS 97  \r\n\r\n Vaginalgel               Vaginal gel                DLS 97  \r\n\r\n Vaginalindlæg            Vaginal device             DLS 97  \r\n\r\n Vaginalkapsler           Vaginal capsule            DLS 97  \r\n\r\n Vaginalkapsler, bløde    Vaginal capsule, soft      Vaginal  \r\n\r\n                                                     preparations  \r\n\r\n Vaginalkapsler, hårde    Vaginal capsule, hard      Vaginal  \r\n\r\n                                                     preparations  \r\n\r\n Vaginalsalve             Vaginal ointment           DLS 97  \r\n\r\n Vaginalskum              Vaginal foam               Vaginal  \r\n\r\n                                                     preparations  \r\n\r\n Vaginalskyllevæske       Vaginal liquid             DLS 97  \r\n\r\n Vaginalskyllevæske,  \r\n\r\n  emulsion                Vaginal emulsion           DLS 97  \r\n\r\n                                                     (Vaginalskylle-  \r\n\r\n                                                     væske)  \r\n\r\n Vaginalskyllevæske,  \r\n\r\n  opløsning               Vaginal solution           DLS 97  \r\n\r\n                                                     (Vaginalskylle-  \r\n\r\n                                                     væske)  \r\n\r\n Vaginalskyllevæske,  \r\n\r\n  suspension              Vaginal suspension         DLS 97  \r\n\r\n                                                     (Vaginalskylle-  \r\n\r\n                                                     væske)  \r\n\r\n Vaginaltabletter         Vaginal tablet             Vaginal  \r\n\r\n                                                     preparations  \r\n\r\n Vaginaltampon            Vaginal tampon             Vaginal  \r\n\r\n                                                     preparations  \r\n\r\n Vagitorier               Pessary                    Vaginal  \r\n\r\n                                                     preparations  \r\n\r\n Vagitorier               Pessary                    DLS 97  \r\n\r\n Vagitorier, hurtigt  \r\n\r\n  henfaldende             Effervescent vaginal  \r\n\r\n                          tablet                     DLS 97  \r\n\r\n Væske til  \r\n\r\n  inhalationsdamp         Inhalation vapour, liquid  Preparations  \r\n\r\n                                                     for inhalation  \r\n\r\n Vævsklæber               Sealant                    DLS 97  \r\n\r\n  Wound stick             Sårstift                   Sticks  \r\n\r\n Øjenbadevand             Eye lotion                 Eye  \r\n\r\n                                                     preparations  \r\n\r\n Øjencreme                Eye cream                  Eye  \r\n\r\n                                                     preparations  \r\n\r\n Øjendråber               Eye drops                  DLS 97  \r\n\r\n Øjendråber, opløsning    Eye drops, solution        Eye  \r\n\r\n                                                     preparations  \r\n\r\n Øjendråber, suspension   Eye drops, suspension      Eye  \r\n\r\n                                                     preparations  \r\n\r\n Øjengel                  Eye gel                    Eye  \r\n\r\n                                                     preparations  \r\n\r\n Øjenlamel                Ophthalmic insert          Eye  \r\n\r\n                                                     preparations  \r\n\r\n Øjensalve                Eye ointment               Eye  \r\n\r\n                                                     preparations  \r\n\r\n Ørecreme                 Ear cream                  Ear  \r\n\r\n                                                     preparations  \r\n\r\n Øredråber                Ear drops                  DLS 97  \r\n\r\n Øredråber, emulsion      Ear drops, emulsion        Ear  \r\n\r\n                                                     preparations  \r\n\r\n Øredråber, opløsning     Ear drops, solution        Ear  \r\n\r\n                                                     preparations  \r\n\r\n Øredråber, suspension    Ear drops, suspension      Ear  \r\n\r\n                                                     preparations  \r\n\r\n Øregel                   Ear gel                    Ear  \r\n\r\n                                                     preparations  \r\n\r\n Ørepudder                Ear powder                 Ear  \r\n\r\n                                                     preparations  \r\n\r\n Øresalve                 Ear ointment               Ear  \r\n\r\n                                                     preparations  \r\n\r\n Øreskyllevæske           Ear wash                   DLS 97  \r\n\r\n Øreskyllevæske,  \r\n\r\n  emulsion                Ear wash, emulsion         Ear  \r\n\r\n                                                     preparations  \r\n\r\n Øreskyllevæske,  \r\n\r\n  opløsning               Ear wash, solution         Ear  \r\n\r\n                                                     preparations  \r\n\r\n Ørespray                 Ear spray                  DLS 97  \r\n\r\n Ørespray, emulsion       Ear spray, emulsion        Ear  \r\n\r\n                                                     preparations  \r\n\r\n Ørespray, opløsning      Ear spray, solution        Ear  \r\n\r\n                                                     preparations  \r\n\r\n Ørespray, suspension     Ear spray, suspension      Ear  \r\n\r\n                                                     preparations  \r\n\r\n Ørestift                 Ear stick                  Sticks  \r\n\r\n Øretampon                Ear tampon                 Ear  \r\n\r\n                                                     preparations  \r\n\r\n</PRE>  \r\n\r\n<P> <B>STANDARDER FOR LÆGEMIDDELFORMER SAMT TERMER DER KAN BENYTTES TIL  \r\n\r\n MÆRKNING</B>  </P>  \r\n\r\n<P>BADEADDITIV </P>  \r\n\r\n<P> <I>Et badeadditiv er beregnet til tilsætning til bad eller badevand.</I>  \r\n\r\n</P>  \r\n\r\n<P>BOLI </P>  \r\n\r\n<P> <I>Boli er beregnet for dyr. De indeholder lægemiddelstof i doseret  \r\n\r\n mængde og er beregnet til peroralt brug. Boli fremstilles i passende  \r\n\r\n størrelse og form ved f.eks. støbning eller komprimering. </I></P>  \r\n\r\n<P>PRØVE </P>  \r\n\r\n<P> <B>Massevariation</B> Boli skal holde prøven &#187;Uniformity of mass of  \r\n\r\n single-dose preparations&#171; for tabletter i Ph. Eur. 3rd Ed., 2.9.5. </P>  \r\n\r\n<P>DENTALPULVER </P>  \r\n\r\n<P> <I>Dentalpulver er et pulver, beregnet til applikation på tænder</I> .  \r\n\r\n</P>  \r\n\r\n<P>DENTALVÆSKE ** </P>  \r\n\r\n<P> <I>Dentalvæske er en betegnelse beregnet til mærkning af såvel  \r\n\r\n dentalemulsion, dentalopløsning som dentalsuspension.</I>  </P>  \r\n\r\n<P>DEPOTGRANULAT * </P>  \r\n\r\n<P> <I>Depotgranulater er granulater, hvor lægemiddelstof er helt eller  \r\n\r\n delvis beregnet til langsomt at frigives og absorberes fra mavesæk og/eller  \r\n\r\n tarm eller til lokalvirkning i mavesæk og/eller tarm.</I>  </P>  \r\n\r\n<P>Depotgranulater skal opfylde kravene for <B>Granules</B> ,  \r\n\r\n Modified-release Granules, Ph. Eur. 3rd Ed. og prøve for udløsning under  \r\n\r\n anvendelse af de apparater og metoder, der er beskrevet under  \r\n\r\n &#187;Dissolution test for solid oral dosage forms&#171; i Ph. Eur. 3rd Ed.,  \r\n\r\n 2.9.3., samt nedenstående prøve. </P>  \r\n\r\n<P>PRØVE </P>  \r\n\r\n<P> <B>Doseringsegenskab</B> 20 doser depotgranulat, afmålt som strøget mål  \r\n\r\n under anvendelse af det tilhørende medicinmål, vejes enkeltvis, og  \r\n\r\n gennemsnitsmassen beregnes. Af de vejede doser må højst 2 have en masse, der  \r\n\r\n afviger mere end 15% fra gennemsnitsmassen, og disse må ikke afvige mere end  \r\n\r\n 25% fra gennemsnitsmassen. Gennemsnitsmassen må højst afvige 20% fra den  \r\n\r\n tilstræbte masse. </P>  \r\n\r\n<P>DEPOTKAPSLER ** * </P>  \r\n\r\n<P> <I>Depotkapsler er hårde eller bløde kapsler, hvor lægemiddelstof er helt  \r\n\r\n eller delvist beregnet til langsomt at frigives og absorberes fra mavesæk  \r\n\r\n og/eller tarm eller til lokalvirkning i mavesæk og/eller tarm. Depotkapsler  \r\n\r\n kan anvendes til mærkning af depotkapsler, bløde og hårde.</I>  </P>  \r\n\r\n<P>Depotkapsler skal opfylde kravene for <B>Capsules</B> , Modified-release  \r\n\r\n Capsules, Ph. Eur. 3rd Ed., og prøve for udløsning under anvendelse af de  \r\n\r\n apparater og metoder, der beskrevet under &#187;Dissolution test for solid  \r\n\r\n oral dosage forms&#171; i Ph. Eur. 3rd Ed., 2.9.3. </P>  \r\n\r\n<P>DEPOTPLASTRE * </P>  \r\n\r\n<P> <I>Depotplastre er lægemidler beregnet til applikation på intakt hud. De  \r\n\r\n indeholder lægemidler i doseret mængde, beregnet til langsomt at frigives og  \r\n\r\n absorberes gennem huden.</I>  </P>  \r\n\r\n<P>Depotplastre skal opfylde kravene for <B>Transdermal patches,</B> Ph. Eur.  \r\n\r\n 3rd Ed. samt nedenstående prøve. </P>  \r\n\r\n<P>PRØVE </P>  \r\n\r\n<P> <B>Mikrobiel renhed</B> Depotplastre skal overholde de angivne krav under  \r\n\r\n kategori 2 i &#187;Mikrobiel renhed&#171; i DLS, sektion 1. Prøveopløsningen  \r\n\r\n fremstilles ved skylning af depotplastret med en egnet opløsning, umiddelbart  \r\n\r\n efter at beskyttelsesfolien er fjernet. Prøven udføres under anvendelse af  \r\n\r\n membranfiltrering. </P>  \r\n\r\n<P>DEPOTTABLETTER * </P>  \r\n\r\n<P> <I>Depottabletter er tabletter, hvor lægemiddelstof er helt eller delvist  \r\n\r\n beregnet til langsomt at frigives og absorberes fra mavesæk og/eller tarm  \r\n\r\n eller til lokalvirkning i mavesæk og/eller tarm. </I></P>  \r\n\r\n<P>Depottabletter skal opfylde kravene for <B>Tablets</B> , Modified-release  \r\n\r\n Tablets, Ph. Eur. 3rd Ed., og prøve for udløsning under anvendelse af de  \r\n\r\n apparater og metoder, der er beskrevet under &#187;Dissolution test for solid  \r\n\r\n oral dosage forms&#171; i Ph. Eur. 3rd Ed., 2.9.3., samt nedenstående prøve.  \r\n\r\n</P>  \r\n\r\n<P>PRØVE </P>  \r\n\r\n<P> <B>Dosisvariation</B> Overtrukne depottabletter skal holde prøven  \r\n\r\n &#187;Uniformity of content of single-dose preparations&#171; i Ph. Eur. 3rd  \r\n\r\n Ed., 2.9.6. For ikke-overtrukne og filmovertrukne depottabletter henvises til  \r\n\r\n bestemmelserne i monografien for <B>Tablets</B> . </P>  \r\n\r\n<P>DEPOTØJENDRÅBER </P>  \r\n\r\n<P> <I>Depotøjendråber er øjendråber, hvor lægemiddelstoffet helt eller  \r\n\r\n delvist er beregnet til langsomt at frigives til virkning i øjet.</I>  </P>  \r\n\r\n<P>DRÅBER ** </P>  \r\n\r\n<P> <I>Dråber er en betegnelse, der kan anvendes til mærkning af såvel  \r\n\r\n emulsion, opløsning som suspension.</I>  </P>  \r\n\r\n<P>ENDOCERVIKAL GEL </P>  \r\n\r\n<P> <I>Endocervikal gel er en gel, beregnet til applikation i livmoderen.</I>  \r\n\r\n</P>  \r\n\r\n<P>ENDOTRACHEOPULMONAL INSTILLATIONSVÆSKE ** </P>  \r\n\r\n<P> <I>Endotracheopulmonal instillationsvæske er en opløsning eller en  \r\n\r\n suspension, beregnet til instillation i luftrør og lunger. Betegnelsen kan  \r\n\r\n anvendes til mærkning af såvel opløsning som suspension.</I>  </P>  \r\n\r\n<P>ENDOTRACHEOPULMONAL INSTILLATIONSVÆSKE, PULVER OG SOLVENS TIL OPLØSNING  \r\n\r\n</P>  \r\n\r\n<P> <I>Endotracheopulmonal intillationsvæske, pulver og solvens til opløsning  \r\n\r\n er et pulver med tilhørende solvens, beregnet til fremstilling af  \r\n\r\n endotracheopulmonal instillationsvæske, opløsning. </I></P>  \r\n\r\n<P>ENDOTRACHEOPULMONAL INSTILLATIONSVÆSKE, PULVER TIL OPLØSNING </P>  \r\n\r\n<P> <I>Endotracheopulmonal instillationsvæske, pulver til opløsning er et  \r\n\r\n pulver, beregnet til fremstilling af endotracheopulmonal instillationsvæske,  \r\n\r\n opløsning.</I>  </P>  \r\n\r\n<P>ENTEROGRANULAT * </P>  \r\n\r\n<P> <I>Enterogranulat er et granulat, hvor lægemiddelstoffet er beregnet til  \r\n\r\n absorption fra eller lokalvirkning i tarmen. De fremstilles under anvendelse  \r\n\r\n af overtræk, der hindrer frigivelse af lægemiddelstof i mavesækken. </I></P>  \r\n\r\n<P>Enterogranulater skal opfylde kravene for <B>Granules</B> ,  \r\n\r\n Gastro-resistent Granules, Ph. Eur. 3rd Ed. samt nedenstående prøver. </P>  \r\n\r\n<P>PRØVER </P>  \r\n\r\n<P> <B>Doseringsegenskab</B> 20 doser enterogranulat, afmålt som strøget mål  \r\n\r\n under anvendelse af det tilhørende medicinmål, vejes enkeltvis, og  \r\n\r\n gennemsnitsmassen beregnes. Af de vejede doser må højst 2 have en masse, der  \r\n\r\n afviger mere end 15% fra gennemsnitsmassen, og disse må ikke afvige mere end  \r\n\r\n 25% fra gennemsnitsmassen. Gennemsnitsmassen må højst afvige 20% fra den  \r\n\r\n tilstræbte masse. </P>  \r\n\r\n<P> <B>Henfald</B> Enterogranulat svarende til 1 dosis overhældes med 100 ml  \r\n\r\n 36-38 graderC varm 0,1 N saltsyre. Blandingen hensættes under jævnlig  \r\n\r\n omrystning, og efter 2 timer må granulatkornene ikke vise tegn på henfald.  \r\n\r\n Væsken erstattes med 100 ml 36-38 graderC varm phosphatstødpude pH 6,8 R, og  \r\n\r\n blandingen hensættes under jævnlig omrystning 1 time. Herefter skal  \r\n\r\n granulatet være opløst eller dispergeret. </P>  \r\n\r\n<P>Såfremt enterogranulatets resistens i 0,1 N saltsyre eller henfaldet i  \r\n\r\n phosphatstødpude pH 6,8 R ikke kan konstateres, bestemmes indholdet af  \r\n\r\n lægemiddelstof i de to henfaldsvæsker. Herved må der i de 100 ml 0,1 N  \r\n\r\n saltsyre højst kunne påvises 10% af den pågældende lægemiddelstofmængde, og  \r\n\r\n der skal mindst være udløst 80% af lægemiddelstofmængden i de 100 ml  \r\n\r\n phosphatstødpude pH 6,8 R. </P>  \r\n\r\n<P>ENTEROKAPSLER ** * </P>  \r\n\r\n<P> <I>Enterokapsler er hårde eller bløde kapsler, hvor lægemiddelstof er  \r\n\r\n beregnet til absorption fra eller lokalvirkning i tarmen. De fremstilles  \r\n\r\n under anvendelse af kapselmateriale eller overtræk, der hindrer frigivelse af  \r\n\r\n lægemiddelstof i mavesækken. Enterokapsler kan anvendes til mærkning af  \r\n\r\n enterokapsler, bløde og hårde. </I></P>  \r\n\r\n<P>Enterokapsler skal opfylde kravene for <B>Capsules</B> , Gastro-resistant  \r\n\r\n capsules, Ph. Eur. 3rd Ed. samt nedenstående prøve. </P>  \r\n\r\n<P>PRØVE </P>  \r\n\r\n<P> <B>Henfald</B> Såfremt enterokapslernes resistens i 0,1 N saltsyre eller  \r\n\r\n henfaldet i phosphatstødpude pH 6,8 R ikke kan konstateres i henhold til  \r\n\r\n henfaldsprøven i Ph. Eur., bestemmes indholdet af lægemiddelstof i de to  \r\n\r\n henfaldsvæsker. Herved må der i den anvendte mængde 0,1 N saltsyre højst  \r\n\r\n kunne påvises 10% af den pågældende lægemiddelstofmængde, og der skal mindst  \r\n\r\n kunne påvises 80% af lægemiddelstofmængden i den anvendte mængde  \r\n\r\n phosphatstødpude pH 6,8 R. </P>  \r\n\r\n<P>ENTEROKAPSLER * </P>  \r\n\r\n<P> <I>Enterotabletter er tabletter, hvor lægemiddelstof er beregnet til  \r\n\r\n absorption fra eller lokalvirkning i tarmen. De fremstilles under anvendelse  \r\n\r\n af overtræk, der hindrer frigivelse af lægemiddelstof i mavesækken.  \r\n\r\n dollarT1'Enterotabletter skal opfylde kravene for</I> <B>Tablets</B> ,  \r\n\r\n Gastro-resistant Tablets, Ph. Eur. 3rd Ed., samt nedenstående prøver. </P>  \r\n\r\n<P>PRØVER </P>  \r\n\r\n<P> <B>Dosisvariation</B> Overtrukne enterotabletter skal holde prøven  \r\n\r\n &#187;Uniformity of content of single-dose preparations&#171; i Ph. Eur. 3rd  \r\n\r\n Ed., 2.9.6. For ikke-overtrukne og filmovertrukne enterotabletter henvises  \r\n\r\n til bestemmelserne i monografien for <B>Tablets</B> . </P>  \r\n\r\n<P> <B>Henfald</B> Såfremt enterotabletternes resistens i 0,1 N saltsyre  \r\n\r\n eller henfaldet i phosphatstødpude pH 6,8 R ikke kan konstateres i henhold  \r\n\r\n til henfaldsprøven i Ph. Eur., bestemmes indholdet af lægemiddelstof i de to  \r\n\r\n henfaldsvæsker. Herved må der i den anvendte mængde 0,1 N saltsyre højst  \r\n\r\n kunne påvises 10% af den pågældende lægemiddelstofmængde, og der skal mindst  \r\n\r\n kunne påvises 80% af lægemiddelstofmængden i den anvendte mængde  \r\n\r\n phosphatstødpude pH 6,8 R. </P>  \r\n\r\n<P>GASTROENTERAL VÆSKE ** </P>  \r\n\r\n<P> <I>Gastroenteral væske er en emulsion, opløsning eller suspension  \r\n\r\n beregnet til anvendelse i mave og/eller tarmkanal. Betegnelsen kan anvendes  \r\n\r\n til mærkning af såvel gastroenteral væske, emulsion, opløsning som  \r\n\r\n suspension.</I>  </P>  \r\n\r\n<P>GRANULAT * </P>  \r\n\r\n<P> <I>Granulater er faste lægemidler, der består af korn af såvidt muligt  \r\n\r\n ensartet størrelse. Granulater anvendes sædvanligvis til oralt brug,  \r\n\r\n eventuelt efter opløsning eller udrøring. De indeholder lægemiddelstof  \r\n\r\n beregnet til umiddelbart at frigøres for at absorberes fra mavesæk og/eller  \r\n\r\n tarm eller til lokalvirkning i mavesæk og/eller tarm. De fremstilles ved  \r\n\r\n granulering eller pelletering af pulverformede stoffer. Granulater doseres  \r\n\r\n sædvanligvis efter volumen. </I></P>  \r\n\r\n<P>Granulater beregnet til dyr kan betegnes <B></B> <I>medicinpellets</I>  .  \r\n\r\n<I>Navnet på dyrearten skal indgå i betegnelsen. Medicinpellets indeholder  \r\n\r\n sædvanligvis foderstof</I> . </P>  \r\n\r\n<P>Granulater skal opfylde kravene for <B>Granules</B> , Uncoated granules  \r\n\r\n eller Coated granules, Ph. Eur. 3rd Ed. samt nedenstående prøver. </P>  \r\n\r\n<P>PRØVER </P>  \r\n\r\n<P> <B>Henfald</B> Granulat svarende til 1 dosis eller indholdet i 1 afdelt  \r\n\r\n granulat overhældes med 100 ml 36-38 graderC varmt vand, og blandingen  \r\n\r\n hensættes ved 36-38 graderC under hyppig svingning af kolben. Efter henstand  \r\n\r\n 1/2 time skal granulatet være opløst eller dispergeret. </P>  \r\n\r\n<P> <B>Doseringsegenskab</B> 20 doser granulat, afmålt som strøget mål under  \r\n\r\n anvendelse af det tilhørende medicinmål, vejes enkeltvis, og  \r\n\r\n gennemsnitsmassen beregnes. Af de vejede doser må højst 2 have en masse, der  \r\n\r\n afviger mere end 15% fra gennemsnitsmassen, og disse må ikke afvige mere end  \r\n\r\n 25% fra gennemsnitsmassen. Gennemsnitsmassen må højst afvige 20% fra den  \r\n\r\n tilstræbte masse. </P>  \r\n\r\n<P>GRANULAT MED MODIFICERET UDLØSNING * </P>  \r\n\r\n<P> <I>Granulat med modificeret udløsning er et overtrukket eller ikke  \r\n\r\n overtrukket granulat, fremstillet med specielle hjælpestoffer eller ved en  \r\n\r\n speciel procedure som, hver for sig eller sammen, giver en modificering af  \r\n\r\n hastigheden eller stedet hvor lægemiddelstoffet udløses. Denne lægemiddelform  \r\n\r\n omfatter ikke depotgranulat eller enterogranulat. dollarT1'Granulater med  \r\n\r\n modificeret udløsning skal opfylde kravene for </I> <B>Granules</B> ,  \r\n\r\n Modified-release granules, Ph. Eur. 3rd Ed. samt nedenstående prøve. </P>  \r\n\r\n<P>PRØVE </P>  \r\n\r\n<P> <B>Doseringsegenskab</B> 20 doser granulat med modificeret udløsning,  \r\n\r\n afmålt som strøget mål under anvendelse af det tilhørende medicinmål, vejes  \r\n\r\n enkeltvis, og gennemsnitsmassen beregnes. Af de vejede doser må højst 2 have  \r\n\r\n en masse, der afviger mere end 15% fra gennemsnitsmassen, og disse må ikke  \r\n\r\n afvige mere end 25% fra gennemsnitsmassen. Gennemsnitsmassen må højst afvige  \r\n\r\n 20% fra den tilstræbte masse. </P>  \r\n\r\n<P>GURGLEVAND </P>  \r\n\r\n<P> <I>Gurglevand er en opløsning, beregnet til at gurgle.</I>  </P>  \r\n\r\n<P>IMPLANTAT * </P>  \r\n\r\n<P> <I>Implantater er faste lægemidler og indeholder lægemiddelstof i doseret  \r\n\r\n mængde beregnet til langsomt at frigives efter implantation i væv. En tablet  \r\n\r\n eller en kæde til implantation betegnes henholdsvis</I>  <B>Tablet til  \r\n\r\n implantation</B> og <B>Kæde til implantation</B> . </P>  \r\n\r\n<P>Implantater skal opfylde kravene for <B>Parenteral preparations</B> ,  \r\n\r\n Implants, Ph. Eur. 3rd Ed., samt nedenstående prøver. </P>  \r\n\r\n<P>PRØVER </P>  \r\n\r\n<P> <B>Massevariation</B> Implantater skal holde prøven &#187;Uniformity of  \r\n\r\n mass of single-dose preparations&#171; i Ph. Eur. 3rd Ed., 2.9.5. </P>  \r\n\r\n<P> <B>Dosisvariation</B> Implantater indeholdende mindre end 2 mg eller 2%  \r\n\r\n lægemiddelstof skal holde prøven &#187;Uniformity of content of single-dose  \r\n\r\n preparations&#171; i Ph. Eur. 3rd Ed., 2.9.6. </P>  \r\n\r\n<P>IMPRÆGNERET GAZE </P>  \r\n\r\n<P> <I>Imprægneret gaze er gaze, imprægneret med et eller flere  \r\n\r\n lægemiddelstoffer.</I>  </P>  \r\n\r\n<P>INFUSIONSVÆSKE * </P>  \r\n\r\n<P> <I>Infusionsvæske er en betegnelse, der kan anvendes til mærkning af  \r\n\r\n såvel infusionsvæske, emulsion, opløsning som suspension.</I>  </P>  \r\n\r\n<P>INHALATIONSDAMP ** </P>  \r\n\r\n<P> <I>Inhalationsdamp er en betegnelse, der kan anvendes til mærkning af  \r\n\r\n såvel opløsning, salve, tablet og væske til inhalationsdamp.</I>  </P>  \r\n\r\n<P>INHALATIONSGAS ** </P>  \r\n\r\n<P> <I>Inhalationsgas er en gas, beregnet til inhalation.</I>  </P>  \r\n\r\n<P>INHALATIONSPULVER ** </P>  \r\n\r\n<P> <I>Inhalationspulver er en betegnelse, der kan anvendes til mærkning af  \r\n\r\n inhalationspulver i beholdere med doseringsanordning eller som i form af  \r\n\r\n afdelte præparater.</I>  </P>  \r\n\r\n<P>INHALATIONSSPRAY ** </P>  \r\n\r\n<P> <I>Inhalationsspray er en betegnelse, der kan anvendes til mærkning af  \r\n\r\n såvel inhalationsspray, emulsion, opløsning som suspension.</I>  </P>  \r\n\r\n<P>INHALATIONSVÆSKE TIL NEBULISATOR ** </P>  \r\n\r\n<P> <I>Inhalationsvæske til nebulisator er en betegnelse, der kan anvendes  \r\n\r\n til mærkning af såvel inhalationsvæske til nebulisator, emulsion, opløsning  \r\n\r\n som suspension samt hvor inhalationsvæsken til nebulisator udelukkende består  \r\n\r\n af aktivt lægemiddelstof.</I>  </P>  \r\n\r\n<P>INJEKTIONSVÆSKE ** </P>  \r\n\r\n<P> <I>Injektionsvæske er en betegnelse, der kan anvendes til mærkning af  \r\n\r\n såvel injektionsvæske, emulsion, opløsning som suspension.</I>  </P>  \r\n\r\n<P>INTRAMAMMARIER * </P>  \r\n\r\n<P> <I>Intramammarier indeholder lægemiddelstof, sædvanligvis i doseret  \r\n\r\n mængde, og er beregnet til dyr til indføring i mælkekirtlen gennem  \r\n\r\n pattekanalen.</I>  </P>  \r\n\r\n<P>Forbrugerpakninger indeholdende intramammarier skal være forsynet med en  \r\n\r\n egnet indføringsspids. </P>  \r\n\r\n<P>Intramammarier skal opfylde kravene for <B>Intramammary praeparations for  \r\n\r\n veterinary use</B> , Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>INTRAUTERINT INDLÆG </P>  \r\n\r\n<P> <I>Intrauterint indlæg er et indlæg, beregnet til brug i urinvejene, hvor  \r\n\r\n lægemiddelstoffet helt eller delvist frigives langsomt.</I>  </P>  \r\n\r\n<P>KAPSLER ** </P>  \r\n\r\n<P> <I>Kapsler er en betegnelse, der kan anvendes til mærkning af kapsler,  \r\n\r\n hårde eller bløde.</I>  </P>  \r\n\r\n<P>KAPSLER MED MODIFICERET UDLØSNING * </P>  \r\n\r\n<P> <I>Kapsler med modificeret udløsning er hårde eller bløde kapsler,  \r\n\r\n fremstillet med specielle hjælpestoffer eller ved en procedure, som giver en  \r\n\r\n modificering af hastigheden eller stedet hvor lægemiddelstoffet udløses.  \r\n\r\n Denne lægemiddelform omfatter ikke depotkapsler eller enterokapsler. </I></P>  \r\n\r\n<P>Kapsler med modificeret udløsning skal opfylde kravene for  \r\n\r\n<B>Capsules</B>  , Modified-release Capsules, Ph. Eur. 3rd Ed., og prøve for  \r\n\r\n udløsning under anvendelse af de apparater og metoder, der er beskrevet under  \r\n\r\n &#187;Dissolution test for solid oral dosage forms&#171; i Ph. Eur. 3rd Ed.,  \r\n\r\n 2.9.3. </P>  \r\n\r\n<P>KOLLODIUM </P>  \r\n\r\n<P> <I>Kollodium er en væske, der sædvanligvis indeholder pyroxylin i en  \r\n\r\n blanding af ether og ethanol. På applikationsstedet vil der dannes en  \r\n\r\n fleksibel film.</I>  </P>  \r\n\r\n<P>KUTAN SPRAY ** </P>  \r\n\r\n<P> <I>Kutan spray er en opløsning, et pulver eller en suspension beregnet  \r\n\r\n til applikation på huden ved forstøvning. Betegnelsen spray kan anvendes til  \r\n\r\n mærkning af såvel kutan spray, opløsning, pulver som suspension.</I>  </P>  \r\n\r\n<P>LINIMENT ** </P>  \r\n\r\n<P> <I>Liniment er en betegnelse der kan anvendes til mærkning af såvel  \r\n\r\n liniment emulsion, opløsning som suspension.</I>  </P>  \r\n\r\n<P>MEDICINSK TYGGEGUMMI </P>  \r\n\r\n<P> <I>Medicinsk tyggegummi er et fast, doseret lægemiddel fremstillet af en  \r\n\r\n neutral gummibase, der kan være tilsat aromatiserende og smagskorrigerende  \r\n\r\n stoffer. Medicinsk tyggegummi frigiver lægemiddelstof ved tygning og må ikke  \r\n\r\n synkes.</I>  </P>  \r\n\r\n<P>MIKSTUR ** </P>  \r\n\r\n<P> <I>Mikstur er en betegnelse der kan anvendes til mærkning af såvel  \r\n\r\n mikstur, emulsion, opløsning som suspension samt hvor miksturen udelukkende  \r\n\r\n består af aktivt lægemiddelstof.</I>  </P>  \r\n\r\n<P>MUNDHULEDRÅBER </P>  \r\n\r\n<P> <I>Mundhuledråber er flydende lægemidler, beregnet til anvendelse i  \r\n\r\n mundhulen.</I>  </P>  \r\n\r\n<P>MUNDHULEGEL </P>  \r\n\r\n<P> <I>Mundhulegel er en gel, beregnet til anvendelse i mundhulen.</I>  </P>  \r\n\r\n<P>MUNDHULEKAPSLER </P>  \r\n\r\n<P> <I>Mundhulekapsler er kapsler, beregnet til lokal virkning i mundhulen  \r\n\r\n efter tygning af kapslen.</I>  </P>  \r\n\r\n<P>MUNDHULEPASTA </P>  \r\n\r\n<P> <I>Mundhulepasta er en pasta, beregnet til anvendelse i mundhulen.</I>  \r\n\r\n</P>  \r\n\r\n<P>MUNDHULESPRAY, OPLØSNING </P>  \r\n\r\n<P> <I>Mundhulespray opløsning er en væske, beregnet til forstøvning i  \r\n\r\n mundhulen. Lægemiddelformen omfatter spray med forstøvning ved hjælp af  \r\n\r\n mekaniske anordninger såvel som forstøvning med hjælp af drivgasser.</I>  \r\n\r\n</P>  \r\n\r\n<P>MUNDHULEVÆSKE </P>  \r\n\r\n<P> <I>Mundhulevæske er en opløsning eller en suspension, beregnet til  \r\n\r\n anvendelse i mundhulen. Lægemiddelformen omfatter ikke gurglevand.  \r\n\r\n Betegnelsen kan anvendes til mærkning af såvel mundhulevæske, opløsning som  \r\n\r\n suspension.</I>  </P>  \r\n\r\n<P>MUNDSKYLLEVÆSKE </P>  \r\n\r\n<P> <I>Mundskyllevæske er en væske, beregnet til vask af mundhulen.</I>  </P>  \r\n\r\n<P>NÆSEDRÅBER ** </P>  \r\n\r\n<P> <I>Næsedråber er en betegnelse, der kan anvendes til mærkning af såvel  \r\n\r\n næsedråber, emulsion, opløsning som suspension.</I>  </P>  \r\n\r\n<P>NÆSESPRAY ** </P>  \r\n\r\n<P> <I>Næsespray er en betegnelse, der kan anvendes til mærkning af såvel  \r\n\r\n næsespray, emulsion, opløsning som suspension.</I>  </P>  \r\n\r\n<P>OBLATKAPSLER </P>  \r\n\r\n<P> <I>Oblatkapsler er en fast, skive-formet lægemiddelform bestående af et  \r\n\r\n papirlignende, opløseligt omslag, indeholdende en doseret mængde lægemiddel  \r\n\r\n til oral anvendelse. </I></P>  \r\n\r\n<P>OMSLAG </P>  \r\n\r\n<P> <I>Omslag er en blød masse, der skal opvarmes inden applikation på huden.  \r\n\r\n Fæstnes sædvanligvis med gaze.</I>  </P>  \r\n\r\n<P>OPLØSNING TIL IONTOFORESE </P>  \r\n\r\n<P> <I>Opløsning til iontoforese er en opløsning, beregnet til anvendelse ved  \r\n\r\n iontophorese.</I>  </P>  \r\n\r\n<P>ORGANOPBEVARINGSVÆSKE </P>  \r\n\r\n<P> <I>Organopbevaringsvæske er en steril vandig væske beregnet til  \r\n\r\n anvendelse ved opbevaring og beskyttelse af organer.</I>  </P>  \r\n\r\n<P>OVERTRUKNE TABLETTER * </P>  \r\n\r\n<P> <I>Overtrukne tabletter er tabletter ovetrukket med et eller flere lag af  \r\n\r\n forskellige stoffer. f.eks. naturligt eller syntetisk harpiks, gummi,  \r\n\r\n gelatine, aktive eller inaktive hjælpestoffer, sukkerarter, blødgørere,  \r\n\r\n polyoler, voks, farvestoffer, smagsstoffer samt lægemiddelstoffer.  \r\n\r\n Lægemiddelformen omfatter ikke tabletter hvor overtrækket består af et tyndt  \r\n\r\n polymert lag, i så fald henvises til lægemiddelformen</I>  <B>Filmovertrukket  \r\n\r\n tablet</B> . </P>  \r\n\r\n<P>Overtrukne tabletter skal opfylde kravene for <B>Tablets</B> , Coated  \r\n\r\n tablets, Ph. Eur. 3rd Ed., samt nedenstående prøve. </P>  \r\n\r\n<P>PRØVE </P>  \r\n\r\n<P> <B>Dosisvariation</B> Overtrukne tabletter skal holde prøven  \r\n\r\n &#187;Uniformity of content of single-dose preparations&#171; i Ph. Eur. 3rd  \r\n\r\n Ed., 2.9.6. </P>  \r\n\r\n<P>PREMIX * </P>  \r\n\r\n<P> <I>Premix er blandinger af et eller flere lægemidler i en egnet  \r\n\r\n grundmasse, udelukkende beregnet til opblanding med foder inden  \r\n\r\n administration til dyr. Premix fremstilles som pulver eller granulat.  \r\n\r\n</I></P>  \r\n\r\n<P>Premix skal opfylde kravene for <B>Premixes for medicated feeding stuffs  \r\n\r\n for veterinary use,</B> Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>PULVER OG SOLVENS TIL ENDOCERVIKAL GEL </P>  \r\n\r\n<P> <I>Pulver og solvens til endocervikal gel er et pulver med tilhørende  \r\n\r\n solvens, beregnet til fremstilling af endocervikalgel.</I>  </P>  \r\n\r\n<P>PULVER OG SOLVENS TIL ØJENDRÅBER </P>  \r\n\r\n<P> <I>Pulver og solvens til øjendråber er pulver og et tilhørende solvens,  \r\n\r\n beregnet til fremstilling af øjendråber, opløsning eller suspension.</I>  \r\n\r\n</P>  \r\n\r\n<P>PULVER TIL GURGLEVAND, OPLØSNING </P>  \r\n\r\n<P> <I>Pulver til gurglevand er et pulver, beregnet til fremstilling af  \r\n\r\n gurglevand.</I>  </P>  \r\n\r\n<P>PULVER TIL INFUSIONSVÆSKE ** </P>  \r\n\r\n<P> <I>Pulver til infusionsvæske er en betegnelse, der kan anvendes til  \r\n\r\n mærkning af pulver til infusionsvæske, opløsning.</I>  </P>  \r\n\r\n<P>PULVER TIL INJEKTIONSVÆSKE ** </P>  \r\n\r\n<P> <I>Pulver til injektionsvæske er en betegnelse, der kan anvendes til  \r\n\r\n såvel mærkning af pulver til injektionsvæske, opløsning som suspension.</I>  \r\n\r\n</P>  \r\n\r\n<P>RADIOAKTIV MÆRKNINGSOPLØSNING </P>  \r\n\r\n<P> <I>Radioaktiv mærkningsopløsning er en opløsning, beregnet til  \r\n\r\n fremstilling af et radiofarmaceutisk præparat.</I>  </P>  \r\n\r\n<P>RADIONUKLIDGENERATOR </P>  \r\n\r\n<P> <I>Radionukleidgeneratorer er systemer, der indeholder en stationær  \r\n\r\n radioaktiv modernuklid, der producerere en radioaktiv datternuklid. Denne  \r\n\r\n isoleres ved eluering eller ved en anden metode med henblik på anvendelse i  \r\n\r\n et radioaktivt lægemiddel.</I>  </P>  \r\n\r\n<P>Radionuklidgeneratorer skal opfylde kravene for  <B>Radiopharmaceutical  \r\n\r\n preparations</B> , Ph. Eur. 3rd Ed. </P>  \r\n\r\n<P>REKTALVÆSKE ** </P>  \r\n\r\n<P> <I>Rektalvæske er en betegnelse der kan anvendes til mærkning af såvel  \r\n\r\n rektalvæske, emulsion, opløsning som suspension.</I>  </P>  \r\n\r\n<P>SMELTETABLETTER </P>  \r\n\r\n<P> <I>Smeltetabletter er faste, doserede lægemidler beregnet til hurtig  \r\n\r\n udløsning efter placering på tungen. De kan eventuelt opløses i vand inden  \r\n\r\n anvendelsen. Smeltetabletter fremstilles i egnet form ved frysetørring af  \r\n\r\n lægemiddelstoffet.</I> </P>  \r\n\r\n<P>SOLVENS TIL PARENTERALT BRUG </P>  \r\n\r\n<P> <I>Solvens til parenteralt brug er et solvens, beregnet til anvendelse  \r\n\r\n ved rekonstitution af parenterale lægemidler.</I>  </P>  \r\n\r\n<P>SOLVENS TIL REKONSTITUTION AF ØJENBADEVAND </P>  \r\n\r\n<P> <I>Solvens til rekonstitution af øjenbadevand er et solvens, beregnet til  \r\n\r\n rekonstitution af øjenbadevand.</I>  </P>  \r\n\r\n<P>SOLVENS TIL REKONSTITUTION AF ØJENDRÅBER </P>  \r\n\r\n<P> <I>Solvens til rekonstitution af øjendråber er et solvens, beregnet til  \r\n\r\n rekonstitution af øjendråber.</I>  </P>  \r\n\r\n<P>TABLETTER ** </P>  \r\n\r\n<P> <I>Betegnelsen tabletter kan anvendes til mærkning af såvel tabletter,  \r\n\r\n overtrukne tabletter som filmovertrukne tabletter.</I>  </P>  \r\n\r\n<P>TABLETTER MED MODIFICERET UDLØSNING * </P>  \r\n\r\n<P> <I>Tabletter med modificeret udløsning er overtrukne eller ikke  \r\n\r\n overtrukne tabletter, som fremstillet med specielle hjælpestoffer eller ved  \r\n\r\n en speciel procedure giver en modificering af hastigheden eller stedet hvor  \r\n\r\n lægemiddelstoffet udløses. Denne lægemiddelform omfatter ikke depottabletter  \r\n\r\n eller enterotabletter. </I></P>  \r\n\r\n<P>Tabletter med modificeret udløsning skal opfylde kravene for  <B>Tablets  \r\n\r\n</B>  , Modified-release tablets, Ph. Eur. 3rd Ed., og prøve for udløsning  \r\n\r\n under anvendelse af de apparater og metoder, der er beskrevet under  \r\n\r\n &#187;Dissolution test for solid oral dosage forms&#171; i Ph. Eur. 3rd Ed.,  \r\n\r\n 2.9.3., samt nedenstående prøve. </P>  \r\n\r\n<P>PRØVE </P>  \r\n\r\n<P> <B>Dosisvariation</B> Overtrukne tabletter skal holde prøven  \r\n\r\n &#187;Uniformity of content of single-dose preparations&#171; i Ph. Eur. 3rd  \r\n\r\n Ed., 2.9.6. For ikke-overtrukne og filmovertrukne tabletter henvises til  \r\n\r\n bestemmelserne i monografien for <B>Tablets</B> . </P>  \r\n\r\n<P>TABLETTER TIL GURGLEVAND, OPLØSNING </P>  \r\n\r\n<P> <I>Tabletter til gurglevand er tabletter, beregnet til fremstilling af  \r\n\r\n gurglevand.</I>  </P>  \r\n\r\n<P>TABLETTER TIL MUNDSKYLLEVÆSKE, OPLØSNING </P>  \r\n\r\n<P> <I>Tabletter til mundskyllevæske er tabletter, beregnet til fremstilling  \r\n\r\n af mundskyllevæske.</I>  </P>  \r\n\r\n<P>TABLETTER TIL VAGINALSKYLLEVÆSKE, OPLØSNING </P>  \r\n\r\n<P> <I>Tabletter til vaginalskyllevæske er tabletter, beregnet til  \r\n\r\n fremstilling af vaginalskyllevæske.</I>  </P>  \r\n\r\n<P>TANDKØDSGEL </P>  \r\n\r\n<P> <I>Tandkødsgel er en gel, beregnet til applikation på tandkødet.</I>  \r\n\r\n</P>  \r\n\r\n<P>TANDKØDSOPLØSNING </P>  \r\n\r\n<P> <I>Tandkødsopløsning er en opløsning, beregnet til applikation på  \r\n\r\n tandkødet.</I>  </P>  \r\n\r\n<P>TANDKØDSPASTA </P>  \r\n\r\n<P> <I>Tandkødspasta er en pasta, beregnet til applikation på tandkødet.</I>  \r\n\r\n</P>  \r\n\r\n<P>URTETE </P>  \r\n\r\n<P> <I>Urtete er et naturlægemiddel bestående af en eller flere tørrede  \r\n\r\n vegetabilske droger, beregnet til anvendelse ved tilberedning af en dekokt,  \r\n\r\n infus eller maceration til oral anvendelse. </I></P>  \r\n\r\n<P>UTERITORIER </P>  \r\n\r\n<P> <I>Uteritorier indeholder lægemiddelstof i doseret mængde og er beregnet  \r\n\r\n til indføring i uterus. De fremstilles i egnet form ved presning, støbning  \r\n\r\n eller komprimering. </I></P>  \r\n\r\n<P>PRØVER </P>  \r\n\r\n<P> <B>Massevariation</B> Uteritorier skal holde prøven &#187;Uniformity of  \r\n\r\n mass of singledose preparations&#171; for suppositorier og vagitorier i Ph.  \r\n\r\n Eur. 3rd Ed., 2.9.5. </P>  \r\n\r\n<P> <B>Dosisvariation</B> Uteritorier indeholdende mindre end 2 mg eller 2%  \r\n\r\n lægemiddelstof, der ikke er helt opløst i grundmassen, skal holde prøven  \r\n\r\n &#187;Uniformity of content of single-dose preparations&#171; for vagitorier  \r\n\r\n i Ph. Eur. 3rd Ed., 2.9.6. </P>  \r\n\r\n<P> <B>Henfald</B> Pressede og støbte uteritorier skal ved udførelse af  \r\n\r\n prøven &#187;Disintegration of suppositories and pessaries&#171; i Ph. Eur.  \r\n\r\n 3rd Ed., 2.9.2., henfalde i vand inden for 60 minutter. Komprimerede  \r\n\r\n uteritorier skal ved udførelse af den tilsvarende prøve for &#187;Vaginal  \r\n\r\n tablets&#171; henfalde i vand inden for 30 minutter. </P>  \r\n\r\n<P> <B>Mikrobiel renhed</B> Uteritorier til veterinært brug skal overholde de  \r\n\r\n angivne krav under kategori 2 i &#187;Mikrobiel renhed&#171; i DLS, sektion  \r\n\r\n 1. </P>  \r\n\r\n<P>VAGINALCREME </P>  \r\n\r\n<P> <I>Vaginalcreme er en creme, beregnet til brug i vagina, sædvanligvis til  \r\n\r\n lokal virkning.</I>  </P>  \r\n\r\n<P>VAGINALGEL </P>  \r\n\r\n<P> <I>Vaginalgel er en gel, beregnet til brug i vagina, sædvanligvis til  \r\n\r\n lokal virkning.</I>  </P>  \r\n\r\n<P>VAGINALINDLÆG </P>  \r\n\r\n<P> <I>Vaginalindlæg er et indlæg, beregnet til brug i vagina, hvor  \r\n\r\n lægemiddelstoffet helt eller delvist frigives langsomt.</I>  </P>  \r\n\r\n<P>VAGINALKAPSLER </P>  \r\n\r\n<P> <I>Vaginalkapsler er en betegnelse, der kan anvendes til mærkning af  \r\n\r\n vaginalkapsler, hårde eller bløde.</I>  </P>  \r\n\r\n<P>VAGINALSALVE </P>  \r\n\r\n<P> <I>Vaginalsalve er en salve, beregnet til brug i vagina, sædvanligvis til  \r\n\r\n lokal virkning.</I>  </P>  \r\n\r\n<P>VAGINALSKYLLEVÆSKE ** </P>  \r\n\r\n<P> <I>Vaginalskyllevæske er en betegnelse der kan anvendes til mærkning af  \r\n\r\n såvel vaginalskyllevæske, opløsning, emulsion som suspension. </I></P>  \r\n\r\n<P>Vaginalskyllevæske er en opløsning, emulsion eller suspension beregnet til  \r\n\r\n skylning i vagina. </P>  \r\n\r\n<P>VAGITORIER ** </P>  \r\n\r\n<P> <I>Vagitorier er en betegnelse der kan anvendes til faste doserede  \r\n\r\n vaginale lægemiddelformer, vaginalkapsler er dog undtaget.</I>  </P>  \r\n\r\n<P>VAGITORIER, HURTIGT HENFALDENDE </P>  \r\n\r\n<P> <I>Hurtigt henfaldende vagitorier, henfalder hurtigt efter  \r\n\r\n administration.</I>  </P>  \r\n\r\n<P>VÆVSKLÆBER </P>  \r\n\r\n<P> <I>Vævsklæber er et klæbemiddel eller en lim, beregnet til sammenhæftning  \r\n\r\n af væv.</I>  </P>  \r\n\r\n<P>ØJENDRÅBER ** </P>  \r\n\r\n<P> <I>Øjendråber er en betegnelse, der kan anvendes til mærkning af såvel  \r\n\r\n øjendråber, opløsning som suspension.</I>  </P>  \r\n\r\n<P>ØREDRÅBER ** </P>  \r\n\r\n<P> <I>Øredråber er en betegnelse, der kan anvendes til mærkning af såvel  \r\n\r\n øredråber, emulsion, opløsning som suspension.</I>  </P>  \r\n\r\n<P>ØRESKYLLEVÆSKE ** </P>  \r\n\r\n<P> <I>Øreskyllevæske er en betegnelse, der kan anvendes til mærkning af  \r\n\r\n såvel øreskyllevæske, emulsion som suspension.</I>  </P>  \r\n\r\n<P>ØRESPRAY ** </P>  \r\n\r\n<P> <I>Ørespray er en betegnelse, der kan anvendes til mærkning af såvel  \r\n\r\n ørespray, emulsion, opløsning som suspension.</I>  </P>  \r\n\r\n<P> <B>INTRODUKTION TIL FORTEGNELSE OVER STANDARDTERMER FOR  \r\n\r\n ADMINISTRATIONSVEJE SAMT STANDARDTERMER FOR BEHOLDERE, LUKKER MV.</B>  </P>  \r\n\r\n<P>Introduktion </P>  \r\n\r\n<P>De i dette afsnit beskrevne standarder og termer er baseret på dokumentet  \r\n\r\n<B>Standard Terms, Pharmaceutical Dosage Forms, Routes of Administration,  \r\n\r\n Containers</B> , der er vedtaget af den europæiske Farmakopekommission og er  \r\n\r\n publiceret i et særnummer af Pharmeuropa (oktober 1996). Disse standarder og  \r\n\r\n termer forventes sat i kraft i alle EU medlemslande den 1. januar 1997, for  \r\n\r\n nye ansøgninger. I skrivende stund er den endelige afgørelse ikke truffet,  \r\n\r\n men når det sker, vil det blive publiceret i Statstidende og i fagpresse,  \r\n\r\n ligesom brancheorganisationerne vil blive underrettet. </P>  \r\n\r\n<P>Søgeord </P>  \r\n\r\n<P>I første spalte i fortegnelsen er samtlige termer, engelske som danske, i  \r\n\r\n alfabetisk orden som søgeord. Den danske betegnelse vil dog kun optræde i  \r\n\r\n første spalte såfremt betegnelserne ikke er identiske. Til den engelske  \r\n\r\n standardterm (anført med halvfed skrifttype) i fortegnelsens første spalte  \r\n\r\n svarer den danske betegnelse i anden spalte. </P>  \r\n\r\n<P> <B>FORTEGNELSE OVER STANDARDTERMER FOR ADMINISTRATIONSVEJE</B>  </P>  \r\n\r\n<PRE>  \r\n\r\n Administationsvej ikke       Route of administration not  \r\n\r\n angivet                      applicable  \r\n\r\n  Auricular use               Til anvendelse i øret  \r\n\r\n  Cutaneous use               Kutan anvendelse  \r\n\r\n Dental anvendelse            Dental use  \r\n\r\n  Dental use                  Dental anvendelse  \r\n\r\n Ekstraamnional anvendelse    Extraamniotic use  \r\n\r\n  Endocervical use            Endocervikal anvendelse  \r\n\r\n Endocervikal anvendelse      Endocervical use  \r\n\r\n  Endosinusial use            Til anvendelse i bihulerne  \r\n\r\n  Endotracheopulmonary use    Endokrakeopulmonar anvendelse  \r\n\r\n Endotrakeopulmonar  \r\n\r\n  anvendelse                  Endotracheopulmonary use  \r\n\r\n Epidural anvendelse          Epidural use  \r\n\r\n  Epidural use                Epidural anvendelse  \r\n\r\n  Extraamniotic use           Ekstraamnional anvendelse  \r\n\r\n  Gastroenteral use           Gastrointestinal anvendelse  \r\n\r\n Gastrointestinal anvendelse  Gastroenteral use  \r\n\r\n  Gingival use                Til anvendelse på tandkødet  \r\n\r\n  Hemodialysis                Hæmodialyse  \r\n\r\n Hæmodialyse                  Hemodialysis  \r\n\r\n Intraamnional anvendelse     Intraamniotic use  \r\n\r\n  Intraamniotic use           Intraamnional anvendelse  \r\n\r\n  Intraarterial use           Intraarteriel anvendelse  \r\n\r\n Intraarteriel anvendelse     Intraarterial use  \r\n\r\n  Intraarticular use          Intraarticulær anvendelse  \r\n\r\n Intraartikulær anvendelse    Intraarticular use  \r\n\r\n Intrabursal anvendelse       Intrabursal use  \r\n\r\n  Intrabursal use             Intrabursal anvendelse  \r\n\r\n  Intracardiac use            Intrakardial anvendelse  \r\n\r\n  Intracavernous use          Intrakavernal anvendelse  \r\n\r\n  Intracervical use           Intracervikal anvendelse  \r\n\r\n Intracervikal anvendelse     Intracervical use  \r\n\r\n  Intracoronary use           Intrakoronar anvendelse  \r\n\r\n  Intradermal use             Intrakutan anvendelse  \r\n\r\n  Intradiscal use             Intradiskal anvendelse  \r\n\r\n Intradiskal anvendelse       Intradiscal use  \r\n\r\n Intrakardial anvendelse      Intracardiac use  \r\n\r\n Intrakavernal anvendelse     Intracavernous use  \r\n\r\n Intrakoronar anvendelse      Intracoronary use  \r\n\r\n Intrakutan anvendelse        Intradermal use  \r\n\r\n Intralymfatisk anvendelse    Intralymphatic use  \r\n\r\n Intralæsional anvendelse     Intralesional use  \r\n\r\n  Intralesional use           Intralæsional anvendelse  \r\n\r\n  Intralymphatic use          Intralymfatisk anvendelse  \r\n\r\n  Intramuscular use           Intramuskulær anvendelse  \r\n\r\n Intramuskulær anvendelse     Intramuscular use  \r\n\r\n  Intraocular use             Intraokulær anvendelse  \r\n\r\n Intraokulær anvendelse       Intraocular use  \r\n\r\n  Intraperitoneal use         Intraperitoneal anvendelse  \r\n\r\n Intraperitoneal anvendelse   Intraperitoneal use  \r\n\r\n  Intrapleural use            Intrapleural anvendelse  \r\n\r\n Intrapleural anvendelse      Intrapleural use  \r\n\r\n Intrasternal anvendelse      Intrasternal use  \r\n\r\n  Intrasternal use            Intrasternal anvendelse  \r\n\r\n Intratekal anvendelse        Intrathecal use  \r\n\r\n  Intrathecal use             Intratekak anvendelse  \r\n\r\n Intrauterin anvendelse       Intrauterine use  \r\n\r\n  Intrauterine use            Intrauterin anvendelse  \r\n\r\n Intravenøs anvendelse        Intravenous use  \r\n\r\n  Intravenous use             Intravenøs anvendelse  \r\n\r\n  Intravesical use            Intravesikal anvendelse  \r\n\r\n Intravesikal anvendelse      Intravesical use  \r\n\r\n Kutan anvendelse             Cutaneous use  \r\n\r\n  Nasal use                   Nasal anvendelse  \r\n\r\n Nasal anvendelse             Nasal use  \r\n\r\n  Ocular use                  Okulær anvendelse  \r\n\r\n Okulær anvendelse            Ocular use  \r\n\r\n  Oral use                    Oral anvendelse  \r\n\r\n Oral anvendelse              Oral use  \r\n\r\n  Oromucosal use              Til anvendelse i mundhulen  \r\n\r\n  Periarticular use           Periartikulær anvendelse  \r\n\r\n Periartikulær anvendelse     Periarticular use  \r\n\r\n Perineural anvendelse        Perineural use  \r\n\r\n  Perineural use              Perineural anvendelse  \r\n\r\n  Rectal use                  Rektal anvendelse  \r\n\r\n Rektal anvendelse            Rectal use  \r\n\r\n  Respiratory use             Til anvendelse i luftvejene  \r\n\r\n  Route of administration  \r\n\r\n  not applicable              Administrationsvej ikke angivet  \r\n\r\n  Subconjunctival use         Subconjunktival anvendelse  \r\n\r\n  Subcutaneous use            Subkutan anvendelse  \r\n\r\n Subkonjunktival anvendelse   Subconjunctival use  \r\n\r\n Subkutan anvendelse          Subcutaneous use  \r\n\r\n Til anvendelse i bihulerne   Endosinusial use  \r\n\r\n Til anvendelse i luftvejene  Respiratory use  \r\n\r\n Til anvendelse i mundhulen   Oromucosal use  \r\n\r\n Til anvendelse på tankødet   Gingival use  \r\n\r\n Til anvendelse i øret        Auricular use  \r\n\r\n Transdermal anvendelse       Transdermal use  \r\n\r\n  Transdermal use             Transdermal anvendelse  \r\n\r\n  Urethral use                Uretral anvendelse  \r\n\r\n Uretral anvendelse           Urethral use  \r\n\r\n Vaginal anvendelse           Vaginal use  \r\n\r\n  Vaginal use                 Vaginal anvendelse  \r\n\r\n  FORTEGNELSE OVER STANDARDTERMER FOR BEHOLDERE, LUKKER MV.  \r\n\r\n  Ampoule                     Ampul  \r\n\r\n Ampul                        Ampoule  \r\n\r\n  Applicator                  Applikator  \r\n\r\n Applikationspude             Dabbing applicator  \r\n\r\n Applikator                   Applicator  \r\n\r\n Applikator med nål           Needle applicator  \r\n\r\n  Bag                         Pose  \r\n\r\n  Barrel                      Tromle  \r\n\r\n  Blister                     Blister  \r\n\r\n  Bottle                      Flaske  \r\n\r\n  Box                         Æske  \r\n\r\n Brev                         Sachet  \r\n\r\n  Brush                       Pensel  \r\n\r\n  Brush applicator            Penselindsats  \r\n\r\n Bæger                        Cup  \r\n\r\n Børnesikret lukke            Child resistant closure  \r\n\r\n  Cannula                     Sprøjte  \r\n\r\n  Cap                         Låg  \r\n\r\n  Cartridge                   Cylinderampul  \r\n\r\n  Child resistant closure     Børnesikret lukke  \r\n\r\n  Cup                         Bæger  \r\n\r\n Cylinderampul                Cartridge  \r\n\r\n  Dabbing applicator          Applikationspude  \r\n\r\n Doseringspumpe               Metering pump  \r\n\r\n Doseringsventil              Metering valve  \r\n\r\n  Dredging applicator         Strølåg  \r\n\r\n  Dropper applicator          Dråbeindsats  \r\n\r\n Dråbeindsats                 Dropper applicator  \r\n\r\n Dåse                         Jar  \r\n\r\n Enkeltdosisbeholder          Single-dose container  \r\n\r\n Flaske                       Bottle  \r\n\r\n Fyldt injektionssprøjte      Pre-filled syringe  \r\n\r\n Gasbeholder                  Gas cylinder  \r\n\r\n  Gas cylinder                Gasbeholder  \r\n\r\n Hætteglas                    Vial  \r\n\r\n  Injection needle            Kanyle  \r\n\r\n  Injection syringe           Injektionssprøjte  \r\n\r\n Injektionssprøjte            Injection syringe  \r\n\r\n  Jar                         Dåse  \r\n\r\n Kanyle                       Injection needle  \r\n\r\n Låg                          Cap  \r\n\r\n  Measuring spoon             Måleske  \r\n\r\n  Metering pump               Doseringspumpe  \r\n\r\n  Metering valve              Doseringsventil  \r\n\r\n Mundstykke                   Nozzle  \r\n\r\n Måleske                      Measuring spoon  \r\n\r\n  Needle applicator           Applikator med nål  \r\n\r\n  Nosepiece                   Næsestuds  \r\n\r\n  Nozzle                      Mundstykke  \r\n\r\n Næsestuds                    Nosepiece  \r\n\r\n Pensel                       Brush  \r\n\r\n Penselindsats                Brush applicator  \r\n\r\n  Pipette                     Pipetteindsats  \r\n\r\n Pipetteindsats               Pipette  \r\n\r\n Pose                         Bag  \r\n\r\n  Pre-filled syringe          Fyldt injektion  \r\n\r\n  Pressurerised container     Trykbeholder  \r\n\r\n Prop                         Stopper  \r\n\r\n Pumpespray                   Spray pump  \r\n\r\n  Sachet                      Brev  \r\n\r\n  Screw cap                   Skruelåg  \r\n\r\n  Single-dose container       Enkeltdosisbeholder  \r\n\r\n Skruelåg                     Screw cap  \r\n\r\n Spatel                       Spatula  \r\n\r\n  Spatula                     Spatel  \r\n\r\n  Spray pump                  Pumpespray  \r\n\r\n  Spray valve                 Sprayventil  \r\n\r\n Sprayventil                  Spray valve  \r\n\r\n Sprøjte                      Cannula  \r\n\r\n  Stopper                     Prop  \r\n\r\n  Strip                       Strip  \r\n\r\n Strølåg                      Dredging applicator  \r\n\r\n Tabletbeholder               Tablet container  \r\n\r\n  Tablet container            Tabletbeholder  \r\n\r\n Tromle                       Barrel  \r\n\r\n Trykbeholder                 Pressurised container  \r\n\r\n  Tube                        Tube  \r\n\r\n  Vial                        Hætteglas  \r\n\r\n Æske                         Box  \r\n\r\n</PRE>  \r\n\r\n<P>INTRODUKTION TIL FORTEGNELSE OVER STANDARDER FOR LÆGEMIDLER </P>  \r\n\r\n<P>Standarder </P>  \r\n\r\n<P>En standard for et lægemiddel er i fortegnelsen anført ved en titel og en  \r\n\r\n henvisning til en monografisamling. Såvel titlen som henvisningen er i  \r\n\r\n fortegnelsen anført med halvfed skrifttype. </P>  \r\n\r\n<P>En standards titel svarer til titlen på en monografi og er et engelsk  \r\n\r\n navn. </P>  \r\n\r\n<P>Ved henvisningen DLS 97 forstås henvisning til afsnittet om standarder for  \r\n\r\n lægemidler i sektion 3 i denne bog. </P>  \r\n\r\n<P>Fastsatte danske navne </P>  \r\n\r\n<P>For hver standard er fastsat et dansk navn. Til titlen på en standard i  \r\n\r\n fortegnelsens første spalte svarer det fastsatte danske navn i anden spalte.  \r\n\r\n</P>  \r\n\r\n<P>Almindeligvis er det fastsatte danske navn en direkte oversættelse af  \r\n\r\n standardens engelske titel. </P>  \r\n\r\n<P>Synonymer og navneændringer </P>  \r\n\r\n<P>Samtlige tidligere anvendte titler og synonymer er udeladt for  \r\n\r\n lægemiddelstandarder. </P>  \r\n\r\n<P>Søgeord </P>  \r\n\r\n<P>I første spalte i fortegnelsen er samtlige standarders titler og fastsatte  \r\n\r\n danske navne opført i alfabetisk orden. </P>  \r\n\r\n<P>Der kan sædvanligvis ikke søges alfabetisk under følgende  \r\n\r\n tillægsbetegnelser: flydende, frysetørret, human, oral og steril. I stedet  \r\n\r\n opsøges det næstfølgende ord. For eksempel skal humant blod søges under blod,  \r\n\r\n humant. </P>  \r\n\r\n<P>Ved at opsøge et fastsat dansk navn i første spalte, findes den  \r\n\r\n tilsvarende standards titel i anden spalte. Tredje spalte indeholder  \r\n\r\n henvisningen til monografisamling, hvori standarden forekommer. </P>  \r\n\r\n<PRE>  \r\n\r\n FORTEGNELSE OVER STANDARDER FOR LÆGEMIDLER  \r\n\r\n  Albumin solution,  \r\n\r\n  human                   Albumininfusionsvæske      Ph. Eur. 3rd Ed.  \r\n\r\n Albumininfusionsvæske    Albumin solution, human    Ph. Eur. 3rd Ed.  \r\n\r\n  Allergen products       Allergen præparater        Ph. Eur. 3rd Ed.  \r\n\r\n Allergen præparater      Allergen products          Ph. Eur. 3rd Ed.  \r\n\r\n  Anthrax spore vaccine  \r\n\r\n  (live)                  Miltbrandvaccine til dyr   Ph. Eur. 3rd Ed.  \r\n\r\n  for veterinary use  \r\n\r\n Anti-D immunglobulin,  \r\n\r\n  humant                  Immunoglobulin, human  \r\n\r\n                          anti-D                     Ph. Eur. 3rd Ed.  \r\n\r\n  Anticoagulant and  \r\n\r\n  preservative            Opløsninger til  \r\n\r\n  solutions for human     blodstabilisering          Ph. Eur. 3rd Ed.  \r\n\r\n  Antithrombin III  \r\n\r\n  concentrate,            Antitrombin III, humant,   Ph. Eur. 3rd Ed.  \r\n\r\n  freezedried human       koncentreret, frysetørret  \r\n\r\n Antitrombin III,  \r\n\r\n  humant,                 Antithrombin III  \r\n\r\n  koncentreret,           concentrate,               Ph. Eur. 3rd Ed.  \r\n\r\n  frysetørret             freezedried human  \r\n\r\n Aujeszky' sygevaccine  \r\n\r\n  til svin                Aujeszky's disease  \r\n\r\n  (inaktiveret)           vaccine for                Ph. Eur. 3rd Ed.  \r\n\r\n                          pigs (inactivated)  \r\n\r\n Aujeszky' sygevaccine  \r\n\r\n  til svin,               Aujeszky's disease  \r\n\r\n  frysetørret til         vaccine (live)             Ph. Eur. 3rd Ed.  \r\n\r\n  injektion               for pigs, for parenteral  \r\n\r\n  (levende)               administration,  \r\n\r\n                          freeze-dried  \r\n\r\n  Aujeszky's disease  \r\n\r\n  vaccine (live)          Aujeszky' sygevaccine til  \r\n\r\n  for pigs, for           svin,                      Ph. Eur. 3rd Ed.  \r\n\r\n  for parenteral          frysetørret til injektion  \r\n\r\n  administration,         (levende)  \r\n\r\n  freeze-dried  \r\n\r\n  Aujeszky's disease  \r\n\r\n  vaccine for             Aujeszky' sygevaccine  \r\n\r\n  pigs (inactivated)      til svin                   Ph. Eur. 3rd Ed.  \r\n\r\n                          (inaktiveret)  \r\n\r\n  Avian infectious  \r\n\r\n  bronchitis vaccine      Infektiøs bronkitis-  \r\n\r\n  (inactivated)           vaccine til                Ph. Eur. 3rd Ed.  \r\n\r\n                          fjerkræ (inaktiveret)  \r\n\r\n  Avian infectious  \r\n\r\n  bronchitis vaccine      Infektiøs bronkitis-  \r\n\r\n  (live), freeze-         vaccine til                Ph. Eur. 3rd Ed.  \r\n\r\n  dried                   fjerkræ, frysetørret  \r\n\r\n  Avian infectious bursal  \r\n\r\n  disease                 Infektiøs bursitis-  \r\n\r\n  vaccine (inactivated)   vaccine til                Ph. Eur. 3rd Ed.  \r\n\r\n                          fjerkræ (inaktiveret)  \r\n\r\n  Avian infectious  \r\n\r\n  bursal disease,         Infektiøs bursitis-  \r\n\r\n  (Gumboro disease)       vaccine (Gumboro           Ph. Eur. 3rd Ed.  \r\n\r\n vaccine (live)           disease) til fjerkræ,  \r\n\r\n  freeze-dried            frysetørret  \r\n\r\n                          (levende)  \r\n\r\n  Avian infectious  \r\n\r\n  encephalomyelitis       Encefalomyelitisvaccine    Ph. Eur. 3rd Ed.  \r\n\r\n  vaccine (live)          til fjerkræ (levende)  \r\n\r\n  Avian infectious  \r\n\r\n  laryngotracheitis       Infektiøs laryngo-  \r\n\r\n  vaccine (live) for      tracheitisvaccine          Ph. Eur. 3rd Ed.  \r\n\r\n  chickens                til fjerkræ (levende)  \r\n\r\n  BCG vaccine,  \r\n\r\n  freeze-dried            BCG vaccine, frysetørret   Ph. Eur. 3rd Ed.  \r\n\r\n BCG vaccine, frysetørret BCG vaccine, freeze-dried  Ph. Eur. 3rd Ed.  \r\n\r\n Blod, humant             Blood, human               DLS 97  \r\n\r\n  Blood, human            Blod, humant               DLS 97  \r\n\r\n  Botulinum antitoxin     Botulismeantitoxin         Ph. Eur. 3rd Ed.  \r\n\r\n Botulismeantitoxin       Botulinum antitoxin        Ph. Eur. 3rd Ed.  \r\n\r\n Botulismevaccine til dyr Clostridium botulinum  \r\n\r\n                          vaccine                    Ph. Eur. 3rd Ed.  \r\n\r\n                          for veterinary use  \r\n\r\n Brucellosevaccine til  \r\n\r\n  dyr (Brucel-            Brucellosis vaccine  \r\n\r\n  la Melitensis Rev.      (live)                     Ph. Eur. 3rd Ed.  \r\n\r\n  1 stamme),              (Brucella melitensis Rev.  \r\n\r\n  frysetørret (levende)   1 strain)  \r\n\r\n                          freeze-dried for  \r\n\r\n                          veterinary use  \r\n\r\n  Brucellosis vaccine  \r\n\r\n  (live)                  Brucellosevaccine til dyr  \r\n\r\n  (Brucella melitensis    (Brucel-                   Ph. Eur. 3rd Ed.  \r\n\r\n  Rev. 1 strain)          la Melitensis Rev.  \r\n\r\n  freeze-dried for        1 stamme),  \r\n\r\n veterinary use           frysetørret (levende)  \r\n\r\n Calicivirusvaccine til  \r\n\r\n  katte                   Feline calicivirosis  \r\n\r\n (inaktiveret)            vaccine                    Ph. Eur. 3rd Ed.  \r\n\r\n                          (inactivated)  \r\n\r\n Calicivirusvaccine til  \r\n\r\n  katte                   Feline calicivirosis  \r\n\r\n  (levende)               vaccine (live)             Ph. Eur. 3rd Ed.  \r\n\r\n  Canine contagious  \r\n\r\n  hepatitis vaccine       Virus-hepatitisvaccine  \r\n\r\n  (live), freeze-dried    til hunde                  Ph. Eur. 3rd Ed.  \r\n\r\n                          frysetørret (levende)  \r\n\r\n  Canine distemper  \r\n\r\n  vaccine (live),         Hundesygevaccine,  \r\n\r\n  freeze-dried            frysetørret                Ph. Eur. 3rd Ed.  \r\n\r\n                          (levende)  \r\n\r\n  Canine parvovirosis  \r\n\r\n  vaccine                 Parvovirusvaccine til  \r\n\r\n  (inactivated)           hunde                      Ph. Eur. 3rd Ed.  \r\n\r\n                          (inaktiveret)  \r\n\r\n  Canine parvovirosis  \r\n\r\n  vaccine (live)          Parvovirusvaccine til  \r\n\r\n                          hund                       Ph. Eur. 3rd Ed.  \r\n\r\n                          (levende)  \r\n\r\n  Cholera vaccine         Koleravaccine              Ph. Eur. 3rd Ed.  \r\n\r\n  Cholera vaccine,  \r\n\r\n  freeze-dried            Koleravaccine,  \r\n\r\n                          frysetørret                Ph. Eur. 3rd Ed.  \r\n\r\n Chrom (51Cr) edetat  \r\n\r\n  injektions-             Chromium (51Cr) edetate  \r\n\r\n  væske                   injection                  Ph. Eur. 3rd Ed.  \r\n\r\n  Chromium (51Cr)  \r\n\r\n  edetate injection       Chrom (51Cr) edetat  \r\n\r\n                          injektions-                Ph. Eur. 3rd Ed.  \r\n\r\n                          væske  \r\n\r\n  Clostridium botulinum  \r\n\r\n  vaccine                 Botulismevaccine til dyr   Ph. Eur. 3rd Ed.  \r\n\r\n  for veterinary use  \r\n\r\n  Clostridium chauvoei  \r\n\r\n  vaccine for             Miltbrandemfysemvaccine  \r\n\r\n  veterinary use          til dyr                    Ph. Eur. 3rd Ed.  \r\n\r\n  Clostridium novyi  \r\n\r\n  (type B) vaccine        Clostridium novyi B-  \r\n\r\n  for veterinary use      vaccine til dyr            Ph. Eur. 3rd Ed.  \r\n\r\n  Clostridium novyi alpha  \r\n\r\n  antitoxin               Clostridium novyi  \r\n\r\n  for veterinary use      alphaantitoxin             Ph. Eur. 3rd Ed.  \r\n\r\n                          til dyr  \r\n\r\n Clostridium novyi  \r\n\r\n  alphaantitoxin          Clostridium novyi alpha  \r\n\r\n  til dyr                 antitoxin                  Ph. Eur. 3rd Ed.  \r\n\r\n                          for veterinary use  \r\n\r\n Clostridium novyi  \r\n\r\n  B-vaccine til dyr       Clostridium novyi  \r\n\r\n                          (type B) vaccine            Ph. Eur. 3rd Ed.  \r\n\r\n                          for veterinary use  \r\n\r\n Clostridium perfringens  Clostridium perfringens  \r\n\r\n betaantitoxin til dyr    beta                        Ph. Eur. 3rd Ed.  \r\n\r\n                          antitoxin for veterinary  \r\n\r\n                          use  \r\n\r\n Clostridium perfringens  Clostridium perfringens  \r\n\r\n  epsilonantitoxin til    epsilon                     Ph. Eur. 3rd Ed.  \r\n\r\n  dyr                     antitoxin for veterinary  \r\n\r\n                          use  \r\n\r\n  Clostridium  \r\n\r\n  perfringens beta        Clostridium perfringens     Ph. Eur. 3rd Ed.  \r\n\r\n  antitoxin for           betaantitoxin til dyr  \r\n\r\n  veterinary use  \r\n\r\n  Clostridium perfringens  \r\n\r\n  epsilon                 Clostridium perfringens     Ph. Eur. 3rd Ed.  \r\n\r\n  antitoxin for           epsilonantitoxin til dyr  \r\n\r\n  veterinary use  \r\n\r\n  Clostridium perfringens  \r\n\r\n  vaccine for             Clostridium perfringens-  \r\n\r\n  veterinary use          vaccine                    Ph. Eur. 3rd Ed.  \r\n\r\n                          til dyr  \r\n\r\n Clostridium  \r\n\r\n  perfringensvaccine      Clostridium perfringens  \r\n\r\n  til dyr                 vaccine for                Ph. Eur. 3rd Ed.  \r\n\r\n                          veterinary use  \r\n\r\n  Clostridium septicum  \r\n\r\n  vaccine for             Clostridium septicum-  \r\n\r\n  veterinary use          vaccine til dyr            Ph. Eur. 3rd Ed.  \r\n\r\n Clostridium  \r\n\r\n  septicumvaccine til dyr Clostridium septicum  \r\n\r\n                          vaccine for                Ph. Eur. 3rd Ed.  \r\n\r\n                          veterinary use  \r\n\r\n Colibacillosevaccine  \r\n\r\n  til nyfødte             Neonatal ruminant  \r\n\r\n  drøvtyggere             colibacillosis             Ph. Eur. 3rd Ed.  \r\n\r\n  (inaktiveret)           vaccine (inactivated)  \r\n\r\n Colibacillosevaccine  \r\n\r\n  til nyfødte             Neonatal piglet  \r\n\r\n  grise (inaktiveret)     colibacillosis             Ph. Eur. 3rd Ed.  \r\n\r\n                          vaccine (inactivated)  \r\n\r\n  Cyanocobalamin (57Co)  \r\n\r\n  capsules                Cyanocobalamin (57Co)-  \r\n\r\n                          kapsler                    Ph. Eur. 3rd Ed.  \r\n\r\n  Cyanocobalamin (57Co)  \r\n\r\n  solution                Cyanocobalamin (57Co)-  \r\n\r\n                          opløsning                  Ph. Eur. 3rd Ed.  \r\n\r\n Cyanocobalamin (57Co)-  \r\n\r\n kapsler                  Cyanocobalamin (57Co)  \r\n\r\n                          capsules                   Ph. Eur. 3rd Ed.  \r\n\r\n Cyanocobalamin (57Co)-  \r\n\r\n opløsning                Cyanocobalamin (57Co)  \r\n\r\n                          solution                   Ph. Eur. 3rd Ed.  \r\n\r\n  Cyanocobalamin (58Co)  \r\n\r\n  solution                Cyanocobalamin (58Co)-  \r\n\r\n                          opløsning                  Ph. Eur. 3rd Ed.  \r\n\r\n Cyanocobalamin (58Co)-  \r\n\r\n opløsning                Cyanocobalamin (58Co)  \r\n\r\n                          solution                   Ph. Eur. 3rd Ed.  \r\n\r\n Difteri-tetanus-  \r\n\r\n  kighostevaccine         Diphtheria, tetanus and  \r\n\r\n  (adsorberet)            pertussis                  Ph. Eur. 3rd Ed.  \r\n\r\n                          vaccine (adsorbed)  \r\n\r\n Difteri-tetanusvaccine   Diphtheria and tetanus  \r\n\r\n  (adsorberet)            vaccine                    Ph. Eur. 3rd Ed.  \r\n\r\n                          (adsorbed)  \r\n\r\n Difteri-tetanusvaccine   Diphteria and tetanus  \r\n\r\n (adsorberet), til        vaccine                    Ph. Eur. 3rd Ed.  \r\n\r\n  voksne                  (adsorbed) for adults and  \r\n\r\n                          adolescents  \r\n\r\n Difteriantitoxin         Diphtheria antitoxin       Ph. Eur. 3rd Ed.  \r\n\r\n Difterivaccine  \r\n\r\n  (adsorberet)            Diphtheria vaccine  \r\n\r\n                          (adsorbed)                 Ph. Eur. 3rd Ed.  \r\n\r\n Difterivaccine  \r\n\r\n  (adsorberet)            Diphteria vaccine  \r\n\r\n  til voksne              (adsorbed)                 Ph. Eur. 3rd Ed.  \r\n\r\n                          for adults and  \r\n\r\n                          adolescents  \r\n\r\n  Diphteria and tetanus  \r\n\r\n  vaccine                 Difteri-tetanusvaccine     Ph. Eur. 3rd Ed.  \r\n\r\n  (adsorbed) for adults   (adsorberet), til voksne  \r\n\r\n  and  \r\n\r\n  adolescents  \r\n\r\n  Diphteria vaccine  \r\n\r\n  (adsorbed)              Difterivaccine  \r\n\r\n  for adults and          (adsorberet)               Ph. Eur. 3rd Ed.  \r\n\r\n  adolescents             til voksne  \r\n\r\n  Diphtheria and tetanus  \r\n\r\n  vaccine                 Difteri-tetanusvaccine     Ph. Eur. 3rd Ed.  \r\n\r\n  (adsorbed)              (adsorberet)  \r\n\r\n  Diphtheria antitoxin    Difteriantitoxin           Ph. Eur. 3rd Ed.  \r\n\r\n  Diphtheria vaccine  \r\n\r\n  (adsorbed)              Difterivaccine  \r\n\r\n                          (adsorberet)               Ph. Eur. 3rd Ed.  \r\n\r\n  Diphtheria, tetanus  \r\n\r\n  and pertussis           Difteri-tetanus-  \r\n\r\n  vaccine (adsorbed)      kighostevaccine            Ph. Eur. 3rd Ed.  \r\n\r\n                          (adsorberet)  \r\n\r\n  Distemper vaccine  \r\n\r\n  (live) for              Hvalpesygevaccine til  \r\n\r\n  mustelids, freeze-dried mink,                      Ph. Eur. 3rd Ed.  \r\n\r\n til fjerkræ (levende)    frysetørret (levende)  \r\n\r\n Encefalomyelitisvaccine  Avian infectious  \r\n\r\n                          encephalomyelitis          Ph. Eur. 3rd Ed.  \r\n\r\n                          vaccine (live)  \r\n\r\n  Equine influenza  \r\n\r\n  vaccine                 Hesteinfluenzavaccine  \r\n\r\n  (inactivated)           (inaktiveret)              Ph. Eur. 3rd Ed.  \r\n\r\n  Factor IX, freeze-  \r\n\r\n dried human              Koagulationsfaktor IX      Ph. Eur. 3rd Ed.  \r\n\r\n  coagulation             infusionssubstans, humant  \r\n\r\n  Factor VIII, freeze-  \r\n\r\n  dried human             Koagulationsfaktor VII     Ph. Eur. 3rd Ed.  \r\n\r\n  coagulation             infusionssubstans, humant  \r\n\r\n  Feline calicivirosis  \r\n\r\n  vaccine                 Calicivirusvaccine til  \r\n\r\n  (inactivated)           katte                      Ph. Eur. 3rd Ed.  \r\n\r\n                          (inaktiveret)  \r\n\r\n  Feline calicivirosis  \r\n\r\n  vaccine (live)          Calicivirusvaccine til  \r\n\r\n                          katte                      Ph. Eur. 3rd Ed.  \r\n\r\n                          (levende)  \r\n\r\n  Feline infectious  \r\n\r\n  enteritis               Kattesygevaccine,  \r\n\r\n  (feline panleucopenia)  frysetørret                Ph. Eur. 3rd Ed.  \r\n\r\n  vaccine                 (levende)  \r\n\r\n  (live), freeze-dried  \r\n\r\n  Feline infectious  \r\n\r\n  enteritis               Kattesygevaccine  \r\n\r\n  (feline panleucopenia)  (inaktiveret)              Ph. Eur. 3rd Ed.  \r\n\r\n vaccine  \r\n\r\n  (inactivated)  \r\n\r\n  Fibrinogen, iodinated  \r\n\r\n  (125I),                 Ioderet (125I) fibrinogen  Ph. Eur. 3rd Ed.  \r\n\r\n  dried human             humant, frysetørret  \r\n\r\n  Foot-and-mouth disease  \r\n\r\n  (ruminants)             Mund- og klovsygevaccine   Ph. Eur. 3rd Ed.  \r\n\r\n  vaccine (inactivated)   (inaktiveret)  \r\n\r\n  Fowl-pox vaccine  \r\n\r\n  (live),                 Fuglekoppervaccine,        Ph. Eur. 3rd Ed.  \r\n\r\n  freeze-dried            frysetørret (levende)  \r\n\r\n Fuglekoppervaccine,      Fowl-pox vaccine (live),   Ph. Eur. 3rd Ed.  \r\n\r\n frysetørret (levende)     freeze-dried  \r\n\r\n Fåresygevaccine  \r\n\r\n  (levende)               Mumps vaccine (live)       Ph. Eur. 3rd Ed.  \r\n\r\n  Gallium (67Ga) citrate  Gallium (67Ga)-citrat      Ph. Eur. 3rd Ed.  \r\n\r\n  injection               injektionsvæske  \r\n\r\n Gallium (67Ga)-citrat    Gallium (67Ga) citrate     Ph. Eur. 3rd Ed.  \r\n\r\n injektionsvæske          injection  \r\n\r\n  Gas-gangrene antitoxin  Gasgangrænantitoxin  \r\n\r\n  (perfringens)           (perfringens)              Ph. Eur. 3rd Ed.  \r\n\r\n  Gas-gangrene antitoxin  Gasgangrænantitoxin  \r\n\r\n  (septicum)              (septicum)                 Ph. Eur. 3rd Ed.  \r\n\r\n  Gas-gangrene antitoxin  \r\n\r\n  (novyi)                 Gasgangrænantitoxin  \r\n\r\n                          (novyi)                    Ph. Eur. 3rd Ed.  \r\n\r\n  Gas-gangrene antitoxin,  \r\n\r\n  mixed                   Gasgangrænantitoxin  \r\n\r\n                          (blandet)                  Ph. Eur. 3rd Ed.  \r\n\r\n Gasgangrænantitoxin  \r\n\r\n  (blandet)               Gas-gangrene antitoxin,  \r\n\r\n                          mixed                      Ph. Eur. 3rd Ed.  \r\n\r\n Gasgangrænantitoxin  \r\n\r\n  (novyi)                 Gas-gangrene antitoxin  \r\n\r\n                          (novyi)                    Ph. Eur. 3rd Ed.  \r\n\r\n Gasgangrænantitoxin  \r\n\r\n  (perfringens)           Gas-gangrene antitoxin     Ph. Eur. 3rd Ed.  \r\n\r\n                          (perfringens)  \r\n\r\n Gasgangrænantitoxin  \r\n\r\n  (septicum)              Gas-gangrene antitoxin     Ph. Eur. 3rd Ed.  \r\n\r\n                          (septicum)  \r\n\r\n Hepatitis A  \r\n\r\n  immunoglobulin, humant  Immunoglobulin, human      Ph. Eur. 3rd Ed.  \r\n\r\n                          hepatitis A  \r\n\r\n  Hepatitis A vaccine  \r\n\r\n  (inactivated)           Hepatitis A vaccine  \r\n\r\n                          (inaktiveret)              Ph. Eur. 3rd Ed.  \r\n\r\n Hepatitis A vaccine  \r\n\r\n  (inaktiveret)           Hepatitis A vaccine  \r\n\r\n                          (inactivated)              Ph. Eur. 3rd Ed.  \r\n\r\n Hepatitis B  \r\n\r\n  immunglobulin, humant   Immunoglobulin, human      Ph. Eur. 3rd Ed.  \r\n\r\n                          hepatitis B  \r\n\r\n Hepatitis B  \r\n\r\n  immunoglobulin til      Immunoglobulin, for  \r\n\r\n  intravenøs brug, humant intravenous                Ph. Eur. 3rd Ed.  \r\n\r\n                          use, human hepatitis B  \r\n\r\n  Hepatitis B vaccine  \r\n\r\n  (rDNA)                  Hepatitis B vaccine (rDNA) Ph. Eur. 3rd Ed.  \r\n\r\n Hepatitis B vaccine  \r\n\r\n  (rDNA)                  Hepatitis B vaccine  \r\n\r\n                          (rDNA)                     Ph. Eur. 3rd Ed.  \r\n\r\n Hesteinfluenzavaccine  \r\n\r\n  (inaktiveret)           Equine influenza vaccine   Ph. Eur. 3rd Ed.  \r\n\r\n                          (inactivated)  \r\n\r\n Hugormeantitoxin         Viper venom antiserum,  \r\n\r\n                          European                   Ph. Eur. 3rd Ed.  \r\n\r\n Hundesygevaccine,  \r\n\r\n  frysetørret             Canine distemper vaccine  \r\n\r\n  (levende)               (live),                    Ph. Eur. 3rd Ed.  \r\n\r\n                          freeze-dried  \r\n\r\n Hvalpesygevaccine til  \r\n\r\n  mink,                   Distemper vaccine (live)  \r\n\r\n                          for                        Ph. Eur. 3rd Ed.  \r\n\r\n frysetørret (levende)    mustelids, freeze-dried  \r\n\r\n  Hydrogen peroxide  \r\n\r\n  solution                Hydrogenperoxidopløsning  \r\n\r\n  (3 per cent)            3%                         Ph. Eur. 3rd Ed.  \r\n\r\n Hydrogenperoxidopløsning  \r\n\r\n  3%                      Hydrogen peroxide  \r\n\r\n                          solution                   Ph. Eur. 3rd Ed.  \r\n\r\n                          (3 per cent)  \r\n\r\n  Immunoglobulin, for  \r\n\r\n  intravenous             Normalt immunglobulin til  Ph. Eur. 3rd Ed.  \r\n\r\n  administration, human   intravenøs brug, humant  \r\n\r\n  normal  \r\n\r\n  Immunoglobulin, for  \r\n\r\n  intravenous             Hepatitis B  \r\n\r\n  use, human hepatitis B  immunoglobulin til         Ph. Eur. 3rd Ed.  \r\n\r\n                          intravenøs brug, humant  \r\n\r\n  Immunoglobulin, human   Hepatitis A immuno-  \r\n\r\n  hepatitis A             globulin, humant           Ph. Eur. 3rd Ed.  \r\n\r\n  Immunoglobulin, human   Hepatitis B  \r\n\r\n  hepatitis B             immunglobulin, humant      Ph. Eur. 3rd Ed.  \r\n\r\n  Immunoglobulin, human  \r\n\r\n  anti-D                  Anti-D immunglobulin,  \r\n\r\n                          humant                     Ph. Eur. 3rd Ed.  \r\n\r\n  Immunoglobulin, human  \r\n\r\n  measles                 Mæslingeimmunglobulin,  \r\n\r\n                          humant                     Ph. Eur. 3rd Ed.  \r\n\r\n  Immunoglobulin, human  \r\n\r\n  normal                  Normalt immunglobulin,  \r\n\r\n                          humant                     Ph. Eur. 3rd Ed.  \r\n\r\n  Immunoglobulin, human  \r\n\r\n  rabies                  Rabiesimmunglobulin,  \r\n\r\n                          humant                     Ph. Eur. 3rd Ed.  \r\n\r\n  Immunoglobulin, human  \r\n\r\n  rubella                 Rubellaimmunglobulin,  \r\n\r\n                          humant                     Ph. Eur. 3rd Ed.  \r\n\r\n  Immunoglobulin, human  \r\n\r\n  tetanus                 Tetanusimmunglobulin,  \r\n\r\n                          humant                     Ph. Eur. 3rd Ed.  \r\n\r\n  Immunoglobulin, human  \r\n\r\n  varicella               Varicellaimmunglobulin,  \r\n\r\n                          humant                     Ph. Eur. 3rd Ed.  \r\n\r\n  Immunosera for human  \r\n\r\n  use                     Immunsera                  Ph. Eur. 3rd Ed.  \r\n\r\n  Immunosera for  \r\n\r\n  veterinary use          Immunsera til dyr          Ph. Eur. 3rd Ed.  \r\n\r\n Immunsera                Immunosera for human use   Ph. Eur. 3rd Ed.  \r\n\r\n Immunsera til dyr        Immunosera for veterinary  \r\n\r\n                          use                        Ph. Eur. 3rd Ed.  \r\n\r\n Indium (111In) oxin  \r\n\r\n  opløsning               Indium (111In) oxine  \r\n\r\n                          solution                   Ph. Eur. 3rd Ed.  \r\n\r\n  Indium (111In) oxine  \r\n\r\n  solution                Indium (111In) oxin  \r\n\r\n                          opløsning                  Ph. Eur. 3rd Ed.  \r\n\r\n Indium (111In) pentetat  Indium (111In) pentetate   Ph. Eur. 3rd Ed.  \r\n\r\n injektionsvæske          injection  \r\n\r\n  Indium (111In)  \r\n\r\n  pentetate               Indium (111In) pentetat    Ph. Eur. 3rd Ed.  \r\n\r\n  injection               injektionsvæske  \r\n\r\n  Infectious bovine  \r\n\r\n  rhinotracheitis         Rhinotracheitisvaccine  \r\n\r\n  vaccine (live),         til kvæg,                  Ph. Eur. 3rd Ed.  \r\n\r\n  freeze-dried            frysetørret (levende)  \r\n\r\n Infektiøs bronkitis-  \r\n\r\n  vaccine til             Avian infectious  \r\n\r\n fjerkræ (inaktiveret)    bronchitis vaccine         Ph. Eur. 3rd Ed.  \r\n\r\n                          (inactivated)  \r\n\r\n Infektiøs bronkitis-  \r\n\r\n  vaccine til             Avian infectious  \r\n\r\n  fjerkræ, frysetørret    bronchitis vaccine         Ph. Eur. 3rd Ed.  \r\n\r\n                          (live), freeze-dried  \r\n\r\n Infektiøs bursitis-  \r\n\r\n  vaccine (Gumboro        Avian infectious bursal  \r\n\r\n  disease) til fjerkræ,   disease,                   Ph. Eur. 3rd Ed.  \r\n\r\n  frysetørret             (Gumboro disease) vaccine  \r\n\r\n  (levende)               (live)  \r\n\r\n                          freeze-dried  \r\n\r\n Infektiøs bursitis-  \r\n\r\n  vaccine til             Avian infectious bursal  \r\n\r\n  fjerkræ (inaktiveret)   disease                    Ph. Eur. 3rd Ed.  \r\n\r\n                          vaccine (inactivated)  \r\n\r\n Infektiøs laryngo-  \r\n\r\n  tracheitisvaccine       Avian infectious  \r\n\r\n  til fjerkræ (levende)   laryngotracheitis          Ph. Eur. 3rd Ed.  \r\n\r\n                          vaccine (live) for  \r\n\r\n                          chickens  \r\n\r\n  Influenza vaccine  \r\n\r\n  (split viron),          Influenzavaccine, split  \r\n\r\n  (inactivated)           virion                     Ph. Eur. 3rd Ed.  \r\n\r\n                          (inaktiveret)  \r\n\r\n  Influenza vaccine  \r\n\r\n  (surface antigen)       Influenzavaccine,  \r\n\r\n  (inactivated)           overfladeantigen           Ph. Eur. 3rd Ed.  \r\n\r\n                          (inaktiveret)  \r\n\r\n  Influenza vaccine  \r\n\r\n  (whole virion),         Influenzavaccine, hele  \r\n\r\n  (inactivated)           virion                     Ph. Eur. 3rd Ed.  \r\n\r\n                          (inaktiveret)  \r\n\r\n Influenzavaccine, hele  \r\n\r\n  virion                  Influenza vaccine (whole  \r\n\r\n (inaktiveret)            virion),                   Ph. Eur. 3rd Ed.  \r\n\r\n                          (inactivated)  \r\n\r\n Influenzavaccine,  \r\n\r\n  overfladeantigen        Influenza vaccine  \r\n\r\n (inaktiveret)            (surface antigen)          Ph. Eur. 3rd Ed.  \r\n\r\n                          (inactivated)  \r\n\r\n Influenzavaccine,  \r\n\r\n  split virion            Influenza vaccine  \r\n\r\n  (aktiveret)             (split viron),             Ph. Eur. 3rd Ed.  \r\n\r\n                          (inactivated)  \r\n\r\n  Insulin injection,  \r\n\r\n  biphasic                Insulin injektionsvæske,  \r\n\r\n                          bifasisk                   Ph. Eur. 3rd Ed.  \r\n\r\n  Insulin injection,  \r\n\r\n  biphasic                Insulin injektionsvæske,  \r\n\r\n  isophane                bifasisk                   Ph. Eur. 3rd Ed.  \r\n\r\n                          isofan  \r\n\r\n  Insulin injection,  \r\n\r\n  isophane                Insulin injektionsvæske,  \r\n\r\n                          isofan                     Ph. Eur. 3rd Ed.  \r\n\r\n  Insulin injection,  \r\n\r\n  soluble                 Insulin injektionsvæske,  \r\n\r\n                          opløst                     Ph. Eur. 3rd Ed.  \r\n\r\n Insulin injektionsvæske,  \r\n\r\n  bifasisk                Insulin injection,  \r\n\r\n                          biphasic                   Ph. Eur. 3rd Ed.  \r\n\r\n Insulin injektions-  \r\n\r\n  væske, bifasisk         Insulin injection,  \r\n\r\n  isofan                  biphasic                   Ph. Eur. 3rd Ed.  \r\n\r\n                          isophane  \r\n\r\n Insulin injektions-  \r\n\r\n  væske, isofan           Insulin injection,  \r\n\r\n                          isophane                   Ph. Eur. 3rd Ed.  \r\n\r\n Insulin  \r\n\r\n  injektionsvæske,  \r\n\r\n  opløst                  Insulin injection,  \r\n\r\n                          soluble                    Ph. Eur. 3rd Ed.  \r\n\r\n Insulin  \r\n\r\n  injektionsvæsker        Insulin preparations,  \r\n\r\n                          injectable                 Ph. Eur. 3rd Ed.  \r\n\r\n  Insulin preparations,  \r\n\r\n  injectable              Insulin injektionsvæsker   Ph. Eur. 3rd Ed.  \r\n\r\n  Insulin zinc  \r\n\r\n  injectable              Insulin zink suspension    Ph. Eur. 3rd Ed.  \r\n\r\n  suspension              injektionsvæske  \r\n\r\n  Insulin zinc  \r\n\r\n  injectable suspension   Insulin zink suspension  \r\n\r\n  (amorphous)             (amorf)                    Ph. Eur. 3rd Ed.  \r\n\r\n                          injektionsvæske  \r\n\r\n  Insulin zinc  \r\n\r\n  injectable suspension   Insulin zink suspension    Ph. Eur. 3rd Ed.  \r\n\r\n  (crystalline)           (krystallinsk)  \r\n\r\n                          injektionsvæske  \r\n\r\n Insulin zink suspension  Insulin zinc injectable  \r\n\r\n  (krystallinsk)          suspension                 Ph. Eur. 3rd Ed.  \r\n\r\n  injektionsvæske         (crystalline)  \r\n\r\n Insulin zink suspension  Insulin zinc injectable    Ph. Eur. 3rd Ed.  \r\n\r\n injektionsvæske          suspension  \r\n\r\n Insulin zink suspension  \r\n\r\n  (amorf)                 Insulin zinc injectable  \r\n\r\n  injektionsvæske         suspension                 Ph. Eur. 3rd Ed.  \r\n\r\n                          (amorphous)  \r\n\r\n  Interferon alfa-2  \r\n\r\n  concentrated            Interferon alfa-2  \r\n\r\n  solution                koncentreret               Ph. Eur. 3rd Ed.  \r\n\r\n                          opløsning  \r\n\r\n Interferon alfa-  \r\n\r\n  2 koncentreret          Interferon alfa-2  \r\n\r\n  opløsning               concentrated               Ph. Eur. 3rd Ed.  \r\n\r\n                          solution  \r\n\r\n Iobenguan (123I)  \r\n\r\n  injektionsvæske         Iobenguane (123I)  \r\n\r\n                          injection                  Ph. Eur. 3rd Ed.  \r\n\r\n Iobenguan (131I)  \r\n\r\n  injektionsvæske         Iobenguane (131I)  \r\n\r\n  til diagnostisk brug    injection for              Ph. Eur. 3rd Ed.  \r\n\r\n                          diagnostic use  \r\n\r\n Iobenguan (131I)  \r\n\r\n  injektionsvæske         Iobenguane (131I)  \r\n\r\n  til terapeutisk brug    injection for              Ph. Eur. 3rd Ed.  \r\n\r\n                          therapeutic use  \r\n\r\n  Iobenguane (123I)  \r\n\r\n  injection               Iobenguan (123I)  \r\n\r\n                          injektionsvæske            Ph. Eur. 3rd Ed.  \r\n\r\n  Iobenguane (131I)  \r\n\r\n  injection for           Iobenguan (131I)  \r\n\r\n  diagnostic use          injektionsvæske            Ph. Eur. 3rd Ed.  \r\n\r\n                          til diagnostisk brug  \r\n\r\n  Iobenguane (131I)  \r\n\r\n  injection for           Iobenguan (131I)  \r\n\r\n  therapeutic use         injektionsvæske            Ph. Eur. 3rd Ed.  \r\n\r\n                          til terapeutisk brug  \r\n\r\n Ioderet (125I)  \r\n\r\n  fibrinogen              Fibrinogen, iodinated  \r\n\r\n  humant, frysetørret     (125I),                    Ph. Eur. 3rd Ed.  \r\n\r\n                          dried human  \r\n\r\n Kattesygevaccine  \r\n\r\n  (inaktiveret)           Feline infectious  \r\n\r\n                          enteritis                  Ph. Eur. 3rd Ed.  \r\n\r\n                          (feline panleucopenia)  \r\n\r\n                          vaccine  \r\n\r\n                          (inactivated)  \r\n\r\n Kattesygevaccine,  \r\n\r\n  frysetørret             Feline infectious  \r\n\r\n  (levende)               enteritis                  Ph. Eur. 3rd Ed.  \r\n\r\n                          (feline panleucopenia)  \r\n\r\n                          vaccine  \r\n\r\n                          (live), freeze-dried  \r\n\r\n Kighostevaccine          Pertussis vaccine          Ph. Eur. 3rd Ed.  \r\n\r\n Kighostevaccine  \r\n\r\n  (adsorberet)            Pertussis vaccine  \r\n\r\n                          (adsorbed)                 Ph. Eur. 3rd Ed.  \r\n\r\n Klassisk svinepest-  \r\n\r\n  vaccine,                Swine-fever vaccine  \r\n\r\n  frysetørret (levende)   (live),                    Ph. Eur. 3rd Ed.  \r\n\r\n                          classical, freeze-dried  \r\n\r\n Koagulationsfaktor IX    Factor IX, freeze-dried  \r\n\r\n  infusionssubstans,      human                      Ph. Eur. 3rd Ed.  \r\n\r\n  humant                  coagulation  \r\n\r\n Koagulationsfaktor VIII  Factor VIII, freeze-dried  \r\n\r\n  infusionssubstans,      human                      Ph. Eur. 3rd Ed.  \r\n\r\n  humant                  coagulation  \r\n\r\n Koleravaccine            Cholera vaccine            Ph. Eur. 3rd Ed.  \r\n\r\n Koleravaccine,  \r\n\r\n  frysetørret             Cholera vaccine,  \r\n\r\n                          freeze-dried               Ph. Eur. 3rd Ed.  \r\n\r\n  Leptospira vaccine for  Leptospirosevaccine til  \r\n\r\n  veterinary use          dyr                        Ph. Eur. 3rd Ed.  \r\n\r\n Leptospirosevaccine  \r\n\r\n  til dyr                 Leptospira vaccine for     Ph. Eur. 3rd Ed.  \r\n\r\n                          veterinary use  \r\n\r\n  Lypressin injection     Lypressininjektionsvæske   Ph. Eur. 3rd Ed.  \r\n\r\n Lypressininjektionsvæske Lypressin injection        Ph. Eur. 3rd Ed.  \r\n\r\n  Marek's disease  \r\n\r\n  vaccine (live)          Marek's diseasevaccine  \r\n\r\n                          (kalkun                    Ph. Eur. 3rd Ed.  \r\n\r\n                          herpesvirus), frysetørret  \r\n\r\n                          (levende)  \r\n\r\n Marek's diseasevaccine  \r\n\r\n  (kalkun                 Marek's disease vaccine  \r\n\r\n  herpesvirus),           (live)                     Ph. Eur. 3rd Ed.  \r\n\r\n  frysetørret  \r\n\r\n  (levende)  \r\n\r\n  Measels vaccine  \r\n\r\n  (live)                  Mæslingevaccine (levende)  Ph. Eur. 3rd Ed.  \r\n\r\n  Measels, mumps and  \r\n\r\n  rubella vaccine         Mæslinger, fåresyge og  \r\n\r\n  (live)                  røde hunde                 Ph. Eur. 3rd Ed.  \r\n\r\n                          vaccine (levende)  \r\n\r\n  Meningococcal  \r\n\r\n  polysaccharide          Meningokokvaccine          Ph. Eur. 3rd Ed.  \r\n\r\n  vaccine  \r\n\r\n Meningokokvaccine        Meningococcal  \r\n\r\n                          polysaccharide             Ph. Eur. 3rd Ed.  \r\n\r\n                          vaccine  \r\n\r\n Miltbrandemfysemvaccine  \r\n\r\n  til dyr                 Clostridium chauvoei  \r\n\r\n                          vaccine for                Ph. Eur. 3rd Ed.  \r\n\r\n                          veterinary use  \r\n\r\n Miltbrandvaccine til dyr Anthrax spore vaccine  \r\n\r\n                          (live)                     Ph. Eur. 3rd Ed.  \r\n\r\n                          for veterinary use  \r\n\r\n  Mumps vaccine (live)    Fåresygevaccine (levende)  Ph. Eur. 3rd Ed.  \r\n\r\n Mund- og klovsygevaccine Foot-and-mouth disease  \r\n\r\n  (inaktiveret)           (ruminants)                Ph. Eur. 3rd Ed.  \r\n\r\n                          vaccine (inactivated)  \r\n\r\n Mæslingeimmunglobulin,  \r\n\r\n  humant                  Immunoglobulin, human  \r\n\r\n                          measles                    Ph. Eur. 3rd Ed.  \r\n\r\n Mæslinger, fåresyge  \r\n\r\n  og røde hunde           Measels, mumps and  \r\n\r\n  vaccine (levende)       rubella vaccine            Ph. Eur. 3rd Ed.  \r\n\r\n                          (live)  \r\n\r\n Mæslingevaccine  \r\n\r\n  (levende)               Measels vaccine (live)     Ph. Eur. 3rd Ed.  \r\n\r\n Natriumchromat (51Cr)-  \r\n\r\n  opløsning,              Sodium chromate (51Cr)  \r\n\r\n  steril                  sterile                    Ph. Eur. 3rd Ed.  \r\n\r\n                          solution  \r\n\r\n Natriumiod (131I)-       Sodium iodohippurate  \r\n\r\n hippuratinjektionsvæske  (131I)                     Ph. Eur. 3rd Ed.  \r\n\r\n                          injection  \r\n\r\n Natriumiodid (123I)-     Sodium iodohippurate  \r\n\r\n hippuratinjektionsvæske  (123I)                     Ph. Eur. 3rd Ed.  \r\n\r\n                          injection  \r\n\r\n Natriumiodid (123I)-  \r\n\r\n  opløsning               Sodium iodide (123I)  \r\n\r\n                          solution                   Ph. Eur. 3rd Ed.  \r\n\r\n Natriumiodid (125I)-  \r\n\r\n  opløsning               Sodium iodide (125I)  \r\n\r\n                          solution                   Ph. Eur. 3rd Ed.  \r\n\r\n Natriumiodid (131I)-  \r\n\r\n  kapsler til             Sodium iodide (131I)  \r\n\r\n  diagnostisk brug        capsules                   Ph. Eur. 3rd Ed.  \r\n\r\n                          for diagnostic use  \r\n\r\n Natriumiodid (131I)-  \r\n\r\n  opløsning               Sodium iodide (131I)  \r\n\r\n                          solution                   Ph. Eur. 3rd Ed.  \r\n\r\n Natriumpertechnetat  \r\n\r\n  (99mTc)-                Sodium pertechnetate  \r\n\r\n  injektionsvæske         (99mTc)                    Ph. Eur. 3rd Ed.  \r\n\r\n  (non-fission)           injection (non-fission)  \r\n\r\n Natriumpertechnetat  \r\n\r\n  (99mTc)-                Sodium pertechnetate  \r\n\r\n  injektionsvæske         (99mTc)                    Ph. Eur. 3rd Ed.  \r\n\r\n  (fission)               injection (fission)  \r\n\r\n Natriumphosphat (32P)-   Sodium phosphate (32P)  \r\n\r\n  injektionsvæske         injection                  Ph. Eur. 3rd Ed.  \r\n\r\n  Neonatal piglet  \r\n\r\n  colibacillosis          Colibacillosevaccine til  \r\n\r\n  vaccine (inactivated)   nyfødte                    Ph. Eur. 3rd Ed.  \r\n\r\n                          grise (inaktiveret)  \r\n\r\n  Neonatal ruminant  \r\n\r\n  colibacillosis          Colibacillosevaccine til  \r\n\r\n  vaccine (inactivated)   nyfødte                    Ph. Eur. 3rd Ed.  \r\n\r\n                          drøvtyggere (inaktiveret)  \r\n\r\n  Newcastle disease  \r\n\r\n  vaccine                 Newcastle diseasevaccine  \r\n\r\n  (inactivated)           til fjerkræ                Ph. Eur. 3rd Ed.  \r\n\r\n                          kræ (inaktiveret)  \r\n\r\n  Newcastle disease  \r\n\r\n  vaccine (live),         Newcastle diseasevaccine  \r\n\r\n  freeze-dried            til                        Ph. Eur. 3rd Ed.  \r\n\r\n                          fjerkræ, frysetørret  \r\n\r\n                          (levende)  \r\n\r\n Newcastle diseasevaccine  \r\n\r\n  til                     Newcastle disease vaccine  \r\n\r\n  fjerkræ, frysetørret    (live),                    Ph. Eur. 3rd Ed.  \r\n\r\n  (levende)               freeze-dried  \r\n\r\n Newcastle disease-  \r\n\r\n  vaccine til fjer-       Newcastle disease vaccine  Ph. Eur. 3rd Ed.  \r\n\r\n  kræ (inaktiveret)       (inactivated)  \r\n\r\n  Norcholesterol  \r\n\r\n  injection,              Norcholesteroliodinat  \r\n\r\n  iodinated (131I)        (131I)- in-                Ph. Eur. 3rd Ed.  \r\n\r\n                          jektionsvæske  \r\n\r\n Norcholesteroliodinat  \r\n\r\n  (131I)- in-             Norcholesterol injection,  Ph. Eur. 3rd Ed.  \r\n\r\n  jektionsvæske           iodinated (131I)  \r\n\r\n Normalt immunglobulin  \r\n\r\n  til intravenøs          Immunoglobulin, for  \r\n\r\n  intravenøs brug,        intravenous  \r\n\r\n  humant                  administration, human      Ph. Eur. 3rd Ed.  \r\n\r\n                          normal  \r\n\r\n Normalt immunglobulin,  \r\n\r\n  humant                  Immunoglobulin, human  \r\n\r\n                          normal                     Ph. Eur. 3rd Ed.  \r\n\r\n Opløsninger til  \r\n\r\n  blodstabilisering       Anticoagulant and  \r\n\r\n                          preservative               Ph. Eur. 3rd Ed.  \r\n\r\n                          solutions for human blood  \r\n\r\n Parvovirusvaccine til  \r\n\r\n  hund                    Canine parvovirosis  \r\n\r\n  (levende)               vaccine (live)             Ph. Eur. 3rd Ed.  \r\n\r\n Parvovirusvaccine til  \r\n\r\n  hunde                   Canine parvovirosis  \r\n\r\n  (inaktiveret)           vaccine                    Ph. Eur. 3rd Ed.  \r\n\r\n                          (inactivated)  \r\n\r\n Parvovirusvaccine til  \r\n\r\n  svin                    Porcine parvovirosis  \r\n\r\n  (inaktiveret)           vaccine                    Ph. Eur. 3rd Ed.  \r\n\r\n                          (inactivated)  \r\n\r\n  Pertussis vaccine       Kighostevaccine            Ph. Eur. 3rd Ed.  \r\n\r\n  Pertussis vaccine  \r\n\r\n  (adsorbed)              Kighostevaccine  \r\n\r\n                          (adsorberet)               Ph. Eur. 3rd Ed.  \r\n\r\n  Pneumococcal  \r\n\r\n  polysaccharide vaccine  Pneumokok polysaccharid-  \r\n\r\n                          vaccine                    Ph. Eur. 3rd Ed.  \r\n\r\n Pneumokok polysaccharid-  \r\n\r\n  vaccine                 Pneumococcal poly-  \r\n\r\n                          saccharide vaccine         Ph. Eur. 3rd Ed.  \r\n\r\n  Poliomyelitis vaccine   Poliovaccine (inaktiveret) Ph. Eur. 3rd Ed.  \r\n\r\n  (inactivated)  \r\n\r\n  Poliomyelitis vaccine  \r\n\r\n  (oral)                  Poliovaccine, oral         Ph. Eur. 3rd Ed.  \r\n\r\n Poliovaccine  \r\n\r\n  (inaktiveret)           Poliomyelitis vaccine      Ph. Eur. 3rd Ed.  \r\n\r\n                          (inactivated)  \r\n\r\n Poliovaccine, oral       Poliomyelitis vaccine  \r\n\r\n                          (oral)                     Ph. Eur. 3rd Ed.  \r\n\r\n  Porcine influenza  \r\n\r\n  vaccine                 Svineinfluenzavaccine  \r\n\r\n  (inactivated)           (inaktiveret)              Ph. Eur. 3rd Ed.  \r\n\r\n  Porcine parvovirosis  \r\n\r\n  vaccine                 Parvovirusvaccine til  \r\n\r\n  (inactivated)           svin                       Ph. Eur. 3rd Ed.  \r\n\r\n                          (inaktiveret)  \r\n\r\n  Products of recombinant  \r\n\r\n  DNA                     Produkter  fremstillet  \r\n\r\n  technology              ved                        Ph. Eur. 3rd Ed.  \r\n\r\n                          rekombinant-DNA teknologi  \r\n\r\n  Rabies vaccine (live),  \r\n\r\n  oral for                Rabiesvaccine til ræve,  \r\n\r\n  foxes                   oral                       Ph. Eur. 3rd Ed.  \r\n\r\n                          (levende)  \r\n\r\n  Rabies vaccine for  \r\n\r\n  human use               Rabiesvaccine,  \r\n\r\n  prepared in cell        fremstillet på             Ph. Eur. 3rd Ed.  \r\n\r\n  cultures                cellekultur.  \r\n\r\n  Rabies vaccine for  \r\n\r\n  veterinary use          Rabiesvaccine til dyr  \r\n\r\n  (inactivated)           (inaktiveret)              Ph. Eur. 3rd Ed.  \r\n\r\n Rabiesimmunglobulin,  \r\n\r\n  humant                  Immunoglobulin, human  \r\n\r\n                          rabies                     Ph. Eur. 3rd Ed.  \r\n\r\n Rabiesvaccine til dyr  \r\n\r\n  (inaktiveret)           Rabies vaccine for  \r\n\r\n                          veterinary use             Ph. Eur. 3rd Ed.  \r\n\r\n                          (inactivated)  \r\n\r\n Rabiesvaccine til  \r\n\r\n  ræve, oral              Rabies vaccine (live),  \r\n\r\n (levende)                oral for                   Ph. Eur. 3rd Ed.  \r\n\r\n                          foxes  \r\n\r\n Rabiesvaccine,  \r\n\r\n  fremstillet på          Rabies vaccine for  \r\n\r\n  cellekultur.            human use                  Ph. Eur. 3rd Ed.  \r\n\r\n                          prepared in cell cultures  \r\n\r\n Radioaktive lægemidler   Radiopharmaceutical  \r\n\r\n                          preparations               Ph. Eur. 3rd Ed.  \r\n\r\n  Radiopharmaceutical  \r\n\r\n  preparations            Radioaktive lægemidler     Ph. Eur. 3rd Ed.  \r\n\r\n Rekombinant-DNA  \r\n\r\n  teknologi,              Producta ab ADN  \r\n\r\n  produkter               recombinante               Ph. Eur. 3rd Ed.  \r\n\r\n Rhinotracheitisvaccine  \r\n\r\n  til kvæg,               Infectious bovine  \r\n\r\n frysetørret (levende)    rhinotracheitis            Ph. Eur. 3rd Ed.  \r\n\r\n                          vaccine (live),  \r\n\r\n                          freeze-dried  \r\n\r\n  Rubella vaccine (live)  Rubellavaccine (levende)   Ph. Eur. 3rd Ed.  \r\n\r\n Rubellaimmunglobulin,  \r\n\r\n  humant                  Immunoglobulin, human  \r\n\r\n                          rubella                    Ph. Eur. 3rd Ed.  \r\n\r\n Rubellavaccine  \r\n\r\n  (levende)               Rubella vaccine (live)     Ph. Eur. 3rd Ed.  \r\n\r\n Rødsygeantitoxin til  \r\n\r\n  svin                    Swine erysipelas  \r\n\r\n                          immunoserum                Ph. Eur. 3rd Ed.  \r\n\r\n Rødsygevaccine til svin  Swine erysipelas vaccine   Ph. Eur. 3rd Ed.  \r\n\r\n  (inaktiveret)           (inactivated)  \r\n\r\n  Sodium chromate  \r\n\r\n  (51Cr) sterile          Natriumchromat (51Cr)-  \r\n\r\n  solution                opløsning,                 Ph. Eur. 3rd Ed.  \r\n\r\n                          steril  \r\n\r\n  Sodium iodide (123I)  \r\n\r\n  solution                Natriumiodid (123I)-  \r\n\r\n                          opløsning                  Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium iodide (125I)  \r\n\r\n  solution                Natriumiodid (125I)-  \r\n\r\n                          opløsning                  Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium iodide (131I)  \r\n\r\n  capsules                Natriumiodid (131I)-  \r\n\r\n  for diagnostic use      kapsler til                Ph. Eur. 3rd Ed.  \r\n\r\n                          diagnostisk brug  \r\n\r\n  Sodium iodide (131I)  \r\n\r\n  solution                Natriumiodid (131I)-  \r\n\r\n                          opløsning                  Ph. Eur. 3rd Ed.  \r\n\r\n  Sodium iodohippurate  \r\n\r\n  (123I)                  Natriumiodid (123I)-       Ph. Eur. 3rd Ed.  \r\n\r\n  injection               hippuratinjektionsvæske  \r\n\r\n  Sodium iodohippurate  \r\n\r\n  (131I)                  Natriumiod (131I)-         Ph. Eur. 3rd Ed.  \r\n\r\n  injection               hippuratinjektionsvæske  \r\n\r\n  Sodium pertechnetate  \r\n\r\n  (99mTc)                 Natriumpertechnetat  \r\n\r\n  injection (fission)     (99mTc)-                   Ph. Eur. 3rd Ed.  \r\n\r\n                          injektionsvæske (fission)  \r\n\r\n  Sodium pertechnetate  \r\n\r\n  (99mTc)                 Natriumpertechnetat  \r\n\r\n  injection (non-fission) (99mTc)-                   Ph. Eur. 3rd Ed.  \r\n\r\n                          injektionsvæske  \r\n\r\n                          (non-fission)  \r\n\r\n  Sodium phosphate (32P)  \r\n\r\n  injection               Natriumphosphat (32P)-     Ph. Eur. 3rd Ed.  \r\n\r\n                          injektionsvæske  \r\n\r\n  Somatropin for  \r\n\r\n  injection               Somatropin injektions-  \r\n\r\n                          substans                   Ph. Eur. 3rd Ed.  \r\n\r\n Somatropin injektions-  \r\n\r\n  substans                Somatropin for injection   Ph. Eur. 3rd Ed.  \r\n\r\n Svineinfluenzavaccine  \r\n\r\n  (inaktiveret)           Porcine influenza vaccine  Ph. Eur. 3rd Ed.  \r\n\r\n                          (inactivated)  \r\n\r\n  Swine erysipelas  \r\n\r\n  immunoserum             Rødsygeantitoxin til svin  Ph. Eur. 3rd Ed.  \r\n\r\n  Swine erysipelas  \r\n\r\n  vaccine                 Rødsygevaccine til svin    Ph. Eur. 3rd Ed.  \r\n\r\n  (inactivated)           (inaktiveret)  \r\n\r\n  Swine-fever vaccine  \r\n\r\n  (live),                 Klassisk svinepestvaccine, Ph. Eur. 3rd Ed.  \r\n\r\n  classical, freeze-dried frysetørret (levende)  \r\n\r\n Technetium (99mTc)  \r\n\r\n  macrosalb               Technetium (99mTc)  \r\n\r\n  injektionsvæske         macrosalb                  Ph. Eur. 3rd Ed.  \r\n\r\n                          injection  \r\n\r\n Technetium (99mTc)  \r\n\r\n  rhenium                 Technetium (99mTc)  \r\n\r\n  sulfidkolloid-          colloidal                  Ph. Eur. 3rd Ed.  \r\n\r\n  injektionsvæske         rhenium sulphide  \r\n\r\n                          injection  \r\n\r\n Technetium (99mTc)  \r\n\r\n  svovl                   Technetium (99mTc)  \r\n\r\n  kolloidinjektionsvæske  colloidal                  Ph. Eur. 3rd Ed.  \r\n\r\n                          sulphur injection  \r\n\r\n Technetium (99mTc) tin   Technetium (99mTc) tin     Ph. Eur. 3rd Ed.  \r\n\r\n  pyrophosphat-           pyrophosphate injection  \r\n\r\n  injektionsvæske  \r\n\r\n Technetium (99mTc)       Technetium (99mTc) human  \r\n\r\n  albumininjektionsvæske  albumin                    Ph. Eur. 3rd Ed.  \r\n\r\n                          injection  \r\n\r\n Technetium (99mTc)       Technetium (99mTc)  \r\n\r\n medronatinjektionsvæske  medronate                  Ph. Eur. 3rd Ed.  \r\n\r\n                          injection  \r\n\r\n Technetium (99mTc)       Technetium (99mTc)  \r\n\r\n pentetatinjektionsvæske  pentetate                  Ph. Eur. 3rd Ed.  \r\n\r\n                          injection  \r\n\r\n Technetium (99mTc)       Technetium (99mTc)  \r\n\r\n succimerinjektionsvæske  succimer                   Ph. Eur. 3rd Ed.  \r\n\r\n                          injection  \r\n\r\n  Technetium (99mTc)  \r\n\r\n  colloidal               Technetium (99mTc) rhenium Ph. Eur. 3rd Ed.  \r\n\r\n  rhenium sulphide        sulfidkolloid-  \r\n\r\n  injection               injektionsvæske  \r\n\r\n  Technetium (99mTc)  \r\n\r\n  colloidal               Technetium (99mTc) svovl   Ph. Eur. 3rd Ed.  \r\n\r\n  sulphur injection       kolloidinjektionsvæske  \r\n\r\n  Technetium (99mTc)  \r\n\r\n  colloidal tin           Technetium (99mTc) tin  \r\n\r\n  injection               kolloid                    Ph. Eur. 3rd Ed.  \r\n\r\n                          injektionsvæske  \r\n\r\n  Technetium (99mTc)  \r\n\r\n  etifenin                Technetium (99mTc)  \r\n\r\n  injection               etifinin                   Ph. Eur. 3rd Ed.  \r\n\r\n                          injektionsvæske  \r\n\r\n Technetium (99mTc)  \r\n\r\n  etifinin                Technetium (99mTc)  \r\n\r\n  injektionsvæske         etifenin                   Ph. Eur. 3rd Ed.  \r\n\r\n                          injection  \r\n\r\n  Technetium (99mTc)  \r\n\r\n  gluconate               Technetium (99mTc)  \r\n\r\n  injection               gluconatin-                Ph. Eur. 3rd Ed.  \r\n\r\n                          jektionsvæske  \r\n\r\n Technetium (99mTc)  \r\n\r\n  gluconatin-             Technetium (99mTc)  \r\n\r\n  jektionsvæske           gluconate                  Ph. Eur. 3rd Ed.  \r\n\r\n                          injection  \r\n\r\n  Technetium (99mTc)  \r\n\r\n  human albumin           Technetium (99mTc)         Ph. Eur. 3rd Ed.  \r\n\r\n  injection               albumininjektionsvæske  \r\n\r\n  Technetium (99mTc)  \r\n\r\n  macrosalb               Technetium (99mTc)  \r\n\r\n  injection               macrosalb                  Ph. Eur. 3rd Ed.  \r\n\r\n                          injektionsvæske  \r\n\r\n  Technetium (99mTc)  \r\n\r\n  medronate               Technetium (99mTc)         Ph. Eur. 3rd Ed.  \r\n\r\n  injection               medronatinjektionsvæske  \r\n\r\n  Technetium (99mTc)  \r\n\r\n  microspheres            Technetium (99mTc)-  \r\n\r\n                          mikrosfære                 Ph. Eur. 3rd Ed.  \r\n\r\n  injection               injektionsvæske  \r\n\r\n  Technetium (99mTc)  \r\n\r\n  pentetate               Technetium (99mTc)         Ph. Eur. 3rd Ed.  \r\n\r\n  injection               pentetatinjektionsvæske  \r\n\r\n  Technetium (99mTc)  \r\n\r\n  succimer                Technetium (99mTc)         Ph. Eur. 3rd Ed.  \r\n\r\n  injection               succimerinjektionsvæske  \r\n\r\n  Technetium (99mTc) tin  Technetium (99mTc) tin     Ph. Eur. 3rd Ed.  \r\n\r\n  pyrophosphate injection pyrophosphatinjektions-  \r\n\r\n                          væske  \r\n\r\n Technetium (99mTc) tin  \r\n\r\n  kolloid                 Technetium (99mTc)  \r\n\r\n injektionsvæske          colloidal tin              Ph. Eur. 3rd Ed.  \r\n\r\n                          injection  \r\n\r\n Technetium (99mTc)-  \r\n\r\n  mikrosfære              Technetium (99mTc)  \r\n\r\n  injektionsvæske         microspheres               Ph. Eur. 3rd Ed.  \r\n\r\n                          injection  \r\n\r\n  Tetanus antitoxin for  \r\n\r\n  human use               Tetanusantitoxin           Ph. Eur. 3rd Ed.  \r\n\r\n  Tetanus antitoxin for  \r\n\r\n  veterinary              Tetanusantitoxin til dyr   Ph. Eur. 3rd Ed.  \r\n\r\n  use  \r\n\r\n  Tetanus vaccine  \r\n\r\n  (adsorbed)              Tetanusvaccine  \r\n\r\n                          (adsorberet)               Ph. Eur. 3rd Ed.  \r\n\r\n  Tetanus vaccine for  \r\n\r\n  veterinary use          Tetanusvaccine til dyr     Ph. Eur. 3rd Ed.  \r\n\r\n Tetanusantitoxin         Tetanus antitoxin for  \r\n\r\n                          human use                  Ph. Eur. 3rd Ed.  \r\n\r\n Tetanusantitoxin til dyr Tetanus antitoxin for  \r\n\r\n                          veterinary                 Ph. Eur. 3rd Ed.  \r\n\r\n                          use  \r\n\r\n Tetanusimmunglobulin,  \r\n\r\n  humant                  Immunoglobulin, human  \r\n\r\n                          tetanus                    Ph. Eur. 3rd Ed.  \r\n\r\n Tetanusvaccine  \r\n\r\n  (adsorberet)            Tetanus vaccine  \r\n\r\n                          (adsorbed)                 Ph. Eur. 3rd Ed.  \r\n\r\n Tetanusvaccine til dyr   Tetanus vaccine for  \r\n\r\n                          veterinary use             Ph. Eur. 3rd Ed.  \r\n\r\n Thallium (201Tl)-  \r\n\r\n  chlorid                 Thallous (201Tl) chloride  Ph. Eur. 3rd Ed.  \r\n\r\n injektionsvæske          injection  \r\n\r\n  Thallous (201Tl)  \r\n\r\n  chloride                Thallium (201Tl)-chlorid   Ph. Eur. 3rd Ed.  \r\n\r\n  injection               injektionsvæske  \r\n\r\n  Tritiated (3H) water  \r\n\r\n  injection               Tritieret (3H) vand til  \r\n\r\n                          injektion                  Ph. Eur. 3rd Ed.  \r\n\r\n Tritieret (3H) vand til  \r\n\r\n  injektion               Tritiated (3H) water  \r\n\r\n                          injection                  Ph. Eur. 3rd Ed.  \r\n\r\n  Typhoid polysaccharide  \r\n\r\n  vaccine                 Typhoid polysaccharid  \r\n\r\n                          vaccine                    Ph. Eur. 3rd Ed.  \r\n\r\n  Typhoid vaccine         Typhoidvaccine             Ph. Eur. 3rd Ed.  \r\n\r\n  Typhoid vaccine (live,  \r\n\r\n  oral,                   Typhoidvaccine (Ty 21a  \r\n\r\n  strain Ty 21a)          stamme, oral,              Ph. Eur. 3rd Ed.  \r\n\r\n                          levende)  \r\n\r\n  Typhoid vaccine,  \r\n\r\n  freeze-dried            Typhoidvaccine,  \r\n\r\n                          frysetørret                Ph. Eur. 3rd Ed.  \r\n\r\n Typhoidvaccine           Typhoid vaccine            Ph. Eur. 3rd Ed.  \r\n\r\n Typhoidvaccine (Ty 21a  \r\n\r\n  stamme, oral,           Typhoid vaccine (live,  \r\n\r\n levende)                 oral,                      Ph. Eur. 3rd Ed.  \r\n\r\n                          strain Ty 21a)  \r\n\r\n Typhoidvaccine,  \r\n\r\n  frysetørret             Typhoid vaccine,  \r\n\r\n                          freeze-dried               Ph. Eur. 3rd Ed.  \r\n\r\n Vaccine mod gul feber  \r\n\r\n  (levende)               Yellow fever vaccine  \r\n\r\n                          (live)                     Ph. Eur. 3rd Ed.  \r\n\r\n Vacciner                 Vaccines for human use     Ph. Eur. 3rd Ed.  \r\n\r\n Vacciner til dyr         Vaccines for veterinary  \r\n\r\n                          use                        Ph. Eur. 3rd Ed.  \r\n\r\n  Vaccines for human use  Vacciner                   Ph. Eur. 3rd Ed.  \r\n\r\n  Vaccines for veterinary  \r\n\r\n  use                     Vacciner til dyr           Ph. Eur. 3rd Ed.  \r\n\r\n  Varicella vaccine  \r\n\r\n  (live)                  Varicellavaccine, levende  Ph. Eur. 3rd Ed.  \r\n\r\n Varicellaimmunglobulin,  \r\n\r\n  humant                  Immunoglobulin, human  \r\n\r\n                          varicella                  Ph. Eur. 3rd Ed.  \r\n\r\n Varicellavaccine,  \r\n\r\n  levende                 Varicella vaccine (live)   Ph. Eur. 3rd Ed.  \r\n\r\n  Viper venom antiserum,  \r\n\r\n  European                Hugormeantitoxin           Ph. Eur. 3rd Ed.  \r\n\r\n Virus-hepatitisvaccine  \r\n\r\n  til hunde               Canine contagious  \r\n\r\n frysetørret (levende)    hepatitis vaccine          Ph. Eur. 3rd Ed.  \r\n\r\n                          (live), freeze-dried  \r\n\r\n  Xenon (133Xe)  \r\n\r\n  injection               Xenon (133Xe)-  \r\n\r\n                          injektionsvæske            Ph. Eur. 3rd Ed.  \r\n\r\n Xenon (133Xe)-  \r\n\r\n  injektionsvæske         Xenon (133Xe) injection    Ph. Eur. 3rd Ed.  \r\n\r\n  Yellow fever vaccine  \r\n\r\n  (live)                  Vaccine mod gul feber  \r\n\r\n                          (levende)                  Ph. Eur. 3rd Ed.  \r\n\r\n</PRE>  \r\n\r\n<P> <B>STANDARDER FOR LÆGEMIDLER</B>  </P>  \r\n\r\n<P>BLOOD, HUMAN </P>  \r\n\r\n<P>Blod, humant </P>  \r\n\r\n<P>Sanguis humanus </P>  \r\n\r\n<P>Humant blod skal opfylde de nedenfor angivne kvalitetskrav og de anførte  \r\n\r\n donortests skal udføres i overensstemmelse med de af Sundhedsstyrelsen  \r\n\r\n fastsatte regler for undersøgelse af donorblod for syfilis, hepatitis B  \r\n\r\n overflade antigen, HIV antistoffer (type 1 og type 2), HTLV antistoffer (type  \r\n\r\n I/II) og hepatitis C antistof. Desuden skal de af Sundhedsstyrelsen fastsatte  \r\n\r\n forholdsregler mod overførsel af leishmaniasis-smitte fra bloddonorer  \r\n\r\n iagttages. </P>  \r\n\r\n<P>Human blood is drawn from a healthy donor whose blood contains not less  \r\n\r\n than 12.5 per cent <I>m/V</I> of haemoglobin and who must, as far as can be  \r\n\r\n ascertained after medical examination, laboratory blood tests and a study of  \r\n\r\n the donor's medical history, be free from detectable agents of infection  \r\n\r\n transmissible by transfusion of blood or blood components. The examinations  \r\n\r\n and tests to be carried out are decided by the national authority. A test for  \r\n\r\n hepatitis B surface antigen is carried out by a suitable sensitive technique  \r\n\r\n and must give negative results. </P>  \r\n\r\n<P>The blood is drawn aseptically through a closed, sterile system consisting  \r\n\r\n of a tube connecting the needle inserted into the donor's vein with a sterile  \r\n\r\n plastic or glass container in which the necessary amount, not exceeding 22  \r\n\r\n per cent of the final volume of the mixture, of an anticoagulant solution has  \r\n\r\n been placed before sterilisation of the container. No antimicrobial  \r\n\r\n preservative is added. When withdrawal is completed, the container is closed  \r\n\r\n in a manner that will exclude microbial contamination and cooled to 5 +/- 3  \r\n\r\n graderC. The final mixture of blood and anticoagulant solution contains not  \r\n\r\n less than 9.7 per cent <I>m/V</I> of haemoglobin. Attached to each container  \r\n\r\n is a small container with a quantity of the blood for compatibility and other  \r\n\r\n tests. The containers comply with the requirements prescribed for glass  \r\n\r\n containers (Ph. Eur. 3rd Ed. 3.2.1.) or plastic containers for blood (Ph.  \r\n\r\n Eur. 3rd Ed. 3.2.3.). </P>  \r\n\r\n<P>CHARACTERS </P>  \r\n\r\n<P>A deep-red liquid which, on standing, separates into a lower layer of  \r\n\r\n sedimented red blood cells and a yellow upper layer of plasma free from signs  \r\n\r\n of haemolysis. A layer may be visible between the two as a whitish film of  \r\n\r\n leucocytes and thrombocytes. </P>  \r\n\r\n<P> <I>Human blood in containers from which samples have been removed for  \r\n\r\n analysis may not be used for transfusion. Consequently, it is not intended  \r\n\r\n that the test for sterility and the determination of haemoglobin be carried  \r\n\r\n out on the contents of each container. The laboratory or service responsible  \r\n\r\n for collecting the blood is responsible for ensuring that the conditions in  \r\n\r\n which the blood is collected and stored are such that if and when tested, the  \r\n\r\n blood will comply with the requirements of the monograph.</I>  </P>  \r\n\r\n<P>TESTS </P>  \r\n\r\n<P> <B>Blood group</B> Determine the blood group of the sample accompanying  \r\n\r\n each donation under the ABO and Rh systems according to the current  \r\n\r\n regulations of the national authority. </P>  \r\n\r\n<P> <B>Haemolysins</B> For blood of group O which is to be transfused to a  \r\n\r\n patient with a different blood group, carry out a test for haemolysins. A  \r\n\r\n suitable method is described in Ph. Eur. 2nd Ed., Annex VIII.12. </P>  \r\n\r\n<P> <B>Sterility</B> (Ph. Eur. 3rd Ed. 2.6.1.) It complies with the test for  \r\n\r\n sterility. </P>  \r\n\r\n<P>ASSAY </P>  \r\n\r\n<P>Determine the haemoglobin content with reference to the International  \r\n\r\n Reference Preparation of haemiglobincyanide. </P>  \r\n\r\n<P>STORAGE </P>  \r\n\r\n<P>Store at a temperature of 5 +/- 3 graderC. It may be used for the period  \r\n\r\n stated on the label. </P>  \r\n\r\n<P>LABELLING </P>  \r\n\r\n<P>The labelling complies with the relevant national legislation and  \r\n\r\n international agreements. </P>  \r\n\r\n<P>The label on the <I>container</I> states: </P>  \r\n\r\n<P>- the name of the preparation, </P>  \r\n\r\n<P>- the producer's name and address, </P>  \r\n\r\n<P>- the reference number, </P>  \r\n\r\n<P>- the ABO group, </P>  \r\n\r\n<P>- the Rh group, specifying &#187;Rh positive&#171; or &#187;Rh  \r\n\r\n negative&#171;, </P>  \r\n\r\n<P>- the composition and volume of the anticoagulant solution, </P>  \r\n\r\n<P>- the date on which the blood was collected, </P>  \r\n\r\n<P>- the date after which the blood is not suitable for transfusion, </P>  \r\n\r\n<P>- the conditions of storage, </P>  \r\n\r\n<P>- that the blood must not be used for transfusion if there is any visible  \r\n\r\n evidence of haemolysis or other deterioration, </P>  \r\n\r\n<P>- for blood of group O, that the blood must be administered only to  \r\n\r\n patients of blood group O unless the absence of haemolysins has been  \r\n\r\n demonstrated by a suitable test. </P>  \r\n\r\n<P> <B>STIKORDSREGISTER</B>  </P>  \r\n\r\n<P> <B>A</B>  </P>  \r\n\r\n<P>Aerosol </P>  \r\n\r\n<P>-beholdere </P>  \r\n\r\n<P>-pudder </P>  \r\n\r\n<P>Afdelte </P>  \r\n\r\n<P>-pulvere, magistrelle </P>  \r\n\r\n<P>Alkohol </P>  \r\n\r\n<P>Almene bestemmelser </P>  \r\n\r\n<P>Analysemetoder </P>  \r\n\r\n<P>Aromastoffer </P>  \r\n\r\n<P>Aromatisk vand </P>  \r\n\r\n<P>Aseptiske lægemidler </P>  \r\n\r\n<P> <B>B</B>  </P>  \r\n\r\n<P>Bekendtgørelser </P>  \r\n\r\n<P>Biologiske indikatorer </P>  \r\n\r\n<P>Blod, humant </P>  \r\n\r\n<P> <B>C</B>  </P>  \r\n\r\n<P>Chlormezanon </P>  \r\n\r\n<P>Cirkulærer </P>  \r\n\r\n<P>Creme </P>  \r\n\r\n<P>-magistrel </P>  \r\n\r\n<P> <B>D</B>  </P>  \r\n\r\n<P>Definitioner </P>  \r\n\r\n<P>Dekokt </P>  \r\n\r\n<P>Diluendum </P>  \r\n\r\n<P>Direktiver </P>  \r\n\r\n<P>Dosisvariation </P>  \r\n\r\n<P>Dråber </P>  \r\n\r\n<P>-magistrelle </P>  \r\n\r\n<P> <B>E</B>  </P>  \r\n\r\n<P>Ekstrakter </P>  \r\n\r\n<P>Emballage </P>  \r\n\r\n<P>Endotoxinfrie lægemidler </P>  \r\n\r\n<P>Ethanol </P>  \r\n\r\n<P>Ethylenoxid </P>  \r\n\r\n<P>Europæiske Farmakope </P>  \r\n\r\n<P> <B>F</B>  </P>  \r\n\r\n<P>Faktisk indhold </P>  \r\n\r\n<P>Farlige kemiske stoffer og produkter </P>  \r\n\r\n<P>Farmakope, europæiske </P>  \r\n\r\n<P>Farveestoffer </P>  \r\n\r\n<P>Forkortelser </P>  \r\n\r\n<P>Fortegnelse </P>  \r\n\r\n<P>-administrationsveje </P>  \r\n\r\n<P>-beholdere, lukker m.v.: </P>  \r\n\r\n<P>-godkendte farvestoffer </P>  \r\n\r\n<P>-lægemiddelformer </P>  \r\n\r\n<P>-lægemiddelstandarder </P>  \r\n\r\n<P>-råvarestandarder </P>  \r\n\r\n<P>Fremstilling </P>  \r\n\r\n<P>-aseptiske lægemidler </P>  \r\n\r\n<P>-magistrelle lægemidler </P>  \r\n\r\n<P>-sterile lægemidler </P>  \r\n\r\n<P>Fructose til injektion </P>  \r\n\r\n<P>Frugtsaft, sur </P>  \r\n\r\n<P> <B>G</B>  </P>  \r\n\r\n<P>Gel </P>  \r\n\r\n<P>-magistrel </P>  \r\n\r\n<P>Glasbeholdere </P>  \r\n\r\n<P>Glycopyrroniumbromid </P>  \r\n\r\n<P>Granulat </P>  \r\n\r\n<P>-depot </P>  \r\n\r\n<P>Guidelines </P>  \r\n\r\n<P>Gummelukker </P>  \r\n\r\n<P> <B>H</B>  </P>  \r\n\r\n<P>Hjælpestof </P>  \r\n\r\n<P>Homøopatiske lægemidler </P>  \r\n\r\n<P>Hæmodialyse </P>  \r\n\r\n<P>-koncentrater, vand til fortynding </P>  \r\n\r\n<P> <B>I</B>  </P>  \r\n\r\n<P>Indhold </P>  \r\n\r\n<P>-faktisk </P>  \r\n\r\n<P>-kvantitativt </P>  \r\n\r\n<P>Indikatorer, biologiske </P>  \r\n\r\n<P>Infus </P>  \r\n\r\n<P>Injektions </P>  \r\n\r\n<P>-væske, magistrel </P>  \r\n\r\n<P>Isotoni </P>  \r\n\r\n<P>-tabel </P>  \r\n\r\n<P>-vandige opløsninger </P>  \r\n\r\n<P> <B>K</B>  </P>  \r\n\r\n<P>Konserveringsstoffer </P>  \r\n\r\n<P>Kontrol </P>  \r\n\r\n<P>-magistrelle lægemidler </P>  \r\n\r\n<P>Kvantitativt indhold </P>  \r\n\r\n<P> <B>L</B>  </P>  \r\n\r\n<P>Lagerhold </P>  \r\n\r\n<P>-magistrelle lægemidler </P>  \r\n\r\n<P>Liniment </P>  \r\n\r\n<P>-magistrel </P>  \r\n\r\n<P>Love </P>  \r\n\r\n<P>Luft, medicinsk </P>  \r\n\r\n<P>Lægemiddelformer </P>  \r\n\r\n<P>-monografier </P>  \r\n\r\n<P>Lægemiddelformstandarder </P>  \r\n\r\n<P>-magistrelle </P>  \r\n\r\n<P>Lægemiddelloven </P>  \r\n\r\n<P>Lægemiddelmonografier </P>  \r\n\r\n<P>Lægemiddelstandarder </P>  \r\n\r\n<P>-fortegnelse </P>  \r\n\r\n<P>- -introduktion </P>  \r\n\r\n<P>Lægemiddelstof </P>  \r\n\r\n<P>-magistrelle lægemidler </P>  \r\n\r\n<P>Lægemidler </P>  \r\n\r\n<P>-aseptiske </P>  \r\n\r\n<P>-ikke sterile </P>  \r\n\r\n<P>-pyrogenfrie </P>  \r\n\r\n<P>-sterile </P>  \r\n\r\n<P> <B>M</B>  </P>  \r\n\r\n<P>magistrelle lægemidler </P>  \r\n\r\n<P>-afdelte pulvere </P>  \r\n\r\n<P>-creme </P>  \r\n\r\n<P>-dråber </P>  \r\n\r\n<P>-fremstilling </P>  \r\n\r\n<P>-gel </P>  \r\n\r\n<P>-injektionsvæske </P>  \r\n\r\n<P>-liniment </P>  \r\n\r\n<P>-mikstur </P>  \r\n\r\n<P>-næsedråber </P>  \r\n\r\n<P>-pudder </P>  \r\n\r\n<P>-pulver </P>  \r\n\r\n<P>-salve </P>  \r\n\r\n<P>-suppositorier </P>  \r\n\r\n<P>-tabletter </P>  \r\n\r\n<P>-vagatorier </P>  \r\n\r\n<P>-øjenbadevand </P>  \r\n\r\n<P>-øjendråber </P>  \r\n\r\n<P>-øjensalve </P>  \r\n\r\n<P>-øredråber </P>  \r\n\r\n<P>Medicinpellets </P>  \r\n\r\n<P>Mellemprodukter </P>  \r\n\r\n<P>-magistrelle lægemidler </P>  \r\n\r\n<P>Metrizoinsyre </P>  \r\n\r\n<P>Mikrobiel renhed </P>  \r\n\r\n<P>Mikrobiel renhed, prøver </P>  \r\n\r\n<P>Mikstur </P>  \r\n\r\n<P>-magistrel </P>  \r\n\r\n<P>Monografier </P>  \r\n\r\n<P>-lægemiddelformer </P>  \r\n\r\n<P>-lægemidler </P>  \r\n\r\n<P>-råvarer </P>  \r\n\r\n<P>Mærkning </P>  \r\n\r\n<P> <B>N</B>  </P>  \r\n\r\n<P>Navne, danske </P>  \r\n\r\n<P>Navneændringer </P>  \r\n\r\n<P>Nyoptaget standard </P>  \r\n\r\n<P>Næse </P>  \r\n\r\n<P>-dråber, magistrelle </P>  \r\n\r\n<P> <B>O</B>  </P>  \r\n\r\n<P>Opbevaringsbestemmelser </P>  \r\n\r\n<P>Opbevaringsbetingelser </P>  \r\n\r\n<P>-magistrelle lægemidler </P>  \r\n\r\n<P>Opbevaringstid </P>  \r\n\r\n<P>-magistrelle lægemidler </P>  \r\n\r\n<P> <B>P</B>  </P>  \r\n\r\n<P>Pentazocinlactat </P>  \r\n\r\n<P>Plasma til fraktionering, humant </P>  \r\n\r\n<P>Plsatbeholdere </P>  \r\n\r\n<P>Produktion </P>  \r\n\r\n<P>-magistrelle lægemidler </P>  \r\n\r\n<P>Pudder </P>  \r\n\r\n<P>-magistrel </P>  \r\n\r\n<P>Pulver </P>  \r\n\r\n<P>-magistrel </P>  \r\n\r\n<P>Pyrogenfrie lægemidler </P>  \r\n\r\n<P> <B>R</B>  </P>  \r\n\r\n<P>Referencesubstanser </P>  \r\n\r\n<P>Råvarekvalitet </P>  \r\n\r\n<P>Råvaremonografier </P>  \r\n\r\n<P>Råvarer </P>  \r\n\r\n<P>-magistrelle lægemidler </P>  \r\n\r\n<P>Råvarestandarder </P>  \r\n\r\n<P>-fortegnelse </P>  \r\n\r\n<P>-introduktion </P>  \r\n\r\n<P> <B>S</B>  </P>  \r\n\r\n<P>Salve </P>  \r\n\r\n<P>-magistrel </P>  \r\n\r\n<P>Sanguis humanus </P>  \r\n\r\n<P>Sektion 1 </P>  \r\n\r\n<P>Sektion 2 </P>  \r\n\r\n<P>Sektion 3 </P>  \r\n\r\n<P>Silicone </P>  \r\n\r\n<P>-lukker </P>  \r\n\r\n<P>-olier </P>  \r\n\r\n<P>Slim </P>  \r\n\r\n<P>Specifikation </P>  \r\n\r\n<P>Sprit, stærk </P>  \r\n\r\n<P>Standard </P>  \r\n\r\n<P>-lægemiddelformer </P>  \r\n\r\n<P>-lægemidler </P>  \r\n\r\n<P>-nyoptaget </P>  \r\n\r\n<P>-råvarer </P>  \r\n\r\n<P>-udgået </P>  \r\n\r\n<P>-ændret </P>  \r\n\r\n<P>Standarder </P>  \r\n\r\n<P>-nyoptaget </P>  \r\n\r\n<P>Sterile lægemidler </P>  \r\n\r\n<P>Sterilt vand </P>  \r\n\r\n<P>Suppositorier </P>  \r\n\r\n<P>-magistrelle </P>  \r\n\r\n<P>Symboler </P>  \r\n\r\n<P>Synonymer </P>  \r\n\r\n<P>Syrup </P>  \r\n\r\n<P>Søgeord </P>  \r\n\r\n<P> <B>T</B>  </P>  \r\n\r\n<P>Tabletter </P>  \r\n\r\n<P>-magistrelle </P>  \r\n\r\n<P>Tinkturer </P>  \r\n\r\n<P>Torskelevertran </P>  \r\n\r\n<P>Trituration </P>  \r\n\r\n<P> <B>U</B>  </P>  \r\n\r\n<P>Udgået standard </P>  \r\n\r\n<P> <B>V</B>  </P>  \r\n\r\n<P>Vagitorier </P>  \r\n\r\n<P>-magistrelle </P>  \r\n\r\n<P>Vand, sterilt </P>  \r\n\r\n<P>Vand til fortynding af hæmodialysekoncentrater </P>  \r\n\r\n<P>Vejledninger </P>  \r\n\r\n<P> <B>Æ</B>  </P>  \r\n\r\n<P>Ændret standard </P>  \r\n\r\n<P>Ændringer </P>  \r\n\r\n<P> <B>Ø</B>  </P>  \r\n\r\n<P>Øjen </P>  \r\n\r\n<P>-badevand, magistrel </P>  \r\n\r\n<P>-dråber, magistrelle </P>  \r\n\r\n<P>-salve, magistrel </P>  \r\n\r\n<P>Øre </P>  \r\n\r\n<P>-dråber, magistrelle </P>  \r\n\r\n</DIV>",
    "isHistorical": true,
    "editorialNotes": [],
    "alternativeMedia": [],
    "ressort": "Indenrigs- og Sundhedsministeriet",
    "isReprint": false,
    "geografiskDaekningId": 0,
    "retsinfoKlassifikationId": 10,
    "caseHistoryReferenceGroup": [],
    "metadata": [
        {
            "displayName": "Offentliggørelsesdato",
            "displayValue": "30/09/1997"
        },
        {
            "displayName": "Accession",
            "displayValue": "B19961503505"
        },
        {
            "displayName": "Entydig dokumentidentifikation",
            "displayValue": "CM043116"
        },
        {
            "displayName": "Dato for førstegangsindlæggelse",
            "displayValue": "30/09/1997"
        },
        {
            "displayName": "Dato for indlæggelse",
            "displayValue": "14/12/2005"
        },
        {
            "displayName": "Dokumenttype",
            "displayValue": "Bekendtgørelse"
        },
        {
            "displayName": "Dokumentets rangering",
            "displayValue": "B "
        },
        {
            "displayName": "Forskriftens nummer",
            "displayValue": "15035"
        },
        {
            "displayName": "År for udstedelse",
            "displayValue": "1996"
        },
        {
            "displayName": "Dato for underskrift",
            "displayValue": "25/11/1996"
        },
        {
            "displayName": "Offentliggjort i (publiceringsmedie)",
            "displayValue": "Retsinformation"
        },
        {
            "displayName": "Ressortministeriets journalnummer",
            "displayValue": "Lægemiddelstyrelsens j.nr. 5456-9-1995"
        },
        {
            "displayName": "Stikord",
            "displayValue": "DLS"
        }
    ],
    "pdfLink": {
        "isPdfAvailable": false
    },
    "documentFobTagGroup": [],
    "hasFobTags": false
}